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SUMMARY 
The main aim of this research is to analyse the European legal framework 
governing cross-border patient movements from a strictly patient-centred approach. 
The ambition is to detect and to bring a better understanding of those legal issues 
which are potentially problematic when obtaining healthcare abroad and to examine 
whether these can be solved with the legal tools currently available on European 
level. 
The dissertation is divided into six parts. After the introductory chapter, the 
conceptual basics concerning the concept and the nature of European cross-border 
patient mobility are formulated. Subsequently, separate chapters are dedicated to the 
examination of three different key areas, namely access, financing and timely 
provision of cross-border healthcare. For each key area, the legal questions are 
basically approached from a European point of view. 
The research led to the conclusion that the current Union legislation on cross-border 
patient mobility cannot fully cope with all of the problems that border-crossing 
patients face. The practical barriers such as language gaps and a lack of reliable 
information, the legal complexity, the lengthy and burdensome administrative 
procedures and the difficulties affiliated to the reimbursement regimes might 
discourage or even prevent patients from using their cross-border healthcare rights. 
The European Union should continue to work towards demolishing these obstacles. 
It is suggested that the establishment of a central institution on European level 
with the responsibility to coordinate European cross-border healthcare issues, the 
creation of an integrated legal and financing system and the implementation of 
information and communication technologies would highly improve the status of 
European patients and provide them with a real opportunity to use their cross-border 
healthcare rights.  
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ÖSSZEFOGLALÓ 
A kutatás legfıbb célja az európai betegmobilitás joganyagának páciens-
központú vizsgálata. Ezen belül cél a külföldi egészségügyi ellátás igénybevétele 
esetén potenciálisan felmerülı problémák feltárása, a mögöttük meghúzódó okok 
mélyebb megértése, és annak a kérdésnek a megválaszolása, hogy a jelenleg 
rendelkezésre álló európai jogi eszközök vajon képesek-e ezen problémák hathatós 
megoldására. 
A disszertáció hat egységre tagolódik. A bevezetést követıen az elméleti 
alapok kerülnek tisztázásra, úgy mint az európai betegmobilitás fogalma, jellemzıi 
és a hozzá kapcsolódó fogalmak közötti kapcsolatok. Ezután külön-külön fejezetet 
szentelek a vizsgálódás három kulcsterületének, a határon átnyúló egészségügyi 
ellátáshoz való hozzájutásnak, ezen ellátás finanszírozásának és az ellátás megfelelı 
idıben való nyújtásának. Az egyes jogi kérdések elemzése az uniós jogi 
szabályrendszeren alapszik. 
A kutatás arra a következtetésre vezetett, hogy a hatályos uniós szabályozás nem 
képes a külföldi ellátást igénybevevı betegek problémáit megfelelıképpen rendezni. 
Az olyan gyakorlati problémák mint a nyelvi akadályok vagy a megbízható 
információ hiánya, a joganyag összetettsége, a hosszú és nehézkes adminisztratív 
eljárások és a költségek megtérésével kapcsolatos nehézségek elbátortalaníthatják, 
rosszabb esetben meg is akadályozhatják a betegeket abban, hogy éljenek a határon 
átnyúló egészségügyi ellátáshoz való jogukkal. 
Javaslatként megfogalmazódik egy európai szintő központi intézmény 
létrehozása a határon átnyúló egészségüggyel kapcsolatos feladatok hatékony 
koordinálására, egy egységes rendszerbe foglalt jogi és pénzügyi szabályozás 
kialakítása és a modern infokommunikációs technológiák szélesebb körő 
alkalmazása, amelyek együttesen nagyban javítanák az európai betegek helyzetét és 
reális lehetıséget nyújtanának számukra, hogy a határon átnyúló egészségügyi 
ellátáshoz kapcsolódó jogaikkal ténylegesen élhessenek.  
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SAMENVATTING 
Het belangrijkste doel van dit onderzoek is de analyse van het Europees 
juridisch kader voor het grensoverschrijdende verkeer van patiënten vanuit een strikt 
patiëntgericht standpunt. Het onderzoek streeft ernaar de juridische problemen op te 
sporen die mogelijk opduiken bij gezondheidszorg in het buitenland, een beter 
inzicht te verschaffen in deze problemen, en na te gaan of deze problemen kunnen 
worden opgelost aan de hand van de juridische instrumenten die vandaag op 
Europees niveau beschikbaar zijn. 
Deze dissertatie is ingedeeld in zes delen. Na het inleidende deel wordt de 
conceptuele basis beschreven: het begrip en de kenmerken van Europese 
grensoverschrijdende mobiliteit van patiënten. De volgende drie hoofdstukken zijn 
gewijd aan het onderzoek van drie speerpunten: de toegang tot, de financiering van 
en het tijdig verlenen van gezondheidszorg. Voor elk speerpunt worden de juridische 
vragen in principe benaderd vanuit een Europees standpunt. 
Uit het onderzoek kon geconcludeerd worden dat de huidige EU wetgeving 
betreffende de grensoverschrijdende mobiliteit van patiënten niet helemaal 
opgewassen is tegen alle problemen waarmee grensoverschrijdende patiënten te 
maken krijgen. Er zijn praktische belemmeringen die patiënten zouden kunnen 
ontmoedigen of zelfs beletten om gebruik te maken van hun rechten bij 
grensoverschrijdende gezondheidszorg, zoals taalbarrières en een gebrek aan 
betrouwbare informatie, de juridische complexiteit, de lange en lastige 
administratieve procedures en de moeilijkheden die toe te schrijven zijn aan de 
terugbetalingsstelsels. De Europese Unie moet deze hindernissen nog weten neer te 
halen. 
Deze dissertatie stelt dat de positie van Europese patiënten erg verbeterd zou 
kunnen worden en dat deze patiënten een echte kans zouden krijgen om gebruik te 
maken van hun rechten bij grensoverschrijdende gezondheidszorg, als er op 
Europees niveau een centrale instelling zou worden opgericht die verantwoordelijk is 
voor de coördinatie van Europese grensoverschrijdende gezondheidszorg, als er een 
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geïntegreerd juridisch en financieringssysteem ontwikkeld zou worden, en als 
informatie- en communicatietechnologieën zouden worden ingezet. 
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“Denn überhaupt ist die Basis unseres Wesens und folglich auch 
unseres Glückes unsere animalische Natur. Daher ist für unsere 
Wohlfahrt Gesundheit das Wesentlichste, nächst dieser aber die 
Mittel zu unserer Erhaltung, also ein sorgenfreies Auskommen. 
Ehre, Glanz, Rang, Ruhm, soviel Wert auch mancher darauf legen 
mag, können mit jenen wesentlichen Gütern nicht kompetieren, 
noch sie ersetzen: vielmehr würden sie erforderlichenfalls 
unbedenklich für jene hingegeben werden. Dieserwegen wird es zu 
unserm Glücke beitragen, wenn wir beizeiten die simple Einsicht 
erlangen, daß jeder zunächst und wirklich in seiner eigenen Haut 
lebt, nicht aber in der Meinung anderer, und daß demnach unser 
realer und persönlicher Zustand, wie er durch Gesundheit, 
Temperament, Fähigkeiten, Einkommen, Weib, Kind, Freunde, 
Wohnort usw. bestimmt wird, für unser Glück hundertmal 
wichtiger ist, als was es andern beliebt aus uns zu machen. Der 
entgegengesetzte Wahn macht unglücklich.” 
 
(Schopenhauer)1 
  
                                                 
1
 Arthur SCHOPENHAUER (1886): Aphorismen zur Lebensweisheit (Separatausgabe aus “Parerga und 
Paralipomena”). Leipzig: F. A. Brockhaus 
“For, after all, the foundation of our whole nature, and, therefore, of our happiness, is our physique, 
and the most essential factor in happiness is health, and, next in importance after health, the ability to 
maintain ourselves in independence and freedom from care. There can be no competition or 
compensation between these essential factors on the one side, and honour, pomp, rank and reputation 
on the other, however much value we may set upon the latter. No one would hesitate to sacrifice the 
latter for the former, if it were necessary. We should add very much to our happiness by a timely 
recognition of the simple truth that every man's chief and real existence is in his own skin, and not in 
other people's opinions; and, consequently, that the actual conditions of our personal life, health, 
temperament, capacity, income, wife, children, friends, home, are a hundred times more important for 
our happiness than what other people are pleased to think of us: otherwise we shall be miserable.” 
Arthur SCHOPEANHAUER (2007): Wisdom of Life. New York: Cosimo Classics, p. 54. 
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“Community law2 provides patients with rights to 
cross-border care under Community law, but we need a 
clear, practical framework to reconcile greater 
individual choice with the sustainability of health 
systems overall. I hope that [...] we can realise the 
potential for European cooperation on healthcare to 
bring benefits to all.”3 
 
I.1. Exploring the research problem 
Cross-border patient mobility is often stigmatised as marginal4 in terms of the 
aggregate volume of patients and healthcare costs related.5 In most cases obtaining 
                                                 
2
 When discussing the legislation of the European Union, instead of “Community law” the expression 
“Union law” or “EU law” shall be used. However, in case of bibliographical citation and when 
referring to case law, the expression “Community law” might be used in the text of this dissertation as 
well. 
3
 Citation from the speech of the European Health and Consumer Protection Commissioner Markos 
KYPRIANOU on 26 September 2006. European Commission – IP-06-1267 (2006): Patient mobility: 
Commission to launch public consultation on EU framework for health services. 
http://europa.eu/rapid/press-release_IP-06-1267_en.htm (10 February 2010). 
4
 See among others George FRANCE (1997): Cross-border flows of Italian patients within the 
European Union - An international trade approach. European Journal of Public Health, Vol 7 Suppl 
3, p. 18; Irene A. GLINOS and Rita BAETEN (2006): A Literature Review of Cross-Border Patient 
Mobility in the European Union. Brussels: European Observatory on Health Systems and Policies, 
Europe for Patients Project, http://www.ose.be/files/publication/health/WP12_lit_review_final.pdf (15 
October 2012), p. 12; Irene A. GLINOS, Rita BAETEN and Nicole BOFFIN (2006): Cross-border 
contracted care in Belgian hospitals. In Magdalene ROSENMÖLLER, Martin MCKEE and Rita BAETEN 
(eds.): Patient Mobility in the European Union – Learning from experience. Brussels: European 
Observatory on Health Systems and Policies, Europe for Patients Project, 
http://www.euro.who.int/__data/assets/pdf_file/0005/98420/Patient_Mobility.pdf (15 October 2012), 
p. 97; Magdalene ROSENMÖLLER, Martin MCKEE, Rita BAETEN, Irene A. GLINOS (2006): Patient 
mobility: the context and issues. In ROSENMÖLLER et al. (2006a: 2.); Matthias WISMAR, Willy PALM, 
Ewout VAN GINNEKEN, Reinhard BUSSE, Kelly ERNST and Josep FIGUERAS (2011): The Health 
Service Initiative: supporting the construction of a framework for cross border health care. In 
Matthias WISMAR, Willy PALM, Josep FIGUERAS, Kelly ERNST, Ewout VAN GINNEKEN (eds.): Cross-
border Health Care in the European Union – Mapping and analysing practices and policies. Brussels: 
European Observatory on Health Systems and Policies, 
http://www.euro.who.int/__data/assets/pdf_file/0004/135994/e94875.pdf (30 October 2012), p. 1; 
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Philippe LHERNOULD (2014): Access to Healthcare by Cross-Border Patients. In Sylvie HENNION and 
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medical treatment in a Member State (hereinafter also referred to as MS) other than 
the Member State of residence is considered as an ultima ratio by patients. Several 
studies have shown that European patients prefer to be treated as close as possible to 
their place of residence.6 Nevertheless, cross-border patient movements are 
considered “non-marginal for certain pathologies and/or geographical areas in 
particular countries.”7 They are highly significant especially (1) in border regions,8 
(2) for smaller Member States, (3) for rare diseases, (4) in areas that attract a large 
number of tourists.9 What is more, the overall willingness to travel for healthcare 
seems to increase in the last years. At the same time, many patients still lack efficient 
and reliable information on their cross-border health rights,10 which prevents them 
                                                                                                                                          
Otto KAUFMANN (eds.): Unionsbürgerschaft und Patientenfreizügigkeit. Berlin, Heidelberg: Springer, 
p. 176. 
5
 “The Commission estimates that around 1% of public healthcare budgets are spent on cross-border 
healthcare, equating to around €10 billion for the Community as a whole.” European Commission: 
Communication from the Commission: A Community framework on the application of patients' rights 
in cross-border healthcare. COM (2008) 415 final, 2. 7. 2008, p. 8. 
6
 Willy PALM, Jason NICKLESS, Henri LEWALLE and Alain COHEUR (2000): Implications of recent 
jurisprudence on the co-ordination of health care protection systems. Association Internationale de la 
Mutualite, http://www.ose.be/health/files/KDsyntEN.PDF (7 November 2012), p. 7; GLINOS and 
BAETEN (2006: 6.); Irene A. GLINOS, Rita BAETEN, Matthias HELBLE and Hans MAARSE (2010): A 
typology of cross-border patient mobility. Health and Place, Vol 16 Issue 6, p. 1147; Helena LEGIDO-
QUIGLEY, Irene A. GLINOS, Rita BAETEN, Martin MCKEE, Reinhard BUSSE (2012): Analysing 
arrangements for cross-border mobility of patients in the European Union: A proposal for a 
framework. Health Policy, Vol 108 Issue 1, p. 27. See also COM (2008) 415, p. 8 and Recital 39 of 
the Preamble of Directive 2011/24/EU of the European Parliament and of the Council of 9 March 
2011 on the application of patients’ rights in cross-border healthcare. OJ L 88 of 4 April 2011. 
7
 FRANCE (1997: 18.). See also PALM et al. (2000: 7.). 
8
 Various research projects have been carried out in order to explore the cross-border use of healthcare 
in the frontier zones. For example in northern France and Belgium: Michael CALNAN, Willy PALM, 
Françoise SOHY, and D. N. A. QUAGHEBEUR (1997): Cross-border use of health care – A survey of 
frontier workers' knowledge, attitudes and use. European Journal of Public Health, Vol 7 Suppl 3, pp. 
26-32; among Belgian, French, German and Luxembourger frontier workers: Jozef PACOLET, Frederic 
DE WISPELAERE and Annelies DE CONINCK (2012): The social security rights of frontier workers – A 
survey on their knowledge, use and satisfaction, focusing on sickness benefits. Produced in the 
framework of SSCALA Project, http://www.sscala.eu/images/Final-report-SSCALA-14June2012.pdf 
(19 October 2012). 
9
 COM (2008) 415, p. 8. 
10
 A survey carried out in 2007 by the European Commission presented that 30 per cent of European 
citizens were not aware of their entitlement to receive medical treatment in another EU country and to 
be reimbursed for that treatment by their national health authority or healthcare insurer. The level of 
ignorance among the citizens of the recently acceded Member States was even higher; for instance 45 
per cent in Hungary. European Commission – Eurobarometer (2007): Cross-border health services in 
the EU. http://ec.europa.eu/public_opinion/flash/fl_210_en.pdf (15 October 2012), p. 6. 
This statement can be supported by the argument that the ‘new’ Member States, such as Bulgaria, 
Cyprus, Estonia, Lithuania, Latvia, Poland and Romania report the lowest percentage (under 10 per 
Gabriella BERKI: Cross-border patient mobility: The legal framework of obtaining 
healthcare abroad within the European Union – a patients’ perspective 
22 
 
from using these rights they are entitled to under Union law. Although the 
prioritisation of the Member State of residence is not surprising, in certain cases, 
receiving healthcare abroad proves to be not only desirable and feasible, but also 
inevitable. Therefore, providing the European patients with a coherent, clear and 
logical legal framework, which enables them to claim their right to cross-border 
patient mobility when in need, is of high importance. 
 
For a long time, two different, simultaneously existing legal schemes were applicable 
to cross-border medical treatments11 in the European Union (hereinafter also referred 
to as EU); on the one hand, the so-called regulation-based approach governed by the 
                                                                                                                                          
cent) of the insured population possessing a European Health Insurance Card (hereinafter also referred 
to as EHIC), which enables entitled people to obtain necessary care abroad. In Romania, only 0.6 per 
cent of the insured persons have an EHIC. Michael COUCHEIR (2013): EHIC Report 2013. Report 
prepared in the framework of the trESS project, pp. 4-5. 
Interestingly, according to the most recent data, besides Croatia as the newest Member State, France 
also belongs to the group of countries, where less than ten per cent of insured persons hold an EHIC. 
Jozef PACOLET and Frederic DE WISPELAERE (2014): The European Health Insurance Card – EHIC 
Quastionnaire. Report prepared in the framework of the Network Statistics FMSSFE project, p. 9. 
The low level of EHIC possession does not necessarily mean that the insured persons of these 
countries have no knowledge of the possibility to receive treatment in another Member State, but it 
can be suspected that the level of awareness is to be improved. 
In relation to statistical evidence, the above cited Eurobarometer survey on cross-border health 
services is often referred to throughout the dissertation. Although it was conducted a couple of years 
ago, unfortunately more recent data on overall cross-border patient mobility, especially on the needs 
and motivations of patients, could not be found. So when looking at the data provided by this 
Eurobarometer survey, the timing must be kept in mind and the figures should be treated with a 
caveat. 
However, on the issues related to the usage of the EHIC, the EHIC reports can be relied on and on the 
issuing of S2 forms in relation to planned care the data collection was relaunched. After the 
transposition of Directive 2011/24/EU on the application of patients’ rights in cross-border healthcare, 
updated data on patient movements can be expected from the Member States. Nevertheless, some data 
was already provided for by the Member States and published in Jozef PACOLET and Frederic DE 
WISPELAERE (2014): Planned cross-border healthcare – PD S2 Questionnaire. Report prepared in the 
framework of the Network Statistics FMSSFE project. 
The results of another recent survey are also used throughout this dissertation, but it must be noted 
that that survey was conducted by the Wissenschaftliches Institute der Techniker Krankenkasse 
(hereinafter also referred to as TK) für Nutzen und Effizienz im Gesundheitswesen (Scientific 
Institute of the TK for Benefits and Efficiency in Health Care). It thus concerns only a specific group 
of European patients, namely the TK insurees with planned EU cross-border treatment. Caroline 
WAGNER and Frank VERHEYEN (2014): Aspects of Planned EU Cross-border Care. In HENNION and 
Otto KAUFMANN (2014: 99.). 
11
 Diane DAWSON and Lyndsay MOUNTFORD (2008): Health Care Services and the Single European 
Market. OHE Briefing, No 44, http://www.ohe.org/publications/recent-publications/list-by-title-
20/detail/date////health-care-services-and-the-single-european-market.html (10 November 2011), p. 5. 
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rules of the European social security Coordination Regulations;12 on the other hand, 
the case law-based approach, which is based on the relevant articles of the Treaty on 
the Functioning of the European Union (hereinafter also referred to as Treaty, Lisbon 
Treaty or TFEU)13 concerning the free movement of goods and services, and the 
connected cases14 of the European Court of Justice (hereinafter also referred to as 
ECJ or the Court).15 There have been some remarkable differences between these 
two, parallel systems. As a result, the discrepancies of the concurrent legal tools have 
caused certain legal problems since the 1990s (e.g. the scope of application of the 
Treaty rules, different levels and mechanisms of reimbursement of medical costs 
occurred abroad, the question of post factum authorisation), and have raised serious 
doubts among patients (e.g. whether a prior permission from the competent authority 
is required in relation to the treatment abroad, which reimbursement regime is 
                                                 
12
 Regulation (EC) No 883/2004 of the European Parliament and of the Council of 29 April 2004 on 
the coordination of social security systems. OJ L 166 of 30 April 2004 (hereinafter also referred to as 
Basic Regulation or BR) and Regulation (EC) No 987/2009 of the European Parliament and of the 
Council of 16 September 2009 laying down the procedure for implementing Regulation (EC) No 
883/2004 on the coordination of social security systems. OJ L 284 of 30 October 2009 (hereinafter 
also referred to as Implementing Regulation or IR). 
13
 The Treaty on the Functioning of the European Union, OJ C 83 of 30 March 2010. In this 
dissertation, articles of the Treaty are referred to as numbered after the TFEU entered into force on 1 
December 2009. However, when referring to case law, the old numbering (as numbered in the Treaty 
establishing the Eurpean Community – hereinafter also referred to as TEC) might be used. 
14
 The milestone cases are the following: C-120/95 Nicolas Decker v Caisse de maladie des employés 
privés [European Court Reports (hereinafter ECR) 1998 Page I-01831]; C-158/96 Raymond Kohll v 
Union des caisses de maladie [ECR 1998 Page I-01931]; C-368/98 Abdon Vanbraekel and Others v 
Alliance nationale des mutualités chrétiennes [ECR 2001 Page I-05363]; C-157/99 B.S.M. Geraets-
Smits v Stichting Ziekenfonds VGZ and H.T.M. Peerbooms v Stichting CZ Groep Zorgverzekeringen 
[ECR 2001 Page I-05473]; C-326/00 Idryma Koinonikon Asfaliseon (IKA) v Vasileios Ioannidis 
[ECR 2003 Page I-01703]; C-385/99 V.G. Müller-Fauré v Onderlinge Waarborgmaatschappij OZ 
Zorgverzekeringen UA and E.E.M. van Riet v Onderlinge Waarborgmaatschappij ZAO 
Zorgverzekeringen [ECR 2003 Page I-04509]; C-56/01 Patricia Inizan v Caisse primaire d'assurance 
maladie des Hauts-de-Seine [ECR 2003 Page I-12403]; C-8/02 Ludwig Leichtle v Bundesanstalt für 
Arbeit [ECR 2004 Page I-02641]; C-145/03 Heirs of Annette Keller v Instituto Nacional de la 
Seguridad Social (INSS) [ECR 2005 Page I-02529]; C-372/04 The Queen, on the application of 
Yvonne Watts v Bedford Primary Care Trust and Secretary of State for Health [ECR 2006 Page I-
04325]; C-466/04 Manuel Acereda Herrera v Servicio Cántabro de Salud [ECR 2006 Page I-05341]; 
C-444/05 Aikaterini Stamatelaki v NPDD Organismos Asfaliseos Eleftheron Epangelmation (OAEE) 
[ECR 2007 Page I-03185]. See http://ec.europa.eu/social/main.jsp?catId=572&langId=en (9 August 
2012). Short descriptions of the ECJ rulings can be found in Annex I. 
15
 Since the Treaty of Lisbon entered into force on 1 December 2009, the name of the Court changed 
to Court of Justice of the European Union (Article 251-281 TFEU). In the relevant literature, the 
abbreviation ECJ and CJEU are both used. For the sake of simplicity, in this dissertation the 
abbreviation ECJ is used. 
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applicable in a certain situation, or which conditions must be met to use either of the 
different routes of cross-border patient mobility). 
 
Consequently, it was considered a remarkable success when on 19 January 2011 the 
European Parliament (hereinafter also referred to as EP) by a large majority 
approved its legislative resolution on the Council position at first reading with a view 
to the adoption of a directive on the application of patients’ rights in cross-border 
healthcare.16 After the second reading was approved by the Council on 28 February, 
a new piece of the legal framework on European patient mobility was born.17 The 
Directive became known as the Patient Mobility Directive (hereinafter also referred 
to as PMD).18 The agreement of the EP and the Council put an end to a lengthy and 
complicated legislative procedure, which began in 2006, when healthcare services 
were excluded from the material scope of the so-called Services Directive19 due to 
their special characteristics,20 and the legislators decided in favour of adopting a 
separate legal instrument on healthcare service provision.21 
                                                 
16
 P7_TA(2011)0007: European Parliament: European Parliament legislative resolution of 19 January 
2011 on the Council position at first reading with a view to the adoption of a directive of the 
European Parliament and of the Council on the application of patients' rights in cross-border 
healthcare, http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P7-
TA-2011-7 (2 January 2013). 
17
 The steps of the legislative procedure can be found on the EP’s website: 
http://www.europarl.europa.eu/oeil/popups/ficheprocedure.do?lang=en&reference=2008/0142(COD) 
(25 October 2013). 
18
 Directive 2011/24/EU of the European Parliament and of the Council of 9 March 2011 on the 
application of patients’ rights in cross-border healthcare. OJ L 88 of 4 April 2011. 
19
 Directive 2006/123/EC of the European Parliament and of the Council of 12 December 2006 on 
services in the internal market. OJ L 376 of 27 December 2006. 
20
 BAETEN argues that the specific features of the healthcare sector such as third-party payer 
involvement, moral hazard, information asymmetry, the principles of social solidarity and universal 
coverage distinguish medical services from the typical commercial services and make the application 
of the Services Directive to healthcare highly problematic. Rita BAETEN (2004): The proposal for a 
Directive on Services in the Internal Market applied to Healthcare Services. 
http://www.ose.be/files/publication/rbaeten/baeten_2004_PaperHearingEP111104.pdf (17 October 
2012), p. 2. See also Charles T. CARLSTROM (1994): The Government’s Role in the Health Care 
Industry: Past, Present, and Future. Economic Commentary, 1 June 1994 and Stephen SHMANSKE 
(1996): Information Asymmetries in Health Services. The Market Can Cope. The Independent 
Review, Vol 1 No 2, http://www.independent.org/pdf/tir/tir_01_2_shmanske.pdf (16 September 
2013), p. 191. SHMANSKE adds adverse selection to the list of special properties of health services. 
Furthermore, see European Commission (2003): High level process of reflection on patient mobility 
and healthcare developments in the European Union. 
http://ec.europa.eu/health/ph_overview/Documents/key01_mobility_en.pdf (17 October 2012), p. 9. 
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The Patient Mobility Directive does not only intend to incorporate the findings of the 
European Court of Justice on the provision of healthcare services22 and to clarify its 
relationship with the existing framework of social security coordination. It also wants 
to facilitate cooperation among the Member States in the field of healthcare.23 
Moreover, its declared intention is to cease the legal uncertainties related to the 
Union legislation on patient mobility.24 Although satisfying this ambition is more 
than desirable from the patients’ point of view, it is debatable whether the recently 
adopted Directive can reach its target and fully tackle the problems mentioned above 
in order to develop the healthcare systems in the European Union in a patient-
friendly way. 
  
                                                                                                                                          
After the removal of health services from the Service Directive’s scope, the European Council 
adopted the Council Conclusions on Common values and principles in European Union Health 
Systems (OJ C 146 of 22 June 2006). 
21
 Rita BAETEN (2007): Health and social services in the internal market. In Christophe DEGRYSE and 
Philippe POCHET (eds): Social Developments in the European Union 2006, Brussels: European 
Observatory on Health Systems and Policies, 
http://www.ose.be/files/publication/bilan_social/bilan06/Bilan06_RitaBaeten_EN.pdf (17 October 
2012), p. 2 and Willy PALM, Matthias WISMAR, Ewout VAN GINNEKEN, Reinhard BUSSE, Kelly 
ERNST and Joseph FIGUERAS (2011): Towards a renewed Community framework for safe, high-quality 
and efficient cross-border health care within the European Union. In WISMAR et al. (2011a: 30.). 
It is worth reading the European Parliament’s report on the benefits which a separate legal tool on 
cross-border healthcare services was expected to bring in this field. European Parliament (2007): 
Report on the impact and consequences of the exclusion of health services from the Directive on 
services in the internal market. 10 May 2007, A6-0173/2007, 
http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&reference=A6-2007-
0173&language=EN (29 January 2014). The report was transformed into an EP resolution: P6_TA 
(2007) 0201. 
22
 In the Council Conclusions the European Council expressed its firm opinion that developments in 
this area should result from political consensus and not solely from case law. Therefore, it was of 
high priority for the European Commission to develop a Community framework for safe, high quality 
and efficient health services including the relevant case law of the Court. EuC (2006: 29.). 
23
 Article 1 (1) PMD. 
24
 Ibid. 
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I.2. Objectives of the research 
The main aim of the research is to analyse the European legal framework 
governing cross-border patient movements with a strictly patient-centred approach. 
The ambition is to detect those legal issues which are potentially problematic when 
obtaining healthcare abroad and to examine whether these can be solved with the 
legal tools currently available on European level.25 In order to reach this target, the 
legislation is scrutinised in its totality, paying special attention to the interrelations of 
the different legal tools, instead of studying the various legal paths separately. 
 
In order to articulate patients’ needs properly, the starting point of this research is an 
axiom, which reads as follows:  
Patients wish to benefit from the most effective, highest quality healthcare 
provided as quickly as possible for the most favourable price.26 
Based on an analysis of the legal status of border-crossing patients, the main aim of 
the dissertation is to offer clear answers to the questions possibly raised by these 
patients in relation to obtaining healthcare abroad within the European Union. While 
detecting the potentially problematic issues, four key areas of concern were 
identified, namely (1) access to cross-border healthcare, (2) financing cross-border 
healthcare, (3) the timely provision of cross-border healthcare and (4) the quality of 
cross-border healthcare and patient safety in cross-border situations.27 
                                                 
25
 On the current legal tools, see section I.3.2. infra. 
26
 The order of the different elements in this sentence does not necessarily indicate an order of 
preference. Whether it is the quality, the timeliness or the price which holds the highest importance for 
a patient, varies from person to person. However, when obtaining healthcare, each of these factors is 
relevant to a certain extent. 
The expression ‘the most favourable price’ must be understood as the amount of money which is to be 
paid by the patient him/herself. 
27
 Since issues related to quality and patient safety require specialised expertise in healthcare protocols 
and are not directly related to social security matters (not included into the Social Security 
Coordination Regulations either), and as they raise questions related to e. g. cross-border medical 
liability and cross-border remedy for medical malpractice, which are worth serving as a subject of an 
entire dissertation, they are beyond the scope of the present research. However, quality is a high 
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As a conclusion to what was said above,28 the research is based on the following 
theses: 
(1) Although European patients have the right to cross-border healthcare, they 
encounter various difficulties – both of a non-legal and legal nature – that 
discourage or even deter them from using their rights. The current Union legislation 
on cross-border patient mobility has several defects due to which it cannot (fully) 
tackle the (potential) problems patients face when obtaining healthcare in a Member 
State other than their Member State of residence. 
In relation to this thesis the following research questions are addressed in this 
dissertation, especially in Chapter III: 
(a) Do European patients have the right to obtain healthcare abroad? 
(b) Are European patients able to exercise their cross-border healthcare 
rights? 
(c) Which are the obstacles of cross-border patient movements? 
(d) Is the current legal framework capable of tackling these obstacles? 
 
(2) Although Union law entitles European border-crossing patients to claim the 
reimbursement of costs occurred in relation to cross-border healthcare, the 
interaction between the different financial regimes which are in place in the 
European Union is often unclear and results in confusion on the patients’ side. 
Furthermore, the financial mechanism of the Patient Mobility Directive has the 
potential to increase inequality and results in a one-sided European patient mobility 
pattern. 
                                                                                                                                          
concern of patients and a leading factor to obtain healthcare abroad, so the in-depth observation of 
legal questions related to that field holds great potential for future research. 
On the issues related to quality and patient safety, see among others European Commission – 
Eurobarometer (2010): Patient safety and quality of healthcare. 
http://ec.europa.eu/public_opinion/archives/ebs/ebs_327_en.pdf (29 January 2014) and Helena 
LEGIDO-QUIGLEY, Irene A. GLINOS, Kieran WALSHE, Benno VAN BEEK, Cule CUCIC and Martin 
MCKEE (2011): Quality and safety. In WISMAR et al. (2011a). 
28
 See section I.1. 
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In relation to this thesis the following research questions are addressed in this 
dissertation, especially in Chapter IV: 
(a) Which alternatives do European patients have to cover the costs of 
medical treatment abroad? 
(b) Which conditions must be met in order to guarantee that cross-border 
healthcare is covered by the patient’s health insurance? How can the patients 
get reimbursed under the current legal mechanisms in the European Union? 
(c) How might the financial regimes affect European patient movements? 
 
(3) European healthcare systems should ensure the timely provision of healthcare. 
Waiting times are thus relevant to cross-border healthcare provision in many 
aspects. If waiting times in a Member State exceed a certain period, patients should 
have the right to seek treatment in another Member State on the account of their 
healthcare insurance. Therefore, it is in the common interest of both the Member 
States and the patients to apply efficient methods that have the potential of reducing 
waiting times, such as eHealth applications. 
In relation to this thesis the following research question is addressed in this 
dissertation, especially in Chapter V: 
(a) How can eHealth applications contribute to European cross-border patient 
mobility? 
 
In addition to these research questions, the main question behind this research is how 
the current landscape of European cross-border patient mobility legislation can be 
improved in a way that better serves the patients’ interests while respecting the 
responsibilities of the Member States in this field. This question is reflected upon in 
the Conclusions by formalising de lege ferenda suggestions. 
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I.3. Methodology of the research 
I.3.1. Scope of the research 
Since the topic of patient mobility is wide and complex, involving various 
fields of expertise (such as health sciences, sociology, economics, statistics and law), 
the scope of the research is to be framed carefully. In this dissertation, the focus is 
first and foremost set on the issues which are legally relevant, although the 
connected demographical, economic and statistical considerations are taken into 
account as well.29 The subject is observed from the patients’ point of view, implying 
a demand-side approach and setting aside the providers’ market-based interests. 
Thus, most emphasis is put on the social rights of the recipients of healthcare 
services concerning the cross-border provision of both planned and unplanned 
medical treatments.30 Undoubtedly, there are numerous legal issues which are closely 
or less closely linked to cross-border patient mobility (e.g. cross-border medical 
liability, the protection of sensitive medical data). However, this dissertation mainly 
targets the social security issues. Matters which do not belong to the field of social 
security law but are subject to other legal branches are touched upon only briefly.31 
I.3.2. Sources of the research 
The primary source of the research is Union legislation, especially the Treaty 
on the Functioning of the European Union,32 the European social security 
                                                 
29
 Questions which do not have a direct link to the European legislation on cross-border patient 
movements are excluded from the scope of this research, but hold considerable potential for future 
observations. 
30
 Although from a legal point of view, in the Coordination Regulations a strict distinction is made 
between planned and unplanned care, the borderline between these two might be rather blurred in 
certain situations (see infra under section III.2.2.1.B.). The scope of this dissertation covers both 
types. 
31
 See footnote 27 and 29. 
32
 See footnote 13. 
Gabriella BERKI: Cross-border patient mobility: The legal framework of obtaining 
healthcare abroad within the European Union – a patients’ perspective 
30 
 
Coordination Regulations,33 the Patient Mobility Directive34 and the connected cases 
of the European Court of Justice.35 Furthermore, in the course of the research, the 
analysis was extended to the decisions of the Administrative Commission for the 
Coordination of Social Security Systems36 and to the legal documents of other EU 
institutions.37 
As secondary sources of the research, a wide range of publications are used, 
published mainly in English by authors from all over Europe.38 As can be deduced 
                                                 
33
 See footnote 12. On 1 May 2010 a new coordination regime replaced the one which had been in 
force for the last forty years [Regulation (EEC) No 1408/71 of the Council of 14 June 1971 on the 
application of social security schemes to employed persons, to self-employed persons and to members 
of their families moving within the Community and Regulation (EEC) No 574/72 of the Council of 21 
March 1972 fixing the procedure for implementing Regulation (EEC) No 1408/71 on the application 
of social security schemes to employed persons and their families moving within the Community]. 
The aim was to modernise and simplify the coordination mechanism of the social security schemes of 
the EU Member States. 
34
 See footnote 18. The Patient Mobility Directive was introduced on 9 March 2011 and – as it is 
indicated in Article 21 (1) PMD – it had to be implemented by 25 October 2013. 
35
 See footnote 14. 
36
 The Administrative Commission (hereinafter also referred to as AC) is one of the bodies set up to 
guarantee the smooth functioning of the coordination mechanism. It is – among other tasks – 
primarily responsible for handling any question of interpretation arising from the provisions of the 
Coordination Regulations. Articles 71-72 BR. 
37
 For instance, the European Commission services (AC 246/12) have made remarkable efforts 
concerning the clarification of the relationship between the Social Security Coordination Regulations 
and the Patient Mobility Directive, which is one of the most delicate issues in the field at stake. See 
the Guidance note of the Commission services on the relationship between Regulations (EC) Nos 
883/2004 and 987/2009 on the coordination of social security systems and Directive 2011/24/EU on 
the application of patients' rights in cross-border healthcare. The joint interpretive note from DG 
EMPL and DG SANCO was released in May 2012. 
Although these documents are not legally binding, they have played a significant role in the course of 
applying and developing the EU’s legislation on cross-border patient mobility. 
38
 However, the scope of this dissertation does not go beyond the territory of the European Union, 
since it seeks to observe the border-crossing patients’ status within the EU law. A remarkable amount 
of literature is available on worldwide patient mobility, especially on self-financed medical tourism 
and the globalized healthcare market. See among others Annette B. RAMÍREZ DE ARELLANO (2007): 
Patients Without Borders: The Emergence of Medical Tourism. International Journal of Health 
Services, Vol 37 Issue 1, pp. 193-198; Milica Z. BOOKMAN and Karla R. BOOKMAN (2007): Medical 
Tourism in Developing Countries. New York: Palgrave MacMillan; Laura HOPKINS, Ronald 
LABONTÉ, Vivien RUNNELS and Corinne PACKER (2010): Medical tourism today: What is the state of 
existing knowledge? Journal of Public Health Policy, Vol 31, pp. 185-198; Neil LUNT and Percivil 
CARRERA (2010): Medical tourism: Assessing the evidence on treatment abroad. Mauritas, Vol 66, 
pp. 27-32; Tomas MAINIL (2012): Transnational health care and medical tourism: Understanding 
21st-century patient mobility – Towards a rationale of transnational health region development. 
Nieuwegein: NRIT Media, 
http://www.equilibri.net/nuovo/sites/default/files/Transnational%20health%20care.TMainil.pdf (23 
November 2014) and John CONNELL (2013): Contemporary medical tourism: Conceptualisation, 
culture and commodification. Tourism Management, Vol 34, pp. 1-13. 
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from the list of sources referred to in this dissertation, the topic of healthcare 
coordination and patient mobility has been greatly popular among scholars in the 
Western European countries, whereas the number of publications in the new Member 
States is rather limited.39 
I.3.3. Terminology of the dissertation 
Since a broad variety of different legal tools are referred to, a more general, 
source-neutral terminology is used in this dissertation. Whereas the social security 
coordination instruments use the specific expressions of sickness benefit in kind40 
and insured persons41 as well as competent Member State;42 in the Patient Mobility 
Directive, references to healthcare services,43 patients44 and Member State of 
affiliation45 can be found. Although the nuances between the different terms might be 
relevant in certain cases, they can often be used as synonyms. Where relevant, the 
specific expressions are used. 
  
                                                 
39
 Hungary is not an exception: despite a few publications related to the topic, which are elaborated in 
this dissertation, until now an in-depth analysis of the legal framework of cross-border healthcare is 
lacking. Therefore, this research fills a long-felt gap in the Hungarian legal research in the field of 
social security law. 
40
 Article 1 (va) (i) BR. 
41
 Article 1 (c) BR. 
42
 Article 1 (s) BR. 
43
 Article 3 (a) PMD. 
44
 Article 3 (h) PMD. 
45
 Article 3 (c) PMD. 
Gabriella BERKI: Cross-border patient mobility: The legal framework of obtaining 
healthcare abroad within the European Union – a patients’ perspective 
32 
 
I.4. Structure of the dissertation 
The dissertation is divided into six parts: (1) Introduction; (2) Conceptual 
basics; (3) Access to healthcare abroad; (4) Financing medical treatment abroad; (5) 
The timely provision of healthcare and eHealth and (6) Conclusions. 
 
After the introductory chapter (Chapter I), the conceptual basics concerning the 
concept and the nature of European cross-border patient mobility are formulated, 
including a typology of cross-border patients and their motivations (Chapter II). 
Subsequently, separate chapters are dedicated to the examination of three different 
key areas, namely access, financing and the timely provision of cross-border 
healthcare. For each key area, the legal questions are basically approached from a 
European point of view. 
Firstly, in Chapter III, the most extensive chapter of this dissertation,46 the 
right to access to cross-border healthcare is examined, and the obstacles to 
practising this right are mapped. These barriers, which may prevent or deter patients 
from claiming treatment across borders, are divided into two groups: (1) obstacles of 
a non-legal nature (e.g. lingual difficulties and lack of reliable information); and (2) 
obstacles of a legal nature (e.g. legal complexity and administrative burden). 
Secondly, in Chapter IV, the options to fund medical treatments abroad in 
accordance with European legislation are analysed. The Coordination Regulations, 
the case law and the Patient Mobility Directive have different rules on the 
reimbursement of costs through public healthcare schemes. The differences relate to 
the requirement of advancing the healthcare costs and to the scope and level of 
reimbursement. As these are crucial questions, they influence patients’ choices to a 
great extent. 
                                                 
46
 Access to cross-border healthcare is the precondition of any further examination in this field. This 
chapter’s topic requires the deepest analysis in this dissertation, since in order to identify the 
problems, which can also serve as a starting point for the following chapters, the legal background and 
the problems arising in relation to accessing healthcare in another MS have to be examined in detail. 
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Thirdly, in Chapter V, questions are raised in relation to the requirement of 
the timely provision of cross-border healthcare. Special attention is paid to 
techniques to reduce waiting times and the potential of modern health applications 
involving information and communication technologies (hereinafter also referred to 
as ICT).47 
Finally, the conclusions of the research are summarised and de lege ferenda 
suggestions are phrased (Chapter VI).  
                                                 
47
 These applications are commonly called eHealth. 
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II. CONCEPTUAL BASICS 
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In order to analyse the legislation on cross-border patient movements within 
the European Union, the concept of patient mobility needs to be clarified beforehand. 
Therefore, in this chapter, the complex nature of European cross-border patient 
mobility is examined in general, including a typology of patient movements, border-
crossing patients and their motivations to obtain healthcare abroad. At the end, the 
definition(s) of patient mobility used in this dissertation are given. 
 
Let us picture some possible scenarios first. A Hungarian national breaks her leg 
while being on holiday in Greece and receives necessary medical help in a Greek 
hospital. A Luxembourg national takes his daughter to Germany to receive treatment 
from a German orthodontist.48 A Belgian national travels to France to undergo 
orthopaedic surgery, which could be provided in better medical conditions abroad 
than in her home country.49 Dutch nationals obtain specific, experimental treatments 
in foreign hospitals, because those treatments are not offered for them in the 
Netherlands.50 A Greek resident who suffers from chronic heart disease is admitted 
to a German hospital while visiting his son in Germany.51 A German national who is 
resident in Spain goes to Germany for family reasons and is diagnosed with a 
malignant tumour that needs to be operated on by a specialist in Switzerland.52 A UK 
citizen suffering from severe arthritis of the hips travels to France to undergo hip 
replacement surgery there, reducing the predicted waiting time significantly.53 A 
Bulgarian citizen, who was diagnosed with a malignant tumour of the eye, seeks 
advanced therapy in Germany instead of the much more radical Bulgarian treatment, 
which would have involved the removal of the eyeball.54 
These examples, most of them taken from the cases of the European Court of Justice, 
nicely illustrate that the variations of patient movements are endless and that 
                                                 
48
 C-158/96 Kohll, 2. 
49
 C-368/98 Vanbraekel, 11, 16. 
50
 C-157/99 Geraets-Smits and Peerbooms, 25-26, 31-32, 38. 
51
 C-326/00 Ioannidis, 14. 
52
 C-145/03 Keller, 12-17. 
53
 C-372/04 Watts, 24-31. 
54
 C-173/09 Elchinov, 12-15. 
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situations like the ones mentioned above can happen to any of us. Ever since people 
have travelled and have possibly needed healthcare, patient mobility has existed.55 
 
From a practical point of view, the core concept of patient mobility can be described 
as a combination of two elements, namely (1) the capability of moving and (2) the 
necessity to obtain healthcare. Although patient mobility is a multifaceted 
phenomenon which encompasses various situations,56 all these cases have the 
following two elements in common: (1) the person concerned moves and (2) he/she 
receives medical treatment outside the area where he/she resides. Therefore, in my 
understanding, it can be said that the broadest definition of patient mobility involves 
a person who moves into an area outside the area where he/she resides, and receives 
medical treatment in the latter area.57 
 
This broad concept can be further specified in certain ways58 by posing questions to 
detect each relevant aspect of the above mentioned basic elements.  
                                                 
55
 A paper focusing on cross-border patient mobility highlights that this kind of mobility dates back to 
the ancient times when borders were created. As an example, it refers to the pilgrims in the Middle 
Ages who could rely on a network of monasteries providing free care in case of need. Luigi 
BERTINATO, Reinhard BUSSE, Nick FAHY, Helena LEGIDO-QUIGLEY, Martin MCKEE, Willy PALM, 
Ilaria PASSARANI, Francesco RONFINI (2005): Cross-Border Health Care in Europe. Brussels: 
European Observatory on Health Systems and Policies, 
http://www.euro.who.int/__data/assets/pdf_file/0006/108960/E87922.pdf (18 July 2011), p. 1. 
56
 In a recent paper, eight possible scenarios of cross-border patient mobility were identified with the 
aim of proposing a typology of patient mobility with global relevance. The analysis was based on two 
dimensions of patient mobility, namely the types of patient motivations and the types of funding. The 
combinations of four types of motivations and two types of funding presented in the paper result in 
eight different situations. GLINOS et al. (2010a: 1145-1155). 
MAINIL developed an even more sophisticated typology resulting in 12 types of transnational patient 
mobility. MAINIL (2012: 49-58.) 
57
 GLINOS and BAETEN (2006: 18.) define patient mobility as a “general term to describe any kind of 
movement which involves patients moving beyond their catchment area or area of residence to access 
healthcare”. Similarly, in the article by GLINOS et al. (2010a:1146.) cross-border patient mobility is 
described as “involving a patient, who travels to another country for the purpose of receiving planned 
care.” The difference between these definitions and the concept outlined above lies in the fact that, in 
my view, the broad concept of patient mobility should not be limited to patients moving with the 
purpose of seeking planned treatment but should be extended to persons moving and receiving 
occasional healthcare abroad. The concept of the broad and narrow definition of patient mobility is to 
be detailed infra, under section II.3.2. 
58
 It is important to note that creating a typology may never impose strict, exhaustive or exclusive 
rules, but has to be flexible, adapt to the changing circumstances and hence may vary from author to 
author. 
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II.1. Specifying the mobility-element: directions and determinants 
If someone changes his/her place of stay, in the majority of cases there is a 
specific direction, a geographical area involved in the movement and a reason behind 
it. Therefore, in this section (1) a distinction will be made according to the direction 
of the mobility, the geographical area involved in the patient’s movement and (2) the 
determinants59 of mobility will be examined. 
II.1.1. Types of patient mobility according to the geographical area involved 
In this section the types of patient mobility are grouped according to the 
geographical area they involve. In the following the difference between (1) intra-
country, (2) inter-country, (3) inter-regional and (4) regional cross-border mobility 
is illuminated. 
 
Mobility can take place (1) within the same country (intra-country mobility or 
domestic) or (2) between countries (inter-country or international mobility). When 
moving between different countries, borders60 are crossed, so the latter type is also 
called cross-border mobility. This term is widely used in the European Union in 
relation to patient mobility. The countries concerned may either share a common 
border or be geographically further apart.61 If the mobility occurs between two 
                                                 
59
 Determinants should be understood as those factors which are decisive when a person considers 
obtaining medical treatment abroad. 
60
 According to the definition of the International Organisation for Migration (hereinafter also referred 
to as IOM) a border is “(a) line separating land territory or maritime zones of two States or subparts 
of States. It can also refer to a region that is found at the margin of settled and developed territory.” 
IOM (2011): Glossary on migration. 
http://publications.iom.int/bookstore/free/Glossary%202nd%20ed%20web.pdf (31 July 2012), p. 14. 
Hereinafter the term border is to be understood as an international border separating two states. 
Some authors note that different types of borders can be distinguished. Most remarkably, a distinction 
can be made between fluid and rigid borders, where the former is physically and geographically easy 
to cross and does not impose a serious administrative burden on the person concerned, whereas the 
latter creates a real barrier, which hinders persons from crossing it. GLINOS and BAETEN (2006: 7.). 
61
 Interestingly, KANGAS distinguishes between international and cross-border mobility, reserving the 
latter exclusively for travel to adjoining countries, while indicating that international mobility involves 
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regions within the same country, we speak of inter-regional mobility (which is a 
specific type of intra-country mobility), although if the region extends beyond an 
international border, the term regional cross-border mobility62 is used (which is a 
specific type of inter-country mobility). These types are categorised in Table 1 infra. 
 
Table 1: Types of mobility according to the geographical area involved 
Direction of 
movement 
Moving between 
two places which 
are in the same 
region 
Moving between 
two places which 
are in the same 
county 
Moving between 
two places which 
are in different 
regions 
Moving between 
two places which 
are in different 
countries 
Area  
involved 
One region domestic, (intra-) 
regional mobility 
domestic, (intra-) 
regional mobility - 
regional cross-
border mobility 
One country domestic, (intra-) 
regional mobility 
domestic, (intra-) 
regional mobility 
domestic, inter-
regional mobility - 
Different 
regions - 
domestic, inter-
regional mobility 
domestic, inter-
regional mobility 
inter-country or 
cross-border 
mobility 
Different 
countries 
regional cross-
border mobility - 
inter-country or 
cross-border 
mobility 
inter-country or 
cross-border 
mobility 
Source: the author’s own summary 
 
Table 1 illustrates the possible directions of patient movements and the geographic 
area involved in a matrix. This dissertation is limited to the analysis of the cross-
border aspects of patient mobility (in Table 1, they are marked in grey), thus 
excluding domestic, intra-country mobility situations from its scope. Hereinafter 
solely cross-border patient mobility within the European Union63 is dealt with even if 
its cross-border nature is not mentioned each time. 
                                                                                                                                          
a journey to a destination beyond neighbouring countries. Beth KANGAS (2010): Traveling for 
Medical Care in a Global World. Medical Anthropology: Cross-Cultural Studies in Health and Illness, 
Special Issue: Medical Travel, Vol 29 Issue 4, pp. 344-362. 
62
 GLINOS and BAETEN (2006: 18.). 
63
 In cross-border situations, at least two countries are involved. The original country is – in principle 
– the one where the person concerned is covered by the public health insurance scheme (competent 
Member State or Member State of affiliation), and the other one is where the medical treatment is 
provided (Member State of treatment). 
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II.1.2. Determinants of cross-border patient mobility 
Although surveys show that the European citizens’ cross-border mobility rate 
is still rather low,64 in 2007 54 per cent of them stated that they were open to 
travelling abroad to seek medical treatment.65 In searching for the answer to why 
people tend to travel across borders to obtain medical treatment, what can motivate 
them, special attention has to be given to four basic factors66 in my view, namely (1) 
familiarity and proximity, (2) availability, (3) price or affordability and (4) quality. 
 
(1) Firstly, familiarity and proximity are key drivers of mobility which are 
especially present in the border areas. People obviously feel more comfortable with a 
system they know and are more often willing to travel for healthcare when they are 
associated with the language,67 the culture68 and the healthcare system of the country 
                                                 
64
 “On average, only slightly more than two percent of EU citizens currently live in another EU 
Member State.” European Commission - Eurobarometer (2010): Geographical and labour market 
mobility. http://ec.europa.eu/public_opinion/archives/ebs/ebs_337_en.pdf (3 August 2011), p. 5. 
65
 Eurobarometer (2007: 5.). It is remarkable, however, that at the same time the proportion of EU 
citizens that actually received treatment in another Member State ranges from only 2 per cent in 
Sweden, Romania, Greece, Latvia, Finland and Bulgaria to 20 per cent in Luxembourg. 
Eurobarometer (2007: 7.). 
66
 GLINOS and BAETEN (2006: 6.) specify five key drivers, considering the factor of bioethical 
legislation a separate driver, whereas I include this type of treatments in the group of non-available 
treatments. However, in a more recent article by GLINOS et al. the very same four factors of 
motivation were identified as mentioned above. (2010a: 1147.) On incentives and barriers see also 
CALNAN et al. (1997: 30-32). 
CROOKS and her colleagues, while dealing with medical tourism on an international scale, apply a 
different approach and identify three types of motivating factors, such as (1) procedure-based (e.g. 
illegal or non-available treatments, experimental procedures in the patient’s country); (2) travel-based 
(e.g. increasing ease and affordability of international travel, frequency of flights to the key 
destinations); and (3) cost-based factors. Valorie A CROOKS, Paul KINGSBURY, Jeremy SNYDER and 
Rory JOHNSTON (2010): What is known about the patient's experience of medical tourism? A scoping 
review. BMC Health Services Research, Vol 10, http://www.biomedcentral.com/1472-6963/10/266 
(19 October 2012), p. 271. 
The data of the TK survey shows that the key reason for the respondents in their decision for EU 
cross-border treatment was their former good experience. As other main drivers, the possibility to 
combine treatment with holiday, better healthcare and the unavailability of treatment were identified. 
WAGNER, C and VERHEYEN (2014: 105-106.). 
67
 The TK survey concludes that a significant part of the responding patients opted for undergoing 
treatment in German-speaking countries (in Austria and Switzerland), so almost 80 per cent of the 
patients communicated in their native language during their treatment. WAGNER, C and VERHEYEN 
(2014: 108.). 
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they are heading to. It is not exceptional that people who migrated to another country 
return to their country of origin to obtain healthcare.69 In border areas it is often seen 
that the closest healthcare provider happens to be settled on the other side of the 
border.70 However, it should be noted that proximity has become relative in the last 
decades. Thanks to – amongst others – low budget airlines, even the bigger distances 
can be covered quite easily and even the farther points of Europe have become 
readily accessible.71 
(2) Secondly, the availability of the required treatments plays an essential 
role. Patients are highly motivated by inadequate availability, which can occur in two 
different ways. (a) On the one hand, when the capacity is insufficient, the treatment 
concerned does exist and is covered by the national healthcare system in the Member 
State of affiliation, but it cannot be provided within a justifiable time limit. This can 
be considered relative unavailability.72 Almost two-thirds of EU citizens say that 
they are willing to travel abroad in order to reduce waiting times and receive 
treatment more quickly than at home.73 (b) On the other hand, certain treatments may 
either not exist or not be covered by the national healthcare system. These are the 
cases of absolute unavailability. The reason behind this unavailability can be purely 
economic if financing the treatment or setting up the necessary infrastructure were 
                                                                                                                                          
68
 In CROOKS et al, religious accessibility is also added as an influencing factor, since “patients may 
seek out facilities that observe the same religious protocols they do.” CROOKS et al. (2010: 271.) 
However, religious beliefs may result in a counter-effect when religious considerations are mirrored in 
the bioethical legislation of the given country. For instance, it can be clearly seen that strict laws on 
abortion or euthanasia may drive people abroad to obtain the requested services there. See footnote 
77-78 infra. 
69
 CORNELL (2013: 3.). 
70
 For example, Dutch patients from the Dutch region Zeeuws-Vlaanderen often choose to receive 
medical treatment in hospitals in the northern part of Belgium, where they share a common language 
and are familiar with the culture and healthcare infrastructure. GLINOS et al. (2006: 99). 
71
 Among others GLINOS and BAETEN (2006: 9.) and Colin PERDUE and Simon NOBLE (2007): 
Foreign travel for advanced cancer patients: a guide for healthcare professionals. Postgraduate 
Medical Journal, Vol 83 Issue 981, p. 437. 
72
 In GLINOS et al, this dimension is considered (un)availability in terms of quantity of services as 
opposed to (un)availability in terms of types of care, which more or less connotes the same as 
absolute unavailability in this dissertation. (2010a: 1147.). 
73
 Eurobarometer (2007: 15.) At the same time, evidence shows that – despite extensive waiting times 
– many patients prefer to be treated in their usual environment over travelling for healthcare. Peter 
BURGE, Nancy DEVLIN, John APPLEBY, Charlene ROHR and Jonathan GRANT (2004): Do patients 
always prefer quicker treatment? : a discrete choice analysis of patients' stated preferences in the 
London Patient Choice Project. Applied Health Economics and Health Policy, Vol 3 Issue 4, p. 192. 
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too expensive and unreasonable.74 This is the case for highly specialised treatments, 
which would result in inefficient investments if the population of the country is 
rather small.75 However, the lack of providing certain treatments can be based on the 
national bioethical legislation as well. There are numerous medical interventions 
which are judged diversely in the different Member States within the European 
Union.76 Thus – in order to circumvent their own national laws77 – patients travel 
abroad for instance for abortion,78 reproductive care,79 stem cell therapy80 or even 
euthanasia.81 European citizens seem most willing to travel abroad if they cannot 
                                                 
74
 GLINOS and BAETEN (2006: 6.). 
75
 For example, there is a trend of Maltese patients going to the United Kingdom for high-cost 
treatments because “(t)he investment cost is too high, the patients are too few and full-time 
professional staff employed to perform this type of service will quickly become deskilled.” Natasha 
AZZOPARDI MUSCAT, Kenneth GRECH, John M. CACHIA, Deborah XUEREB (2006): Sharing capacities 
– Malta and the United Kingdom. In ROSENMÖLLER et al. (2006a: 122.). 
76
 LUNT and CARRERA (2010: 30.). 
77
 Wolfram HENN (1999): Genetic screening with the DNA chip: a new Pandora's box? Journal of 
Medical Ethics, Vol 25, p. 202; Margaret BRAZIER (1999): Regulating the reproduction business? 
Medical Law Journal, Vol 7, p. 191. 
Guido PENNINGS argues, however, in relation to reproductive tourism (the cross-border movement of 
patients to obtain specific types of medical assistance in reproduction that they cannot receive at 
home) that ethically controversial treatments should not be seen as circumvention of restrictive 
national laws, but rather as “a safety valve that avoids moral conflict, and as such, contributes to a 
peaceful coexistence of different ethical and religious views in Europe.” Guido PENNINGS (2004): 
Legal harmonization and reproductive tourism in Europe. Human Reproduction, Vol 19 No.12, p. 
2694. See also Guido PENNINGS (2002): Reproductive tourism as moral pluralism in motion. Journal 
of Medical Ethics, Vol 28, pp. 337-341. 
78
 Many cases have shown that adopting strict anti-abortion laws in the Member States does not result 
in women not undergoing these kinds of treatments. They are just forced to do it “underground or 
abroad.” Gareth PRICE (2010): Polish women increasingly head abroad for abortions. Warsaw 
Business Journal, 27 August 2010, http://www.wbj.pl/article-50875-polish-women-increasingly-head-
abroad-for-abortions.html (4 August 2011). See also Abigail-Mary E. W. STERLING (1997): European 
Union and Abortion Tourism: Liberalizing Ireland's Abortion Law. Boston College International and 
Comparative Law Review, Vol 20 Issue 2, pp. 385-406. 
79
 Linda NIELSEN (1996): Procreative Tourism, Genetic Testing and The Law. In Nigel LOWE and 
Gillian DOUGLAS (eds.): Families Across Frontiers. The Hague: Kluwer Academic Publisher, pp. 
831-848; PENNINGS (2004); A. MCKELVEY, A. L. DAVID, F. SHEFIELD and E. R. JAUNIAUXC (2009): 
The impact of cross-border reproductive care or ‘fertility tourism’ on NHS maternity services. BJOG: 
An International Journal of Obstetrics & Gynaecology, Vol 116 Issue 11, pp. 1520–1523; Petra 
THORN and Sandra DILL (2010): The role of patients’ organizations in cross-border reproductive 
care. Fertility and Sterility, Vol 94 No 1, p. 23 and CONNELL (2013: 9.). 
80 Kirsten A. RYAN, Amanda N. SANDERS, Dong D. WANG and Aaron D. LEVINE (2010): Tracking the 
rise of stem cell tourism. Regenerative Medicine, Vol 5 Issue 1, pp. 27-33; Priscilla Posuan SONG 
(2010): Biotech pilgrims and the transnational quest for stem cell cures. Medical Anthropology, Vol 
29 Issue 4, pp. 384-402. 
81
 DeMond Shondell MILLER and Christopher GONZALEZ (2013): When Death is the Destination: The 
Business of Death Tourism – Despite Legal and Social Implications. International Journal of Culture, 
Tourism and Hospitality Research, Vol 7 Issue 3. 
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obtain the desired medical care in their home country.82 Although it is worth 
mentioning that if the treatment is not illegal in the given country but just not 
covered by the public healthcare system, the majority of this demand is usually 
absorbed by the private healthcare sector of the given country. 
(3) A third crucial factor is the price of the treatment. There are enormous 
differences between the medical costs in the various Member States, which are 
especially remarkable with regard to co-payments, the formal service fees which 
have to be paid by the patients out of pocket.83 Since receiving the same treatment 
abroad can result in considerable savings on the patients’ side84 even with the 
additional costs considered, a significant percentage of the EU population chooses to 
seek cheaper healthcare abroad.85 A clear trend can be seen of patient flow from the 
old Member States with higher prices towards the new Member States with lower 
prices86 but good quality healthcare.87 
                                                 
82
 Eurobarometer (2007: 12.). 
83
 Corina C. ROS, Peter P. GROENEWEGEN, Diana M. J. DELNOIJ (2000): All rights reserved, or can we 
just copy? Cost sharing arrangements and characteristics of health care systems. Health Policy Vol 
52 No 1, http://nvl002.nivel.nl/postprint/PPpp846.pdf (4 August 2011), p. 2. See also Ray ROBINSON 
(2002): User charges for healthcare. In Elias MOSSIALOS, Anna DIXON, Josep FIGUERAS and Joe 
KUTZIN (eds.): Funding health care: options for Europe. Buckingham, Philadelphia: Open University 
Press, http://www.euro.who.int/__data/assets/pdf_file/0003/98310/E74485.pdf (9 August 2011), p. 
162. 
84
 GLINOS and BAETEN (2006: 6.). 
85
 Eurobarometer (2007: 16.). 
86
 VAN DEN BOSSCHE and PLOSCAR aptly call the phenomenon of travelling from developed to less 
developed countries due to costs and waiting lists “reverse globalization.” Anne-Marie VAN DEN 
BOSSCHE and Paula PLOSCAR (2012): Rights of Dental Patients in the EU – A Legal Assessment. 
Journal of Forensic Odonto-Stomatology, Vol 30 Suppl 1, p. 6. See also CONNELL (2013: 1.). 
87
 A typical example is dental tourism, when patients coming from the United Kingdom, Ireland or 
Austria travel to Hungary or Poland for cheaper but high-quality dental care. Leigh TURNER (2008): 
Cross-border dental care: ‘dental tourism’ and patient mobility. British Dental Journal, Vol 204 No 
10, 
http://www.ahc.umn.edu/bioethics/prod/groups/ahc/@pub/@ahc/@bioethics/documents/asset/ahc_ass
et_178870.pdf (4 August 2011), p. 553. See also GLINOS and BAETEN (2006: 6.); TOLNAI Zsolt, 
BILLIK Beáta és FUCHS Péter (2009): Magyarország és a fogászati turizmus (Hungary and the dental 
tourism). Egészségügyi Gazdasági Szemle (Journal of Health Economics) 2009, Issue 4, 
http://www.weborvos.hu/adat/egsz/2009jul/34-40.pdf (19 August 2011), pp. 34-40; August OSTERLE, 
Peter BALAZS, Jose Jimenez DELGADO (2009): Travelling for teeth: characteristics and perspectives 
of dental care tourism in Hungary. British Dental Journal, Vol 206 No 8, pp.425-428; VAN DEN 
BOSSCHE and PLOSCAR (2012) and Juliane WINKELMANN, Maria M. HOFMARCHER, Eszter KOVACS 
and Gabor SZOCSKA (2013): Cross-border dental care between Austria and Hungary. Eurohealth, Vol 
19 No 4. 
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(4) Fourthly, the quality of the healthcare service is also one of the main 
driving forces prompting people to go abroad. In this way they also express their 
dissatisfaction with the national system in the country they live.88 Almost 80 per cent 
of EU citizens indicated their readiness to travel for better quality.89 However, it 
should be mentioned that in numerous Member States, mainly in Central East 
Europe, it is a widespread habit to seek better quality treatment in the public sector 
by informally providing an extra ‘under-the-table’ payment – also called gratitude 
money – for the healthcare professionals.90 Another solution can simply be to ‘buy’ 
better treatment on the private healthcare market. So patients in these countries tend 
to consider first to pay some extra within the public healthcare system or turn to a 
private provider before deliberating the possibility of obtaining healthcare abroad. 
 
Figure 1: Motivating factors of cross-border patient mobility within Europe 
 
Source: Eurobarometer (2007: 11.) 
                                                 
88
 As RUNNELS and CARRERA points out the fact “(t)hat patients seek access to care abroad says 
something about how health is construed and how domestic healthcare is regarded and, as such, 
reflects to a certain extent on the performance and responsiveness of domestic health care systems.” 
Vivien RUNNELS and Percivil M. CARRERA (2012): Why do patients engage in medical tourism? 
Mauritas, Vol 73, p. 303. 
89
 Eurobarometer (2007: 13.). 
90
 Sara ALLIN, Konstantina DAVAKI and Elias MOSSIALOS (2005): Paying for ‘free’ health care: the 
conundrum of informal payments in post-communist Europe. Global Corruption Report, 
http://www.bu.edu/actforhealth/actforhealth04/Part%201_4_informal_payments.pdf (9 August 2011), 
p. 63 and Maureen LEWIS (2002): Informal health payments in central and eastern Europe and the 
former Soviet Union: issues, trends and policy implications. In MOSSIALOS et al. (2002: 184.) The 
details and consequences of this phenomenon are nevertheless beyond the scope of this paper. 
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It has to be added that other determinants of patient mobility influencing the patients’ 
choice can also be identified, such as former experience abroad91 or receiving 
treatment from a renowned specialist (Figure 1 supra).92 
 
Besides the motivating factors, it must be revealed that the level of cross-border 
patient mobility is still rather low in the European Union,93 mainly because patients 
prefer to be treated near their home,94 where it is much easier to keep in contact with 
family and friends; because they are satisfied with the healthcare provided in their 
home country; because they lack information about their rights and the medical 
treatment available abroad; because they are afraid of language difficulties, which 
can be especially problematic in medical situations; or because they simply cannot 
afford to be treated in other Member States, where they possibly have to pay upfront, 
out of pocket (Figure 2 infra).95 
 
Figure 2: Discouraging factors of cross-border patient mobility within Europe 
 
Source: Eurobarometer (2007: 18.)  
                                                 
91
 Eurobarometer (2007: 9.). 
92
 Eurobarometer (2007: 14.). 
93
 See footnote 4. 
94
 See footnote 6. 
95
 Eurobarometer (2007: 18.) These factors are elaborated further infra in section III.2.1. 
86 83
61
49 47
0
10
20
30
40
50
60
70
80
90
100
More convenient 
to be treated near 
home
Satified with the 
health care which 
can be received at 
home
Not enough 
information about 
the availability 
and quality of 
medical treatment 
abroad
Language reasons Cannot afford to 
receive medical 
treatment abroad
Gabriella BERKI: Cross-border patient mobility: The legal framework of obtaining 
healthcare abroad within the European Union – a patients’ perspective 
45 
 
II.2. Specifying the healthcare element: content and actors 
Besides the realisation of a cross-border movement, the other core element of 
patient mobility is to obtain healthcare in a country other than the country of 
residence. Therefore, it is inevitable to concisely summarise what is understood by 
the expression healthcare in this dissertation. In this section, the types of healthcare 
and the categories of European mobile patients are briefly touched upon. 
 
Healthcare – in a broad sense – is a complex system designed to cope with the social 
risk of sickness and injury.96 While dealing with social issues as a consequence of 
sickness and injury, the social system needs to tackle two separate – nevertheless 
interrelated – problems at the same time: (1) on the one hand, the healthcare system 
aims to compensate the person who cannot carry out his/her working activity due to 
medical reasons for the loss of income and (2) on the other hand, it attempts to 
handle the health problem itself.97 
II.2.1. Types of sickness benefits 
The first aim indicated above can be achieved by offering the person sickness 
benefits in cash (in pecuniam).98 These benefits can be considered as financial 
support to maintain the standard of living during the incapacity to work and are 
provided by means of a simple money transfer. This transfer evokes a bipolar 
                                                 
96
 Long-term care benefits – however connected – are not subject of this dissertation. Even more so 
since they are excluded from the material scope of the Patient Mobility Directive. See Article 1 (3) (a) 
PMD. Nevertheless, cross-border long-term care does exist, and that phenomenon is also of a great 
value for further research. Kate CONNOLLY (2012): Germany 'exporting' old and sick to foreign care 
homes. The Guardian, 26 December 2012, http://www.theguardian.com/world/2012/dec/26/german-
elderly-foreign-care-homes (5 March 2014). 
97
 Similarly in Philippa WATSON (1980): Social Security Law of the European Communities. London: 
Mansell Publishing, p. 1. 
98
 See Part III of the International Labour Organization’s (hereinafter also referred to as ILO) 
Convention concerning Minimum Standards of Social Security (ILO 102). 
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relationship between the insured person and the health insurance fund, which makes 
the cross-border provision of the benefits rather smooth.99 
In this dissertation, the term healthcare is to be understood as its more narrow 
meaning, also called medical care. According to the ILO contingencies covered shall 
include any morbid condition, whatever its cause, and pregnancy and confinement 
and their consequences.100 Whereas the ILO’s definition of medical care focuses on 
the social risks covered and the particular benefits included,101 in the European 
Union, where the term sickness benefits in kind (in naturam) or healthcare services 
are more widely used, emphasis is put on the various methods of healthcare delivery. 
According to the Coordination Regulations these benefits intend to supply, make 
available, pay directly or reimburse the cost of medical care and products and 
services ancillary to that care.102 Similarly, the European Court of Justice described 
them as benefits which are designed to cover care received by the person concerned, 
inter alia, by the direct payment or reimbursement of medical expenses incurred by 
that person’s state.103 
From a functional point of view, healthcare can be defined as a collective phrase for 
all the “(g)oods and services provided to promote health, or prevent, alleviate or 
eliminate ill-health”104 or “(t)he total human and material resources that a nation or 
community deploys to preserve, protect, and restore health and to minimize suffering 
caused by disease and injury”.105 It can be agreed upon that the function of 
                                                 
99
 See footnote 111 and 112 infra. 
100
 Article 8 of ILO 102. 
101
 In Article 10, ILO 102 states that medical care shall include at least (a) in case of a morbid 
condition (i) general practitioner care, including domiciliary visiting; (ii) specialist care at hospitals 
for in-patients and out-patients, and such specialist care as may be available outside hospitals; (iii) 
the essential pharmaceutical supplies as prescribed by medical or other qualified practitioners; and 
(iv) hospitalisation where necessary; and (b) in case of pregnancy and confinement and their 
consequences (i) pre-natal, confinement and post-natal care either by medical practitioners or by 
qualified midwives; and (ii) hospitalisation where necessary. 
102
 Article 1 (va) (i) BR. The Regulation’s definition shows precisely the different types of healthcare 
funding. 
103
 C-160/96 Molenaar [ECR 1998 Page I-00843], 32 and 34 (in the context of a statutory scheme of 
social insurance against the risk of reliance on care); C-372/04 Watts, 137 and C-466/04 Acereda 
Herrera, 29. 
104
 Anthony J. CULYER (2005): The Dictionary of Health Economics. Cheltenham, UK; Northampton, 
MA, USA: Edward Elgar Publishing, p. 149. 
105
 John M. LAST (2007): A Dictionary of Public Health. Oxford: University Press, p. 156. 
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healthcare is twofold: (1) preventive106 on the one hand and (2) curative on the 
other.107 It is an especially wide term including (1) self-care (personal health 
maintenance, care provided by the person in need of healthcare himself/herself), (2) 
informal care (care provided through an informal framework of family members, 
friends etc) and (3) institutionalised care (organised by a private or public body, care 
provided through a formal institutional framework). This dissertation deals with the 
third form of healthcare. 
During the research, solely the sickness benefits in kind are examined that are 
organised by the Member States within the European Union108 and are provided in 
the framework of a national healthcare system109 according to the relevant legal 
regulations of the given Member State. In the course of the provision of these 
benefits a ‘new’ actor becomes involved: the healthcare provider, an individual or an 
institution that provides healthcare services. The result is – in contrast with the 
bipolarity of cash benefit provision – a tripolar relationship, in which the provider is 
the actor whom the insured person receives the benefit from and the healthcare fund 
plays the role of the ‘third party payer’ who ensures – at least partly – the funding for 
the health expenses.110 
 
                                                 
106
 The Directive’s definition, which says that healthcare means health services provided by health 
professionals to patients to assess, maintain or restore their state of health, including the prescription, 
dispensation and provision of medicinal products and devices seems to miss the preventive side of 
healthcare. See Article 3 (a) PMD. 
107
 Rehabilitation can be seen as a third pillar of healthcare. 
108
 On competencies in the field of healthcare within the EU see section III.1.3.1. infra. 
109
 FLEAR calls them public health care systems, which implies on the one hand that these schemes are 
– at least partly – publicly financed and on the other hand they are “established, guaranteed and often 
funded and/or provided by the welfare states of the EU Member States.” Mark FLEAR (2004): Case C-
385/99 V.G. Müller-Fauré v. Onderlinge Waarborgmaatschappij O.Z. Zorgverzekeringen U.A. and 
E.E.M. van Riet v. Onderlinge Waarborgmaatschappij Z.A.O. Zorgverzekeringen, Judgement of the 
Court of 13 May 2003. Common Market Law Review, Vol 41 Issue 1, p. 209. 
110
 Employing a third party payer is an example of the implementation of a solidarity mechanism in 
the European public health insurance systems in order “to share the costs for medical care between 
the sick and the well and to adjust for different levels of ability to pay”. European Parliament – 
Directorate General for Research (1998): Health Care Systems in the EU: A Comparative Study. 
http://www.europarl.europa.eu/workingpapers/saco/pdf/101_en.pdf (20 October 2013), p. 10. On the 
different types of healthcare funding see OECD, Eurostat and WHO (2008): A Proposal for the Main 
Categories of the Classification of Financing Schemes. 
http://www.oecd.org/dataoecd/17/32/41016651.pdf (1 April 2012). 
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As mentioned supra, in cross-border situations, within the European Union the 
provision of sickness cash benefits is properly coordinated by Regulation (EC) No 
883/2004111 and its Implementing Regulation.112 However, the provision of sickness 
benefits in kind is greatly problematic and gives rise to numerous legal questions if 
the person concerned stays or resides abroad. Thus, these issues are worth being 
further examined in detail. 
II.2.2. Categories of border-crossing patients 
The actors involved in healthcare service provision are (1) the insurer or 
healthcare fund, (2) the healthcare provider and (3) the insured person. In other 
words, they are the payer of the service, the provider of the service and the potential 
recipient of the service, also called the patient.113 Since the topic is observed from the 
patients’ point of view, meaning that the main focus is on their social rights 
concerning the cross-border healthcare provision, it seems necessary to take a closer 
look at this personal group. The Patient Mobility Directive defines a patient as “any 
natural person who seeks to receive or receives healthcare in a Member State”.114 
By analogy, a border-crossing patient115 is any natural person who seeks to receive 
or receives healthcare in a Member State other than the State of affiliation. At this 
point, it must be noted that this dissertation's scope is restricted to persons covered 
by a compulsory healthcare system; neither uninsured persons,116 nor people subject 
only to voluntary healthcare systems are dealt with. 
                                                 
111
 Article 21 (1) BR: An insured person and members of his/her family residing or staying in a 
Member State other than the competent Member State shall be entitled to cash benefits provided by 
the competent institution in accordance with the legislation it applies. 
112
 Article 27-28 IR. 
113
 It is important to note that in case of derived rights, the patient is not the insured person 
him/herself, but regularly a family member. See Article 1 (i) BR on the definition of family members. 
114
 Article 3 (h) PMD. 
115
 They are also called “transnational EU-patients.” Katrien KESTELOOT, Sabrina POCCESCHI and 
Emmanuel VAN DER SCHUEREN (1995): The reimbursement of the expenses for medical treatment 
received by ’transnational’ patients in EU-countries. Health Policy, Vol 33 Issue 1, p. 43. 
116
 See on this issue Jean-Philippe LHERNOULD (ed.), Bernd SCHULTE (ed.), Jean-Claude FILLON, 
József HAJDÚ, Herwig VERSCHUEREN (2010): trESS Think Tank Report 2010 – Healthcare provided 
during a temporary stay in another Member State to persons who do not fulfil conditions for statutory 
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Notwithstanding, according to one of the most widespread categorisations five main 
categories of European border-crossing patients can be distinguished,117 namely (1) 
temporary visitors, (2) long-term residents, (3) people living in the border areas, (4) 
‘posted patients’ and (5) the ‘real’ mobile patients, persons choosing to travel abroad 
in order to obtain healthcare. 
(1) The first group are temporary visitors who become in need of healthcare 
while staying abroad temporarily. These people travel for tourism, business, study or 
any other purpose. The point is that while they are visiting a country other than the 
country where they are covered by health insurance, they need to use the health 
system in the country of stay. The European Health Insurance Card118 was designed 
especially for this personal group in order to avoid the need to return to the home 
country before the intended date of return.119 
(2) The second category are the long-term residents who decide to retire in 
another Member State and wish to use the healthcare system of that country.120 
Examples are Scandinavian pensioners who spend the winters in the 
Mediterranean121 or Irish workers who return back home after spending their 
working life in England.122 In my opinion, we will face a similar phenomenon when 
                                                                                                                                          
health insurance coverage. http://www.tress-
network.org/tress2012/EUROPEAN%20RESOURCES/EUROPEANREPORT/ThinkTank_Healthcar
eUninsuredCitizens_Final_140111.pdf (7 November 2013). 
117
 BERTINATO et al. (2005: 2-5.); ROSENMÖLLER et al. (2006a: 6.); LUNT and CARRERA (2010: 28.).  
118
 On the rules related to the usage of EHIC, see section III.2.2.2.B. infra. 
119
 BERTINATO et al. (2005: 3.). 
120
 On the migration patterns of the elderly, see Anthony M. WARNES and Allan WILLIAMS (2007): 
Older Migrants in Europe: A New Focus for Migration Studies. Journal of Ethnic and Migration 
Studies, Vol 32 Issue 8, pp. 1257-1281. See also Stephanie KUMPUNEN and Lisa TRIGG (2013): Intra-
European retirement migrants’ access to state-funded long-term care and health entitlements. 
Eurohealth, Vol 19 No 4. 
121
 Simon ROBERTS (ed.). Bernd SCHULTE (ed.), Carlos Garcia de CORTAZAR, Teodoras MEDAISKIS 
and Herwig VERSCHUEREN (2009): trESS Think Tank Report 2009 – Healthcare for Pensioners.  
http://www.tress-
network.org/tress2012/EUROPEAN%20RESOURCES/EUROPEANREPORT/ThinkTank_Pensioner
s_2009.pdf (22 November 2013), p. 5. Here the authors distinguish two main groups of retirement 
migrants, namely the ones who move to another Member State on a permanent basis and fully 
integrate into the society of this Member State and those who “retain their centre of interest in the 
country where they lived and worked and consider themselves to be resident in that country while they 
share their time between the two or more Member States.” p. 5. 
122
 BERTINATO et al (2005: 4.). 
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the workers from the recently acceded East European countries, who sought 
employment in the old Member States, reach retirement age.123 
In these categories the mobility element precedes the healthcare element, whereas in 
the other three groups first the need for healthcare occurs and then the patients cross 
the border(s) to obtain treatment. 
(3) The third category are people living in the border areas. Those who share 
close linguistic and cultural links with the people living on the other side of the 
border might be more willing to cross the border for treatment than to receive 
healthcare service in their own country, in an environment which they are less 
familiar or comfortable with. In border areas, special arrangements are often made 
between providers in order to share the capacities and ensure appropriate service for 
all even if the closest provider happens to be settled on the other side of the border.124 
(4) The patients belonging to the fourth category are encouraged to go 
abroad or even sent abroad by the insurer to receive the required treatment. They are 
also called ‘posted patients’ or ‘outsourced patients’.125 The reason behind this is 
usually the uneconomic setting of the infrastructure for certain, often highly-
specialised treatments. This problem can be easily solved by treatment abroad, which 
is “actively managed by public authorities, seeking to ensure continuity of care, 
coverage of extra expenses and appropriate selection of providers abroad.”126 
(5) Lastly, the fifth group are patients choosing to travel abroad in the hope 
of receiving quicker, better or cheaper treatment there.127 These are often self-
managed arrangements, not or at most partly funded by the insurer. The treatments 
obtained often fall outside of the circle that is covered by the public health insurance, 
like cosmetic surgery or dental treatment.128 This type of mobility is generally called 
medical tourism.129  
                                                 
123
 WARNES and WILLIAMS call them “return migrants.” WARNES and WILLIAMS (2007: 1262). 
124
 BERTINATO et al (2005: 4.). See also footnote 70. 
125
 LUNT and CARRERA (2010: 28.). 
126
 ROSENMÖLLER et al. (2006a: 7.) See also footnote 75. 
127
 On the motivating factors, see section II.1.2. supra. 
128
 BERTINATO et al. (2005: 5.). 
129
 On the different terms used in relation to patient mobility see section II.3.2. infra. 
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Nevertheless, this typology reflects mainly on the practical circumstances of the 
various groups of patients and not on their legal status. However, since this 
dissertation focuses on the social rights of European border-crossing patients, this 
categorisation might not cover all of them. Nevertheless, patients dealt with in the 
course of this research share some characteristics, namely (1) they do reside in one 
Member State, but receive healthcare in another one, (2) they receive medical 
treatment which is (or is supposed to be) in the benefit package of at least one of 
these countries and (3) the medical costs are (or are supposed to be) partly or fully 
covered by their health insurance. The different legal situations are scrutinised 
infra.130 
In fact, what needs to be kept in mind when categorising is that each patient wants 
the same: the best healthcare for the most favourable price within the most 
reasonable time frame. The basic idea of this dissertation is to find out whether 
European patients have the right and access to such healthcare if it happens to be 
provided outside their Member State of residence. 
  
                                                 
130
 See section III.2.2.1. 
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II.3. The definition of cross-border patient mobility 
In the previous sections, the conceptual elements of patient mobility were 
discussed, although the term patient mobility is not mentioned literally in Union 
legislation: it is not a legal expression. It is a concept which was created by the 
literature and which not only includes the legal aspects of the phenomenon, but all 
issues related to mobile patients. The so-called Patient Mobility Directive itself uses 
the phrase cross-border healthcare.131 Thus, before moving to the analysis of the 
legislation, it is indispensable to clarify the various terms and concepts. 
II.3.1. The concept of cross-border healthcare 
Although patient mobility is a wide and complex phenomenon in itself,132 it is 
regarded as a subset of the broader notion of cross-border healthcare. In the course 
of the high level process of reflection on patient mobility and healthcare 
developments in the European Union,133 cross-border care was described as a general 
term which covers both cooperation in the border regions and more generally, care 
received in another Member State, without any implication of proximity.134 In 
comparison, the Patient Mobility Directive defines cross-border healthcare as 
                                                 
131
 Interestingly, the Committee on the Internal Market and Consumer Protection of the European 
Parliament suggests to make a distinction between (1) cross-border health services (which are situated 
on either side of a border common to two Member States in order to maintain and offer patients a 
high standard of access and care) on the one hand; and, on the other hand, (2) international health 
services within the European Union (which must offer health care for the treatment of rare or orphan 
diseases and/or diseases which require rare and very expensive technologies or provide access to 
care which their Member State or State of residence cannot at present offer them). EP-IMCO (2007), 
26. 
In my opinion, this terminology would have been confusing and the definitions too restrictive, thus it 
is right that the drafters of the PMD did not follow this approach, but applied a more general one. See 
footnote 135. 
132
 See footnote 56. 
133
 The high level process of reflection on patient mobility and healthcare developments in the 
European Union was convened by the European Commission following the conclusions of the Health 
Council on 26 June 2002. The Council and the representatives of the Member States meeting in the 
Council recognised that there would be value in the Commission pursuing a high level process of 
reflection, in close cooperation with the Council and all the Member States, particularly with health 
ministers and other key stakeholders. 
134
 EUComm (2003: 4.) 
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healthcare provided or prescribed in a Member State other than the Member State of 
affiliation.135 This broad approach is abstract enough to be able to absorb all the 
actors and types of cross-border healthcare provision and clearly shows that this 
concept is not restricted to patient mobility. 
Each healthcare provision which – in one or more elements – reaches beyond the 
national border and thus implicates at least one international element136 is considered 
cross-border healthcare:137 cross-border healthcare includes the cross-border mobility 
of all goods, services and persons related to healthcare. Four main fields can be 
distinguished, namely (1) patient mobility, (2) the mobility of healthcare 
professionals, (3) the mobility of health services themselves and (4) institutional 
cross-border collaboration on healthcare.138 
Health professionals139 cross borders in search of higher wages, better working 
conditions, training and career opportunities, and new professional or personal 
experiences.140 Provider mobility comprises all forms of mobility “whether they are 
establishing themselves in another Member State or simply providing services on an 
occasional or temporary basis.”141 
                                                 
135
 Article 3 (e) PMD. 
136
 In case of European cross-border healthcare, the international element must be a European one. 
137
 This definition resembles the concept of PEETERS, who says that cross-border healthcare “covers 
all situations, different from the one the patient is treated in his own Member State (the one he is 
socially insured in) by a local healthcare provider (established in that Member State).” Miek PEETERS 
(2012): Free Movement of Patients: Directive 2011/24 on the Application of Patients’ Rights in 
Cross-Border Healthcare. European Journal of Health Law, Vol 19, p. 29. 
138
 WISMAR et al. (2011b: 2.)  
139
 Article 3 (f) PMD: ‘health professional’ means a doctor of medicine, a nurse responsible for 
general care, a dental practitioner, a midwife or a pharmacist within the meaning of Directive 
2005/36/EC, or another professional exercising activities in the healthcare sector which are restricted 
to a regulated profession as defined in Article 3(1)(a) of Directive 2005/36/EC, or a person 
considered to be a health professional according to the legislation of the Member State of treatment. 
140
 Clare JINKS, Bie Nio ONG and Calum PATON (2000): Mobile medics? The mobility of doctors in 
the European Economic Area. Health Policy, Vol 54 Issue 1, p. 57; Bruno MARCHAL and Guy 
KEGELS (2003): Health workforce imbalances in times of globalization: brain drain or professional 
mobility? The International Journal of Health Planning and Management, Vol 18 Issue S1, p. 95; 
Matthias WISMAR, Irene A. GLINOS, Claudia B. MAIER, Gilles DUSSAULT, Willy PALM, Jeni 
BREMNER and Josep FIGUERAS (2011): Health professional mobility and health systems: evidence 
from 17 European countries. Euro Observer, Vol 13 No 2, 
http://www.euro.who.int/__data/assets/pdf_file/0006/145158/EuroObserver-Summer-2011_web.pdf 
(16 August 2011), p. 1. 
141
 Miek PEETERS, Martin MCKEE and Sherry MERKUR (2010): EU law and health professionals. In 
Elias MOSSIALOS, Govin PERMANAND, Rita BAETEN and Tamara K. HERVEY (eds.): Health Systems 
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In certain cases, cross-border healthcare can be realised without either the patient or 
the provider moving: healthcare services can be provided from a distance. This 
means that the services ‘move’ across borders themselves by using modern 
information and communication technology – typically telemedicine142 – to transfer 
or exchange diagnostics, expert advice, tests or images.143 In these cases the real 
mobility element is missing and is replaced by ICT.144 
Finally, cross-border healthcare also includes cross-border collaboration between 
healthcare providers – mainly between hospitals145 – or between providers and 
insurance institutions to support patient flow or to ensure proper and adequate care 
for patients.146 
Although theoretically these forms can be clearly distinguished, in real life situations, 
they often appear together in the context of cross-border healthcare provision and are 
inseparable.147 
                                                                                                                                          
Governance in Europe – The Role of European Union Law and Policy. New York: Cambridge 
University Press, p. 592. On the recognition of health professionals’ qualification see the European 
Parliament and Council Directive 2005/36/EC. 
142
 Telemedicine is the provision of healthcare services, through use of ICT, in situations where the 
health professional and the patient (or two health professionals) are not in the same location. It 
involves secure transmission of medical data and information, through text, sound, images or other 
forms needed for the prevention, diagnosis, treatment and follow-up of patients. European 
Commission: Communication from the Commission to the European Parliament, the Council, the 
European Economic and Social Committee and the Committee of the Regions on telemedicine for the 
benefit of patients, healthcare systems and society. COM (2008) 689 final, 4. 11. 2008, http://eur-
lex.europa.eu/LexUriServ/LexUriServ.do?uri=COM:2008:0689:FIN:EN:PDF (17 August 2011), p. 3. 
143
 WISMAR et al. (2011b: 14.). 
144
 See this issue in Chapter V. 
145
 One of the most successful cross-border arrangements functions between the Universitätsklinikum 
Aachen in Germany and the university hospital of Maastricht. “The two institutes have agreed on a 
contract for top clinical patient care as well as research and training in the fields of cardiovascular 
diseases, oncology and transplant medicine.” http://www.english.azm.nl/info/azMorganisatie/6011 
(17 August 2011). On the topic of cross.border hospital collaboration, see Irene A. GLINOS and 
Matthias WISMAR (2013): Hospitals and Borders – Seven case studies on cross-border collaboration 
and health system interactions. European Observatory on Health Systems and Policies. 
http://www.euro.who.int/__data/assets/pdf_file/0019/233515/e96935.pdf (23 November 2014). 
146
 In the framework of the HealthACCESS Project, six categories of cross-border collaboration were 
classified. Reinhard BUSSE, Markus WÖRZ, Thomas FOUBISTER, Elias MOSSIALOS and Philip 
BERMAN (2006): Mapping Health Services Access: National and Cross-Border Issues – Final Report. 
HealthACCESS Project, 
http://ec.europa.eu/health/ph_projects/2003/action1/docs/2003_1_22_frep_en.pdf (17 August 2011), 
p. 22. 
147
 For instance, one can easily picture a situation in which a doctor from MS A needs to ask for the 
medical records of the patient affiliated with MS B, who travelled to receive healthcare in MS A, from 
his/her general practitioner in MS B. Or another situation, when a patient temporarily staying in MS 
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II.3.2. The concept of cross-border patient mobility 
The opinions in legal literature on what can be considered as patient mobility 
slightly differ. Two main approaches can be observed: (1) whereas PALM and 
GLINOS say that “(f)ree movement of patients – or patient mobility, as it is commonly 
referred to – implies people accessing health care services outside their home 
state”148 and thus patient mobility includes any type of patient movement involving 
consumption of healthcare services abroad, (2) in another article, GLINOS and her 
colleagues define cross-border patient mobility as “the movement of a patient 
travelling to another country to seek planned healthcare,”149 narrowing down the 
notion of patient mobility to scheduled care and excluding unplanned healthcare 
abroad from its scope.150 
 
It is important to note that there are many widely used terms with similar meanings 
concerning persons receiving healthcare abroad. A clear distinction has to be made 
between them. One of the most commonly used expressions is medical tourism. I 
share the opinion that “the industry-driven term151 ‘medical tourism’ insinuates 
leisurely travelling and does not capture the seriousness of most patient mobility”.152 
The term tourism is often affixed to diverse forms of patient movements, such as 
‘abortion tourism’,153 ‘reproductive tourism’,154 ‘stem cell tourism’,155 ‘transplant 
                                                                                                                                          
A, whereas insured in MS B, when in need during his/her stay, prefers to visit a doctor in MS A, who 
originates from MS B, but came to establish a practice in MS A. 
148
 Willy PALM and Irene A. GLINOS (2010): Enabling patient mobility in the EU: between free 
movement and coordination. In MOSSIALOS et al. (2010: 509.). 
149
 GLINOS et al. (2010a: 1145.). See footnote 57.  
150
 STRBAN shares this view by stating that “the notion of patient mobility can hardly be used for 
unplanned treatment, since a person is not moving as a patient, but only becomes one in another 
Member State.” Grega STRBAN (2013): Patient mobility in the European Union: between social 
security coordination and free movement of services. ERA Forum, Vol 14 Number 3, p. 398. 
151
 In this context, medical tourists are looked at as consumers on the healthcare market. LUNT and 
CARRERA (2010: 28.) and CONNELL (2013: 2.). 
152
 GLINOS et al. (2010a: 1146.). MAINIL observes that there is “a shift between EU perceptions of 
patient mobility and Asian/US perceptions of the medical tourist.” In his opinion, whereas the former 
focuses on individual patients and thus the demand-side of healthcare, the latter follows a rather 
supply-side logic and puts the emphasis on the medical tourism industry. MAINIL suggests that the 
term ‘transnational healthcare’ “fits both types of discourse and practice.” MAINIL (2012: 48-49.). 
153
 See footnote 78. 
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tourism’156 or even ‘euthanasia tourism’,157 in which cases the intention behind the 
patient movement is far from the traditional notion of tourism. On the contrary, these 
are usually very delicate situations that involve persons who are desperately seeking 
the medical treatment which their state of health requires.158 However, medical 
tourism also includes situations in which health services159 and ancillary touristic 
services are closely linked together. Health tourism is a broader category. It 
encompasses not only medical tourism, which always relates to a medical 
intervention, but any travel with direct or indirect health purposes, such as recreation, 
sport activities or wellness services.160 In KINCSES et al (2009), within the notion of 
health tourism, medical tourism and recreation or wellness tourism is distinguished. 
Within the latter, wellness and sport activities can be differentiated from medical 
wellness, which comprises “measures guided by medical science, for sustained 
improvement of quality of life, and of the subjective sense of well-being, by means of 
                                                                                                                                          
154
 See footnote 79. 
155
 See footnote 80. 
156
 HENN (1999: 202.); Debra BUDIANI-SABERI and Francis Leo DELMONICO (2008): Organ 
Trafficking and Transplant Tourism: A Commentary on the Global Realities. American Journal of 
Transplantation, Vol 8, pp. 925-929. 
157
 See footnote 81. 
158
 Andrea WHITTAKER (2008): Pleasure and pain: Medical travel in Asia. Global Public Health, Vol 
3 Issue 3, p. 272; SONG (2010: 386.); CONNELL (2013: 3.). 
159
 These healthcare services most often are dental or cosmetic surgery services. For instance, in a 
research paper’s definition of medical tourism, expressed emphasis is put on these treatments: 
“travelling to a destination in another country to receive medical, dental and surgical care because 
the destination enables better access to care, provides higher quality care or offers the same 
treatment at a more affordable price.” Grail Research (2009): The Rise of Medical Tourism. 
http://www.grailresearch.com/pdf/ContenPodsPdf/Rise_of_Medical_Tourism_Summary.pdf (19 
August 2011), p. 2. 
160
 KINCSES Gyula, BORBÁS Ilona, MIHALICZA Péter, VARGA Eszter, UDVARDY Enikı (2009): A 
gyógyturizmus tendenciái a világban (Tendencies of health tourism around the world). Egészségügyi 
Gazdasági Szemle (Journal of Health Economics) Issue 5, 
http://www.weborvos.hu/adat/files/2008/egsz3337.pdf (6 August 2011), p. 34. See also John 
CONNELL (2006): Medical tourism: Sea, sun, sand... and surgery? Tourism Management, Vol 27, p. 
1098 and Percivil M. CARRERA and John F. P. BRIDGES (2006): Globalization and healthcare: 
understanding health and medical tourism. Expert Review of Pharmacoeconomics & Outcomes 
Research, Vol 6 No 4, pp. 447-454. CONNELL says that health tourism is “primarily concerned with 
low-key, therapeutic and non-invasive ’procedures’ – while allowing the inclusion of dentistry and 
check-ups, since that might lead to medical intervention.” CONNELL (2013: 2.). 
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prevention and health promotion for which the individuals themselves assume 
responsibility, and motivation for a health-conscious lifestyle.” 161 
 
While browsing through the various definitions, an important issue must be kept in 
mind: although a great variety of patient movements can be detected in the European 
Union, basically two different types of cross-border patient mobility can be defined 
to which different legal rules apply.162 As mentioned above,163 patient mobility 
contains two elements: border-crossing movement and the need for healthcare. 
However, it is decisive which component occurs first.164 
(1) On the one hand, insured persons might need healthcare while (staying or 
residing) abroad. They first cross the border, then become in need of healthcare. The 
reason for the border-crossing is legally irrelevant in this case; the point is that the 
mobility precedes the need for healthcare. So at the moment of going abroad the 
persons cannot be considered patients in a narrow sense because they do not seek to 
receive healthcare. (2) On the other hand, people may choose to look for medical 
treatment abroad. Strictly interpreted, they are the real mobile patients who, when 
the need of healthcare arises, decide to travel to another Member State to obtain 
medical treatment.165 
In theory, this distinction is rather clear-cut. However, it must be kept in mind that in 
real life the circumstances can be highly complicated, sometimes making it 
impossible to investigate which element of patient mobility appeared first. Even 
more so since the distinction is based on the intention of the person concerned: 
                                                 
161
 This definition was created by the 1st Medical Wellness Congress 2007 in Berlin. http://i-m-w-
a.com/definition.html (9 July 2013). 
162
 The Coordination Regulations have traditionally made a strict distinction between planned and 
unplanned care, which has remained until today. However, a change of approach can be seen, since 
the Patient Mobility Directive does not make such distinction and is applicable to both types. One 
might wonder whether the approach of the Regulations is still valid in today’s circumstances and 
serves the interest of the patients. See footnote 30. This issue is further dealt with in section III.2.2.1. 
and Chapter VI. infra. 
163
 See the introductory part of this chapter supra. 
164
 PALM and GLINOS (2010: 529.). 
165
 This double approach can be seen in the PMD’s patient definition as well (see under section II.2.2 
supra), as it distinguishes between persons who seek to receive healthcare in another Member State 
and persons who actually receive medical treatment outside the Member State of affiliation. Article 3 
(h) PMD. 
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whether he/she travelled abroad for any other reason than receiving healthcare and 
became in need of medical intervention during the stay in the other country, or 
whether the purpose of his/her journey was exactly to obtain medical treatment 
outside his/her country of residence. This leads to the question how the intention of 
the patient can be revealed.166 
 
To sum up, according to the broad approach, cross-border patient mobility within the 
European Union can be defined as a situation in which the insured person receives 
healthcare in a Member State other than the Member State of affiliation. In other 
words, the Member State of treatment differs from the Member State of residence. 
Similarly, the European Court of Justice considers it cross-border patient mobility, 
when a healthcare provider provides healthcare without moving from the Member 
State in which he/she is established for recipients established in other Member 
States.167 
In the narrow approach, patient mobility means that the insured person travels 
abroad to seek healthcare in a Member State other than the Member State of 
affiliation (Table 2 infra). 
 
Table 2: The concept of patient mobility 
Cross-border healthcare 
Patient mobility 
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Broad approach to patient mobility 
people needing 
healthcare while residing 
in a Member State other 
than the Member State of 
affiliation 
people needing 
healthcare while staying 
in a Member State other 
than the Member State of 
affiliation 
Narrow approach to 
patient mobility 
people travelling to a 
Member State other than 
the Member State of 
affiliation to seek 
healthcare 
Source: the author’s own summary 
                                                 
166
 This question is dealt with in detail in section III.2.2.1. infra. 
167
 C-211/08 Commission v Spain [ECR 2010 Page I-05267], 48. 
The ECJ defined cross-border service provision uniformly in relation to other services: see C-384/93 
Alpine Investments [ECR 1995 I-1141], 21 (financial services); C-243/01 Gambelli and Others [ECR 
2003 I-13031], 53 (betting services). 
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In this dissertation, the phenomenon of patient mobility is analysed primarily from a 
legal point of view without limiting the scope to planned treatments. In the following 
chapters, the diverse aspects of cross-border patient mobility are observed 
commencing with the issues related to access to healthcare across borders. 
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III. ACCESS TO HEALTHCARE ABROAD 
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Whether a person can access the healthcare system of a Member State other 
than the one he/she is affiliated to, is primarily a legal question. Therefore, first of 
all, the question must be raised who is legally entitled to obtain medical treatment 
outside of the Member State where he/she is covered by the national healthcare 
scheme, and in which circumstances. 
 
However essential it is to have a certain right, it is equally significant how that right 
can be used in real life situations. For European patients, having the right to travel 
abroad and receive healthcare in another Member State is a theoretical matter, 
whereas being able to act upon this right in practice is of utmost importance. 
Therefore, after observing the existence of the right to access to cross-border 
healthcare, the realisation of this right must be investigated. Carrying out this 
investigation, a problem-based approach is followed and the potential obstacles of 
patient movements are focused on. In each case, the aim is to find realistic solutions 
to tackle the hurdle in question and improve accessibility in favour of the patients. 
 
As it is described above, in this chapter four of the research questions168 are 
answered: 
(1) Do European patients have the right to obtain healthcare abroad? 
(2) Are European patients able to exercise their cross-border healthcare rights? 
(3) Which are the obstacles of cross-border patient movements? 
(4) Is the current legal framework capable to tackle these obstacles? 
  
                                                 
168
 See section I.2. 
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III. 1. THE RIGHT TO ACCESS TO HEALTHCARE ACROSS BORDERS 
In the first half of this chapter, the existence of the right to access to 
healthcare in another Member State is the focal point of the observations. The main 
question posed is whether people have the right under Union law to receive medical 
treatment beyond the borders of the country they are affiliated to. 
Since it was shown in the above sections that the phenomenon of cross-border patient 
mobility includes two components,169 it can be said that from a legal point of view, 
the right to cross-border patient mobility is a result of the fusion of two rights: the 
right to move freely across borders and the right to health(care). First, the origins of 
these rights are outlined briefly. Then, the right to cross-border patient mobility itself 
is examined by analysing the legislative basics of its different aspects in the 
European Union, such as healthcare, social security and public health, and the 
protection of migrants’ social rights. Subsequently, the evolution of this right and its 
legislative background is dealt with. 
III.1.1. The right to move freely across borders 
Ever since the dawn of human evolution, humans have migrated:170 it became 
a genuine characteristic of human history and also a part of mankind’s survival 
strategy. However, the causes and methods of migration have changed enormously 
throughout the centuries171 and certain limitations of such movements came into 
existence. Nowadays the countries have the authority – as a part of their sovereignty 
– to regulate who can cross their borders either to enter the state or to leave it, and 
                                                 
169
 See Chapter II. supra. 
170
 John Noble WILFORD (2007): Skull Supports Theory of Human Migration. The New York Times, 
12 January 2007, http://www.nytimes.com/2007/01/12/science/12skull.html (15 July 2013). 
171
 See among others Douglas S. MASSEY, Joaquin ARANGO, Graeme HUGO, Ali KOUAOUCI, Adela 
PELLEGRINO and J. Edward TAYLOR (1993): Theories of International Migration: A Review and 
Appraisal. Population and Development Review, Vol 19 No 3, pp. 431-466 and Roel JENNISSEN 
(2004): Macro-economic determinants of international migration in Europe. Amsterdam: Dutch 
University Press. 
Gabriella BERKI: Cross-border patient mobility: The legal framework of obtaining 
healthcare abroad within the European Union – a patients’ perspective 
63 
 
under which conditions. These arrangements are justified by safety issues on the one 
hand and by controlling and monitoring the flow across the national borders on the 
other.172 The regulatory power of the states is nevertheless restricted by various legal 
instruments both on international and regional level which aim to ensure the 
individual’s right to move freely across borders. 
 
On international level, the human right treaties of the United Nations (hereinafter 
also referred to as UN) specify this right. Article 13 (2) of the Universal Declaration 
of Human Rights173 and Article 12 of the International Covenant on Civil and 
Political Rights stipulate that everyone shall be free to leave any country, including 
his own174 and this right [...] shall not be subject to any restrictions except those 
which are provided by law, are necessary to protect national security, public order 
[...], public health or morals or the rights and freedoms of others, and are consistent 
with the other rights recognized in the [...] Covenant.175 The right to leave176 
guaranteed by the aforementioned treaties was complemented by the right to enter in 
the International Convention on the Protection of the Rights of All Migrant Workers 
and Members of Their Families adopted by the UN in 1990.177 
In the European region the European Union’s legislation on free movement is the 
most remarkable. European integration is based on the so-called four fundamental 
freedoms covering the free movement of persons, services, goods and capital.178 
Originally, when the predecessor of the European Union, the European Economic 
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 David JACOBSON (1996): Rights across borders: Immigration and the decline of citizenship. 
Baltimore: Johns Hopkins University Press, p. 21. 
173
 Article 13 (2) of the Universal Declaration of Human Rights: Everyone has the right to leave any 
country, including his own, and to return to his country. 
174
 Article 12 (2) of the International Covenant on Civil and Political Rights. 
175
 Article 12 (3) of the International Covenant on Civil and Political Rights. 
176
 On this issue in more details, see Satvinder S. JUSS (2004): Free Movement and the World Order. 
International Journal of Refugee Law, Vol 16 Issue 3, pp. 289-335; Colin HARVEY and Robert P. 
BARNIDGE (2005): The right to leave one’s own country under international law. 
http://www.qub.ac.uk/schools/SchoolofLaw/Research/HumanRightsCentre/Publications/ResearchRep
orts/researchfilestore/Filetoupload,56100,en.pdf (16 July 2013). 
177
 Article 8 (2) of the International Convention on the Protection of the Rights of All Migrant 
Workers and Members of Their Families: Migrant workers and members of their families shall have 
the right at any time to enter and remain in their State of origin. 
178
 On the four freedoms, see Catherine BARNARD (2010): The substantive law of the EU: the four 
freedoms. Oxford, New York: Oxford University Press. 
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Community (hereinafter also referred to as EEC), was established in 1957 its 
Founding Fathers179 aimed to open the borders of the Member States – with the 
intention to support the functioning of the common market – only for workers and 
their family members.180 Thus, the promotion of the freedom of movement of 
workers and the removal of all possible obstacles which may hinder the flow of 
labour force were major concerns of the European Union from its very creation.181 
Throughout the decades, this purely economic approach became out of date as the 
Community revaluated its aims and extended its field of activities. Nowadays, the 
Treaty on the Functioning of the European Union ensures the right to move and 
reside freely within the territory of the Member States182 for each European citizen183 
without any discrimination on grounds of nationality.184 
It can be concluded from this that EU citizens do hold the right under Union law to 
cross borders freely within the European Union and travel to another Member State, 
and that the mobility element of patient mobility is thus ensured on a theoretical 
level. 
III.1.2. The right to health(care) 
The right to health is a highly complex legal issue the exact meaning of which 
is somewhat unclear.185 It is generally categorised as a second-generation human 
                                                 
179
 On the political leaders who mainly inspired the creation of the European Community, see 
http://europa.eu/about-eu/eu-history/founding-fathers/index_en.htm (31 July 2012). 
180
 Article 48 of the Treaty of Rome establishing the European Economic Community. 
181
 The first significant legislative act adopted in this field was Regulation (EEC) No 1612/68 of the 
Council of 15 October 1968 on freedom of movement for workers within the Community. OJ L 257 
of 19 October 1968. Since it had been substantially amended several times, it was recently codified 
and repealed by Regulation (EU) No 492/2011 of the European Parliament and of the Council of 5 
April 2011 on freedom of movement for workers within the Union. OJ L 141 of 27 May 2011. A 
selected list of ECJ cases on free movement of workers can be found on the website of the European 
Commission: http://ec.europa.eu/social/main.jsp?catId=953&langId=en (17 July 2013). 
182
 Article 20 (2) (a) TFEU. 
183
 Article 20 (1) TFEU. 
184
 Article 18 TFEU. 
185
 On the problem of its definition see Brigit C. A. TOEBES (1999): The Right to Health as a Human 
Right in International Law. Antwerpen, Groningen, Oxford: Intersentia, pp. 16-20. 
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right,186 also called socio-economic human right. As opposed to first-generation civil 
and political rights promoting equal treatment of individuals and prohibiting state 
interference (also called negative rights), second-generation economic, social and 
cultural rights provide equal opportunity and evoke active measures of the state (also 
called positive rights).187 
The right to health – the term most often used on international level188 – was first189 
formulated in the Weimar Constitution190 in Germany in 1919, and throughout the 
20th century it appeared in numerous national constitutions and human rights treaties. 
On international level, it was introduced by the Charter of the United Nations in 
1945, which stipulates that the United Nations shall promote [...] solutions of 
international economic, social, health, and related problems.191 Shortly after, the 
World Health Organization (hereinafter also referred to as WHO) came to existence 
in 1946 and its Constitution gave a rather individual character to the right to health, 
defining it as the right to the enjoyment of the highest attainable standard of 
physical, mental and social well-being, which is one of the fundamental rights of 
every human being without distinction of race, religion, political belief, economic or 
social condition.192 While the UN Universal Declaration on Human Rights of 1948 
                                                 
186
 On human rights issues related to the right to health see also Elisabeth WICKS (2007): Human 
Rights and Healthcare. Oxford and Portland: Hart Publishing. 
187
 SÁRI János (2005): Alapjogok (Fundamental rights). Budapest: Osiris Kiadó, p. 19 and TRÓCSÁNYI 
László (2006): A mi alkotmányunk (Our constitution). Budapest: Complex Kiadó Kft., p. 474. On the 
distinction between positive and negative rights, see also Tom L. BEAUCHAMP and Ruth R. FADEN 
(1979): The Right to Health and the Right to Health Care. The Journal of Medicine and Philosophy, 
Vol 4 No 2, p. 120. 
188
 On the different terms concerning the right to health see TOEBES (1999: 16-17.). 
189
 Although a right to health was first adopted in the 20th century, TOEBES is of the opinion that its 
roots can be found in the public health measures which have existed since the ancient civilisations. 
TOEBES (1999: 8.). 
190
 The Weimar Constitution (Die Verfassung des Deutschen Reichs also known as Weimarer 
Reichsverfassung) was adopted on 11 August 1919 and governed Germany during the era of the 
Weimar Republic (1919-1933). In Article 161 (1), it places the responsibility on the state to establish 
an insurance scheme, which – among others – aims to promote the conservation of the insured 
persons’ health. http://www.documentarchiv.de/wr/wrv.html (30 December 2013). 
191
 Article 55 (b) of the Charter of the United Nations. 
192
 Preamble of the Constitution of the World Health Organization. 
This definition was reaffirmed by the Alma Ata Declaration in 1978. However, it goes further by 
stating that governments have a responsibility for the health of their people which can be fulfilled only 
by the provision of adequate health and social measures. 
http://www.who.int/publications/almaata_declaration_en.pdf (20 Aug 2014). 
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lays down that everyone has the right to a standard of living adequate for the health 
and well-being of himself and the right to security in the event of […] sickness,193 
Article 12 of the UN International Covenant on Economic, Social and Cultural 
Rights (1966) completely corresponds to the wording of the WHO’s Constitution as 
well as Article 14 of the Universal Declaration on Bioethics and Human Rights 
adopted by the UN Educational, Scientific and Cultural Organisation (hereinafter 
also referred to as UNESCO) in 2005. 
Similarly, on European level the Council of Europe (hereinafter also referred to as 
COE) incorporated the right to health – either implicitly194 or expressly – into its 
human rights treaties. The European Social Charter adopted in 1961 and revised in 
1996 imposes exact tasks on the contracting parties to take appropriate measures to 
guarantee the right to the protection of health. These measures include the removal of 
the possible causes of ill health, the provision of advisory and educational facilities 
for the promotion of health and the encouragement of individual responsibility in 
matters of health and the prevention of epidemic, endemic and other diseases.195 In 
1997, the European Convention on Human Rights and Biomedicine (also called the 
Oviedo Convention) touched upon the right to health by prescribing that the parties 
[...] shall take appropriate measures with a view to providing [...] equitable access 
to health care of appropriate quality.196 
The Charter of Fundamental Rights of the European Union (hereinafter also referred 
to as CFREU), which was attached to the Treaty of Lisbon and became legally 
binding from 1 December 2009, also stipulates that everyone has the right of access 
to preventive health care and the right to benefit from medical treatment under the 
conditions established by national laws and practices. A high level of human health 
                                                 
193
 Article 25 (1) of the UN Universal Declaration of Human Rights. 
194
 Most authors agree that “the right to healthcare is also indirectly supported by the more general 
right to life” (Article 2 of the Convention for the Protection of Human Rights and Fundamental 
Freedoms adopted by the COE in 1950). Elisabeth RYNNING (2008): The Ageing Populations of 
Europe – Implications for Health Systems and Patients’ Rights. European Journal of Health Law, Vol 
15, p. 303 and WICKS (2007: 13-14.). See also Andreas WALUS (2015): National healthcare planning 
and the internal market: A conceptual view on the impact of EU law on Member States’ regulatory 
autonomy in the field of healthcare. European Journal of Social Security, Vol 17 No 1, p. 53. 
195
 Article 11 of the European Social Charter. 
196
 Article 3 of the European Convention on Human Rights and Biomedicine. 
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protection shall be ensured in the definition and implementation of all the Union's 
policies and activities.197 Notwithstanding the possible legal consequences of failing 
to respect and guarantee this right, this provision is presumed to have a deeper 
political effect, namely by inspiring the institutions of the Union – especially the 
European Court of Justice – “to develop and embroider a new right to effective and 
speedy medical treatment.”198  
At the same time, among the provisions on social security, it is expressly confirmed 
that (t)he Union recognises and respects the entitlement to social security benefits 
and social services providing protection in cases such as [...] illness, [...] in 
accordance with the rules laid down by Community law and national laws and 
practices.199 And similarly, (e)veryone residing and moving legally within the 
European Union is entitled to social security benefits [...] in accordance with 
Community law and national laws and practices.200 One may wonder what this 
exactly means from the patients’ point of view. Does it imply that a patient can 
establish a claim based on these provisions? Using the expression “recognises and 
respects” in Article 34 (1) softens the legal effect of the provision and does not place 
a responsibility on the Member States. Thus, it can be deduced that the Member 
States do not have any obligation to develop their healthcare schemes or offer 
healthcare benefits they did not offer before as long as their legislation is in 
conformity with Union law. So at the end of the day, the CFREU does not create any 
specific healthcare entitlement for patients. 
 
Although these human rights treaties201 clearly show that the right to health covers a 
wide range of health-related issues (e.g. the right to safe drinking water or adequate 
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 Article 35 CFREU. 
198
 Alina KACZOROWSKA (2006): A Review of the Creation by the European Court of Justice of the 
Right to Effective and Speedy Medical Treatment and its Outcomes. European Law Journal, Vol 12 
No 3, p. 346. On the evolution of the right to cross-border healthcare, see section III.1.3.4. infra. 
199
 Article 34 (1) CFREU. 
200
 Article 34 (2) CFREU. 
201
 The list of treaties dealing with the right to health is far not complete; I took the liberty to select 
those ones I find the most important. For a complete list consult World Health Organization (2008): 
The Right to Health. Fact Sheet No. 31, 
http://www.ohchr.org/Documents/Publications/Factsheet31.pdf (24 July 2012), p. 9. 
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sanitation),202 the focus of this dissertation concerns only a part of it, namely the 
right to healthcare203 or as it is formulated in the CFREU, the right of access to 
healthcare. It is of crucial importance for each person to have access to good quality 
health services, goods and facilities without any discrimination.204 However, this 
individual right – as it can be seen from the wording of these treaties – evokes 
positive duties on the states’ side: they are required to take all necessary measures to 
ensure access for all.205 So the question should be raised whether the Member States 
of the European Union take all the measures necessary to guarantee equal access for 
all, irrespective of the nationality of the person concerned. Nevertheless, Union law 
leaves this to the national legislatures.206 
III.1.3. The right to cross-border healthcare 
As can be concluded from the legal documents enumerated in the former 
sections, in the European Union both the right to free movement207 and the right to 
access to healthcare208 is guaranteed by Union law. However, the question still 
remains whether the coexistence of these rights is identical to the existence of the 
right to cross-border patient mobility. In the European Union, the right to access to 
healthcare across borders is rooted in the protection of the social security rights of 
migrant workers. It thus grew out of the coordination of European social security 
schemes. It was improved through the proactive approach of the European Court of 
Justice, and became a cross-cutting field between the areas of free movement, social 
security and public health. The legislative basics of these fields are outlined in this 
section infra. 
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In relation to patient mobility, the main question which must be raised concerning 
the relationship between the right to healthcare and patients’ cross-border mobility is 
whether the right of access to healthcare extends beyond the borders of the state of 
affiliation.209 Traditionally, in line with the principle of territoriality,210 states cannot 
take the responsibility to ensure protection for all persons.211 Therefore, they use 
territorial elements in order to define and organise their systems: they are free to use 
these territorial elements in defining the scope of their social security schemes, 
including healthcare systems.212 WATSON adds that “(t)he territorial basis of social 
security systems leads therefore to the non-recognition by the law of one country of 
social security rights acquired in other countries and to the non-availability of 
benefits outside the territory of the country under whose legal system the title to 
benefit is acquired.”213 The principle of territoriality serves three basic objectives: (1) 
controlling the quality of care, (2) protecting the financial sustainability of the 
national system and (3) ensuring adequate planning of healthcare infrastructure and 
capacity.214 
However, “patient mobility goes beyond conventional territorial logic.”215 It 
deterritorialises national healthcare schemes and requires Member States to handle 
external elements within their healthcare systems. For example, a person covered 
may receive medical care in the territory of another Member State, or the Member 
State concerned may provide treatment for a person who is not affiliated to the 
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state’s healthcare system. The question is whether the above mentioned objectives 
can still be achieved with a more open legal structure. 
 
Since these matters are as old as the modern social insurance schemes themselves,216 
several legal instruments have been developed in the field of international social 
security in order to overcome the conflict of laws which occurs in such cases. These 
instruments aim to coordinate the social security systems of the individual states “in 
such a way as to ensure that the migrant does not suffer any loss of rights”217 due to 
practising his/her right to free movement. This function can be achieved by 
concluding bi-218 or multilateral219 agreements or by means of supranational 
legislation within the European Union. Despite their discrepancies, these legal tools 
are posited on the same logic based on the same principles: (1) migrants must be 
treated equally with the citizens of the state concerned and may not be discriminated 
against on the ground of their nationality (principle of equal treatment); (2) migrants 
may claim benefits on the basis of their aggregated insurance period irrespective in 
which country they completed those periods (principle of aggregation); (3) the 
territorial requirements of national social security systems must be removed, so the 
benefits granted must be available for migrants in the territory of other states 
(principle of exportability); (4) the conflict of laws must be prevented, so migrants 
are aware of which social security rules apply to them.220 
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As seen supra, the right to healthcare is generally considered a positive right.221 
However, it is important to note that the right to cross-border healthcare appears in 
the case law of the European Court of Justice as a rather negative right, in relation to 
which the Member States are obliged to remove all possible obstacles in order to 
guarantee the free movement of patients. It is regarded as “a right promoting the 
individual’s liberty”,222 namely the freedom to choose from which provider the 
patient wants to receive treatment regardless in which Member State the healthcare 
provider is established. 
In each case, if a legal subject is observed, one of the first questions that should be 
posed is who has the legislative competence to regulate the matter in question.223 
This issue is especially crucial in Union law.224 Therefore, this section outlines how 
the legislation on EU level functions and complements national legislations in this 
field. To understand the controversial legal nature of cross-border patient mobility, 
the intersection of different fields of the European Union’s policy in which the 
current issue lies, will be examined further below. 
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III.1.3.1. The legislation on healthcare within the European Union 
As MCKEE and MOSSIALOS point out “there is a paradox. Health systems in 
Europe are diverse, yet they are also interdependent. In themselves, they are exempt 
from European law, yet almost everything they do, and those elements that are 
essential for them to function, are governed by it.”225 
The social security systems of the Member States are based on centuries of tradition. 
Each national social security legislation is unique:226 the result of an organic 
development which is constantly taking place and reflects on the one hand the recent 
historical, social, economic, legal and political circumstances of the state and on the 
other hand the upcoming challenges. Therefore, although the Member States are 
highly autonomous to determine their social security – including healthcare – 
schemes and tend to defend this competence obstinately,227 they face similar 
problems228 some of which might be tackled more efficiently on supranational 
level.229 
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In the field of social dimension, including healthcare, competences are split between 
the Member States and the Union. I do share the opinion that in this regard the 
actions of the European Union can be grouped into two distinct categories. (1) The 
first category consists of those actions which intend to implement the European 
Union’s social and health policy, to improve the social schemes mainly by 
harmonising measures230 and to encourage cooperation among the Member States.231 
(2) The second set of tools aims to ensure the freedom of movement of persons by 
removing the potential social disadvantages related to migration within the European 
Union, such as impediments to access to healthcare in another Member State, by 
means of coordination.232 
 
Before observing the exact provisions of the legislation, it is inevitable to make a 
strict distinction between harmonisation and coordination within Union law.233 While 
harmonisation intends to approximate the national laws and to reduce the disparities 
between them by introducing common values, targets, guidelines or a minimum level 
of standards, coordination links the systems of the individual Member States 
together without intervening in the national legislation in order to serve a purpose of 
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the Union. On the one hand, according to VOGELAAR’s definition, “harmonization is 
the creation by the Community of the legal provisions required for its existence and 
development and which have at the same time an effect on national law in the sense 
that it will have to be modified or supplemented, i. e. adapted to the Community 
rule.”234 In practice, this effect is achieved on EU level by adopting directives which 
must be implemented by the Member States. On the other hand, PENNINGS defines 
European social security coordination as a set of rules which “intend to adjust social 
security schemes in relation to each other […] in order to regulate transnational 
questions, with the objective of protecting the social security position of migrants.”235 
For this purpose, regulations are adopted. 
Although their objectives and functioning mechanisms considerably differ from each 
other (summarised in Table 3 infra), in certain cases it is not easy to make a 
distinction236 mainly because the definition of coordination within Union law is 
lacking and the Court has not taken the opportunity so far to provide a definition 
either.237 However, it dealt with the matter in numerous cases and repeatedly came to 
the conclusion that given the disparities between one Member State and another in 
matters of social security cover and the fact that the objective of social security 
coordination regulations is to coordinate the national laws but not to harmonise 
them, the conditions attached to a certain benefit in another Member State may, 
according to the circumstances, be to the insured person’s advantage or 
disadvantage.238 
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Table 3: The distinction between harmonisation and coordination 
 Harmonisation Coordination 
Objective To approximate national 
schemes 
To link national schemes 
together 
Effect on disparities between 
national legislations 
Differences decrease or even 
cease. 
Differences remain to exist. 
Legal instrument Directive Regulation 
Impact on national 
legislations 
Member States must implement 
the directives through which the 
substance of national 
legislations might need to be 
changed. 
The regulations are directly 
applicable, they affect the 
sphere of operation of national 
legislations leaving the legal 
content untouched. 
Source: the author’s own summary 
 
As will be shown in the next sections, in the field of healthcare legislation both types 
of instruments are used: patient mobility legislation “oscillates between coordination 
and harmonisation.”239  
III.1.3.2. The legislation on social security and public health 
As to the first group of measures mentioned above,240 the Treaty stipulates 
among the provisions on social policy241 that the Union shall support and 
complement the activities of the Member States – among others – in the field of social 
security and social protection of workers.242 This provision basically says that the 
Member States have most of the legislative power in this domain. The measures 
taken by the European Union in order to support and complement the Member 
States’ activities are thus limited to the extent that the Member States have not 
exercised their competence.243 This implies that in the absence of harmonisation at 
Community level, it is for the legislation of each Member State to determine, first, the 
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conditions concerning the right or duty to be insured with a social security scheme 
and, second, the conditions for entitlement to benefits.244 
Moreover, the Treaty itself adds that the provisions adopted by the European Union 
shall not affect the right of Member States to define the fundamental principles of 
their social security systems and must not significantly affect the financial 
equilibrium thereof.245 This phrase constantly returns in the rulings of the Court on 
cross-border healthcare provision as well, which confirms that Community law does 
not detract from the powers of the Member States to organise their social security 
systems,246 but at the same time, Member States must nevertheless comply with 
Community law when exercising those powers.247 FLEAR points out the contradiction 
between these assertions by saying that “the ECJ flatters the Member States by 
asserting their sovereignty, only to deliver a legal conclusion that places them on the 
defensive.”248 
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In the field of healthcare, the competence of the European Union is limited249 to the 
completion of the national health policies concerning certain issues related to public 
health250 such as preventing physical and mental illness and diseases, obviating 
sources of danger to physical and mental health, reducing drug-related health 
damage,251 safeguarding the quality and safety of organs and substances of human 
origin, blood and blood derivatives252 and of medical products and devices,253 
combating the major cross-border health scourges, monitoring and early warning of 
and combating serious cross-border threats to health and reducing health damage in 
relation to tobacco and the abuse of alcohol.254 The Treaty also emphasises that a 
high level of human health protection shall be ensured in the definition and 
implementation of all the Union's policies and activities.255 
Additionally to what was already mentioned supra concerning the national 
competence in the field of social security, it is incorporated also with regard to 
healthcare that each Union action shall respect the responsibilities of the Member 
States for the definition of their health policy and for the organisation and delivery of 
health services and medical care. The responsibilities of the Member States shall 
include the management of health services and medical care and the allocation of the 
resources assigned to them.256 
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To sum up, from the observation above the following conclusion can be drawn: 
firstly, the Member States are principally free to determine their social security and 
healthcare schemes and secondly, the European Union may complement their 
national measures, but is not permitted to extend its actions beyond the limits of the 
competence which was conferred on it in the Treaty. 
III.1.3.3. The legislation on the protection of migrants’ social rights 
The significant discrepancies257 between the Member States’ national 
healthcare systems258 pose a great threat to persons willing to use their right to free 
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On the typology of European healthcare systems see among others Yves JORENS (2002): The Right to 
Health Care across Borders. In Martin MCKEE, Elias MOSSIALOS and Rita BAETEN (eds.): The Impact 
of EU Law on Health Care Systems. Brussels: P.I.E.-Peter Lang, pp. 83-84; FLEAR (2004: 209.); 
NÉMETH György (2007): Az egészségbiztosítási rendszerekrıl – nemzetközi összehasonlításban I. 
(Healthcare schemes – in international context). Egészségügyi Gazdasági Szemle, Vol 45 Issue 5-6, 
pp.5-7; KARNER Cecília (2008): Nemzetközi egészségügyi finanszírozási modellek és az állam 
szerepvállalása (International models of healthcare financing and the role of the state). Egészségügyi 
Gazdasági Szemle, Vol 46 Issue 2, pp. 3-9; ROBERTS et al. (2009: 6-9.) and FICSÓR Katalin (2011): Az 
egészségügyi ellátórendszer finanszírozási modelljei – nemzetközi kitekintés (Financial models of 
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movement. Thus, unlike what is the case in the field of social policy and public 
health,259 as regards the promotion of free movement the European Union has legal 
permission to adopt coordination measures in the field of social security as are 
necessary to provide freedom of movement for workers; to this end, they shall make 
arrangements to secure for employed and self-employed migrant workers and their 
dependants: (a) aggregation, for the purpose of acquiring and retaining the right to 
benefit and of calculating the amount of benefit, of all periods taken into account 
under the laws of the several countries and (b) payment of benefits to persons 
resident in the territories of Member States.260 This part of the provision, 
“deterritorialising social security”,261 remained basically unchanged262 since the 
formulation of the Treaty of Rome in 1957263 and serves as the legal basis for the 
social security Coordination Regulations thenceforth.264 
It was rather clear for the Founding States that the desired flow of workers within the 
internal market could not be ensured without social security legislation measures,265 
since the workers cannot be expected to move at the expense of losing their social 
rights.266 As the European Commission articulated in the late 1990s, Community 
legislation on social security is a sine qua non for exercising the right to free 
movement of persons.267 The Coordination Regulations seek to prevent a person 
                                                                                                                                          
healthcare systems). In BERKI Gabriella (ed.): Opuscula Szegediensia 4, Szeged: Pólay Elemér 
Alapítvány. 
259
 See section III.1.3.2. 
260
 Article 48 TFEU (Article 51 in the Treaty of Rome). 
261
 WATSON (1980: 35.) and CORNELISSEN (1996: 446.). 
262
 There is a remarkable change, though, in relation to the regime of legislative procedure. Whereas 
under Article 51 of the Treaty of Rome unanimity was required in the Council, according to the Treaty 
of Lisbon the Parliament and the Council must adopt the social security coordination measures acting 
in accordance with the ordinary legislative procedure (ex-codecision). Article 48 TFEU. This change 
does indeed not only strengthen the EP’s position in social security questions, but also facilitates the 
smoother legislative work in this field. 
263
 However, the history of social security coordination within Europe goes far beyond the date of 
birth of the European Communities. See footnote 218. ROBERTS argues that “(t)he need for 
coordination can be traced back […] to 1648 when the Treaty of Westphalia brought the Thirty Years 
War to an end.” ROBERTS (2010: 8.). 
264
 WHITE (2004: 166.). 
265
 On this issue, see Vicki PASKALIA (2007): Free movement, social security and gender. Oxford and 
Portland: Hart Publishing, pp. 54-55. 
266
 PENNINGS (2010: 3.) and WATSON (1980: 35.). 
267
 European Commission: Proposal for a Council Regulation (EC) on coordination of social security 
systems. COM (1998) 779 final, 21. 12. 1998. 
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being penalised, facing disadvantages or losing social security rights due to moving 
across borders.268 
The relevance of the issue at stake is shown by the fact that the first set of 
Coordination Regulations, Regulation (EEC) No 3/58269 and 4/58,270 were among the 
first legal instruments ever adopted by the Community.271 Recently, the third 
generation of social security Coordination Regulations, i.e. Regulation (EC) Nos 
883/2004 and 987/2009,272 entered into force. These were the result of a lengthy and 
highly ponderous legislative procedure273 and replaced Regulation Nos (EEC) 
1408/71274 and 574/72275 on 1 May 2010. The latter regulations were used for almost 
forty years, during which they were amended nearly on a yearly basis276 and 
consequently became “infamous for [their] complexity”.277 Although one of the main 
                                                 
268
 Yves JORENS, Barbara de SCHUYTER and Cindy SALAMON (2007): Towards a rationalisation of the 
EC Co-ordination Regulations concerning Social Security? Ghent: Academia Press, p. 11. 
269
 Regulation No 3 of the Council concerning social security for migrant workers. OJ 30 of 16 
December 1958. 
270
 Regulation No 4 of the Council laying down detailed rules for implementing and supplementing 
the provisions of Regulation No 3 concerning social security for migrant workers. OJ 30 of 16 
December 1958. 
271
 On the first generation of social security Coordination Regulations see Rob CORNELISSEN (2009): 
50 years of social security coordination. European Journal of Social Security, Vol 11 Issue 1-2, pp. 
11-13. See also LIPSTEIN (1974: 94-111.); WATSON (1980: 28-29.) and Frans PENNINGS (2009): 
Introduction: Regulation 883/2004 – the third coordination regulation in a row. European Journal of 
Social Security, Vol 11 Issue 1-2, p. 4. 
272
 See footnote 12. 
273
 On the legislative process see Herwig VERSCHUEREN (2012): The EU social security co-ordination 
system: A close interplay between the EU legislature and judiciary. In Philip SYRPIS (ed.): The 
Judiciary, the Legislature and the EU Internal Market. New York: Cambridge University Press, p. 
180. 
274
 See footnote 33. Regulation (EEC) No 1408/71 of the Council of 14 June 1971 on the application 
of social security schemes to employed persons, to self-employed persons and to members of their 
families moving within the Community. OJ L 149 of 5 July 1971. 
275
 See footnote 33. Regulation (EEC) No 574/72 of the Council of 21 March 1972 fixing the 
procedure for implementing Regulation (EEC) No 1408/71 on the application of social security 
schemes to employed persons and their families moving within the Community. OJ L 74 of 27 March 
1972. 
276
 VERSCHUEREN (2012: 178.) See also Bernhard SPIEGEL (2005): Die neue europäische 
Sozialrechtskoordinierung. Wie neu ist die Verordnung 883/2004? Allgemeine Überlegungen. (The 
new European social security coordination. How new is the Regulation 883/2004? General 
considerations.) In Franz MARHOLD (ed.): Das neue Sozialrecht der EU (The new social law of the 
EU). Wien: Linde Verlag, p. 13. 
277
 Frans PENNINGS (2001): The European Commission Proposal to Simplify Regulation 1408/71. 
European Journal of Social Security, Vol 3 Issue 1, p. 45. PENNINGS explains that the complexity was 
mainly caused by (1) the many exceptions to the main rules, which were often the result of a political 
compromise, (2) the extended amount of ECJ rulings interpreting the regulation provisions in a way 
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objectives of the proposal for a new Coordination Regulation278 was to modernise279 
and to simplify the former one,280 some scholars complain that the new regulations 
did not fully meet the expectations.281 This is especially right for the coordination of 
healthcare benefits, as will be shown infra.282 
As one of the main developments, the personal scope of coordination was 
extended,283 making Regulation 883/2004 and 987/2009 applicable to both all the EU 
citizens284 and nationals of third countries.285 Moreover, the Regulations not only 
cover the European Union itself, but are applicable also in relation to the countries of 
                                                                                                                                          
which compelled the legislature to amend the Regulation and (3) the lack of an explanatory 
memorandum to the Regulation which left room for different interpretations both on the Member 
States’ and the ECJ’s sides. 
JORENS and his colleagues described the Regulations “as a patchwork, in which special rules exist for 
different categories of persons and whereby different principles are applied to different risks.” JORENS 
et al. (2007: 6.). See also VERSCHUEREN (2012: 178.). 
278
 COM (1998) 779. 
279
 One of the most innovative and ambitious ideas of the new Regulations was that the traditional, 
paper-based communication between Member States was to be replaced by a more modern, speedy 
and efficient communication system, named the Electronic Exchange of Social Security Information 
(hereinafter also referred to as EESSI). Further details on EESSI can be found in section V.1.2. 
280
 See footnote 361 infra. 
281
 Maija SAKSLIN (2000): Social Security Co-ordination – Adapting to Change. European Journal of 
Social Security, Vol 2 Issue 2, p. 172; PENNINGS (2001a: 58.); SPIEGEL (2005: 21) and Franz 
MARHOLD (2009): Modernisation of European coordination of sickness benefits. European Journal of 
Social Security, Vol 11 Issue 1-2, p. 131. 
282
 See section III.1.3.4. 
283
 Regulation 1408/71 was subject to lots of criticism due to its restricted personal scope, which was 
originally limited to economically active persons. In this respect, Regulation 883/2004 is definitely 
considered as a step forward, since it is applicable to both active and non-active persons. Article 2 BR. 
Frans PENNINGS (2009): Conclusion: Simplification, Modernisation and Regulation 883/2004. 
European Journal of Social Security, Vol 11 Issue 1-2, p. 237. 
284
 According to Article 20 TFEU, every person holding the nationality of a Member State shall be a 
citizen of the Union. Citizenship of the Union shall be additional to and not replace national 
citizenship. 
285
 The personal scope of Regulation 883/2004 was extended to third country nationals (hereinafter 
also referred to as TCN) by Regulation (EU) No 1231/2010 of the European Parliament and of the 
Council of 24 November 2010 extending Regulation (EC) No 883/2004 and Regulation (EC) No 
987/2009 to nationals of third countries who are not already covered by these Regulations solely on 
the ground of their nationality. OJ L 344 of 29 December 2010. 
Regulation 1408/71 was also applicable to TCNs after adopting Council Regulation (EC) No 
859/2003 of 14 May 2003 extending the provisions of Regulation (EEC) No 1408/71 and Regulation 
(EEC) No 574/72 to nationals of third countries who are not already covered by those provisions 
solely on the ground of their nationality. OJ L 124 of 20 May 2003. The main idea concerning 
extending the scope of coordination to TCNs remained unchanged: the Regulations are applicable to 
them if they fulfil two conditions, namely (1) they are legally resident in the territory of the European 
Union and (2) they are in a situation which is not confined in all respects within a single Member 
State. Article 1 of Regulation 1231/2010. 
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the European Economic Area (hereinafter referred to as EEA), Iceland, Liechtenstein 
and Norway from 1 June 2012,286 and in relation to Switzerland from 1 April 
2012.287 
A slight change can be seen in the material scope as well: as new elements paternity 
benefits and pre-retirement benefits were included, so that the coordination 
mechanism now covers ten branches of social security,288 inter alia sickness 
benefits.289 
III.1.3.4. The evolution of the legislation on European cross-border patient 
mobility 
As RAPTOPOULOU aptly recaps, “patient mobility as a normative corpus 
emerged from the lacunae of secondary law, was developed into a solid case law 
edifice, subsequently acquired a quasi-compulsory character capable of generating 
sanctions in case of improper implementation, and, eventually, after many trials and 
turbulences, it was crystallised into secondary law.”290 
As said above,291 patient mobility can be considered as a crossroads between 
healthcare legislation and the rules on free movement. Accordingly, the legal 
instruments in this field are complex and different in nature. The current instruments 
governing cross-border patient mobility can be grouped into three main categories: 
(1) the coordination scheme approaching patient mobility from the free movement of 
persons’ point of view, generally referred to as the Regulation-based approach; (2) 
                                                 
286
 Decision of the EEA Joint Committee No 76/2011 of 1 July 2011 amending Annex VI (Social 
security) and Protocol 37 to the EEA Agreement. OJ L 262 of 6 October 2011. 
287
 Decision No 1/2012 of the Joint Committee established under the Agreement between the 
European Community and its Member States, of the one part, and the Swiss Confederation, of the 
other, on the free movement of persons of 31 March 2012 replacing Annex II to that Agreement on 
the coordination of social security schemes. OJ L 103 of 13 April 2012. 
288
 Article 3 BR: This Regulation shall apply to all legislation concerning the following branches of 
social security: (a) sickness benefits; (b) maternity and equivalent paternity benefits; (c) invalidity 
benefits; (d) old-age benefits; (e) survivors' benefits; (f) benefits in respect of accidents at work and 
occupational diseases; (g) death grants; (h) unemployment benefits; (i) pre-retirement benefits; (j) 
family benefits. 
289
 Title III, Chapter I of the Basic Regulation and Title III, Chapter I of the Implementing Regulation. 
290
 RAPTOPOULOU (2012: 193.). 
291
 See section III.1.3. 
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the rulings of the European Court of Justice considering healthcare as subject to the 
Treaty rules on free movement of services, developing a case law based approach; 
and (3) the Patient Mobility Directive aiming to create a coherent legal framework on 
cross-border healthcare. 
 
(1) The first group of instruments consists of social security coordination 
measures based on the principle of promoting free movement of persons: the social 
security Coordination Regulations themselves,292 the decisions of the Administrative 
Commission for the Coordination of Social Security Systems293 and the explanatory 
notes from the European Commission.294 The basic logic behind this regulatory 
framework295 is to ensure access to healthcare for insured persons moving across 
borders within Europe in any state covered by the geographical scope of the 
coordination296 other than the country of affiliation as if they were covered by the 
healthcare scheme in that country. Under the current coordination mechanism a strict 
distinction is made between necessary care occurring unexpectedly during a 
temporary stay in another Member State and the deliberate patient movements the 
express purpose of which is to receive planned care abroad. The possibility to obtain 
non-planned medical care during a temporary stay abroad was already offered by the 
very first set of Coordination Regulations,297 whereas – as a rather progressive step at 
that time and that level of European integration – provisions on planned care were 
introduced in 1972 by Regulation 1408/71.298 
                                                 
292
 See footnote 12. 
293
 See footnote 36. 
294
 Although these notes are not legally binding, they promote the coherent, EU-compatible 
application of the provisions of the Coordination Regulations in the Member States by providing 
interpretation on problematic coordination issues and concepts. See footnote 37. 
295
 The legal base of these legal tools is Article 48 TFEU. See section III.2.2.3. infra, especially 
footnote 907. 
296
 Currently, the 28 Member States, Norway, Iceland, Liechtenstein and Switzerland are covered by 
the geographical scope of the social security Coordination Regulations. 
297
 See footnotes 269 and 270. 
298
 See especially Articles 22 (1) (c) and 22 (2) of Regulation 1408/71. 
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Until the mid-1990s, the social security Coordination Regulations were the sole legal 
source governing cases of cross-border patient mobility.299 Since the Member States 
held considerable discretionary powers concerning the authorisation of scheduled 
treatments,300 speaking about free movement of patients at the time sounds like a 
slight exaggeration.301 Nevertheless, in 1998 the Court took the lead and provided a 
completely new perspective for border-crossing patients.302 
 
(2) In the second category, the Court’s healthcare rulings can be found, 
commencing with the landmark cases Kohll303 and Decker,304 which have been 
followed by a whole series of judgements305 dealing with different aspects of 
obtaining healthcare abroad.306 The novelty of this case law lies in the fact that the 
Court based its argumentation directly on the Treaty provisions307 by revealing that 
healthcare services are considered services in the meaning of the Treaty and are thus 
                                                 
299
 Rob CORNELISSEN (2010): Achievements of 50 years of European Social Security Coordination. In 
JORENS (2010), p. 68. 
300
 See section III.2.2.2.C. on administrative mechanisms under the coordination regime. 
301
 VAN DER MEI notes that throughout the last decade of the 20th century, the Coordination 
Regulations increasingly became the subject of criticism due to “the limited degree to which EC 
Regulations 1408/71 and 574/72 and the relevant national rules enable patients to obtain medical 
care in other Member States.” Anne Pieter VAN DER MEI (1998): Cross-Border Access to Medical 
Care within the European Union – Some Reflections on the Judgments in Decker and Kohll. 
Maastricht Journal of European and Comparative Law, Vol 5, p. 277. 
302
 The ECJ has had a considerable role in the development of European legislation on many fields, 
including European patient mobility: it has found creative ways to expand the Union’s competence 
and ‘conquer’ areas which were considered entirely national ‘territory’. As STONE SWEET points out 
aptly, “(t)oday, the ECJ has no rival as the most effective supranational judicial body in the history of 
the world.” Alec STONE SWEET (2003): European Integration and the Legal System. In Tanja A. 
BÖRZEL and Rachel A. CICHOWSKI (eds.): The State of the European Union. Law, Politics and 
Society. New York: Oxford University Press, p. 18. 
On the Court’s approach towards cross-border patient mobility, see the recent article: Vassilis 
HATZOPOULOS and Tamara HERVEY (2013): Coming into line: the EU’s Court softens on cross-
border health care. Health Economics, Policy and Law, Vol 8 Issue 1, pp. 1-5. 
303
 C-158/96 Raymond Kohll v Union des caisses de maladie [ECR 1998 Page I-01931]. 
304
 C-120/95 Nicolas Decker v Caisse de maladie des employés privés [ECR 1998 Page I-01831]. 
305
 See footnote 14. 
306
 On a more detailed description of ECJ rulings, see Annex I. As FOOTMAN and her colleagues 
describe, “the law developed in a piecemeal fashion, based on precedents derived from individual and 
often quite atypical cases.” Katharine FOOTMAN, Cécile KNAI, Rita BAETEN, Ketevan GLONTI and 
Martin MCKEE (2014): Cross-border health care in Europe. 
http://www.euro.who.int/__data/assets/pdf_file/0009/263538/Cross-border-health-care-in-Europe-
Eng.pdf (23 November 2014), p. 6. 
307
 The Court referred to Articles 59 and 60 TEC (now Articles 56-57 TFEU). 
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subject to the rules on free movement of services. Therefore, any national measures 
resulting in making the provision of services between Member States more difficult 
than the provision of services purely within one Member State308 breach primary law 
unless properly justified. Starting from this basis, the Court has systematically 
demolished the (discretionary) power of the Member States in the field of healthcare. 
Each case before the Court proved to be another dent and to open the door wider for 
the application of internal market rules to healthcare services. “In effect a freedom of 
movement for patients was created, reinforcing and shaping the development of an 
internal health care market and transgressing territoriality more deeply”309 – FLEAR 
says. In the patient mobility case law a clear trend could be seen as the Court 
proceeded to develop a new route for patient mobility: 310 (a) on the one hand, it was 
extending (or – others might say – clarifying) the scope of application of the Treaty 
rules311 “in an incremental manner”312 and (b) on the other hand, it added 
interpretive remarks on various aspects of patient mobility situations313 (Table 4 
infra). 
As a first step,314 even before the famous Kohll and Decker rulings, the Court made 
two important statements, which served as preconditions in regard to the further 
                                                 
308
 C-381/93 Commission v France, 17; C-158/96 Kohll, 33; C-368/98 Vanbraekel, 44; C-157/99 
Geraets-Smits and Peerbooms, 61; C-8/02 Leichtle, 37; C-372/04 Watts, 94; C-444/05 Stamatelaki, 
25; C-211/08 Commission v Spain, 55; C-490/09 Commission v Luxemburg, 16, 33. 
309
 FLEAR (2004: 210.). 
310
 On the phases of patient mobility case law, see FLEAR (2004: 210-212.) and KACZOROWSKA (2006: 
347-359.). 
311
 The rules concerned are the rules on free movement of goods regulated by Article 28-37 TFEU 
(especially Articles 34 and 36 TFEU; in the case law reference is usually made to Articles 30 and 36 
TEC) and the rules on free movement of services regulated by Article 56-62 TFEU (especially 
Articles 56 and 57 TFEU; in the case law reference is usually made to Articles 59 and 60 TEC). 
312
 FLEAR (2004: 210.). 
313
 The aim of this section is to demonstrate the line of evolution of the right to cross-border 
healthcare and the legislative body governing it. Therefore, mainly the first dimension of the evolution 
of the case law, namely the extension of the application of the internal market rules is examined here, 
whereas the further clarifications from the Court are to be analysed infra, at the exact issues. 
314
 In fact, the very first cameo was presented by the ECJ at the end of the 1970s through the 
surprising outcome of the Pierik I and II cases, which concerned a Dutch national who worked and 
lived in the Netherlands, but went to Germany in order to receive hydrotherapy treatment there. Upon 
return, she requested a refund of the costs she had incurred. The sickness fund, however, refused to 
pay the costs on the ground that the treatment in question was not included into the benefit package, 
thus not covered by the Dutch health insurance. C-117/77 Bestuur van het Algemeen Ziekenfonds 
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development. It was first declared in the Luisi and Carbone case315 that (a) on the 
one hand, a healthcare service must be regarded as a service within the meaning of 
the Treaty,316 consequently making the rules on free movement of services applicable 
to healthcare;317 and (b) on the other hand, that the freedom to provide services 
includes the freedom for the recipients of services, including persons in need of 
                                                                                                                                          
Drenthe-Platteland v G. Pierik (I) [ECR 1978 Page 00825] and C-182/78 Bestuur van het Algemeen 
Ziekenfonds Drenthe-Platteland v G. Pierik (II) [ECR 1979 Page 01977]. 
The judgements implied that patients could have the right to obtain authorisation for types of 
treatment which had been deliberately excluded from the national insurance package on medical, 
ethical or financial grounds. C-182/78 Pierik II, 13. 
Although the decisions were very favourable for the patients, the rulings caused remarkable 
opposition from the Member States, which as a countermeasure pushed through a modification of the 
then wording of the Coordination Regulation and inserted a condition to the rules on planned care, 
authorising the Member States to refuse to reimburse the costs of treatments which are not included 
into the benefit basket of the competent Member State. VAN DER MEI (1998: 285-286). On the rules on 
planned care, see section III.2.2.1.C. infra. 
KACZOROWSKA refers to this action of the Member States as something which “stopped, neutralised, 
or reversed” the activism of the ECJ, when it went too far with broadening the interpretation of the 
EU rules in favour of the patients. KACZOROWSKA (2006:353.) On the issue of competence, see 
section III.2.2.3. infra. 
315
 The joined cases concerned two Italian nationals, Graziana Luisi and Guiseppe Carbone, who 
travelled abroad (to France and to Germany) for medical and touristic purposes. While doing so, the 
amount of foreign currency they purchased exceeded the maximum amount permitted by Italian 
national law. During the trial the Court dealt not only with the free movement of capital but also with 
the notion of service provision. Joined cases C-286/82 and C-26/83 Graziana Luisi and Guiseppe 
Carbone v Ministero del Tesoro [ECR 1984 Page 00377]. 
316
 Joined Cases C-286/82 and C-26/83 Luisi and Carbone, 16; C-159/90 Society for the Protection of 
Unborn Children Ireland, 18; C-158/96 Kohll, 29; C-368/98 Vanbraekel, 41; C-157/99. Geraets-Smits 
and Peerbooms, 53; C-385/99 Müller-Fauré and Van Riet, 38; C-56/01 Inizan, 16; C-8/02 Leichtle, 
28; C-372/04 Watts, 86; C-444/05 Stamatelaki, 19; C-211/08 Commission v Spain, 47; C-173/09 
Elchinov, 36; C-512/08 Commission v France, 30; C-490/09 Commission v Luxemburg, 16, 34. 
Healthcare services also belong to the broader notion of social services of general interest (hereinafter 
also referred to as SSGI). Although the special characteristics of healthcare as a service have been 
dealt with (see footnote 20), the wide discussion about SSGI is beyond the scope of this dissertation. 
On this topic, see among others European Commission (2007): Communication from the Commission 
to the European Parliament, the Council, the European Economic and Social Committee and the 
Committee of the Regions. Accompanying the Communication on “A single market for 21st century 
Europe.” Services of general interest, including social services of general interest: a new European 
commitment. COM (2007) 725 final, 20. 11. 2007; European Commission (2011): Communication 
from the Commission to the European Parliament, the Council, the European Economic and Social 
Committee and the Committee of the Regions. A Quality Framework for Services of General Interest 
in Europe. COM (2011) 900 final, 20. 12. 2011; and also, Johan Willem VAN DE GRONDEN (2011): 
Social Services of General Interest and EU Law. In Erika SZYSZCZAK, Jim DAVIES, Mads ANDENÆS, 
Tarjei BEKKEDAL (eds.): Developments in Services of General Interest. The Hague: T. M. C. Asser 
Press and Ulla NEERGAARD, Erika SZYSZCZAK, Johan Willem VAN DE GRONDEN, Markus KRAJEWSKI 
(2013): Social Services of General Interest in the EU. The Hague: T. M. C. Asser Press. 
317
 It must be added that the Court made it clear that the special nature of certain services does not 
remove them from the ambit of the fundamental principle of freedom of movement. C-33/74 van 
Binsbergen; C-279/80 Webb, 10; C-158/96 Kohll, 20; C-368/98 Vanbraekel, 42; C-157/99 Geraets-
Smits and Peerbooms, 54. 
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medical treatment, to go to another Member State in order to receive those services 
there.318  
Although the baseline was established already in the 1980s,319 the breakthrough was 
delayed for another decade, when Decker320 and Kohll321  “brought down a first wall 
in the compartmentalised structure of medical care in the European Union.”322 The 
main message of these judgements can be summarised as follows: (a) the 
determination of the national social security schemes falls within the competence of 
the Member States alone;323 (b) medical goods and treatments are subject to the 
Treaty rules on free movement of goods324 and services;325 (c) the prior authorisation 
(hereinafter also referred to as PA) scheme implemented in the national legislation is 
considered a barrier to free movement;326 and (d) this restriction of free movement 
                                                 
318
 Joined Cases C-286/82 and C-26/83 Luisi and Carbone, 16; C-294/97 Eurowings Luftverkehr, 33-
34; C-243/01 Gambelli and Others, 55; C-372/04 Watts, 87; C-444/05 Stamatelaki, 20; C-211/08 
Commission v Spain, 48-50; C-173/09 Elchinov, 37; C-512/08 Commission v France, 31; C-490/09 
Commission v Luxemburg, 35. 
The ECJ holds the same about other types of services as well. See among others C-398/95 SETTG, 8 
(touristic services) and C-55/98 Vestergaard, 20 (organisation of professional training courses). 
319
 As HATZOPOULOS and HERVEY phrase it, “(t)he revolution started without anybody realizing it.” 
HATZOPOULOS and HERVEY (2013: 1.). 
320
 Mr Decker, a Luxembourg national, requested reimbursement of the cost of a pair of spectacles 
with corrective lenses purchased from an optician established in Arlon, Belgium, with a prescription 
from an ophthalmologist established in Luxembourg. The Health Insurance Fund refused to reimburse 
him for the cost of those spectacles, on the ground that they had been purchased abroad without its 
prior authorisation. Mr Decker contested the decision of the Fund, relying in particular on the Treaty 
rules on the free movement of goods. C-120/95 Decker, 2-4. 
321
 Mr Kohll, a Luxembourg national, requested prior authorisation for his daughter, who was a minor, 
to receive treatment from an orthodontist established in Trier, Germany. The request was rejected by 
the Health Insurance Fund on the grounds that the proposed treatment was not urgent and that it could 
be provided in Luxembourg. Mr Kohll appealed against the decision, arguing that the provisions 
relied on were contrary to the Treaty provisions on the free movement of services. C-158/96 Kohll, 2-
4. 
322
 Pedro CABLAR (1999): Cross-border medical care in the European Union – bringing down a first 
wall. European Law Review, Vol 24 Issue 4, p. 387. 
323
 C-120/95 Decker, 21-23; C-158/96 Kohll, 17-19. See also footnote 244, 246 and 247. 
324
 C-120/95 Decker, 24. See also C-238/82 Duphar, 18. 
325
 C-158/96 Kohll, 21. 
Furthermore, the Court added that the fact that the national rules (in these cases the legislation of 
Luxembourg) fall within the sphere of social security cannot exclude the application of the Treaty 
rules on free movement. C-120/95 Decker, 25; C-158/96 Kohll, 21. See also C-368/98 Vanbraekel, 42; 
C-157/99 Geraets-Smits and Peerbooms, 54. 
326
 C-120/95 Decker, 36; C-158/96 Kohll, 35. The argument of the Court was that authorisation 
mechanisms encourage insured persons to purchase medical products in the competent MS rather 
than in other Member States or deter insured persons from approaching providers of medical services 
established in another Member State. See also Joined Cases C-286/82 and C-26/83 Luisi and 
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cannot be justified.327 Undoubtedly, the merit of Kohll and Decker is that they 
unequivocally strengthened the patients’ position by declaring that “the 
reimbursement of the cost of medical products and services obtained in other 
Member States is no longer to be regarded as a privilege given by the competent 
insurance organ, but rather as an enforceable individual right which can only in 
some cases be (partly) limited.”328 However, both judgements concerned the 
consumption of a medical good or service provided outside of a hospital environment 
– a pair of glasses in the Decker case and an orthodontic treatment in the Kohll case. 
Furthermore, in both proceedings, the legislation of Luxembourg, operating a 
reimbursement system, was challenged. These facts gave many the impression that 
                                                                                                                                          
Carbone, 16; C-18/84 Commission v France, 16; C-204/90 Bachmann, 31; C-368/98 Vanbraekel, 45; 
C-157/99 Geraets-Smits and Peerbooms, 69; C-385/99 Müller-Fauré and Van Riet, 44, 103; C-56/01 
Inizan, 18, 53; C-8/02 Leichtle, 30; C-372/04 Watts, 98; C-173/09 Elchinov, 41; C-512/08 
Commission v France, 32; C-490/09 Commission v Luxemburg, 41. 
327
 C-120/95 Decker, 39-45; C-158/96 Kohll, 53. 
In these cases the Member States came up with four possible grounds of justification, consistently 
rejected by the ECJ one by one. (1) On the control of the health expenditure, the Court held that aims 
of a purely economic nature cannot justify a barrier to the fundamental principle of the free 
movement. C-398/95 SETTG, 23; C-120/95 Decker, 37-39; C-158/96 Kohll, 37, 41; C-385/99 Müller-
Fauré and Van Riet, 72. 
(2) When the Member States used the argument of safeguarding the financial balance of the social 
security system, the ECJ admitted that the risk of seriously undermining the financial balance of the 
social security system may constitute an overriding reason in the general interest capable of justifying 
a barrier of that kind. However, since the health insurance system in Luxembourg provided a flat-rate 
reimbursement, the ECJ affirmed that reimbursement at a flat rate of the cost of medical goods 
purchased or treatment obtained in another Member States has no effect on the financing or balance 
of the social security system. C-120/95 Decker, 39-40; C-158/96 Kohll, 38-42; C-368/98 Vanbraekel, 
47; C-157/99 Geraets-Smits and Peerbooms, 72; C-385/99 Müller-Fauré and Van Riet, 73-74; C-
145/03 Keller, 68; C-372/04 Watts, 103; C-444/05 Stamatelaki, 30; C-173/09 Elchinov, 42; C-490/09 
Commission v Luxemburg, 43. 
(3) To the argument of protecting public health by supplying goods and providing services by persons 
authorised by law to pursue the profession, the ECJ answered that since the conditions for taking up 
and pursuing regulated professions have been harmonised on Community level, the provision of a 
treatment by a healthcare provider established in another Member State provides guarantees 
equivalent to those provided by a healthcare practitioner established in the national territory. C-
215/87 Schumacher, 20; C-62/90 Commission v Germany, 18; C-120/95 Decker, 41-45; C-158/96 
Kohll, 44-49; C-145/03 Keller, 50, 52; C-444/05 Stamatelaki, 37. 
(4) Finally, the ECJ closed the debate on the justification by stating that the rules on prior 
authorisation are not necessary to provide a balanced medical and hospital service accessible to all. 
C-158/96 Kohll, 50-52; C-368/98 Vanbraekel, 48-49; C-157/99 Geraets-Smits and Peerbooms, 73-74; 
C-385/99 Müller-Fauré and Van Riet, 67; C-372/04 Watts, 104-105; C-444/05 Stamatelaki, 31-32; C-
173/09 Elchinov, 42; C-490/09 Commission v Luxemburg, 43. 
328
 VAN DER MEI (1998: 293.). 
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the application of internal market rules is highly limited:329 they apply only to 
purchasing medical goods and to outpatient330 medical services within the national 
healthcare schemes based on a reimbursement principle, whereas inpatient care and 
social security systems without reimbursement rates331 are left intact by the activist 
approach of the European Court of Justice.332 
In the Vanbraekel333 and Geraets-Smits and Peerbooms334 rulings, the Court made it 
clear that this is not the case, and expressly extended the application of the rules on 
free movement of services to benefit-in-kind schemes335 and inpatient healthcare 
                                                 
329
 FLEAR (2004: 211.). 
330
 Hereinafter, outpatient care, extramural care and non-hospital care are used as synonyms, as well 
as inpatient care, intramural care and hospital care. 
331
 These are the Member States with national health services (e.g. the United Kingdom and Spain) 
and the ones with social insurance systems providing benefits in kind (e.g. the Netherlands and 
Hungary). On the classification of the European healthcare schemes, see footnote 258 supra. 
332
 Carlos Garcia DE CORTAZAR (1999): Kohll and Decker, or That is Somebody Else’s Problem. The 
Challenge Facing Spain. European Journal of Health Law, Vol 6, p. 398. 
333
 Ms Descamps, a Belgian national residing and insured in Belgium, suffered from bilateral 
gonarthrosis. She sought authorisation from the competent healthcare fund to undergo orthopaedic 
surgery in France, to be paid for by the fund. The authorisation was refused on the ground that the 
request was not adequately supported, since Ms Descamps had not produced the opinion of a doctor 
practising in a national university institution. Despite this decision, Ms Descamps went ahead with the 
operation in France and subsequently brought an action against the healthcare fund before the national 
court for reimbursement of the cost of that treatment. Ms Descamps died in the course of the 
proceedings, but her heirs pursued the action. C-368/98 Vanbraekel, 11-13. 
334
 The judgement concerns two Dutch nationals insured under Dutch law. Mrs Geraets-Smits suffered 
from Parkinson's disease. She requested the healthcare fund to reimburse the costs of care received at 
the Elena-Klinik in Kassel in Germany for specific, multidisciplinary treatment of that disease. That 
method involves, inter alia, examinations and treatment to determine the ideal medical treatment, 
physiotherapy and ergotherapy and sociopsychological support. The fund rejected to cover the costs of 
the treatment on the ground that satisfactory and adequate treatment for Parkinson's disease was 
available in the Netherlands, and that the specific clinical treatment provided at the Elena-Klinik 
provided no additional advantage. The latter implies that there was no medical necessity justifying 
treatment in that clinic. C-157/99 Geraets-Smits and Peerbooms, 25-26. 
Mr Peerbooms fell into a coma following a road accident. He was taken to hospital in the Netherlands 
and then transferred in a vegetative state to the University Clinic in Innsbruck in Austria. The 
Innsbruck clinic gave Mr Peerbooms special intensive therapy using neurostimulation. In the 
Netherlands, that technique is used only experimentally at two medical centres and patients over the 
age of 25 years are not allowed to undergo this therapy. It is therefore common ground that if Mr 
Peerbooms had remained in the Netherlands, he would not have been able to receive such treatment. 
Mr Peerbooms's neurologist requested the Dutch healthcare fund to pay the costs of the treatment at 
the University Clinic in Innsbruck. That request was rejected on the ground that adequate treatment 
could have been obtained in the Netherlands. C-157/99 Geraets-Smits and Peerbooms, 31-34. 
335
 In the Court’s opinion, it must be accepted that a medical service provided in one Member State 
and paid for by the patient should not cease to fall within the scope of the freedom to provide services 
guaranteed by the Treaty merely because reimbursement of the costs of the treatment involved is 
applied for under another Member State's sickness insurance legislation which is essentially of the 
type which provides for benefits in kind. C-157/99 Geraets-Smits and Peerbooms, 55. See also C-
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services.336 Whereas the Member States operating a national health service were still 
convinced that these judgements did not concern them,337 after the Watts338 ruling, no 
doubt was left that the Treaty rules on free movement of services affect the social 
security system of each Member State irrespective of how it is organised and 
financed.339 
Whereas in the Kohll case the Court seemed to refuse each possible ground for 
justification for the restriction of free movement by the Member States maintaining a 
prior authorisation system,340 it proved to be more indulgent when it was confronted 
with the ‘planning argument’ for hospital treatments in the Geraets-Smits and 
Peerbooms case. The Court acknowledged that the number of hospitals, their 
geographical distribution, the mode of their organisation and the equipment with 
which they are provided, and even the nature of the medical services which they are 
able to offer, are all matters for which planning must be possible.341 For the purpose 
                                                                                                                                          
385/99 Müller-Fauré and Van Riet, 39, 103; C-372/04 Watts, 89; C-444/05 Stamatelaki, 21; C-211/08 
Commission v Spain, 47; C-490/09 Commission v Luxemburg, 36. 
336
 The Court stated that medical activities fall within the scope of the Treaty rules on free movement 
of services, there being no need to distinguish in that regard between care provided in a hospital 
environment and care provided outside such an environment. C-368/98 Vanbraekel, 41; C-157/99 
Geraets-Smits and Peerbooms, 53. See also footnote 316. 
337
 DE CORTAZAR argues that “in States with a national health service, like Spain, there is no free 
competition among the healthcare providers within the framework of social security, and therefore the 
same restrictions operating internally could and should operate externally.” DE CORTAZAR (1999: 
398-399.). 
338
 Mrs Watts, a UK national covered by the British NHS, suffered from arthritis of the hips and made 
enquiries of the competent institution into the possibility of her undergoing surgery abroad. She was 
seen by a UK consultant and her case was classified as ‘routine’, which meant a wait of approximately 
one year for surgery in a local hospital. On the ground that the treatment in a local hospital is available 
‘within the government's NHS Plan targets’ and therefore ‘without undue delay’, Mrs Watts’s request 
was refused. She challenged the decision before the Administrative Court and in the meantime went to 
see a consultant in France. She was told that her need for surgery was becoming more urgent because 
of deterioration in her state of health. Mrs Watts was re-examined by the UK consultant, and was now 
categorised as a patient requiring surgery ‘soon’, in an intermediate category between the most urgent 
cases and the routine cases. That meant that she would be operated on within three or four months. 
Consequently, the competent institution repeatedly refused to authorise her treatment abroad. 
Nevertheless, Mrs Watts underwent a hip replacement operation in Abbeville, France. She paid the 
fees for that surgery and continued with her application for permission to apply for judicial review of 
the refusal decision, claiming in addition reimbursement of the medical fees incurred in France. 
339
 On financing the medical costs incurred abroad, see Chapter IV. infra. 
340
 See footnote 327. 
341
 C-157/99 Geraets-Smits and Peerbooms, 76, 78-80. On this issue see also C-385/99 Müller-Fauré 
and Van Riet, 77-81; C-56/01 Inizan, 56; C-145/03 Keller, 62; C-372/04 Watts, 108-110; C-173/09 
Elchinov, 43; C-512/08 Commission v France, 33-42. 
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of planning and to prevent any wastage of financial, technical and human resources, 
a requirement that the assumption of costs, under a national social security system, 
of hospital treatment provided in another Member State must be subject to prior 
authorisation appears to be a measure which is both necessary and reasonable.342 
This way, another parallelism was introduced (and confirmed with the Müller-Fauré 
and Van Riet343 judgement) in the system: whereas receiving extramural care abroad 
did not impose the obligation on the patient to request a prior authorisation from the 
competent institution, to obtain intramural care, the Member States could 
legitimately require patients to apply for permission in advance. 
After the inclusion of inpatient care and also national healthcare schemes basically 
functioning without reimbursement rates,344 the Court’s endeavour was completed in 
this dimension: the rules on free movement of services became applicable to both 
types of care and to each type of healthcare system. 
  
                                                 
342
 See footnote 341. 
343
 While on holiday in Germany, Ms Müller-Fauré, a Dutch national insured in the Netherlands, 
underwent dental treatment involving the fitting of six crowns and a fixed prosthesis on the upper jaw. 
The treatment was provided without recourse to any hospital facilities. When she returned from her 
holiday, she applied to the competent healthcare fund for reimbursement of the costs of the treatment. 
The fund refused reimbursement on the basis of the opinion of its advisory dental officer and argued 
that insured persons are entitled only to treatment itself and not to reimbursement of any related costs, 
except in exceptional circumstances which did not exist in this case. C-385/99 Müller-Fauré and Van 
Riet, 20-22. 
Ms Van Riet, another Dutch national, had been suffering from pain in her right wrist. An authorisation 
was requested to enable her to have an arthroscopy performed in Deurne hospital in Belgium, where 
that examination could be carried out much sooner than in the Netherlands. The healthcare fund 
rejected the request on the ground that the test could also be performed in the Netherlands. In the 
meantime, Ms Van Riet had already had the arthroscopy in Deurne hospital and, following that 
examination, the decision was taken to carry out an ulnar reduction to relieve the patient's pain. Care 
before and after the treatment, and the treatment itself, were provided in Belgium, partly in hospital 
and partly elsewhere. The fund refused to reimburse the cost on the ground that there was no 
emergency nor any medical necessity such as to justify Ms Van Riet receiving treatment in Belgium, 
since appropriate treatment was available in the Netherlands within a reasonable period. C-385/99 
Müller-Fauré and Van Riet, 25-26. 
344
 The Court is of the opinion that there is no need, from the perspective of freedom to provide 
services, to draw a distinction by reference to whether the patient pays the costs incurred and 
subsequently applies for reimbursement thereof or whether the sickness fund or the national budget 
pays the provider directly. C-385/99 Müller-Fauré and Van Riet, 103. 
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Table 4: The evolution of ECJ case law on patient mobility345 
Dimension 1: Clarification of the 
scope of application of the Treaty 
rules on free movement of goods 
and services to health services 
Patient 
mobility 
case law of 
the ECJ 
Dimension 2: Clarification of conditions of the 
application of internal market rules to health 
services346 
Ph
a
se
 
0 Medical service: a service 
within the meaning of the 
Treaty 
C-26/83 
Luisi and 
Carbone 
 
Ph
a
se
 
1 
Prior authorisation: a barrier 
to free movement of goods 
and services, and this 
restriction cannot be 
justified 
C-120/95 
Decker; C-
158/96 Kohll 
• Potential grounds of justification for 
restriction of free movement 
Ph
a
se
 
2 
Extension of internal market 
rules also to benefit-in-kind 
systems and inpatient care 
C-368/98 
Vanbraekel 
• Additional reimbursement 
• Post-factum authorisation 
C-157/99 
Geraets-
Smits and 
Peerbooms 
• Acceptance of the ‘planning-argument’ as 
justification in case of inpatient care 
• Procedural requirements 
• Necessity on medical grounds, availability of 
the same or equally effective treatment 
• Determination of benefits covered 
• Undue delay 
C-385/99 
Müller-
Fauré and 
Van Riet 
• Distinction between outpatient and inpatient 
care 
Ph
a
se
 
3 Extension of internal market 
rules also to national health 
services 
C-372/04 
Watts 
• The relation between undue delay and 
waiting lists 
Ph
a
se
 
4 
Full application of the rules on free 
movement of services to both types of care 
and each type of healthcare scheme 
Further clarification of the issues mentioned 
above and also other ones such as 
• Distinction between scheduled care and 
unscheduled care 
• Coverage of ancillary costs etc. 
Source: the author’s own summary 
 
While Coordination Regulations 1408/71 and 574/72 absorbed only a few drops of 
this case law, high expectations were expressed towards the new set of regulations to 
abolish the duality of the system by incorporating the conclusions of the Court into 
                                                 
345
 Advocate General (hereinafter also referred to as AG) MERGOZZI similarly highlights the 
evolutionary steps of the development of the healthcare case law in his opinion delivered on 25 
February 2010 in C-211/08 European Commission v Kingdom of Spain [ECR 2010 Page I-05267]. 
37-41. 
346
 These issues are dealt with infra, in section III.2.2. and Chapter IV. 
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secondary law.347 However, to the disappointment of many, the Member States 
missed this regulatory moment to transform the patient mobility legislation, simplify 
it and adapt it to the needs of the patients. Instead, the new Coordination Regulations 
maintained the “coexistence of two separate ‘coordination methods’, [...] which were 
difficult to reconcile.”348 Despite the generally passive attitude of the Member States 
towards the case law,349 following the ruling of the Court in the Watts case, a 
remarkable modification was made to the Regulations350 concerning the second 
condition attached to the situation in which Member States may not refuse to 
authorise a treatment abroad. In Regulation 1408/71 “a factual, administrative 
criterion”351 was included which was based on the time normally necessary for 
obtaining the treatment in question in the Member State of residence352 and which 
provided Member States with a significant discretionary power.353 This condition 
was slightly transformed, so that the current wording of Regulation 883/2004 implies 
that the authorisation shall be accorded if the treatment in question cannot be given 
to the patient within a time limit which is medically justifiable.354 This rephrasing can 
be seen as a positive improvement, since it serves the interest of the patients better355 
and limits the discretionary power of the competent Member State: the condition is 
personalised, and requires the competent institutions to take due account of the 
                                                 
347
 “The bulk of case law on the national authorisation procedures with regard to cross-border health 
care was so closely linked to the coordination of sickness benefits that an integration of it into the text 
of the regulation was to be expected.” JORENS and VAN OVERMEIREN (2009: 59) See footnote 281. 
348
 JORENS and VAN OVERMEIREN (2009: 59). 
349
 MARHOLD (2009: 128). 
350
 On this issue, see among others Elias FELTEN (2008): Patientmobilität im Spiegel des primären 
und sekundären Gemeinschaftsrecht (Patient mobility in the mirror of the primary and secondary 
Community law). Das Recht der Arbeit, Issue 1, pp. 89-90 and JORENS and VAN OVERMEIREN (2009: 
60.). 
351
 CORNELISSEN (1996: 464). 
352
 Article 22 (2) of Regulation 1408/71. 
353
 CORNELISSEN is of the opinion that “such a discretionary power on the part of the competent 
institution is too wide.” CORNELISSEN (1996: 464). 
354
 Article 20 (2) BR. 
355
 It was the European Parliament that articulated the needs of the patients nicely during the 
legislative procedure and insisted on this amendment in its position on the first reading of the 
proposal. European Parliament: European Parliament legislative resolution on the proposal for a 
European Parliament and Council regulation on coordination of social security systems. P5_TA 
(2003) 0365, 3. 09. 2003. 
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medical circumstances of the person concerned instead of basing their decisions 
mainly on abstract administrative standards.356 
To the question why the Member States mostly ignored the findings of the Court and 
failed to gradually reform the legal landscape of patient mobility, different answers 
can be given. MARHOLD holds that “the Court [...] introduced harmonising elements 
into the coordination of sickness benefits” 357 through its case law and since it can be 
very much interpreted as reaching beyond the European Union’s competence in the 
field of social security, the Member States were reluctant to include “further 
harmonisation-promoting provisions relating to medical treatment in Regulation 
883/2004.”358 Without saying that this reason might not have played a role,359 it must 
be noted that refusing to codify the case law did not alter the fact that the findings of 
the Court concern each Member State and that they must apply the rules declared by 
the Court in practice. In fact, the reform of secondary law offered the Member States 
an ideal opportunity to reverse the activism of the European Court of Justice, if they 
wished, as they did as a reaction to the Pierik judgements.360 
Nevertheless, instead of taking effective countermeasures, they left the legislation in 
question mostly intact, so there might have been something else behind their 
reluctance. In my opinion, at the time of drafting the new basic regulation361 the 
Member States could not yet clearly see the far-reaching effects of the case law, 
since the Court clarified the scope of the ‘second way’ of patient mobility step-by-
                                                 
356
 On this condition, see section III.2.2.1.C. infra. 
357
 MARHOLD (2009: 127). 
358
 MARHOLD (2009: 128). 
359
 It is well-known that the Member States act highly sensitively in relation to the competence debate. 
Protecting their autonomy could thus have been a motivating factor. On the issues of competence, see 
section III.2.2.3. 
360
 See footnote 314. 
However, notably in the Pierik cases the Court interpreted secondary law, namely Article 22 (1) (c) 
and (2) of Regulation 1408/71, whereas in the patient mobility case law national legislation was 
confronted with primary law, namely the Treaty provisions on free movement of services. 
361
 Strictly interpreted, it was an approximately six-year legislative work commencing with the 
Commission’s proposal at the end of 1998 [COM (1998) 779] until the adoption of the Basic 
Regulation on 30 April 2004. Nevertheless, the preparatory works started way earlier, since social 
security coordination was one of the areas involved in the SLIM project, launched after the Edinburgh 
European Summit in 1992. The project on ‘Simpler Legislation for the Single Market’ aimed “not 
only at elimination of legislation that has become superfluous or invalid, but also at the improvement 
and adaptation of existing legislation.” Linda SENDEN (2004): Soft Law in European Community Law. 
Oxford: Hart Publishing, p. 19. See also SPIEGEL (2005: 14.). 
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step at the end of the 1990s and at the beginning of the 2000s. Moreover – as shown 
above362 – some of the Member States were firmly convinced that the healthcare case 
law was not applicable to them. In the Commission’s proposal on the renewal of the 
Coordination Regulations,363 the intention to incorporate the findings of the Court 
was not present364 and although attempts were made especially during the Danish 
presidency in the second half of 2002 to reflect on the case law, they all failed due to 
the lack of unanimity in the Council.365 This argumentation is supported by the fact 
that after the Court completed the extension of the case law based approach by the 
middle of the last decade,366 the Member States reached a compromise and 
incorporated at least some elements of the case law into Implementing Regulation 
987/2009, such as the rules on additional reimbursement,367 the reimbursement of 
ancillary costs368 and the referrals by the Member State of treatment.369 
Although from the patients’ point of view a one-track system would have been more 
desirable instead of the maintenance of the separate paths of patient mobility, “their 
disunion”370 was codified with the adoption of the Patient Mobility Directive. 
 
(3) The third, newest element of this trichotomous system of patient mobility 
legislation (Figure 3 infra) is the Patient Mobility Directive.371 The Directive has a 
rather long history which dates back to the time of drafting the so-called Services 
Directive372 in 2004. Although the proposal for the Services Directive373 did include 
medical services as well,374 after lengthy negotiations healthcare was withdrawn375 
                                                 
362
 See footnotes 332 and 337. 
363
 COM (1998) 779. 
364
 Comment on Article 18, COM (1998) 779, p. 8. 
365
 See footnote 262. 
366
 See the process of extension in Table 4. 
367
 C-368/98 Vanbraekel incorporated into Article 26 (7) IR. 
368
 C-8/02 Leichtle and C-466/04 Acereda Herrera incorporated into Article 26 (8) IR. 
369
 C-145/03 Keller incorporated into Article 26 (5) IR. 
370
 JORENS and VAN OVERMEIREN (2009: 60). 
371
 See footnote 18. 
372
 See footnote 19. 
373
 European Commission: Proposal for a Directive of the European Parliament and of the Council on 
services in the internal market. COM (2004) 2 final, 5. 3. 2004. 
374
 Article 23 of the Proposal for Directive 2006/123. 
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from the scope of the Services Directive due to its special characteristics.376 It was 
decided to adopt a separate legal instrument on the cross-border provision of 
healthcare services.377 The Proposal of the Patient Mobility Directive378 also evolved 
remarkably during the legislative negotiations and it incorporated uneasy 
compromises.379 As a result, the Directive – in certain respects at least – falls short of 
the prior expectations of many.380 
 
Figure 3: The coexistence of legal instruments in the field of European cross-border patient mobility 
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The Patient Mobility Directive reaches far beyond patient mobility per se:381 its 
ambition was not only to incorporate the findings of the Court on the provision of 
                                                                                                                                          
375
 European Parliament: European Parliament legislative resolution on the proposal for a directive of 
the European Parliament and of the Council on services in the internal market. P6_TA (2006) 0061, 
16. 2. 2006. 
376
 See footnote 20. 
377
 See footnote 21. 
378
 European Commission: Proposal for a Directive of the European Parliament and of the Council on 
the application of patients' rights in cross-border healthcare. COM (2008) 414 final, 2. 7. 2008 
379
 In the course of the discussions, a tension was built up “between the Council of Ministers, which 
tends to see itself as a guardian of national health systems, and the European Parliament, which tends 
to see itself as a voice of Europe’s citizens (and potential patients).” Helena LEGIDO-QUIGLEY, Ilaria 
PASSARANI, Cecile KNAI, Reinhard BUSSE, Willy PALM and Matthias WISMAR (2011): Cross-border 
healthcare in Europe: clarifying patients’ rights. British Medical Journal, Vol 342, p. 367. 
380
 European Patients Forum (2013): EU Directive 2011/24/EU on the application of patients’ rights 
in cross-border healthcare: Legislation Guidance for Patient Organisations. http://www.eu-
patient.eu/Documents/Policy/Cross-borderHealthcare/2013%2011%2018_CBHC_guidance-final.pdf 
(18 January 2014), p. 5. 
381
 Elisabeth JELFS and Rita BAETEN (2011): Simulation on the EU Cross-Border Care Directive. 
Final Report. 
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healthcare services382 and to clarify its relationship with the existing framework of 
social security coordination, but also to facilitate cooperation between the Member 
States.383 Consequently, the measures incorporated into the Directive target two main 
fields of cross-border healthcare: (a) on the one hand the questions directly related to 
the free movement of patients, such as the reimbursement of medical costs, the 
requirement of prior authorisation and administrative procedures regarding cross-
border patient mobility,384 and (b) on the other hand, measures promoting inter-
country cooperation, such as mutual assistance, the recognition of prescriptions 
issued in another Member State, the development of European reference networks, 
cooperation in relation to the diagnosis and treatment of rare diseases and 
cooperation on eHealth and health technology assessment.385 
As both the Council Conclusions and the Patient Mobility Directive state, a clear, 
coherent legal framework must be ensured for Union citizens about their rights and 
entitlements when they move from one Member State to another, in order to ensure 
legal certainty.386 However, with the new Directive a complex, multi-functional, 
mixed source was created, which once again, instead of simplifying the legislation on 
European cross-border patient movements, added to the unanswered questions.387  
III.1.4. Conclusion 
The main finding of this subchapter is that European citizens have the right – 
if they fulfil some exact conditions – to obtain certain healthcare benefits abroad on 
behalf of their health insurance. However, this has not always been the case: the 
current form of the regulatory framework on patient mobility is the result of a long 
progress, which – in my opinion – has not ended yet. 
                                                                                                                                          
http://www.uems.net/uploads/media/CrossBorderHealthcareSimulation_FinalRep_09052012.pdf (2 
September 2013), p. 8 and PEETERS (2012: 29.). 
382
 See footnote 22. 
383
 Article 1 (1) PMD. 
384
 Chapter III PMD. 
385
 Chapter IV PMD. 
386
 Recital 9 of the Preamble of the Patient Mobility Directive. 
387
 On the conflicting rules, see section III.2.2.3. 
Gabriella BERKI: Cross-border patient mobility: The legal framework of obtaining 
healthcare abroad within the European Union – a patients’ perspective 
98 
 
The coexistence of three separate legal tools, which are very different in nature, has 
generated abundant discussions both on national and EU level, since their relation to 
each other is still unclear to a certain extent, despite the apparent efforts from the 
European legislature’s side to clarify it.388 The uncertainties, doubts, questions and 
conflicting rules surrounding the issue result – as will be shown infra389 – in serious 
difficulties which patients are facing when using their European citizenship rights in 
practice to access healthcare in a Member State other than the Member State where 
they reside. On this point, the aim is clear: ceasing legal uncertainty in order to 
enable European patients to rely on the rights conferred on them by the European 
Union. 
  
                                                 
388
 In May 2012 the Commission issued a Guidance note on the relationship between Regulation (EC) 
Nos 883/2004 and 987/2009 on the coordination of social security systems and Directive 2011/24/EU 
on the application of patients' rights in cross border healthcare. See footnote 37. 
389
 See section III.2.2.3. 
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III.2. THE REALISATION OF ACCESS TO HEALTHCARE ACROSS BORDERS 
Rights provided by law are of no use to the addressees of these rights if the 
rights themselves cannot be effectively used and enforced by the power of law. Each 
patient comes across different boundaries when accessing healthcare.390 Being in 
need of medical care principally implies being in an extremely vulnerable position 
which often involves “extraordinary moments of fear, anxiety and doubt.”391 
Accessing healthcare in a state other than the state of residence might significantly 
increase the number of potential sources of difficulties, which are consequently very 
likely to add to the feeling of being helpless and exposed in such situations. 
This subchapter aims to enumerate the main areas of problems patients might face. 
The hurdles, which might constrain or even prevent patients from accessing 
healthcare abroad, are divided into two groups: (1) on the one hand, the obstacles to 
access of a non-legal nature and (2) on the other hand, the obstacles to access of a 
legal nature are examined. The question which needs to be answered throughout this 
analysis is whether European border-crossing patients are provided with efficient 
tools to cope with these obstacles. 
                                                 
390
 BUSSE and his colleagues identified six hurdles of access, namely (1) the population covered by 
health insurance, (2) the benefits covered, (3) cost-sharing arrangements, (4) geographical barriers, (5) 
organisational barriers and (6) the utilisation of accessible services. BUSSE et al. (2006: 4.) The 
European Commission mentioned the following barriers to access to healthcare: (1) a lack of 
insurance, (2) high costs of care, (3) a lack of information about services provided, (4) language and 
cultural barriers. European Commission: Communication from the Commission to the European 
Parliament, the Council, the European Economic and Social Committee and the Committee of the 
Regions. Solidarity in health: Reducing health inequalities in the EU. COM (2009) 567 final, 20. 10. 
2009. 
391
 Jessica D. FOWLER (2008): Cultural and Structural Barriers that Affect the Doctor-Patient 
Relationship: A Bolivian perspective. 
http://ir.library.oregonstate.edu/xmlui/bitstream/handle/1957/9896/Fowler.pdf?sequence=1 (13 
August 2013), p. 1. 
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III.2.1. Obstacles to access of a non-legal nature 
As was mentioned supra,392 statistical data support the view that European 
patients do prefer to receive medical treatment as close to their homes as possible. 
Among the usual arguments behind this phenomenon, the proximity of the healthcare 
provider and familiarity with the provider itself, with the cultural and lingual 
circumstances and with the local healthcare system can be found. This environment – 
as acknowledged by the European Court of Justice – allows the patient to build up a 
relationship of trust with the doctor treating him/her,393 which is a cornerstone of 
healthcare provision. 
However, when accessing healthcare abroad, the advantages of proximity and 
familiarity might be replaced by geographical distance, cultural differences, 
linguistic barriers and unfamiliarity. Since the European Court of Justice has also 
explicitly referred394 to (1) geographic distance, (2) linguistic barriers and (3) the 
lack of information as potentially discouraging factors of cross-border patient 
movements, these problems are addressed below. 
III.2.1.1. Geographical distance 
By definition,395 European cross-border patient movements involve at least 
two Member States.396 Crossing a border between two Member States397 does not in 
itself constitute a real barrier in the Schengen Area398 with regard to formalities to 
                                                 
392
 See footnote 6. 
393
 C-385/99 Müller-Fauré and Van Riet, 96. 
394
 C-385/99 Müller-Fauré and Van Riet, 95. 
395
 On the concept of cross-border patient mobility within the EU, see section II.3.2. 
396
 See section II.1.1. 
397
 The two (or more) countries involved might be either neighbouring or non-neighbouring countries. 
See footnote 60 and 61. 
398
 The Schengen Agreement concluded on 14 June 1985 and the Convention Implementing the 
Schengen Agreement concluded on 19 June 1990 created a solid foundation for the “borderless 
Europe of today” by articulating the basic principle of the abolition of internal border control for 
individuals. Anais Faure ATGER (2008): The Abolition of Internal Border Checks in an Enlarged 
Schengen Area: Freedom of movement or a web of scattered security checks? Challenge Research 
Paper No 8, p. 13. See also WHITE (2004: 8.). 
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enter another country.399 Still, geographical distance plays a considerable role in 
cross-border healthcare situations. The question of distance occurs mainly in two 
respects: (1) when the patient movement involves a long-distance travel and (2) 
when in the periphery of the country, the healthcare provider on the other side of the 
border is situated closer to the patient then the one in his/her country of residence. 
 
With today’s transportation facilities, proximity has become relative. In an age of 
developed highway systems, railway networks and international bus lines all over 
Europe,400 people have plenty of options to travel abroad. The boost of low-cost 
airlines in the European Union made it even simpler to reach remote destinations.401 
Nevertheless, depending also on the method of transportation, special travelling 
arrangements might be necessary for certain groups of persons, such as the elderly, 
the chronically ill and people living with a disability. In these cases, the journey will 
be preceded by an extensive pre-travel medical evaluation to identify the special 
needs of the individual concerned402 and a careful planning to ensure that those needs 
are met in the course of the travelling.403 Travelling can be not only lengthy and 
physically exhaustive, but costly as well. It must be kept in mind that the extra costs 
                                                                                                                                          
The Schengen acquis was integrated into primary law by the Treaty of Amsterdam, which entered into 
force on 1 May 1999. KUIJPER describes the process as “Amsterdamization”. Pieter Jan KUIJPER 
(2000): Some legal problems associated with the communitarization of policy on visas, asylum and 
immigration under the Amsterdam Treaty and incorporation of the Schengen acquis. Common Market 
Law Review, Vol 37 Issue 2, p. 345. See also Eckart WAGNER (1998): The Integration of Schengen 
into the Framework of the European Union. Legal Issues of Economic Integration, Vol 25 Issue 2, pp. 
1-60. 
399
 Article 20 of Regulation (EC) No 562/2006 of the European Parliament and of the Council of 15 
March 2006 establishing a Community Code on the rules governing the movement of persons across 
borders (Schengen Borders Code). OJ L 105 of 13 April 2006. 
400
 It must be noted that it applies also to the transportation facilities that some parts of Europe are 
more developed than others and that there are areas where transportation facilities are rather 
underdeveloped. However, addressing the problem of unequal access to transport services is beyond 
the scope of this dissertation. On disparities in access to transport services, see Terry WARD and Erhan 
OZDEMIR (2012): Disparities in access to essential services. Research note 2012/8, Prepared for the 
use of the European Commission DG EMPL, pp. 13-15. 
401
 TOLNAI et al. (2009: 36). See footnote 71. 
402
 On this topic, see Jan Evans PATTERSON (1992): The Pre-Travel Medical Evaluation: The 
Traveller with Chronic Illness and the Geriatric Traveller. The Yale Journal of Biology and 
Medicine, Vol 65, pp 317-327. 
403
 PERDUE and NOBLE (2007). 
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that come with journeys abroad also influence the access to cross-border 
healthcare.404 
 
As indicated also in the Patient Mobility Directive,405 cross-border patient 
movements are more usual in frontier areas, where the nearest appropriate facility is 
on the other side of the border: for the inhabitants of border areas it is often more 
reasonable to visit a doctor abroad than in their own Member State because the 
foreign healthcare provider is closer to them. These people can thus avoid relatively 
long travels if they opt for ‘going abroad’ instead. A whole series of cross-border 
arrangements, national and European efforts have aimed to facilitate the easy access 
to the nearest healthcare provider of people living in border areas, irrespective of 
whether this is in the Member State of residence or in the neighbouring country. Both 
(1) the Coordination Regulations and (2) the Patient Mobility Directive lay down 
rules on this exact situation. These rules are briefly summarised below. 
 
(1) On the one hand, the logic of the Coordination Regulations406 implies that 
they do not specifically focus on healthcare provision in the border areas, but that 
they create a specific category of workers who most likely – but not necessarily – 
live close to the frontiers. The frontier workers407 had a privileged position in this 
respect under the rules of the former coordination regulation, i.e. Regulation (EEC) 
No 1408/71. The specialty of their status was based on the frequent (at least weekly) 
return to the Member State of residence, while working outside of that Member State 
                                                 
404
 The issue of covering travel costs is addressed in Chapter IV. on financing medical treatment 
abroad. 
405
 Recital 39 of the Preamble of the PMD. 
406
 On the basic idea of the coordination of social security schemes within the EU, see section 
III.1.3.3. supra. 
407
 Article 1 (f) BR defines frontier workers as follows: any person pursuing an activity as an 
employed or self-employed person in a Member State and who resides in another Member State to 
which he/she returns as a rule daily or at least once a week. It is legally irrelevant whether the 
Member State of residence and the Member State of the working activity are neighbouring countries. 
Therefore, CALNAN’s definition, which says that “frontier workers […] are those who live on the 
frontiers of two countries and live in one country but work in another,” is lacking the condition of 
frequent return on the one hand and excludes those frontier workers who commute between non-
neighbouring countries. CALNAN et al. (1997: 26.). 
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(the competent MS). It is argued that there is a strong link with the competent 
Member State and with the Member State of residence at the same time.408 
Therefore, these persons had the unconditional freedom of choice where they 
intended to obtain healthcare benefits in kind: they could receive them in the 
Member State of residence, or in the competent Member State while staying there.409 
Regulation 883/2004 expressly extended the right to double access to each insured 
person and his/her family members residing outside the competent Member State,410 
erasing frontier workers’ privileged status in this respect. At the same time, the new 
Coordination Regulations replaced numerous bilateral agreements that existed 
between the Member States ensuring the freedom of choice for the family members 
of frontier workers.411 However, some Member States restrict this right of the 
frontier workers' family members and apply the same rules to them as they do to 
temporary visitors.412 Consequently, when Denmark, Ireland, Croatia, Finland, 
                                                 
408
 Frontier workers have enjoyed a privileged situation concerning social security coordination: 
specific, mostly more beneficial rules apply to them not only for sickness benefits but for example for 
unemployment benefits too (Article 65a BR). 
However, in certain situations these special rules might prove to be less favourable as demonstrated in 
relation to unemployment benefits for wholly unemployed frontier workers by the judgement of the 
Court in C-443/11 F.P. Jeltes, M.A. Peeters, J.G.J. Arnold v Raad van bestuur van het 
Uitvoeringsinstituut werknemersverzekeringen [ECR 2013 Page 00000]. 
Although one of the main aims of the new generation of Coordination Regulations was to simplify the 
legislation (see section III.1.3.4.), it maintained and even developed the rules applicable to frontier 
workers and their family members. However, the question may be raised whether these rules are still 
justified, whether maintaining the category of frontier workers is still desirable. Does the requirement 
of weekly return establish a link that is stronger compared to migrant workers who do not meet this 
requirement? For instance, does a migrant worker who frequently spends four weeks in the competent 
MS and then two consecutive weeks in the MS of residence have a less strong link on the ground that 
he/she does not meet the requirement of weekly return compared to a frontier worker who spends one 
and a half days in the MS of residence each weekend? And in a borderless Europe, how can the 
fulfilment of the weekly-return requirement be verified? In my opinion, this categorisation is rather 
vague and hardly justifiable. It would thus be worth considering whether the category of frontier 
workers is still needed within the coordination of social security schemes as an exception to the 
general rules applicable to insured persons. 
409
 In this case, the benefits in kind shall be provided by the competent institution and at its own 
expense, in accordance with the provisions of the legislation it applies, as though the persons 
concerned resided in that Member State. Article 20 of Regulation 1408/71. 
Workers residing outside of the competent Member State and their family members also had this right 
under Article 21 of Regulation 1408/71 while staying in the competent Member State. 
410
 Article 18 (1) BR. 
411
 Such agreements existed e.g. between Belgium and France, Belgium and Luxembourg and 
Luxemburg and Germany. See JORENS et al. (2007: 30.). 
412
 See infra under section III.2.2.1.B. 
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Sweden or the United Kingdom413 is the competent Member State, the family 
members of frontier workers are entitled only to sickness benefits in kind necessary 
on medical grounds while staying on the territory of this country.414 In my opinion, 
the reasoning behind these exceptional rules is questionable.415 According to the 
current legislation, the category of frontier workers represents a special group of 
migrant workers, who – thanks to their ‘unique situation’ – are provided with special 
coordination rules.416 However, if the Member States apply the same rules on 
migrant workers and their family members, I see no legally justifiable reason not to 
apply the same rules to frontier workers and their family members. In this regard, I 
share PENNINGS's opinion that it is preferable to remove these rules.417 
Another debated issue in the course of drafting the new Coordination Regulations 
was whether the right to choose should be maintained when the former frontier 
worker retires. This was not the case under the former regulation: the freedom to 
choose the country of healthcare provision ended as soon as the frontier worker 
                                                 
413
 Listed in Annex III BR; the restriction is not limited in time, but will be reviewed no later than 31 
October 2014. Article 87 (10b) BR. 
Estonia, Spain, Italy, Lithuania, Hungary and the Netherlands were also listed in Annex III BR; but 
the restriction concerning these MSs was applicable only until 30 April 2014, the end of the 
transitional period. Article 87 (10a) BR. 
In the trESS European Report a specific problem was noted concerning the family members of 
frontier workers who work in the Netherlands. Until 1 May 2014, they were only entitled to claim 
necessary care during a temporary stay in the Netherlands. However, this did not create problems in 
practice, since “(o)n the basis of bilateral agreements with the neighbouring countries, family 
members of frontier workers are entitled to claim benefits in kind in the Netherlands on the condition 
that they have an MVG 111 form, which can be obtained from a particular insurance company. […] 
In practice, this may complicate the position of frontier workers since they may have to deal with four 
institutions.” Yves JORENS and Jean-Philippe LHERNOULD (2013): European Report 2013. Report 
prepared in the framework of the trESS project. http://www.tress-
network.org/tress2012/EUROPEAN%20RESOURCES/EUROPEANREPORT/TRESSIII_European%
20Report%202013.pdf (11 March 2014), p. 28. Nevertheless, this difficulty is solved since 1 May 
2014. 
414
 PENNINGS states that this rule was the result of a political compromise made by the drafters of the 
Regulation 883/2004, since a certain number of Member States were reluctant to allow choosing for 
the family members in fear of extra costs. PENNINGS (2010: 158.). 
415
 I find this reasoning improper to justify such a limitation of the freedom of the family members to 
choose where they wish to obtain medical treatment. Irrespective of whether the healthcare is 
provided for the family members in the MS of residence or the MS of working activity, it is the 
competent MS which must borne the costs. So one may wonder how much extra cost it would cause if 
this restriction would be abolished. 
416
 See footnote 408. 
417
 PENNINGS (2010: 158.).  
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stopped pursuing his/her former working activity.418 Nevertheless, this rule could 
cause a treatment that began in the competent Member State not to be continued any 
longer, because the retired frontier worker became subject to the healthcare scheme 
of the Member State of residence. To overcome this problem, Regulation 883/2004 
introduced a new rule according to which a frontier worker who has retired because 
of old-age or invalidity is entitled in the event of sickness to continue to receive 
benefits in kind in the Member State where he/she last pursued his/her activity as an 
employed or self-employed person, in so far as this is a continuation of treatment419 
which began in that Member State.420 More advantageous rules were adopted with 
regard to pensioners who in the five years preceding the effective date of an old-age 
or invalidity pension have been pursuing an activity as an employed or self-employed 
person for at least two years as a frontier worker.421 Their healthcare protection was 
highly strengthened by providing them the right to entitlement to sickness benefits in 
kind in the Member State of the former working activity, provided that one condition 
is met: both the Member State of the former working activity and the Member State 
of residence opted for this.422  
The question is rightfully raised why the right to continuity of treatment is only 
provided to frontier workers and not extended to each migrant person. It can be 
argued that it might be unfavourable to anyone to have to suspend an ongoing 
medical treatment due to a shift between national healthcare regimes. The very 
existence of the social security coordination mechanism is based on the idea that 
migrant persons should not suffer from social disadvantages because they used their 
                                                 
418
 Between certain Member States agreements were conducted to prolong this right of the frontier 
workers even after they were retired. See the example of Belgium and Luxembourg in JORENS et al. 
(2007: 29.). 
419
 Continuation of treatment includes continued investigation, diagnosis and treatment of an illness 
for its entire duration. Article 28 (1) BR. 
420
 Article 28 (1) BR. The same rule applies to the family members of the retired frontier worker 
unless the competent MS is listed in Annex III of the Regulation. 
421
 Article 28 (2) BR. 
422
 Member States listed in Annex V of the Regulation are Belgium, Germany, Spain, France, 
Luxembourg, Austria and Portugal. If both MSs are one of these countries, the freedom to choose 
remains even after retirement. 
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right to free movement.423 In my opinion, it would very well serve the interest of 
European patients to grant the right to continuity of treatment to everyone424 who 
falls under the scope of the Coordination Regulations. 
 
(2) On the other hand, the Patient Mobility Directive intends to facilitate 
cross-border healthcare cooperation to ensure safe, high-quality and efficient cross-
border healthcare and emphasises the special importance of joint action in the border 
areas.425 The cooperation may involve different actors,426 namely healthcare 
providers, healthcare funds, purchasers and regulators of the participating Member 
States, and can take various forms,427 such as joint planning, mutual recognition or 
adaptation of procedures or standards, interoperability of respective national 
information and communication technology systems, practical mechanisms to ensure 
continuity of care or practical facilitating of cross-border provision of healthcare by 
health professionals on a temporary or occasional basis.428 
Although nice examples of cross-border healthcare cooperation can be seen in the 
European Union,429 its full potential is far from being tapped. Each Member State 
                                                 
423
 This is the core of the so-called Petroni principle, worked out by the ECJ in a case related to the 
payment of pensions to employed persons and the successors of a migrant worker. C-24/75 Teresa et 
Silvana Petroni v Office national des pensions pour travailleurs salaries [ECR 1975 Page 01149], 13. 
424
 The Patient Mobility Directive takes a small, but remarkable step in this regard, namely as part of 
the responsibility of the Member State of treatment it stipulates that in order to ensure continuity of 
care, patients who have received treatment are entitled to a written or electronic medical record of 
such treatment, and access to at least a copy of this record. Article 4 (2) (f) PMD. This provision 
imposes the obligation on the healthcare practitioners to provide the patients with data which might be 
essential for their further treatment, and is thus a relevant addition to cross-border patients’ rights. 
425
 Recital 50 of the Preamble of the PMD. 
426
 In LEGIDO-QUIGLEY et al. (2012) five actors are identified: “(1) health care providers, (2) third-
party payers/purchasers, (3) regulators/public authorities and (EU) policy-makers, and (4) brokers 
(individuals and organisations that facilitate links between the involved parties) and, usually only 
indirectly, (5) patients (or potential patients).” LEGIDO-QUIGLEY et al. (2012: 30.). 
427
 BUSSE and his colleagues set up a classification with four categories of cross-border arrangements: 
“(1) border area emergency coordination arrangements, (2) arrangements among providers 
(typically, hospitals located in border areas), (3) arrangements between insurers/purchasers (in one 
country) and providers (in another), and (4) administrative arrangements designed to facilitate access 
to care abroad, but not actually involving the purchase or provision of care.” BUSSE et al. (2006: 37.). 
428
 Recital 50 of the Preamble of the PMD. 
429
 “Many cross-border arrangements, especially in the Euregios between Belgium, France, the 
Netherlands, and Germany, are seeing improvements in access to hospital and emergency care 
services in particular.” BUSSE et al. (2006: 5.) In GLINOS et al. (2006) three exemplary cross-border 
initiatives are described: (1) in the Dutch region Zeeuws Vlaanderen inhabitants have had the 
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should make efforts to cooperate with its neighbouring countries in order to ensure 
easy access to the nearest healthcare provider. The European institutions, especially 
the Commission, are to encourage any type of cooperation,430 especially in the border 
regions.431 However, the Commission seems to lack exact legal entitlements and 
effective tools to carry out this exercise. In my view, the Patient Mobility Directive 
does not contain any provisions that predict a quick development in this field. 
Cross-border contracting is one of the possibilities which might offer a solution for 
people living in the border areas, although it is “not necessarily rooted in EU 
legislation but in explicit contractual agreements between purchasers and 
providers.”432 Whereas the national healthcare systems in Europe have been 
constructed on geographical and membership boundaries and are traditionally based 
on the principle of territoriality,433 cross-border contracting opens up this rigid 
structure and builds on the possibility to involve foreign providers. A research report 
suggests that “(p)olicy makers should seriously consider whether the general 
limitation of contracted care to providers within the country can be upheld or 
whether the right to access health care should not “automatically” be extended to 
foreign providers if they are geographically closer or are delivering the service at a 
higher quality.”434 Although the idea of automatically extending contracted care is 
highly patient-friendly and in line with the concept of limitless European patient 
                                                                                                                                          
possibility of receiving some, mainly highly specialised treatments in specified Belgian hospitals since 
1978 (see also footnote 70); (2) in the Euregio Meuse-Rhine (covering parts of the Netherlands, 
Belgium and Germany) patients from the three countries can receive predefined treatments across 
borders since 2000; (3) seven Belgian hospitals concluded contracts with the NHS in 2003 in order to 
“improve waiting times and satisfaction for patients in London, and develop the necessary capacity 
and a working system to promote patient choice.” GLINOS et al. (2006: 102) See also Helmut BRAND, 
Alfons HOLLEDERER, Ulrike WOLF and Angela BRAND (2008): Cross-border health activities in the 
Euregios: Good practice for better health. Health Policy, Vol 86, pp. 245-254. 
430
 Recital 51 of the Preamble of the PMD specifies certain exact tasks of the European Commission 
in this respect, such as (1) identifying major obstacles to collaboration between healthcare providers in 
border regions, (2) making recommendations and (3) disseminating information and best practices on 
how to overcome the obstacles. 
431
 Article 10 (3) PMD. 
432
 Irene A. GLINOS, Rita BAETEN and Hans MAARSE (2010): Purchasing health services abroad: 
Practices of cross-border contracting and patient mobility in six European countries. Health Policy, 
Vol 95, p. 103. 
433
 On the principle of territoriality, see section III.1.3. 
434
 BUSSE et al. (2006: 5.). 
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mobility, in the current legal435 and political436 circumstances, it seems unrealistic to 
achieve in the near future. However, cross-border contracting is not unknown in 
Europe437 and well-managed cross-border healthcare arrangements between the 
Member States can pave the path to an enhanced EU-wide cooperation and may 
result in legislation more flexible and more favourable for European patients.438 
 
Cross-border health cooperation is crucial not only because it can ease geographical 
access but also because it facilitates the timely provision of healthcare services.439 
The same applies to eHealth applications,440 especially telemedicine,441 in which case 
travelling might be replaced by the usage of information and communication 
technologies, geographic distance thus becoming irrelevant.442 
In the long run, opening up the closed national healthcare systems through 
contracting outside the national territory and efficient cross-border cooperation, as 
well as the development of eHealth applications can lead to strengthened social 
security and easier access to healthcare. Therefore, it would be desirable to define the 
exact competences the European institutions are provided with in order to enhance 
cross-border cooperation between the Member States.443 
                                                 
435
 One can rightfully argue that such an initiative would go beyond the EU’s competence in the field 
of healthcare and would detract from the power of the Member States concerning the organisation of 
their own healthcare systems. 
436
 The legislative procedure of adopting the Patient Mobility Directive proved that despite the 
currently relatively low number of border-crossing patients, these issues are politically very sensitive 
and have been subject to “heavy political wrangling.” JELFS and BAETEN (2011: 6.) See also footnote 
379. 
437
 So far, cross-border contracting is “limited to few medical treatments in certain EU countries” and 
is often provisional. GLINOS et al. (2010b: 111.) For instance, the NHS has sent patients to Belgium 
for knee or hip replacement surgeries. GLINOS et al. (2006: 102). 
438
 As BRAND and his colleagues found, “(t)ransparency and evaluation of cross-border activities in 
health are needed as a basis for decisions in health policy regarding the adaption of existing activities 
and to build up new activities especially in the new EU Member States. It would promote the 
development of further steps towards European integration.” BRAND et al. (2008: 253-254.). 
439
 The methods of facilitating the timely provision of healthcare are further dealt with in Chapter V. 
440
 See footnote 47. 
441
 See footnote 142. 
442
 eHealth applications are also dealt with in Chapter V. 
443
 Union initiatives could take various forms to enhance cross-border cooperation, such as 
establishing a common platform for exchanging best practices, creating a recommendation on cross-
border cooperation, funding cross-border collaboration programmes etc. 
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III.2.1.2. Linguistic barriers 
Communication is a key element of healthcare provision,444 in the course of 
which it is of essential importance that each party involved expresses him/herself 
clearly and exactly.445 If the mutual communication works properly, it “ultimately 
leads to an enhanced doctor-patient relationship resulting in satisfaction with the 
encounter by both parties and thus improved health care outcomes”,446 whereas the 
lack of or inappropriate information exchange might result in incomplete medical 
assessment, distrust between the parties and inadequate medical treatment.447 
Interestingly enough, this problem has not been addressed on EU level so far.448 
 
In the currently 28 Member States of the European Union 24 official languages449 are 
spoken beside the relatively high number of regional and minority languages.450 
Although the Union committedly safeguards multilinguism451 as a proof and a 
                                                 
444
 Both patients and health practitioners claim that there is a need for improved communication 
between the parties involved. European Commission – Eurobarometer Qualitative Study (2012): 
Patient involvement. Aggregate Report. 
http://ec.europa.eu/public_opinion/archives/quali/ql_5937_patient_en.pdf (30 August 2013), p. 13. 
445
 Mark TWAIN’s famous quote is very appropriate for these situations: “The difference between the 
right word and the almost right word is the difference between lightning and the lightning bug.” 
Quoted by Victoria SORLIE and Rebeca A. LOPEZ (2011): When Language, Health Literacy, and 
Miscommunication Collide: Tremors Versus Seizures. Family Medicine, Vol 43 Issue 1, p. 48. 
446
 FOWLER (2008: 5.) See also Michael SIMPSON, Robert BUCKMAN, Moira STEWART, Peter 
MAGUIRE, Mack LIPKIN, Dennis NOVACK, James TILL (1991): Doctor-patient communication: the 
Toronto consensus statement. British Medical Journal, Vol 303, p. 1385. 
447
 FOWLER (2008: 5-6.) See also Olivia CARTER-POKRAS, Marla J.F. O’NEILL, Vasana 
CHEANVECHAI, Mikhail MENIS, Tao FAN and Angelo SOLERA (2004): Providing Linguistically 
Appropriate Services to Persons With Limited English Proficiency: A Needs and Resources 
Investigation. The American Journal of Managed Care, Vol 10, Special Issue, p. 30. 
448
 However, the problem was undoubtedly recognised. See COM (2009) 567, p. 3 (footnote 390). 
449
 Regulation No 1 determining the languages to be used by the European Economic Community. OJ 
17 of 6 October 1958, Article 1. 
450
 European Commission – Eurobarometer (2012): Europeans and their languages. 
http://ec.europa.eu/public_opinion/archives/ebs/ebs_386_en.pdf (15 August 2013), p. 2. 
451
 Although multilingualism can be considered an asset of the Union, language policy is often 
attacked for its costliness. See among others Philip OLTERMANN (2013): Something in common: 
should English be the official language of the EU? The Guardian, 24 April 2013, 
http://www.theguardian.com/world/2013/apr/24/europa-english-official-language-eu (16 January 
2014). 
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guarantee of European diversity,452 it constitutes a serious obstacle in cross-border 
healthcare situations: if the patient and the healthcare professional do not speak the 
same language, the risk of misunderstanding and – as a consequence – of 
misdiagnosis increases significantly, and “extensive physical examinations and 
diagnostic tests [are] sometimes required to compensate for the inability to 
communicate verbally.”453 
Ideally, this problem could be solved through the improvement of language 
knowledge on both the patients’ and health professionals’ sides, so that they would 
have a common language to communicate. However, in the mirror of the statistical 
data454 and the long history of attempts to establish a lingua franca,455 it is not very 
                                                 
452
 It is this diversity that makes the European Union what it is: not a ‘melting pot’ in which 
differences are rendered down, but a common home in which diversity is celebrated, and where our 
many mother tongues are a source of wealth and a bridge to greater solidarity and mutual 
understanding. European Commission: Communication from the Commission to the Council, the 
European Parliament, the European Economic and Social Committee and the Committee of the 
Regions. A New Framework Strategy for Multilingualism. COM (2005) 596 final, 22. 11. 2005, p. 2. 
See also Article 22 CFREU. 
The issue is similarly problematic in the – theoretically monolingual – USA, where a considerable 
share of the society speaks English as a foreign language and encounters problems when accessing 
healthcare. The extensive US literature on this topic uses a specific expression for them: LEP aka 
persons with limited English proficiency. See among others CARTER-POKRAS et al. (2004: 29.); Glenn 
FLORES (2005): The Impact of Medical Interpreter Services on the Quality of Health Care: A 
Systematic Review. Medical Care Research and Review, Vol 62 No 3, p. 255 and Glenn FLORES 
(2006): Language Barriers to Health Care in the United States. The New England Journal of 
Medicine, Vol 355 No 3, p. 229. 
453
 Stefan PRIEBE, Sima SANDHU, Sónia DIAS, Andrea GADDINI, Tim GREACEN, Elisabeth IOANNIDIS, 
Ulrike KLUGE, Allan KRASNIK, Majda LAMKADDEM, Vincent LORANT, Rosa PUIGPINÓSI RIERA, 
Attila SARVARY, Joaquim J. F. SOARES, Mindaugas STANKUNAs, Christa STRAßMAYR, Kristian 
WAHLBECK, Marta WELBEL, Marija BOGIC (2011): Good practice in health care for migrants: views 
and experiences of care professionals in 16 European countries. BMC Public Health, Vol 11 Issue 
187, http://www.biomedcentral.com/content/pdf/1471-2458-11-187.pdf (15 August 2013), p. 4. 
See also Louis C. HAMPERS and Jennifer E. MCNULTY (2002): Professional Interpreters and 
Bilingual Physicians in a Pediatric Emergency Department. Effect on Resource Utilization. Archives 
of Pediatrics and Adolescent Medicine, Vol 156 No 11, pp. 1108-1113, describing the phenomenon of 
“language-barrier premium”, which refers to the increase of resource utilisation in case of language 
discordance between patient and healthcare professional. HAMPERS and MCNULTY (2002: 1110.). 
454
 Just over half of Europeans (54%) are able to hold a conversation in at least one additional 
language, a quarter (25%) are able to speak at least two additional languages and one in ten (10%) 
are conversant in at least three. Just over two fifths (44%) of Europeans say that they are able to 
understand at least one foreign language well enough to be able to follow the news on radio or 
television. Eurobarometer (2012: 5-6.). 
455
 European Commission, Directorate General for Translation (2011): Lingua Franca: Chimera or 
Reality? http://cordis.europa.eu/fp7/ict/language-technologies/docs/lingua-franca-en.pdf (15 August 
2013). 
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realistic to expect this scenario to happen in the near future in the European Union.456 
A much more realistic alternative to fill the language gap for now is the involvement 
of an interpreter. 
Medical interpretation can be provided basically in two different ways:457 (1) a friend 
or a family member of the patient or a random person with the required language 
skills can act as an ad hoc interpreter or (2) a professional interpreter can be asked 
for. In either case, the involvement of a third party raises ethical and legal 
concerns458 related to the sensitive nature of the information communicated such as 
doctor-patient confidentiality,459 data protection460 and medical liability.461 Indirect 
communication and the presence of a third party make it more difficult to discuss 
personal intimate issues, which might be highly relevant for the diagnosis. In 
addition to these disadvantages, ad hoc interpreters tend to translate selectively, to 
summarise or even to censor, which also leads to loss of information.462 Moreover, 
interpretation in general increases process time and – especially when professional 
interpreters are involved – induces extra costs. However, without the help of a 
professional interpreter, it might prove difficult or even impossible to take a proper 
                                                 
456
 As an article in the Economist aptly highlights the reason behind this, establishing a lingua franca 
would impose on the Member States which did not use that language as their official language before 
“to accept second-class linguistic citizenship”. 
http://www.economist.com/blogs/prospero/2013/09/language-diversity (16 January 2014). Switching 
to monolingualism in the EU – although it might seem desirable from certain aspects – is thus a 
political impossibility in today’s Europe. 
Nevertheless, promoting to learn foreign languages has been set high on the EU’s agenda; it is one of 
the main objectives of life-long learning. See among others European Commission: Communication 
from the Commission to the Council, the European Parliament, the Economic and Social Committee 
and the Committee of the Regions: Promoting Language Learning and Linguistic Diversity: An Action 
Plan 2004 – 2006. COM (2003) 449 final, 24. 07. 2003; Recommendation of the European Parliament 
and of the Council of 18 December 2006 on key competences for lifelong learning. OJL 394 of 30 
December 2006 and European Commission: Commission Staff Working Document. Language 
competences for employability, mobility and growth. SWD (2012) 372 final, 20. 11. 2012. 
457
 CARTER-POKRAS and her colleagues provide a wide variety of interpretation service options 
pointing out both their positive and negative sides. CARTER-POKRAS et al. (2004: 31-33.). 
458
 PRIEBE et al. (2011: 5.). 
Notably, a lack of interpretation might also invoke ethical and legal questions, for instance in relation 
to informed consent. CARTER-POKRAS et al. (2004: 31.). 
459
 This issue goes beyond the scope of this dissertation, and is therefore not dealt with in detail. 
460
 On the issues of medical data protection, see section V.1.1. infra. 
461
 For instance, the possibility of mistranslation or misinterpretation might shed light on a whole new 
aspect of medical liability. 
462
 PRIEBE et al. (2011: 5.) and CARTER-POKRAS et al. (2004: 31.). 
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medical history, to discuss the symptoms, to establish a right diagnosis or to explain 
the treatment and the medical instructions.463 Therefore, keeping in mind the 
downsides of the involvement of interpretation, it must be acknowledged that 
involving a professional medical interpreter seems to be the best solution to 
overcome language barriers464 in the course of cross-border healthcare provision. 
 
From a legal point of view, it can be brought into question whether European patients 
hold a right to medical interpretation. While no direct reference to medical 
interpretation can be found in the human rights treaties of the UN or the COE, 
PHELAN argues that the requirement of non-discrimination on language grounds and 
of equality of treatment implies the provision of interpreters.465 In the European 
Union, non-discrimination is a high-rated requirement, but the Treaty provisions on 
non-discrimination466 do not enumerate the grounds of language. However, the 
Treaty stipulates that any discrimination on grounds of nationality is strictly 
forbidden.467 At the same time, the Charter of Fundamental Rights of the European 
Union does specify language as a possible ground of discrimination468 and within the 
framework of the right to the integrity of the person it pays special attention to free 
and informed consent469 as a value which must be particularly respected in the field 
of healthcare.470 Interestingly, the Proposal for the Patient Mobility Directive471 – 
                                                 
463
 Mary PHELAN (2012): Medical Interpreting and the Law in the European Union. European Journal 
of Health Law, Vol 19, pp. 336-337. 
464
 See among others the findings of Warren J. FERGUSON and Lucy M. CANDIB (2002): Culture, 
Language, and the Doctor-Patient Relationship. Modern Culture and Physician-Patient 
Communication, Vol 34 No 5, p. 359. 
465
 PHELAN (2012: 337.). 
466
 Article 10 TFEU: In defining and implementing its policies and activities, the Union shall aim to 
combat discrimination based on sex, racial or ethnic origin, religion or belief, disability, age or 
sexual orientation. See also Article 19 (1) TFEU. 
467
 Article 18 TFEU. See also Article 21 (2) CFREU. 
468
 Article 21 (1) CFREU. 
469
 As JELFS and BAETEN underline, a distinction must be made between informed consent, where the 
patient agrees to a certain treatment while being aware of the risks and possible consequences, and 
informed decision, where the patient has all the relevant information on the different treatment 
options, procedures and alternatives. JELFS and BAETEN (2011: 21.) In cross-border healthcare 
situations both informed consent and informed decision-making is essential, and linguistic barriers can 
easily jeopardise them both. 
470
 Article 3 (2) CFREU. 
471
 COM (2008) 414. 
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referring directly to the Charter – included rules on equity and non-discrimination, 
where language was mentioned.472 One may wonder, though, why these parts were 
not adopted in the final version of the Directive. By adding the above provisions to 
the right to access to healthcare,473 PHELAN deduces that “the high level of human 
health protection could include the provision of translations and of interpreters to 
people who need such help to access healthcare.”474 
Despite the fact that the patient’s informed consent is likely to be jeopardised by 
poor communication between the patient and the healthcare professional,475 I 
strongly doubt that these legal provisions establish an enforceable obligation for the 
Member States to provide foreign patients with professional medical interpreters for 
free. Obviously, the question here does not only imply whether patients have access 
to linguistic services, but also who bears the costs of these services. Currently, in 
most Member States the costs of interpretation and translation burden the patients,476 
and these extra costs might constitute another argument against using cross-border 
healthcare rights. However, since the regulation of language policies belongs to the 
sole responsibility of the Member States477 within the Union,478 in my opinion, 
momentarily the European Union has no solid legal ground to require the Member 
States to guarantee free access to medical interpretation for border-crossing patients. 
The situation would be slightly different if a specific reference to the right to 
interpretation or to equal treatment on language grounds had been incorporated into 
the Patient Mobility Directive.479 In that case, the Member States would still have 
                                                 
472
 COM (2008) 414, p. 12 and Recital 13 of the Preamble of the Proposal for the PMD. 
473
 Article 35 CFREU. 
474
 PHELAN (2012: 337.). 
475
 CARTER-POKRAS et al. (2004: 31.). 
476
 JELFS and BAETEN (2011: 15-16.). 
477
 “In principle, EU Member States retain the full capacity to initiate and develop language policies 
that are suited to their own particular political and cultural context.” Julie BERNIER (2005): EU 
Economic Integration and National Language Policies: An Overlooked Tension. 
http://www.sciencessociales.uottawa.ca/crfpp/pdf/debat/Bernier.pdf (20 August 2013), p. 1. 
478
 BERNIER notes that “this capacity is significantly circumscribed by internal market rules requiring 
the unhampered circulation of persons, goods and services.” BERNIER (2005: 1-2.). 
479
 Interestingly enough, in the Preamble of the Directive it is expressly indicated that Member States 
are required to provide information to patients through their national contact points (Article 6 PMD) 
in any of the official languages of the Member State in which the contact points are situated. 
Additionally, information may be provided in any other language (Recital 48, Article 4 (5) PMD). 
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had the liberty to choose through what kind of measures they wished to provide 
access to medical interpretation, but they would have been obliged to ensure access 
to these services.480 In fact, the Directive’s provision which establishes the obligation 
of the Member State of treatment to provide relevant information to help patients to 
make an informed choice481 might be of interest in this respect. 
It is not very likely that the obligation to provide relevant information is fulfilled 
without the interpretation or translation of this information: the expressed aim of this 
rule is to enable patients to make an informed choice. Consequently, the unilateral 
provision of the information on the healthcare provider’s side without an ambition to 
induce understanding on the patient’s side – in my opinion – fails to fulfil the 
obligation imposed by the Directive.482 Nevertheless, it would be interesting to see 
how the Court would interpret this provision. The question is how the Union can 
relax the tension between its expressed commitment to linguistic diversity483 and its 
                                                                                                                                          
Consequently, Member States can voluntarily choose to deliver information in the language which the 
patient is most familiar with. A study suggests that “(i)n order to make the information on cross-
border healthcare accessible for both own citizens and visitors from other Member States we 
recommend to use other relevant (frequently used by groups of citizens or visitors) languages next to 
the native one.” Pricewaterhouse Coopers International Limited (2012): Recommendation Report – A 
best practice based approach to National Contact Point websites: feasibility study. 
http://ec.europa.eu/health/cross_border_care/docs/pwc_national_contact_points_website_en.pdf (30 
August 2013), p. 27. 
It would have been only one step further to integrate in the Directive that Member States are required 
to give patients information through their national contact points in any of the official languages of the 
EU according to the patient’s request. However, this would not have offered a full solution, since the 
preamble of the Directive is not legally binding and does not need to be transposed by the Member 
States. 
480
 The right to interpretation and translation is not unknown in Union law, Directive 2010/64/EU 
introduced this right in criminal proceedings for persons who do not speak or understand the language 
of the criminal proceedings concerned. Directive 2010/64/EU of the European Parliament and of the 
Council of 20 October 2010 on the right to interpretation and translation in criminal proceedings. OJ L 
280 of 26 October 2010. 
481
 Article 4 (2) (b) PMD. See also Recitals 19-20 of the Preamble of the PMD. 
482
 In relation to the requirement set out by Article 6 (3) of the Directive, according to which the 
information shall be easily accessible, Nys rightfully raises the question “whether information in a 
language that one cannot understand is not by definition difficult or even impossible to access.” He 
suggests to solve the problem by obliging the Member States to provide information (also) in English. 
Herman NYS (2014): The Transposition of the Directive on Patients’ Rights in Cross-Border 
Healthcare in National Law by the Member States: Still a Lot of Effort to Be Made and Questions to 
Be Answered. European Journal of Health Law, Vol 21, Special Issue, p. 10. 
483
 See footnote 452. 
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commitment to secure internal market freedoms,484 more specifically, the free 
movement of patients. 
 
In my view, two possible solutions could support border-crossing patients to cope 
with linguistic difficulties in the long run: either (1) establishing an obligation for the 
Member States to ensure access to medical translation and interpretation services for 
patients who need them or (2) establishing a specific organisation within the 
institutional structure of the European Union, which itself provides professional 
medical translation and interpretation services for patients lacking sufficient 
language knowledge. 
 
(1) Imposing such a duty on the Member States requires a legitimate legal 
basis the Union can act upon if the Member States fail to fulfil their obligations. As 
said above, it would have been more than appropriate to have inserted rules on the 
right to interpretation for patients into the Directive, which is entitled Directive on 
the application of patients’ rights in cross-border healthcare. However, adopting a 
separate legal tool as happened regarding the right to interpretation and translation in 
criminal proceedings,485 would also be a satisfactory way of solving the problem.486 
The medical interpretation could be carried out by trained staff487 at the newly 
founded national contact points (hereinafter also referred to as NCP),488 where the 
knowledge base on national and cross-border healthcare is given, and which are 
dedicated to facilitate the exchange of healthcare information in cross-border 
situations.489 
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 BERNIER (2005: 7.). 
485
 Directive 2010/64/EU. See footnote 475. 
486
 PHELAN (2012: 353.). 
487
 FLORES and his colleagues emphasise the importance of specialised training for medical 
interpreters: “medical interpreter training should include a detailed review of medical terms, with 
attention to linguistic issues such as variation among cultural subsets of a single linguistic group.” 
Glenn FLORES, M. Barton LAWS, Sandra J. MAYO, Barry ZUCKERMAN, Milagros ABREU, Leonardo 
MEDINA and Eric J. HARDT (2003): Errors in Medical Interpretation and Their Potential Clinical 
Consequences in Pediatric Encounters. Pediatrics, Vol 111 No 1, p. 11. 
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 Article 6 PMD. 
489
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If such an initiative came up, the Member States – without any doubt – would 
complain about the costliness of providing interpretation. It cannot be denied that 
professional interpretation services are far from cost neutral,490 but “in any budget 
discussion, it should be recognized that there are costs associated with not providing 
language interpretation,”491 which are mainly related to increased resource 
utilisation,492 a higher risk of medical malpractice,493 and decreased patient 
compliance. 
 
(2) Another alternative to fill the language gap would be to set up a special 
organisation within the institutional framework of the Union: a European medical 
interpretation agency, which could function as a call centre and provide EU-wide 
professional medical interpretation services for patients who need them. It could 
have decentralised national administrators (for example at the national contact 
points) and a central unit, which would be able to offer prompt services by means of 
ICT devices. The method of interpretation is apparently also crucial: research results 
confirmed that the highest patient satisfaction can be reached by remote simultaneous 
medical interpretation.494 Although distance provision of services and the 
involvement of ICT devices raise concerns495 as well, the possibility to overcome the 
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 PHELAN (2012: 353.). 
491
 CARTER-POKRAS et al. (2004: 35.). 
492
 HAMPERS and MCNULTY (2002). See footnote 453.  
Another US research proved that the length of hospital stays may also be affected by language 
barriers. It found that “the length of a hospital stay for LEP patients was significantly longer when 
professional interpreters were not used at admission or both admission/discharge.” Mary LINDHOLM, 
J. Lee HARGRAVES, Warren J. FERGUSON and George REED (2012): Professional language 
interpretation and inpatient length of stay and readmission rates. Journal of General Internal 
Medicine, Vol 27 Issue 10, pp. 1297-1298. 
493
 On this issue see Kelvin QUAN and Jessica LYNCH (2010): The High Costs of Language Barriers in 
Medical Malpractice. 
http://www.healthlaw.org/images/stories/High_Costs_of_Language_Barriers_in_Malpractice.pdf (20 
August 2013). 
494
 See among others FLORES et al. (2003: 10.) and Francesca GANY, Jennifer LENG, Ephraim 
SHAPIRO, David ABRAMSON, Ivette MOTOLA, David C. SHIELD and Jyotsna CHANGRANI (2007): 
Patient Satisfaction with Different Interpreting Methods: A Randomized Controlled Trial. Journal of 
General Internal Medicine, Vol 22 Suppl 2, p. 317. 
495
 Beside the concerns originating from the involvement of a third party (see footnote 458), both the 
non-presence of the interpreter and the usage of information and communication technology carry 
certain risks. Remote (online or telephone) interpretation deprives the interpreter of the non-verbal 
cues of the communication. Therefore, when training professional interpreters, special attention 
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linguistic barriers and provide cross-border patients with greater certainty in this 
respect is worth the investment. Either way, it is highly desirable that the European 
Union takes efforts to improve the access to professional medical interpretation and 
translation services.496 
III.2.1.3. Lack of reliable information on cross-border patient mobility 
How could European citizens be expected to use their cross-border healthcare 
rights if they are not even aware of the existence of these rights and of the 
functioning of these mechanisms? The Patient Mobility Directive clearly articulates 
the patients’ need for information on cross-border healthcare.497 It acknowledges that 
appropriate information on all essential aspects of cross-border healthcare is 
necessary in order to enable patients to exercise their rights on cross-border 
healthcare in practice.498 Statistics show, however, that the European citizens’ 
awareness of their cross-border healthcare rights is rather low: an EU-wide survey 
demonstrated in 2007,499 and a recent cross-border healthcare simulation 
confirmed,500 that a large share501 of the European population has no or very little 
                                                                                                                                          
should to be paid to the development of their ability to decode non-verbal cues from the parties’ tone 
of voice. CARTER-POKRAS et al. (2004: 32.) On the usage of ICT devices in healthcare, see chapter V. 
496
 The access to professional medical interpretation and translation services is of high importance not 
only in the course of the communication between the healthcare provider and the patient, but also 
between two (or more) healthcare professionals in different Member States, involved in the cross-
border healthcare situation. Linguistic problems can easily manifest themselves for instance if a 
consultation is needed between the patient’s former and current doctor and they do not share a 
common language. These difficulties also affect the provision of cross-border healthcare and the 
patient him/herself. 
497
 See Recital 19 of the Preamble of the PMD, which stipulates that when a patient receives cross-
border healthcare, it is essential for the patient to know in advance which rules will be applicable. A 
recent study found that “cross-border patients want to be informed on multiple health-related aspects 
of care,” such as the risk of treatment and infection rates, and financial issues. Michela TINELLI, 
Zlatko NIKOLOSKI and Dimitra PANTELI (2013): What information do patients want when choosing a 
hospital at home or abroad? A case study from Germany. Eurohealth, Vol 19 No 4. 
498
 Recital 48 of the Preamble of the PMD. 
499
 See footnote 10. 
500
 JELFS and BAETEN (2011: 20.). 
501
 In 2007, about 30 per cent of European citizens were not aware of their cross-border healthcare 
entitlements. See footnote 10. 
A German survey found similar trends in 2009: 27 per cent of patients were not aware of their 
entitlement to have the costs of outpatient treatment in another EU country reimbursed, 47 per cent of 
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information about the possibility to receive medical treatment in another EU country 
and to be reimbursed for that treatment by their national health authority or 
healthcare insurer. So who should spread the knowledge and supply patients with 
reliable information502 on cross-border healthcare? 
 
In the framework of the recently introduced principle of good administration, the 
current set of Coordination Regulations provides rules on the Member States’ 
information duties. According to these rules, the healthcare authorities503 are required 
to respond to all queries within a reasonable period of time and to provide the 
persons concerned with any information required for exercising the rights conferred 
on them by the Coordination Regulations.504 Although the declaration of this 
obligation is very welcome, there are some blurred points in its phrasing: both the 
method and the content of the information provision raise doubts. 
                                                                                                                                          
patients were not familiar with the European Health Insurance Card and 74 per cent of patients never 
heard about the Patient Mobility Directive. Techniker Krankenkasse (2009): Europe Survey 2009: 
German patients en route to Europe. 
http://www.tk.de/centaurus/servlet/contentblob/220638/Datei/2028/Europe-Survey-2009.pdf (6 
September 2013), pp. 26-28. 
These data might have changed somewhat in the last years, but the level of awareness still calls for 
action. 
502
 Patients receive information about health from various sources, but the question is whether this 
information can be trusted. This is especially important for information from the media and the 
internet, which “is rapidly establishing itself as a central source of health information.” Per Egil 
KUMMERVOLD and Rolf WYNN (2012): Health Information Accessed on the Internet: The 
Development in 5 European Countries. International Journal of Telemedicine and Applications, Vol 
2012, http://www.hindawi.com/journals/ijta/2012/297416/#B4 (16 September 2013), p. 1. See also 
Miriam MCMULLAN (2006): Patients using the Internet to obtain health information: How this affects 
the patient–health professional relationship. Patient Education and Counseling, Vol 63 Issue 1-2, p. 
27. 
503
 According to Article 1 (p) BR, institution means, in respect of each Member State, the body or 
authority responsible for applying all or part of the legislation. In the field of healthcare, these 
authorities are the healthcare funds, insurers and national healthcare services. Article 1 (2) (b) IR uses 
the expression ‘liaison body’ for those bodies designated by the competent authority of a Member 
State for one or more of the branches of social security to respond to requests for information and 
assistance for the purposes of the application of the Basic Regulation and the Implementing 
Regulation. 
504
 Article 76 (4) BR. Article 3 (1) IR adds that Member States shall ensure that the necessary 
information is made available to the persons concerned in order to inform them of the changes 
introduced by the basic Regulation and by the implementing Regulation to enable them to assert their 
rights. They shall also provide for user friendly services. However, the question what the drafters of 
the Implementing Regulation mean by ‘user friendly services’ remains unanswered. 
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First of all, it is highly questionable what can be considered ‘a reasonable period of 
time’. As a tool of coordination,505 the Regulations do not intend and take no effort to 
harmonise the processing times in the Member States, but the lack of definition gives 
this obligation a sense of uncertainty since the patient has no indication how long it 
takes to receive the required information.506 For the sake of certainty, a maximum 
time span could be inserted in the legislation on EU level. 
An additional question, to which there is no reference in the Regulation, is in which 
language the requested information should be provided by the Member State. In this 
respect, one may presume that the national policies on language regime must be 
applied, and national authorities can be expected to communicate in the official 
languages of their Member State. However, if the patient who is asking for 
information in the Member State concerned is familiar with none of these languages, 
which might easily occur if a foreign patient tries to collect information about 
treatment options in a Member State other than the Member State of residence, this 
directly leads to a linguistic obstacle,507 which – for lack of a satisfying alternative 
solution so far – potentially results in extra costs for the patient. 
The last point of concern relates to the material scope of the provision: according to 
the Regulation, national healthcare authorities are only obliged to inform the patients 
about matters related to rights included in the Coordination Regulations. Strictly 
interpreted, in a cross-border healthcare situation, the Member States can fulfil this 
requirement without even mentioning the additional entitlements of patients worked 
out by the Court of Justice or introduced by the Patient Mobility Directive. To sum 
up, although the codification of information duties is an applaudable improvement of 
the coordination mechanism, it suffers from several weaknesses. It should therefore 
                                                 
505
 See section III.1.3.1. and Table 3. 
506
 However, in certain Member States, national legislation exists that concerns delays for dealing with 
requests (e.g. in Belgium and in Germany). Presentations by Chris SEGAERT and Marc SCHNEIDER at 
AIM Cross-border Heathcare Workshop – Implementation of the Directive 2011/24/EU: Are we 
ready? on 17 September 2013 in Brussels, http://www.aim-mutual.org/fileadmin/events/2013/Cross-
Border_Healthcare_Workshop/2013_09_17_-_AIM_CBH_Workshop_Chris_Segaert.pdf and 
http://www.aim-mutual.org/fileadmin/events/2013/Cross-
Border_Healthcare_Workshop/Praes_AIM_170913_Marc_Schreiner.pdf (20 September 2013). 
507
 On the issues related to linguistic obstacles, see section III.2.1.2. supra. 
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be made more exact and patient-friendly in order to ensure quick, reliable and 
understandable cross-border healthcare information for free. 
 
In contrast to the rather general provisions of the Regulations, the Patient Mobility 
Directive specifies the Member States’ obligations and clearly splits the 
responsibility of delivering reliable information to the patients between the Member 
State of treatment and the Member State of affiliation. (Table 5 infra). 
 
Table 5: The Member States’ responsibilities in relation to information provision under the PMD 
Responsible 
MS 
The scope of the 
information 
provision 
The content of the information provision 
MS of 
affiliation 
patients’ rights and 
entitlements in that 
MS relating to 
receiving cross-
border healthcare 
information on their rights and entitlements in that MS relating 
to receiving cross-border healthcare, in particular as regards (1) 
the terms and conditions for reimbursement of costs and (2) 
procedures (2a) for accessing and determining those 
entitlements and (2b) for appeal and redress508 
MS of 
treatment 
standards and 
guidelines on quality 
and safety laid down 
by that MS 
from the national contact point:509 relevant information on the 
standards and guidelines, including (1) provisions on 
supervision and assessment of healthcare providers, (2) 
information on which healthcare providers are subject to these 
standards and guidelines and (3) information on the accessibility 
of hospitals for persons with disabilities 
from healthcare providers:510 relevant information to help 
individual patients to make an informed choice, including (1) on 
treatment options, (2) on the availability, quality and safety of 
the healthcare they provide in that state, (3) on prices, as well as 
(4) on their authorisation or registration status, their insurance 
cover or other means of personal or collective protection with 
regard to professional liability 
Source: the author’s own summary 
 
Primarily, the Member State of affiliation must provide information on the patients’ 
rights and entitlements in that state in relation to receiving cross-border healthcare511 
and the Member State of treatment must inform the patient about the standards and 
guidelines on quality and safety laid down in that state.512 
                                                 
508
 Article 5 (b) PMD. 
509
 Article 4 (2) (a) PMD. 
510
 Article 4 (2) (b) PMD. 
511
 Article 5 (b) PMD. 
512
 Article 4 (1) PMD. 
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Compared to the rules of the Regulation, the rules of the Directive are more specific 
and detailed and guarantee access to a broader scale of information. However, they 
do not offer a solution to the problem that if a patient wants to collect all relevant 
information concerning a certain treatment abroad, this involves at least three sources 
he/she needs to contact in (at least) two different Member States. So even if a patient 
possesses the necessary language skills to acquire the essential information, the 
multi-source investigation puts a considerable burden on him/her. The question is 
how this burden can be reduced so that it would not discourage patients to receive 
healthcare abroad. In order to answer this, the current sources of information have to 
be examined: (1) the national healthcare authorities, (2) the national contact points, 
and (3) the healthcare providers. Are these actors aware of and capable to fulfil their 
obligations concerning information provision? 
 
(1) National healthcare authorities – irrespective of how the healthcare 
system is organised in the Member State concerned – are the most traditional sources 
of information when it comes to healthcare rights, entitlements and conditions 
attached to them. They have the required knowledge both of the legislative 
background and of daily practice. They are often even involved in one way or 
another in the legislative procedures. Thus, they are very well-positioned to offer 
expert advice to patients in cross-border healthcare situations. However, these 
authorities, healthcare funds, health insurers – besides taking into account the 
patients’ interests – have financial concerns too: while the patient wants to benefit 
from the most favourable situation possible, the national healthcare authorities have 
to balance between the interest of the patient and of the national healthcare system 
itself. No wonder that in the healthcare cases of the Court, representatives of the 
national governments often came up with the argument that patient mobility might 
endanger the financial sustainability of the national healthcare budget.513 Therefore, 
with a good faith assumption, it can be presumed that national healthcare authorities 
will fully inform the patients about all possible options, but it must be kept in mind 
                                                 
513
 See footnote 327. 
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that at the same time they do guard the financial equilibrium of their healthcare 
system and might tend to encourage patients to opt for the alternative which is more 
economical for the state. Besides, the personnel of these institutions is usually only 
familiar with the national system of the Member State they work for, which is a 
disadvantage in cross-border situations where at least one other Member State – and 
its national healthcare system – is involved. 
 
(2) As mentioned above,514 the national contact points are newborns of the 
European social security systems, introduced by the Patient Mobility Directive515 to 
serve the purpose of promoting cross-border healthcare. In the Directive’s regime 
they are the bodies responsible for providing patients with information. It is to be 
seen after the implementation of the Patient Mobility Directive how the Member 
States will organise their national contact points and how they will function.516 
However, their very existence is a great achievement and an added value of the 
Directive: they are to be a neutral source of reliable, transparent and easily 
accessible517 information on cross-border healthcare issues. Since they are created to 
carry out this specific task,518 it can be rightfully expected that the persons working 
at the NCPs can answer most of the patients’ relevant questions related to cross-
border treatments, and if they cannot, that they have the competence to find the 
answer quickly through their professional network of NCPs in other Member States, 
healthcare providers, healthcare authorities and other organisations.519 Therefore, it is 
highly important that the NCPs work closely together both with the European and 
national institutions involved and with each other.520 However, the form of this 
                                                 
514
 See footnote 488 and 489. 
515
 Article 6 PMD. 
516
 The Member States should decide on the form and number of their national contact points. Recital 
49 of the Preamble of the PMD. Some scholars criticise that “the Directive is vague about the way 
these contact points should actually work.” NYS (2014: 9.). 
517
 Article 6 (5) PMD. It is worth mentioning that special reference is made to the accessibility by 
persons with a disability. 
518
 Article 6 (3) and (4) PMD. 
519
 National contact points should be established in an efficient and transparent way and they should 
be able to consult with patient organisations, healthcare insurers and healthcare providers. Recital 49 
of the Preamble of the PMD and Article 6 (1) PMD. 
520
 Article 6 (2) PMD. 
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cooperation is far from clear yet.521 Additionally, it would be desirable if they could 
provide patients with information in a language the patient is most familiar with.522 
The expectations towards the national contact points are undoubtedly high and it is in 
the coming years that they will have to show whether they are up to their tasks. 
 
(3) In my opinion, healthcare providers are the weakest point of the 
information providing triumvirate. Although patients might trust them the most and 
expect the information primarily from them,523 they are often neither trained nor 
willing to function as a source of non-medical information.524 Training opportunities 
should be offered for the healthcare professionals and for other staff members of 
healthcare providers to enable them to provide patients with the information 
required. At the same time, national healthcare authorities – in cooperation with the 
European Commission – should develop a monitoring system to ensure that all the 
obliged parties fulfil their information obligations. 
 
In addition to these bodies’ obligations laid down in the European legislation, the 
European Union should take serious efforts to spread proper information on cross-
border patient rights. Since the developments of patient mobility were elaborated by 
the EU institutions through various EU instruments,525 it can be seen as much as an 
obligation of the European Union itself as an obligation of the Member States to 
                                                 
521
 For instance, (1) organising joint trainings, frequent multilateral consultations or seminars, (2) 
sharing experience and good practices and (3) building out a common online platform to enable the 
administrators to promptly contact each other at different NCPs would be efficient ways to cooperate. 
522
 On this issue, see section III.2.1.2. supra. According to recent information, most of the NCPs 
provide information to patients in English next to the official language of their MS (e.g. Belgium, 
Germany, Hungary, Croatia). However, there are exemplary attempts by certain Member States which 
aim to be able to provide information in more than twenty different languages (e.g. the Czech 
Republic). Presentation by Sarga POLAKOVA at AIM Cross-border Heathcare Workshop – 
Implementation of the Directive 2011/24/EU: Are we ready? on 17 September 2013 in Brussels, 
http://www.aim-mutual.org/fileadmin/events/2013/Cross-Border_Healthcare_Workshop/AIM-
Brussels-Directive_CMU_Mgr._Sarka_Polakova.pdf (18 September 2013). 
523
 European Commission – Eurobarometer (2003): European Union citizens and sources of 
information about health. http://ec.europa.eu/public_opinion/archives/ebs/ebs_179_en.pdf (16 
September 2013), p. 5. 
524
 JELFS and BAETEN note that the preparedness of healthcare providers to fulfil their obligation 
concerning information provision under the Direction is questionable. JELFS and BAETEN (2011: 21.) 
525
 On this topic, see section III.1.3.4. supra. 
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make information available and easily accessible in order to raise the awareness 
among European patients.526 
In my opinion, patient organisations should also take a bigger part in raising patients’ 
awareness, since its basic role is “to empower patients by providing support, 
information and education.”527 Although initiatives can be seen on European level,528 
it is questionable whether these efforts reach the unique patients themselves. 
Even if a clear and consistent legal framework was given, without tackling the 
practical obstacles to patient mobility efficiently, patients will not be able to exercise 
their cross-border healthcare rights. These obstacles were examined in the above 
sections. In Table 6 infra, the core problems are summarised along with the risks 
they carry and some possible ways of reducing these risks are indicated. However, 
throughout the following sections, it is shown that the legal framework is far from 
flawless either. 
  
                                                 
526
 The EU has a wide variety of tools to provide information to citizens: the websites of the EU 
institutions, specialised websites to increase the general understanding of European issues (e.g. the 
Your Europe portal), leaflets, online campaigns, videos on video sharing sites etc. 
527
 THORN and DILL (2010: 24.). 
528
 For instance, the European Patients Forum (hereinafter also referred to as EPF) did not only 
participate in the negotiations of the PMD by issuing statements and recommendations, but also 
disseminates information on the Directive through its website (http://www.eu-
patient.eu/whatwedo/Policy/Patients-Mobility/) and other activities. 
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Table 6: Obstacles to access of a non-legal nature 
Obstacle 
to access 
Geographical distance Linguistic barriers Lack of information 
Core of 
the 
problem 
Long 
distance 
travel  
The closest 
healthcare 
provider 
situated on the 
other side of 
the border 
Poor communication 
between patients and 
healthcare professionals 
Low awareness of cross-
border patients’ rights 
Risks • special 
needs 
might 
occur in 
the 
course 
of the 
travel 
• delayed 
access to 
healthcare 
• higher risk of 
misdiagnoses and 
malpractice 
• extra physical 
examinations and 
diagnostic tests required 
• prolonged and more 
complicated 
administrative 
procedures 
• difficulties or inability to 
make an informed 
decision concerning cross-
border healthcare 
Possible 
solutions 
(1) Pre-
travel 
medical 
evaluation 
and 
planning 
(2) Facilitating 
cross-border 
cooperation 
and cross-
border 
contracting 
Interpreter’s involvement: 
(1) national responsibility 
to ensure access to medical 
interpretation or  
(2) EU-wide medical 
interpretation and 
translation service 
(1) Providing more 
transparent, impartial, 
reliable, easily collectable 
and accessible information 
to patients within a 
reasonable time 
(2) Training people 
responsible for information 
provision 
(3) Monitoring whether the 
obligations on information 
provision are fulfilled 
(3) eHealth applications, 
telemedicine 
Source: the author’s own summary 
  
Gabriella BERKI: Cross-border patient mobility: The legal framework of obtaining 
healthcare abroad within the European Union – a patients’ perspective 
126 
 
III.2.2. Obstacles to access of a legal nature 
After analysing the practical obstacles to the realisation of the right to access 
to cross-border healthcare, the current European legislation on cross-border patient 
mobility must be scrutinised in order to explore the potential sources of legal 
uncertainty which can constitute a legal obstacle to receiving treatment abroad. Three 
obstacles of a legal nature are highlighted: (1) legal complexity, (2) administrative 
burden and (3) financial burden. However, the difficulties related to financing cross-
border healthcare are discussed in detail in the next chapter, which is dedicated 
entirely to the financial aspect of European patient mobility. Therefore, in this 
section the issues of legal complexity and administrative burden are discussed. 
 
The European legislation governing intra-EU patient movements across the Member 
States is in itself very complex. In this dissertation, two dimensions of the legal 
complexity are identified: (1) the complexity of legal rules applicable to the various 
scenarios of cross-border patient mobility and (2) the complexity of the simultaneous 
application of legal tools. 
(1) On the one hand, access to healthcare outside the Member State of 
residence includes three different situations to which different rules apply: (a) access 
to healthcare in the competent Member State when residing outside the competent 
Member State; (b) access to necessary healthcare during a temporary stay outside 
the Member State of residence; and (c) access to planned healthcare outside the 
Member State of residence.  
(2) On the other hand, these situations are currently regulated by two (if 
counting the case law as well, three) separate sets of rules:529 (a) the social security 
coordination mechanism and (b) the case law based Patient Mobility Directive, 
which partly overlap and partly conflict with each other, creating doubts and legal 
uncertainty. 
                                                 
529
 On the multipillar legislative system, see section III.1.3.4. supra. 
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These two dimensions of legal complexity are examined in the next sections to show 
which difficulties border-crossing patients face and how these difficulties could be 
tackled. Firstly, the rules applicable to various scenarios of cross-border patient 
mobility are analysed, synthetising the provisions of the different legal tools. 
Secondly, the administrative requirements and procedures, which must be followed 
in the different scenarios, are scrutinised. Finally, the conflicts and defects of the 
recent legal and administrative framework are pointed out. 
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III.2.2.1. Various legal scenarios of cross-border patient mobility 
The broad concept of patient mobility530 includes all situations in which the 
person concerned receives healthcare in a Member State other than the Member State 
of affiliation. In these situations at least two Member States are involved: the 
Member State of the healthcare provision and the competent Member State. The 
latter State is the one where the person is covered by the compulsory health 
insurance scheme.531 If the person concerned resides outside of the competent 
Member State, there is potentially a third Member State involved. 
Under this section, the legal rules on the three above mentioned possible scenarios, 
namely (1) access to healthcare in the competent Member State when residing 
outside the competent Member State; (2) access to necessary healthcare during a 
temporary stay outside the Member State of residence; and (3) access to planned 
healthcare outside the Member State of residence, are the focus point. For each 
scenario, the starting point is the body of the Regulation. The picture is completed 
with what the Court concluded in its case law and the Patient Mobility Directive 
added to the legal framework. 
III.2.2.1.A. Access to healthcare in the competent Member State when residing 
outside that Member State 
If someone resides in the competent state, it is self-evident that if he/she is 
insured, this implies that he/she is entitled to sickness benefits in kind in that country 
according to its national legislation. In this case, we cannot speak of cross-border 
healthcare, since no borders are crossed and there is no need to look up the European 
                                                 
530
 On the definitions, see section II.3.2. 
531
 See Article 1 (q) and (s) BR. According to the lex loci laboris principle, this MS is usually the MS 
of pursuing working activity. Article 11 (3) (a) BR. In the case of inactive persons, this MS is usually 
the MS of residence according to the lex loci domicilii principle. Article 11 (3) (e) BR. 
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legislation either.532 This is an entirely national matter and all related questions are 
answered by the national legislation of this state. However, if the person resides in a 
Member State other than the competent Member State, supranational legislation 
comes into play. 
Under the coordination rules, a distinction is made between certain groups of people 
in relation to their entitlements: in addition to (1) the general rules, special rules (2) 
on frontier workers533 and (3) pensioners are in place. In principle, a person residing 
in a Member State other than the competent Member State is entitled – if he/she 
fulfils the entitlement conditions under the national legislation of the competent 
Member State534 – to sickness benefits in kind in the Member State of residence,535 
meaning that the healthcare benefits are provided in the latter state. 
One may wonder, though, how it can be decided which one of the countries involved 
is considered the Member State of residence, since in certain cross-border cases it is 
not quite obvious. The following definition of residence is given in Article 1 (j) BR: 
the place where a person habitually resides. However, no other criterion was 
originally added,536 so it was the European Court of Justice that described the 
                                                 
532
 Nevertheless, if the competent Member State requires a certain length of qualifying period in order 
to ensure the right to sickness benefits in kind, the competent institution must take into account the 
qualifying periods completed in other Member States as well. JORENS et al. (2007: 22.) See also VAN 
DER MEI (2003: 236.). 
However, this exact provision is no longer incorporated in the sickness chapter of the Regulation, as it 
was under Article 18 of Regulation 1408/71; “it is now applicable through the general principles of 
aggregation of periods and assimilation of facts (Articles 6 and 7 of Regulation 883/2004), which 
fully apply to sickness benefits.” Yves JORENS, Jean-Philippe LHERNOULD and Simon ROBERTS 
(2011): Handbook on European Social Security Law. p. 267. http://www.sgk-
kap.org/en/database/db/B2_C8_717.pdf (5 December 2011). 
533
 On the rules of healthcare entitlements for frontier workers and their family members, see section 
III.2.1.1. supra. 
534
 “The question as to whether the claimant has the right to benefits in kind is […] always assessed 
on the basis of the legislation of the competent country, where he/she is insured.” JORENS et al. (2007: 
24.). 
535
 Article 17 BR. 
536
 On the concept of residence see Michael COUCHEIR (ed.), Maija SAKSLIN (ed.), Stefano GIUBBONI, 
Dorte MARTINSEN and Herwig VERSCHUEREN (2008): trESS Think Tank Report 2008 – The 
relationship and interaction between the coordination Regulations and Directive 2004/38/EC.  
http://www.tress-
network.org/tress2012/EUROPEAN%20RESOURCES/EUROPEANREPORT/ThinkTank_Residence
.pdf (15 November 2013) and European Commission (2014): Practical guide on the applicable 
legislation in the European Union (EU), the European Economic Area (EEA) and Switzerland. 
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circumstances which should be taken into account when determining the Member 
State of residence, in particular the employed person's family situation; the reasons 
which have led him/her to move; the length537 and continuity of the residence; the 
                                                                                                                                          
http://ec.europa.eu/social/main.jsp?langId=en&catId=89&newsId=2021&furtherNews=yes (18 
January 2014), pp. 41-49. 
537
 Union law does not make a distinction between temporary stay and residence according to their 
lengths. As the ECJ has said, all the circumstances have to be evaluated carefully on a case-by-case 
basis. So according to my understanding, a two years’ stay may be considered a temporary stay if it is 
clear from the circumstances that the person intends to return to his/her Member State (for example a 
temporary labour contract, temporary accommodation abroad, family remaining in the MS of origin), 
whereas a four-week long stay may already be considered residence if the person intends to habitually 
reside in that MS. In fact, the Court stated in its judgement in Swaddling that the length of residence in 
the Member State cannot be regarded as an intrinsic element of the concept of residence. C-90/97 
Robin Swaddling v Adjudication Officer [ECR 1999 Page I-01075] 30. 
The Court’s recent judgement (C-255/13 I v Health Service Executive [ECR 2014 Page 00000]) 
reaffirmed this interpretation. Mr I, an Irish resident who performed a professional activity in Ireland 
and the United Kingdom, was holidaying in Germany when he was admitted as an emergency patient 
to the university hospital in Düsseldorf. He was soon diagnosed with a rare, bilateral infarct to his 
brain stem, which resulted in severe quadriplegia and loss of motor function. Later he was found to 
have a genetic mutation affecting the composition of his blood and was diagnosed with cancer. Ever 
since he had been admitted to hospital in the summer of 2002, he remained gravely ill, wheelchair-
bound and his health status required constant monitoring and treatment. (21-24.) As the Irish High 
Court pointed out, he was compelled to live in Germany due to his medical condition and the 
necessity of continuous treatment. During the legal proceedings, Mr I assured that he was willing to 
return to Ireland and was not attempting to integrate into German society. As a matter of illustration 
he stressed that he kept contact with his family living in Ireland, that he had not opened a bank 
account or did not own any properties in Germany and that he did not speak German. In its decision, 
the Court declared that the simple fact that such a person has remained in a Member State, even 
continuously over a long period, does not necessarily mean that he resides in that State within the 
meaning of Regulation 883/2004 (48.) and for the purpose of determining a person’s habitual centre of 
interests, all relevant factors must be taken into account (54.), among which no hierarchy exists. 
Consequently, although Mr I had lived in Germany for a long time (more than 11 years), this situation 
did not reflect a personal choice on his part (56.). Hence, he must be regarded as staying in Germany. 
See on this case Mel COUSINS (2014): Habitual residence: fact or (legal fiction)? Case C-255/13, I v. 
Health Service Executive. 
http://works.bepress.com/cgi/viewcontent.cgi?article=1146&context=mel_cousins (22 November 
2014). 
However, it is worth noting that different rules apply to residence situations of up to three months and 
to those of more than three months. The rules are included in Directive 2004/38/EC of the European 
Parliament and of the Council of 29 April 2004 on the right of citizens of the Union and their family 
members to move and reside freely within the territory of the Member States (hereinafter also referred 
to as the Residence Directive). OJ L 158 of 30 April 2004. The different concepts of residence in 
Regulation 883/2004 and Directive 2004/38 create numerous implementation problems. The main 
difference between the views is that the Regulation refers to an EU-wide notion which was further 
clarified by the ECJ based on a factual situation, whereas in the Residence Directive no residence 
definition was included, which means that it can be interpreted as extremely widely covering the 
short-term residence periods as well. See COUCHEIR et al. (2008: 26.) and European Commission, DG 
Employment, Social Affairs and Inclusion (2011): Explanatory notes on modernised social security 
coordination – Relationship between Regulation (EC) No 883/2004 and Directive No 2004/38/EC. p. 
4. http://ec.europa.eu/social/main.jsp?catId=866&langId=en (25 November 2011). 
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fact that he/she is in stable employment; and his/her intention as it appears from all 
the circumstances.538 These criteria were incorporated into the Implementing 
Regulation afterwards. It stipulates that if the Member States involved cannot agree 
on the determination of the Member State of residence, they must establish the centre 
of interests of the person concerned, based on an overall assessment of all available 
information relating to relevant facts, especially the duration and continuity of 
presence on the territory of the Member States concerned539 and the person’s 
situation.540 If this assessment does not result in an agreement, the person’s intention, 
as it appears from such facts and circumstances, especially the reasons that led the 
person to move, shall be considered to be decisive for establishing that person’s 
actual place of residence.541 This is not the only situation in which the Regulations 
order the national institutions to make a legal decision on the basis of the intention of 
the person concerned.542 Although it is true that in most situations the factual 
circumstances reveal more or less clearly what the person’s intention might be, this is 
not always so, and when doubts arise it is highly complicated to investigate and 
prove a mental condition such as intention behind a certain action. Therefore, it is 
worth considering whether there is a possibility to select another decisive factor 
which is more exact and more easily controllable. 
 
                                                                                                                                          
It is also remarkable that whereas Regulation 883/2004 distinguishes between stay [Article 1 (k)] and 
residence [Article 1 (j)], the Patient Mobility Directive lacks this distinction. 
538
 C-76/76 Silvana di Paolo v Office national de l'emploi [ECR 1977 Page 00315] 17-21; C-102/91 
Doris Knoch v Bundesanstalt für Arbeit [ECR 1992 Page I-04341] 19-24; C-90/97 Swaddling, 29 and 
C-255/13 I v HSE, 44-45.See also LHERNOULD et al. (2010: 11.). 
539
 Article 11 (1) (a) IR. 
540
 Here a broad scale of various circumstances must be taken into account: (1) the nature and the 
specific characteristics of any activity pursued, in particular the place where such activity is 
habitually pursued, the stability of the activity, and the duration of any work contract; (2) his family 
status and family ties; (3) the exercise of any non-remunerated activity; (4) in the case of students, the 
source of their income; (5) his housing situation, in particular how permanent it is; (6) the Member 
State in which the person is deemed to reside for taxation purposes. Article 11 (1) (b) IR. 
541
 Article 11 (2) IR. 
542
 It will be seen infra that when making a distinction between planned and unplanned care the same 
logic is used and the intention of the person concerned is the decisive factor. 
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It is important to note that the benefit is provided in the Member State of residence in 
accordance with the legal regulations of this country.543 This rule might seem 
illogical considering that the costs of the treatment must be borne by the competent 
Member State.544 However, from the practical point of view this is the only 
acceptable solution, since it is unrealistic to expect the healthcare provider to be 
familiar with the legislation of another Member State.545 Nevertheless, as a result of 
the application of this rule, it is of no relevance whether the required sickness 
benefits in kind are included into the insurance package of the competent Member 
State, because the legislation of the Member State of residence determines the 
available benefits and the rules of provision.546 This way, it may happen that the 
competent Member State is obliged to reimburse the cost of a treatment provided in 
another Member State; a medical cost which it would not cover if the treatment was 
provided on its own territory. Or, to the contrary, an insured person might not be 
entitled to a certain benefit in the Member State of residence, irrespective of the fact 
that he/she pays health contributions for that in the competent Member State.547 
However, this latter case should not cause a problem, since the insured persons have 
the right to benefits in kind in the competent Member State as well when staying 
there.548 
                                                 
543
 Article 17 BR. 
544
 It is obvious that the medical treatment is provided at the expense of the competent Member State, 
since the health contributions must be paid in that country. VAN DER MEI (2003: 236.). However, this 
provision also implies that the patient “is entitled to a package of sickness benefits in kind in 
accordance with the legislation of a Member State to whose social security he or she does not 
contribute financially.” Herwig VERSCHUEREN (2001): Financing Social Security and Regulation 
(EEC) 1408/71. European Journal of Social Security, Vol 3 Issue 1, p. 14. 
545
 It might therefore have been thought logical to require the institution of the place of residence to 
provide benefits in accordance with the legislation administered by the competent institution, which 
will after all have to meet the cost. Such a solution would not, however, be practical, since it would 
require an institution to apply the legislation of another Member State. That doubtless explains why 
the authors of the regulation decided instead that benefits in kind should be provided by the institution 
of the place of residence in accordance with the provisions of the legislation administered by that 
institution as though the person concerned were insured with it. The obvious practical advantage of 
that solution is that the institution which provides benefits in kind does so in accordance with the only 
legislation that it can be expected to be familiar with, namely its own legislation. Opinion of AG 
Jacobs in C-451/93 Claudine Delavant v Allgemeine Ortskrankenkasse für das Saarland [ECR 1995 
Page I-01545] 16. 
546
 JORENS et al. (2007: 25.) See also COUCHEIR and JORENS (2005:19.) and PENNINGS (2010: 157.). 
547
 VERSCHUEREN (2001:14.) and VAN DER MEI (2003: 238.). 
548
 Article 18 (1) BR. 
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The Regulation provides that the healthcare benefits must be given to the insured 
persons in the Member State of residence as though they were insured under the said 
legislation.549 The full integration550 of these persons into the healthcare system of 
the Member State of residence has several consequences. One concerning the 
applicable healthcare basket could be seen above. Looking at this from the 
obligations’ side, however, it has to be noted that these persons are required to make 
the same forms of payment as the nationals of that state do.551 
The same rules apply for the insured person's family members552 residing outside the 
competent Member State. 
In addition to the special rules applicable to the family members of frontier 
workers,553 which were discussed supra,554 special rules also apply to pensioners and 
their family members residing outside the competent Member State.555 If the 
                                                 
549
 Article 17 BR. 
550
 This comes from the rule on equal treatment as well, since the persons to whom [the] Regulation 
applies shall enjoy the same benefits and be subject to the same obligations under the legislation of 
any Member State as the nationals thereof. Article 4 BR. 
551
 See an example on drug provision PENNINGS (2010: 157.) Chapter IV. gives a deeper insight into 
financing medical treatments abroad. 
552
 The definition of family members under the coordination rules can be found in Article 1 (i) BR, 
which is detailed further with regard to sickness benefits in kind in Article 1 (i) (1) (ii) as any person 
defined or recognized as a member of the family or designated as a member of the household by the 
legislation of the Member State in which he/she resides. So here again the MS of residence's 
legislation applies. However, if under the national legislation of the MS of residence the concerned 
person’s family members are not entitled to sickness benefits in kind, the legislation of the competent 
MS applies. C-451/93 Claudine Delavant v Allgemeine Ortskrankenkasse für das Saarland [ECR 
1995 Page I-01545] 19. […] when a worker resides with the members of his family in the territory of a 
Member State other than the Member State in which he works, under whose legislation he is insured 
by virtue of the regulation, the conditions for entitlement to sickness benefits in kind for members of 
that person' s family are also governed by the legislation of the State in which that person works in so 
far as the members of his family are not entitled to those benefits under the legislation of their State of 
residence. See also JORENS (2002: 88.). The different family concepts of the Member States are 
especially relevant for example when determining the social security status of non-married partners, 
same sex couples and children during the adoption procedure. 
553
 Article 18 (2) BR. 
554
 On the special rules for frontier workers and their family members, see section III.2.1.1. supra.  
555
 An interesting aspect of healthcare entitlements for pensioners residing in a MS other than the 
competent MS was highlighted by the ECJ’s ruling in the van Delft case. C-345/09 J. A. van Delft and 
Others v College voor zorgverzekeringen [ECR 2010 Page I-09879]. 
The appellants in the main proceedings were Dutch nationals, receiving statutory pensions from the 
Netherlands while residing in other Member States. Due to a change to national legislation, the Dutch 
competent institution started to deduct from the pensions paid to the appellants the contributions for 
benefiting from the compulsory statutory sickness insurance scheme. The appellants contested the 
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pensioner receives his/her pension from only one Member State and he/she resides in 
this state, he/she is obviously entitled to sickness benefits in kind in this country – if 
he/she fulfils the conditions of entitlement under the national legislation. 
However, if the old-age, invalidity or survivors’ benefits come from more than one 
Member State, the situation is slightly more complicated. If one of the pension 
paying Member States is the Member State of residence, the pensioner and his/her 
family members are entitled to sickness benefits in kind in this country as though the 
pension was payable solely under the legislation of that Member State.556 
Consequently, the entire medical cost is borne by the Member State of residence. If 
the pensioner receives his/her pension from more than one Member State, but the 
Member State of residence is not one of them, the pensioner and his/her family 
members have the right to obtain healthcare benefits in the Member State of 
residence in so far as he/she would be entitled thereto under the legislation of the 
Member State557 or of at least one of the Member States558 competent in respect of 
his/her pensions. 
It must be added, though, that if the Member State of residence and the competent 
Member State which allocates the pension differ from each other, the competent 
Member State is free to opt for ensuring the pensioner the benefits in kind while 
staying on its territory.559 The different entitlements of the different groups under the 
Regulation are summarised in Table 7 infra. 
  
                                                                                                                                          
decision of the competent institution and argued that in accordance with the Coordination Regulation 
they must be provided with the opportunity to choose whether they wish to receive benefits in kind in 
the MS of residence or to conclude an insurance contract privately (as they did before the change to 
the Dutch legislation). In the latter case the Netherlands does not have the right to deduct the 
contributions since it does not bear the costs of healthcare. In this case, the ECJ interpreted the 
Coordination Regulations as not precluding such a national legislation. 
556
 Article 23 BR. 
557
 The medical cost has to be borne by this MS. Article 24 (2) (a) BR. 
558
 The medical cost has to be borne by the MS to whose legislation the person concerned has been 
subject for the longest period of time. Article 24 (2) (b) BR. 
559
 Article 27 (2) BR. The Member States ensuring this additional right are listed in Annex IV BR: 
Belgium, Bulgaria, the Czech Republic, Germany, Greece, Spain, France, Cyprus, Luxembourg, 
Hungary, the Netherlands, Austria, Poland, Slovenia and Sweden. 
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Table 7: Entitlement to sickness benefits in kind for people residing outside the competent MS 
Persons residing 
outside the 
competent MS 
in the MS of 
residence in the competent MS 
 
1) Insured persons entitled to healthcare 
benefits in kind 
entitled to healthcare benefits in 
kind 
Double access: 
unconditional 
freedom of 
choice 2) Family members 
of insured persons 
entitled to healthcare 
benefits in kind 
entitled to healthcare benefits in 
kind 
3) Frontier 
workers 
entitled to healthcare 
benefits in kind 
entitled to healthcare benefits in 
kind 
4) Family members 
of frontier workers 
entitled to healthcare 
benefits in kind 
in certain Member States 
entitlement is limited to 
necessary care 
MSs listed in 
Annex III BR 
5) Retired frontier 
workers 
entitled to healthcare 
benefits in kind 
entitled to continuation of 
treatment 
 
6) Family members 
of retired frontier 
workers 
entitled to healthcare 
benefits in kind 
entitled to continuation of 
treatment, unless MS listed in 
Annex III BR 
 
7) Pensioners entitled to healthcare 
benefits in kind 
entitled to healthcare benefits in 
kind if MS listed in Annex IV 
BR. If MS is not listed in Annex 
IV, entitlement is limited to 
necessary care. 
determination 
of competent 
MS is based on 
which MS is 
responsible for 
paying the 
pension or 
pensions 
8) Family members 
of pensioners 
entitled to healthcare 
benefits in kind 
entitlement is limited to 
necessary care if it differs from 
the MS of residence 
Source: the author's own summary 
 
The Patient Mobility Directive does, however, not apply to situations in which a 
patient residing outside of the competent state receives healthcare in the Member 
State of residence. The Patient Mobility Directive is applicable to cross-border 
healthcare, which – by definition – involves healthcare provision in a Member State 
other than the Member State of affiliation.560 According to the wording of the 
Directive, the Member State of affiliation is the Member State competent to grant to 
the insured person a prior authorisation to receive appropriate treatment outside the 
Member State of residence.561 Since in this case, no treatment is obtained outside the 
Member State of residence, the Commission argues that under the Directive’s rules, 
                                                 
560
 Article 3 (e) PMD. 
561
 Article 3 (c) (i) PMD. 
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“such a scenario is considered as lacking a cross-border element” and therefore falls 
outside of the scope of the Patient Mobility Directive.562 
However, if the healthcare is obtained in the competent Member State instead of the 
Member State of residence, the Directive might be applicable. In order to apply the 
Directive’s rules, two conditions must concurrently be met in addition to the fact that 
the healthcare is provided in the competent Member State, namely (1) the treatment 
is not subject to prior authorisation under the Directive’s regime and (2) the 
treatment is provided in accordance with the Directive instead of in accordance with 
the sickness benefit chapter of the Coordination Regulation.563 Among these 
circumstances, the Directive stipulates that the medical costs have to be assumed by 
the competent Member State.564 
As to the first condition, whether or not the treatment in question is subject to prior 
authorisation, the Member States have the freedom to determine within the limits of 
the Directive565 which elements of their national benefit baskets require a prior 
authorisation for the cross-border healthcare costs to be reimbursed. The fulfilment 
of the second condition, however, is related to the patient, who cannot or does not 
want to use the coordination route and opts for the Directive’s route instead. The 
persons who do not have full entitlement to healthcare in the competent Member 
State can benefit from the Directive to gain access to the healthcare which they are 
not entitled to under the Regulations.566 These persons are (1) the family members of 
frontier workers if the competent Member State is listed in Annex III of the Basic 
Regulation567 and (2) pensioners and their family members if the competent Member 
                                                 
562
 AC 246/12, p. 19. 
In 2013, an appendix was added summarising the answers to the most significant questions that arose 
in relation to the Guidance note. Administrative Commission for the Coordination of Social Security 
Services (2013): Appendix to the interpretative note of the Commission on the relationship between 
Regulations (EC) Nos 883/2004 and 987/2009 on the coordination of social security systems and 
Directive 2011/24/EU on the application of patients' rights in cross-border healthcare. AC 270/13, 28 
May 2013. 
563
 Chapter 1 (Sickness, maternity and equivalent paternity benefits) of Title III (Special provisions 
concerning the various categories of benefits) BR. 
564
 Article 7 (2) (b) PMD. 
565
 Article 8 PMD. 
566
 AC 246/12, p. 23. 
567
 Article 18 (2) BR and Article 7 (2) (b) PMD. See footnote 413. 
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State is not listed in Annex IV of the Basic Regulation.568 However, also other 
persons who have full entitlement in the competent Member State can voluntarily 
decide to get reimbursed in accordance with the Directive, if they wish to receive 
healthcare under circumstances which would exclude the healthcare provision from 
the scope of the Regulation, for instance at a non-contracted healthcare provider.  
The scenarios examined in this section are summarised in Table 8 infra. 
 
Table 8: Access to healthcare when residing outside the competent MS 
MS of treatm. 
MS of res. MS of residence competent MS 
competent MS When a person resides in the competent MS and is treated in that MS: 
 the national legislation of the competent MS applies 
MS other than the 
competent MS 
When a person resides in a MS other 
than the competent MS and is treated 
in the MS of residence: 
 
Coordination Regulations apply (Art. 
17 BR): the person concerned is – as a 
principle – entitled to healthcare in the 
MS of residence as though he/she 
were insured in that state. 
Patient Mobility Directive does not 
apply (cross-border element is 
lacking). 
When a person resides in a MS other 
than the competent MS and is treated 
in the competent MS: 
 
Coordination Regulations apply (Art. 
18 (1) BR): the person concerned is – 
as a principle – entitled to healthcare 
in the competent MS as though he/she 
resided in that state. 
Patient Mobility Directive might 
apply (Art. 7 (2) (b) PMD): the costs 
must be assumed by the competent 
MS. 
Source: the author’s own summary 
 
So far, the situation was observed in which the Member State of residence and the 
competent Member State differ from each other and in which the required healthcare 
benefit was provided in one of these states. In the next sections, those cases are dealt 
with in which the healthcare is provided in a third state other than the Member State 
of residence or the competent Member State. In this sense, necessary or unplanned 
and planned or scheduled care should be distinguished from each other. 
                                                 
568
 Article 27 (2) BR and Article 7 (2) (a) PMD. See footnote 559. 
Gabriella BERKI: Cross-border patient mobility: The legal framework of obtaining 
healthcare abroad within the European Union – a patients’ perspective 
138 
 
III.2.2.1.B. Access to necessary healthcare during a temporary stay outside of the 
Member State of residence 
People can have plenty of reasons to take a temporary visit abroad: for 
instance, going on holiday, visiting friends or family members, going on a business 
trip, studying abroad, participating in a training or a conference or taking up short-
term employment. The obvious interest of the person who becomes in need of 
healthcare during a temporary stay is to obtain the necessary treatment as quickly as 
possible; therefore the European Union's continuing intention is to guarantee the 
entitlement to benefits in kind for temporary visitors in the Member State where they 
are staying at the very moment. 
Under the social security coordination rules two categories of temporary stay must 
be strictly distinguished.569 (1) The first category is the temporary stay which is 
based on any other reason than obtaining healthcare in another Member State, 
meaning that the reason of the stay is legally irrelevant. The only requirement is that 
the temporary visitor becomes in need of healthcare while abroad. (2) The second 
category is the temporary stay which is based on the patient's (expressed) intention to 
obtain healthcare after crossing the border(s). So once again, the decisive criterion 
is the intention of the person concerned, although it was already noted570 that – in 
certain cases – it is far from simple to determine it.571 
Since different rules apply to these cases, they are observed separately. Firstly, the 
temporary visitors' necessary healthcare is scrutinised further in this section, while 
                                                 
569
 See footnote 30. 
570
 See footnote 542. 
571
 See infra C-326/00 Idryma Koinonikon Asfaliseon (IKA) v Vasileios Ioannidis [ECR 2003 Page I-
01703]. 
The distinction between occasional and planned care is continuously reported as problematic. Austrian 
authorities reported on a case recently, which concerned an Austrian national who wanted to undergo 
a sex-changing operation in Germany. The planned treatment was not authorised, but the patient 
obtained the desired healthcare anyway. However, after the operation, due to post-operative 
complications, another surgery was needed and he had to stay in the German hospital for another 
week. The patient argued that the latter operation was not planned and occurred as a necessary 
treatment, so he claimed for reimbursement of the related costs. The request for reimbursement was 
turned down and the Austrian authorities confirmed that “(w)hat is essential for the distinction 
between ‘planned’ and ‘occasional’ health care is the purpose of the stay abroad which led to health 
care.” JORENS and LHERNOULD (2013: 29-30.). 
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the rules on planned healthcare, which is considered as the narrow concept of patient 
mobility,572 will be detailed in the next one. 
 
In principle, the insured persons and their family members who stay in a Member 
State other than the competent Member State are entitled to sickness benefits in kind 
which become necessary on medical grounds during their temporary stay in the 
Member State of stay.573 
The same logic can be seen here as for persons residing outside the competent 
Member State,574 namely (1) the healthcare is provided by the Member State where 
the patient can be found at the moment of the need for healthcare, in this case the 
Member State of temporary stay; (2) the healthcare is provided on behalf of the 
competent state, meaning that this state determines the conditions of entitlement and 
bears the medical costs; and (3) the patient is fully integrated into the healthcare 
scheme of the Member State providing the treatment, meaning that the healthcare is 
provided in accordance with the legislation of this country and that the patient must 
be treated equally with the patients insured in this country as though he/she was 
insured there as well.575 
Currently, the access to necessary healthcare benefits abroad is open to all who is 
entitled to these benefits in the competent Member State, although this was not 
always so. Before Regulation (EC) No 631/2004576 entered into force on 1 July 2004 
different levels of benefit coverage had been guaranteed to certain groups of people 
falling under the personal scope of Regulation 1408/71. The former legislation 
provided a highly limited circle of benefits for the employed and self-employed by 
                                                 
572
 On the definitions, see section II.3.2. 
573
 Article 19 (1) BR. This article must apply mutatis mutandis to the pensioners and the members of 
their family as well. Article 27 (1) BR. 
574
 See section III.2.2.1.A. 
575
 Article 19 (1) BR. See also JORENS et al. (2007: 34.). 
576
 Regulation (EC) No 631/2004 of the European Parliament and of the Council of 31 March 2004 
amending Council Regulation (EEC) No 1408/71 on the application of social security schemes to 
employed persons, to self-employed persons and to members of their families moving within the 
Community, and Council Regulation (EEC) No 574/72 laying down the procedure for implementing 
Regulation (EEC) No 1408/71, in respect of the alignment of rights and the simplification of 
procedures. OJ L 100 of 6 April 2004. 
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saying that the benefits abroad are available only for those whose condition 
necessitates immediate benefits during a stay in the territory of another Member 
State.577 The necessity of immediate care referred to a situation in which the 
provision of the appropriate treatment cannot be postponed without endangering the 
life or health of the person concerned.578 Healthcare in conjunction with pregnancy 
and childbirth provided before the beginning of the 38th week of pregnancy was 
regarded as immediately necessary care as well.579 
At the same time, a more favourable scheme applied for instance to pensioners and 
their family members, jobseekers and students who had a right to any benefits in 
kind which appeared necessary580 irrespective of the fulfilment of the urgency 
condition. When the European Council opted for the introduction of the European 
Health Insurance Card in 2002,581 the stakeholders were unified in the opinion that 
certain changes were necessary to the rules on the coordination of healthcare benefits 
in kind. They agreed that for greater protection for insured persons, provision should 
be made to bring into line the rights of all insured persons in respect of access to 
benefits in kind during a temporary stay in a Member State other than the State in 
which the person concerned is insured or resident.582 
The amending regulation ended the above mentioned difference by equalising the 
claim to healthcare and guaranteeing equal access to necessary care during a 
temporary stay.583 Nevertheless, defining the category of necessary care is still 
considered somewhat problematic in practice: (1) the person holding the authority of 
                                                 
577
 Article 22 (1) (a) of Regulation 1408/71 before 1 July 2004. 
578
 Decision No 135 of the Administrative Commission of 1 July 1987 concerning the granting of 
benefits in kind provided for in Article 17 (7) and Article 60 (6) of Regulation (EEC) No 574/72 and 
the concepts of urgency within the meaning of Article 20 of Regulation (EEC) No 1408/71 and of 
extreme urgency within the meaning of Articles 17 (7) and 60 (6) of Regulation (EEC) No 574/72, 4. 
OJ C 281 of 4 November 1988. 
579
 Paragraph 1 of the Preamble of Decision No 195 of the Administrative Commission of 23 March 
2004 on the uniform application of Article 22(1)(a)(i) of Council Regulation (EEC) No 1408/71 as 
regards healthcare in conjunction with pregnancy and childbirth. OJ L 160 of 30 April 2004. 
580
 JORENS et al. (2007: 34.). 
581
 European Council: Presidency Conclusions. Barcelona, 15-16 March 2002, 34. 
http://www.consilium.europa.eu/ueDocs/cms_Data/docs/pressData/en/ec/71025.pdf (24 November 
2011). 
582
 Paragraph 3 of the Preamble of Regulation 631/2004. 
583
 Article 1 (1) (a) of Regulation 631/2004. 
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deciding about the necessity of the healthcare on the one hand and (2) the material 
scope of necessary care on the other have been subject to discussions. 
 
(1) A first question that arises is whose task it is to decide which benefits fall 
under the scope of necessary care. It should be pointed out that the necessity of the 
healthcare provision is evaluated on a case-by-case basis by the healthcare provider 
and that is must be determined in the light of the nature of the benefits and the 
expected length of the stay.584 The healthcare practitioner, who is in the physical 
proximity585 of the patient, is in the optimal position to examine the person 
concerned, to estimate his/her health status and needs, and to decide whether the 
treatment is necessary. Therefore, the physician is in charge of taking the decision to 
provide the treatment as necessary on medical grounds or not. In accordance with the 
Regulation, this patient-specific assessment must be based on two concrete criteria: 
(a) the medical status of the patient and (b) the planned duration of his/her stay in the 
territory of the Member State concerned.586 It is indeed a good solution to leave this 
decision to the healthcare professional who is able to provide the necessary treatment 
on the spot, but at the same time, it requires that each healthcare professional all over 
the European Union is to be aware of these rules. Whether this is the case, is 
questionable.587 
                                                 
584
 Article 19 (1) BR. 
585
 The traditional doctor-patient relationship requires personal, face-to-face contact, although the 
application of ICT technologies may change – or at least influence – this in the future by a broad 
introduction of remote care delivery through telemedicine. “Telemedicine involves the use of 
telecommunications and computer technology in the delivery of health services to enable provider-
patient and provider-provider consultation across geographic boundaries.” Edward Alan MILLER 
(2010): Telemedicine and the Provider-Patient Relationship: What We Know So Far. Report Prepared 
for the Nuffield Council’s Working Party on Medical Profiling and Online Medicine: The Ethics of 
‘Personalised’ Medicine in a Consumer Age, 
http://www.nuffieldbioethics.org/sites/default/files/files/Miller%20E%20(2010)%20[Evidence%20rev
iew]%20Telemedicine%20and%20the%20ProviderPatient%20Relationship%20%20what%20we%20
know%20so%20far.pdf (24 November 2011), p. 4. See this issue in detail infra under Chapter V. 
586
 European Commission, DG Employment, Social Affairs and Inclusion (2011): Explanatory notes 
on modernised social security coordination - Necessary care. 
http://ec.europa.eu/social/main.jsp?catId=866&langId=en (25 November 2011), p. 3. 
587
 In my opinion, each Member State has the obligation – as a way of carrying out the Regulations – 
to train its healthcare professionals in this sense and to ensure that healthcare professionals practicing 
in its territory are able and willing to provide foreign patients with healthcare in accordance with the 
EU legislation. 
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(2) The second question is related to the content of the healthcare, namely 
which benefits are covered by the concept of care necessary on medical grounds. 
Necessary care is – however often mixed up – a broader concept than immediate or 
emergency care, because it does not necessarily require the condition of immediate 
urgency of healthcare provision.588 At the same time, certain treatments principally 
cannot be considered necessary within the meaning of the Regulation, because they 
do not serve the basic goal of necessary care.589 While defining this category, its aim 
has to be kept in mind: to enable the insured person to continue his/her stay under 
safe medical conditions, taking account of the planned length of the stay590and to 
prevent an insured person from being forced to return, before the end of the planned 
duration of stay, to the competent Member State to obtain necessary care.591 Thus, 
the idea is to make available all benefits in kind which serve the purpose of avoiding 
the undesired interruption of the patient’s stay abroad, but not exceeding this level of 
healthcare by providing benefits which can be obtained also at the patient’s Member 
State of residence upon his/her arrival back home.592 
 
It has to be noted, though, that there are a few groups of specific benefits in kind to 
which these rules apply, the qualification of which has however been highly 
problematic593 and needed to be clarified partly by the Court of Justice and partly by 
                                                                                                                                          
The same goes, for instance, for the dissemination of information related to the proper application of 
the EHIC, in the course of which the providers also play a key role. On information for the healthcare 
providers see COUCHEIR (2013: 13.) and PACOLET and DE WISPELAERE (2014a: 15.). 
The Implementing Regulation confirms this opinion by stipulating that the competent authorities shall 
ensure that their institutions are aware of and apply all the Community provisions, legislative or 
otherwise, including the decisions of the Administrative Commission, in the areas covered by and 
within the terms of the basic Regulation and the implementing Regulation. Article 89 (3) IR. 
588
 Therefore, the Austrian practice, namely that Austrian providers have refused to accept EHICs on 
the ground that the care was not deemed urgent, is incorrect and not in line with the Union legislation. 
COUCHEIR (2013: 19.). 
589
 An example can be aesthetic surgery. 
590
 Decision No 194 of the Administrative Commission of 17 December 2003 concerning the uniform 
application of Article 22(1)(a)(i) of Council Regulation (EEC) No 1408/71 in the Member State of 
stay, 1. OJ L 104 of 8 April 2004. 
591
 Article 25 (A) (3) IR. 
592
 For instance, the majority of dental treatments fall under this category, so dental care is rarely 
provided as necessary care. COUCHEIR and JORENS (2005: 29.). 
593
 Despite the efforts for clarification, problems repeatedly occur regarding these controversial groups 
of healthcare services. See examples in COUCHEIR (2013: 21.). 
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the Administrative Commission: these are (1) the healthcare benefits in kind in 
conjunction with pregnancy and childbirth; (2) the healthcare benefits in kind in 
conjunction with pre-existing and chronic diseases and (3) illnesses which require 
continuous treatment and specialised medical infrastructure or environment. 
(1) The first group, the healthcare benefits in kind in conjunction with 
pregnancy and childbirth, was already mentioned supra,594 since under the former 
coordination regime this was considered immediate necessary care, although the 
legislation contained a time limit element, namely the beginning of the 38th week of 
pregnancy. This restriction is not in force any longer, so necessary care shall include 
all the benefits in kind in conjunction with pregnancy and childbirth.595 One may 
wonder why the former limitation was left out from the revised AC decision. 
However, as far as I believe, the truth is that it was not: just the formalisation of the 
rule was changed. The obvious logic behind the 38th week rule was to avoid the 
misuse of the legislation on the benefits in kind available during a temporary stay 
abroad and to prevent this procedure from being used at the end of the pregnancy for 
deliberate travelling to give birth in another Member State. Thus, this logic has 
remained within the legislation, which indicates that the benefits in kind in 
conjunction with childbirth are not covered by these provisions when the objective of 
the stay in another Member State is to receive these treatments.596 Consequently, in 
accordance with the current wording of the AC decision, it is still an exception to the 
necessary care provisions if someone travels abroad for the purpose of giving birth in 
that Member State, irrespective of whether she does so before or after the beginning 
of the 38th week of her pregnancy. However, once again the question pops up: how 
can the mother’s intention be investigated? How can any competent institution prove 
that the objective behind the travel abroad was to give birth in that other Member 
State? 
                                                 
594
 See footnote 579. 
595
 Article 1 of Decision No S3 of the Administrative Commission of 12 June 2009 defining the 
benefits covered by Articles 19(1) and 27(1) of Regulation (EC) No 883/2004 of the European 
Parliament and of the Council and Article 25(A)(3) of Regulation (EC) No 987/2009 of the European 
Parliament and of the Council. 
596
 Article 2 of AC Decision S3. 
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Nonetheless, in its explanatory notes on necessary care the European Commission 
takes it a step further by saying that this restriction must be applied carefully and 
assessed on a case by case basis.597 It also gives two concrete examples of situations 
in which the benefits provided must be considered as necessary care. These situations 
are (a) the migrant woman wishes to go back to her home country in order to take 
advantage of the help offered by her family, or (b) a woman wants to give birth in the 
State of residence of her husband or partner. Some problems concerning this 
interpretation should be pointed out. First of all, one cannot ignore the contradiction 
between on the one hand the original intentions of the Union legislature when 
creating the rules of necessary care and on the other hand the reasoning in the recent 
interpretation by the Commission. While the former is clearly declared as to ensure 
medical treatments which become necessary during a temporary stay abroad, where 
the purpose of this stay may be anything else than obtaining healthcare, the latter 
considers the purpose of the stay as twofold: giving birth and receiving support from 
the relatives before and after the birth of the child. Also, the Commission reveals that 
one of the purposes is to deliberately travel to give birth in another Member State. So 
why are these cases not considered planned care? If it is accepted that among these 
demographic prognoses598 pregnant women must enjoy a higher level of protection 
and be considered as an exceptional group receiving healthcare in accordance with 
this procedure even if they travel for medical purposes, how can these cases be 
distinguished from the ones where the family support element lacks and where a 
woman travels to another Member State to receive a better treatment, thereby 
‘misusing’ this procedure? How can the Member State where the family support 
element exists be identified? Which Member State is meant by the ‘home country’ of 
the pregnant women? And which Member State is to be considered as ‘the State of 
the residence of her husband or partner’? Which residence concept applies? To sum 
up, the Commission’s intention as indicated in the explanatory notes is appreciated, 
but this interpretation raises more questions than it gives answers. If the Commission 
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 EUComm – DG EMPL (2011a: 3.). 
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 Rainer MÜNZ (2007): Europe: Population Change and its Consequences – An Overview. 
http://www.berlin-institut.org/online-handbookdemography/europe.html#_ftn8 (28 November 2011). 
Gabriella BERKI: Cross-border patient mobility: The legal framework of obtaining 
healthcare abroad within the European Union – a patients’ perspective 
145 
 
insists on these exceptions, they will have to be clarified carefully and placed within 
the framework of planned care in order to sustain the consistency of legislation and 
implementation, because they completely contradict the elementary aim of necessary 
care. 
(2) To the second group, the healthcare benefits in kind in conjunction with 
pre-existing and chronic diseases, the same rules apply as a consequence of one of 
the Court’s healthcare rulings, namely the Ioannidis599 judgement.600 In this case, the 
Court faced the problem of determining the decisive criterion to decide between 
necessary care and planned care when there is a disease that was diagnosed before 
leaving the Member State of residence. The European Court of Justice held that the 
Regulation provisions on necessary care cannot be interpreted as meaning that those 
benefits are limited solely to cases where the treatment provided has become 
necessary because of a sudden illness. In particular, the circumstance that the 
treatment necessitated by developments in the insured person's state of health during 
his temporary stay in another Member State may be linked to a pre-existent 
pathology of which he is aware, such as a chronic illness, cannot suffice to prevent 
him from enjoying the benefit of the Regulation provisions on necessary care.601 An 
interpretation which considers any treatment obtained by a patient with a chronic 
disease abroad as planned care irrespective of the original aim of the patient’s 
temporary stay outside the Member State of residence highly restricts the free 
movement of these persons. Therefore, AC Decision S3 clearly stipulates that 
sickness benefits in kind necessary on medical grounds include the benefits provided 
in conjunction with chronic or existing illnesses602 unless the objective of the stay in 
another Member State is to receive these treatments.603 
                                                 
599
 See footnote 571. 
600
 Mr Ioannidis, a Greek pensioner residing in Greece (Greece was the competent MS from which Mr 
Ioannidis received his pension), travelled to Germany to visit his son. During his temporary stay in 
Germany, he was admitted to a clinic in Munich for cardiovascular diseases. As it appeared in his 
medical record, his illness was chronic. For this reason, his health insurance refused to reimburse his 
medical costs on the ground that his hospital treatment in Germany had been planned. 
601
 C-326/00 Ioannidis, 41. 
602
 Article 1 of AC Decision S3. 
603
 Article 2 of AC Decision S3. 
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(3) The third group contains certain concrete illnesses which require 
continuous treatment and a specialised medical infrastructure or environment. In 
these cases, in order to ensure that the treatment is available during a temporary stay 
abroad, for practical reasons a prior agreement has to be concluded with the 
specialised medical unit.604 It is incumbent on the Administrative Commission to set 
up and frequently update the list of diseases that are subject to prior agreement 
between the person concerned and the institution providing the care.605 Needless to 
say that despite the requirement to conclude a prior agreement these treatments are 
also considered necessary care. 
To conclude, the medical practitioner assesses all the relevant circumstances as 
indicated supra and decides in the first instance whether the treatment may be 
considered necessary care. In this respect, I share the opinion that “[t]he relevant 
factor is the place where the illness occurs, i.e. the Member State where a person 
resides temporarily or the Member State where he or she is insured.”606 It is 
therefore essential whether the healthcare component or the cross-border mobility 
component of patient mobility occurs first,607 or in other words, when and where the 
need for healthcare manifests itself. However, as shown above, this question is often 
not easy to answer. 
Nevertheless, the scope of necessary care and its distinction from planned care 
remains a neuralgic question and calls for further clarification from the European 
institutions.608 
 
The healthcare decisions of the Court of Justice609 mostly concern planned care.610 
However, an infringement procedure against the Kingdom of Spain offered the 
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 Article 19 (2) BR and Article 3 of AC Decision S3. 
605
 This non-exhaustive list is attached to the AC Decision S3 and currently includes the following 
treatments: kidney dialysis, oxygen therapy, special asthma treatment, echocardiography in case of 
chronic autoimmune diseases and chemotherapy. 
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 JORENS (2002: 89.). 
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 See supra in Chapter II. 
608
 The Member States complain that “the concept is not defined in a sufficiently accurate way, […] 
precise guidelines are lacking. […] As a result, the interpretation varies between countries and 
between providers within the same country.” COUCHEIR (2013: 22.). 
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 See footnote 14. 
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opportunity for the Court to clarify its views on unplanned care as well.611 Although 
the Court mainly dealt with financial matters in this judgement,612 there is an issue 
which should be underlined here, namely that necessary healthcare as well as 
planned healthcare are classified as a service within the meaning of the Treaty613 and 
therefore the application of the Regulations does not exclude the simultaneous 
application of the Treaty provisions. On the contrary, the Court reiterated what was 
already stated on several occasions:614 the fact that a national legislation is in 
conformity with the Coordination Regulations does not result in that legislation being 
removed from the scope of the Treaty provisions.615 
 
That being said, it will not come as a surprise that the material scope of the Patient 
Mobility Directive also covers both unplanned and planned care.616 However, it was 
indeed rather unexpected when this came to the surface, because from the proposal 
of the Directive exactly the opposite could be deduced. In the proposal, the 
Commission indicated that the new directive “would allow patients to seek any 
healthcare in another Member State”.617 The expression seek unequivocally implies 
that the original intention was to “put in place an alternative mechanism based on 
the principles of free movement and building on the principles underlying decisions 
                                                                                                                                          
610
 See in section III.2.2.1.C. 
611 C-211/08 European Commission v Kingdom of Spain [2010 Page I-05267]. 
The infringement procedure was based on a complaint from a French citizen resident at the material 
time in Spain and insured under the Spanish national health system. On returning to Spain after being 
admitted to hospital during a stay in France, under cover of form E 111 (predecessor of the European 
Health Insurance Card), that person met with refusal on the part of the Spanish institution to reimburse 
the portion of the hospitalisation costs which, in accordance with the French legislation, the French 
institution had left him to pay. 
612
 The questions related to financing are dealt with in Chapter IV. 
613
 See footnote 316. C-211/08 Commission v Spain, 47. 
614
 C-120/95 Decker, 27;C-158/96 Kohll, 25; C-372/04 Watts, 46-47. See also C-173/09 Elchinov, 38. 
615
 C-211/08 Commission v Spain, 45. 
616
 This point is still disputed. Both BIEBACK and STRBAN argue that the Directive exclusively applies 
to planned medical treatment. I on the other hand support the argument – as shown infra – that the 
standpoint of the Court and the current wording of the Directive (especially Article 1 (2) PMD) allows 
the conclusion that the Directive has to be applied to unplanned care too. Nevertheless, the issue is far 
from clear, so it leaves room for a converse interpretation. What is even more problematic is that it is 
a potential source of diverse implementation and thus legal uncertainty. Karl-Jürgen BIEBACK (2013): 
Rechtlinie 2011/24/EU – Patientenrechtlinie. In Maximilian FUCHS (ed.): Europäisches Sozialrecht. 
Baden-Baden: Nomos, p. 656 and STRBAN (2013: 398.). See footnote 150. 
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of the Court of Justice,”618 which at that time exclusively concerned planned care 
abroad. Moreover, the preamble of the proposed Directive expressly stated that 
“(t)his Directive does not address the assumption of costs of healthcare which 
become necessary on medical grounds during a temporary stay of insured persons in 
another Member State”619 and similarly, in Chapter III the proposal referred to 
“insured persons travelling to another Member State with the purpose of receiving 
healthcare there or seeking to receive healthcare provided in another Member 
State.”620 One may wonder how – after all – the material scope of the Directive was 
extended to cover the provision of necessary care as well. 
In my opinion, the above mentioned argumentation of the Court might be – at least 
partly – responsible for this change of view. Since healthcare services were as a 
principle acknowledged as falling under the scope of the Treaty provisions on free 
movement of services, no legitimate reason can be found to argue that necessary care 
has to be exempted from this rule. At the same time, the exclusion of unplanned care 
from the scope of the Directive could have been based on the argument that the 
provision of necessary healthcare during a temporary stay abroad has been efficiently 
coordinated by the coordination mechanism and no major failures of the system 
made it reasonable to apply a new legal instrument to these situations. 
 
Nevertheless, the adopted version of the Directive is less clear-cut on this point, and 
leaves the door open for a more extensive interpretation. Whereas in the Preamble it 
still provides that the Directive should apply to individual patients who decide to 
seek healthcare in a Member State other than the Member State of affiliation,621 
where the word decide and seek suggest that the Directive was basically constructed 
to cover only planned care, both the definition of cross-border healthcare622 and of 
patient623 are abstract enough to be interpreted as covering planned as well as 
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 COM (2008) 414, p. 4. 
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 Recital 20 of the Preamble, COM (2008) 414, p. 25. 
620
 Article 6 (1), COM (2008) 414, p. 25. 
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 Recital 11 of the Preamble of the Patient Mobility Directive. 
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 Article 3 (e) PMD. See footnote 135. 
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 Article 3 (h) PMD. See footnote 114. 
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unplanned care. The Commission’s interpretive note finally erased the doubts by 
pointing out that both the Regulations and the Directive apply to planned and 
unplanned healthcare.624 Although the note itself is legally not binding, the Member 
States are supposed to implement the Directive accordingly. This, however, does not 
only lead to administrative pitfalls, but also raises the question when it can be more 
beneficial for the patient to opt for the Directive instead of the Regulations when 
obtaining necessary care. 
The Coordination Regulations cover the Member States’ compulsory healthcare 
schemes and the healthcare providers which concluded an agreement with the 
competent institution of the country they are established in. On the coordination 
route of patient mobility, medical costs are only reimbursed if the healthcare is 
obtained at a contracted healthcare provider.625 On the route of the Directive, 
however, this restriction does not exist; Member States are obliged to reimburse the 
costs for treatments obtained either at contracted or at non-contracted providers.626 
Therefore, if necessary care is provided by a non-contracted provider, the Directive 
ensures a higher level of protection for patients. In any other case, the Regulations 
seem to offer a more sufficient solution. 
 
As a last possible scenario, in the next section the rules applicable to planned care are 
examined in detail. 
III.2.2.1.C. Access to planned healthcare outside of the Member State of residence 
Healthcare is of high priority for most people. Thus, if they suffer from a 
serious illness, every possible solution is carefully assessed in order to receive proper 
medical care, which includes the possibility to travel to obtain treatment outside the 
country where they reside. 
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The European Union has guaranteed the – rather limited – right to planned treatment 
abroad for decades in the framework of social security coordination.627 However, the 
legal rules related to scheduled healthcare were completely redefined by the 
European Court of Justice, when it applied the fundamental principles of the free 
movement of services and goods for the sector of healthcare in two milestone 
cases628 in the late 1990s. The Court made it clear that despite the limited EU 
competence in the field of social security,629 healthcare provision is not “an island 
beyond the reach of Community law.”630 
In this section, the different approaches towards the narrow concept of patient 
mobility631 will be observed in order to investigate whether they are able to ensure a 
clear and consistent legal framework for mobile patients. 
 
As described supra,632 the Coordination Regulations distinguish two different cases 
of obtaining treatment while temporarily staying abroad. The rules on necessary 
healthcare were already scrutinised,633 so hereinafter solely the diverse legal rules 
applicable to planned healthcare are dealt with. 
What is typical of planned healthcare is that the expressed aim of leaving the 
Member State of residence and entering another Member State is to receive a certain 
medical treatment, preferably at the expense of the health insurance of the person 
concerned. So here the need for healthcare precedes the intention of travelling abroad 
as opposed to necessary care, which requires that the need for healthcare occurs after 
crossing the border(s). While in the latter case the possible occurrence of healthcare 
provision is adventitious, in the former case the healthcare provision is the reason 
and the goal of the journey, so it is very likely to happen. Accordingly, this right of 
patients634 is highly limited under the coordination regime: patients travelling to 
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 See section III.1.3.4. 
628
 See footnote 303 and 304. 
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 See section III.1.3.2. 
630
 JORENS et al. (2005: 2.). 
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 See section II.3.2. 
632
 See section III.2.2.1.B. 
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 See section III.2.2.1.B. 
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another Member State with the purpose of receiving benefits in kind during the stay 
shall seek authorisation from the competent institution.635 The authorisation is 
therefore the sole competence of the competent Member State, which is completely 
understandable taking into account that this state must bear the costs of the treatment. 
However, its discretion is fairly restricted: if two criteria are simultaneously met, the 
competent institution must accord the authorisation without evaluation.636 This two-
limb test consists of the following conditions: (1) the requested treatment is included 
into the benefit package of the Member State of residence and (2) this benefit in kind 
cannot be provided to the patient within a medically justifiable time limit, taking into 
account his/her current state of health and probable course of his/her illness.637 
These criteria, if satisfied, render it mandatory to grant the patient prior authorisation. 
Notwithstanding, similar rules apply to the provision of the medical treatment itself 
as in the event of necessary care described supra:638 the healthcare is provided in the 
Member State of stay in accordance with the provisions of the legislation it applies, 
as though the patient were insured under the said legislation.639 It cannot be doubted 
that the European legislature supports the idea of full integration in order to ensure 
the highest possible protection for the migrant persons in these sensitive situations. 
Additionally, the pensioners and their family members are entitled to planned care 
under the same conditions outside the Member State of residence.640 
 
Although the full integration model seems to be patient-friendly and clear, the 
conditions included in the Coordination Regulations connected to (1) the benefit 
coverage and (2) the medically justifiable time limit are far from obvious. They 
already offered the Court several opportunities for clarification and interpretation. It 
is thus worth analysing them here. Nevertheless, it must be noted that it is the Court 
itself which can be held responsible for the very existence of these conditions in the 
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first place, since their introduction was merely a response from the Member States to 
the two Pierik judgements.641 As mentioned supra, in these decisions the Court “had 
virtually recognized a free movement of patients”, but at the same time it “had almost 
fully ignored the Member States’ health care interests.”642 Consequently, however 
welcomed the rulings were from the patients’ perspective, the Court went a step too 
far when granting the right to obtain treatment that is not included in the benefit 
package of the home state. By doing so, the Court seemingly lost sight of the 
sensitive balance between the interests of the Member States and the patients in a 
field which is very delicate from both sides.643 As a consequence, the Member States 
used the most effective way to neutralise the Court’s initiative: they modified the 
secondary EU legislation.644 They inserted rules into Regulation 1408/71 that 
expressly allowed Member States to deny authorisation if the treatment required was 
not among the benefits provided for by the legislation of the Member State on whose 
territory the person concerned resided.645 
 
(1) As to this first condition, the benefit baskets646 provided by the statutory 
healthcare schemes as well as the methods used to determine the available healthcare 
benefits differ from each other in the various Member States.647 As COUCHEIR and 
JORENS point out, “it has to be well understood that the definition of the benefits 
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 VAN DER MEI (1998: 286). 
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package forms an integral part of Member States’ autonomy.”648 In most cases, the 
Member States set up a list, a benefit catalogue, enumerating the healthcare benefits 
which can be received in the framework of the public health insurance in the 
Member State concerned.649 The Court summarised the possible solutions as follows: 
(a) to list precisely the treatments or treatment methods or (b) to state more generally 
the categories or types of treatments or treatment methods.650 The first solution is 
less flexible, but it provides more certainty, while the second one “insert[s] some 
flexibility by using ’open’ criteria in order to adapt to the constantly and rapidly 
changing developments in medical circles.”651 
In the case of scheduled treatment this issue is highly relevant, since the patients 
have the right to receive a prior authorisation only if the benefit in question is 
included into the benefit package of the Member State of residence.652 Although the 
Court has confirmed numerous times that the Member States have the liberty to 
organise their healthcare systems653 including the determination of the healthcare 
benefit baskets, this national autonomy was undermined on several occasions by the 
European Court of Justice itself. 
Firstly, the European Court of Justice touched upon the benefit package question in 
its Geraets-Smits and Peerbooms judgement,654 in which it evaluated the conditions 
required by the Dutch healthcare system. Under the national legislation, which does 
not provide a pre-established list of types of healthcare benefits in kind covered by 
the social insurance system, two conditions must be satisfied in order to receive 
medical treatment funded by the social insurance:655 (a) the treatment in question 
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must be capable of being regarded as a qualifying benefit, meaning that it is 
considered normal in the professional circles concerned, not experimental;656 and (b) 
the treatment in question must be necessary,657 meaning that no similar treatment is 
available without undue delay in the Netherlands.658 The first condition is related to 
determining the benefit package, whereas the second one can be linked to the 
question of availability, which will be discussed later in this section. 
Concerning the normality of the treatment,659 the Court pointed out that – keeping in 
mind that each Member State has the competence to organise its own national social 
security system and in particular to determine the conditions governing the 
entitlement to benefits660 – it is not in principle incompatible with Community law for 
a Member State to establish, with a view to achieving its aim of limiting costs, 
limitative lists excluding certain products from reimbursement under its social 
security scheme.661 Thus, the national competence for healthcare organisation 
includes the liberty to exclude certain benefits from the benefit package. Moreover, 
the Court added that Community law cannot in principle have the effect of requiring 
a Member State to extend the list of medical services paid for by its social insurance 
system.662 
However, not the extension, but the way of exclusion is at stake here, namely 
whether the Member State must set up limitative lists expressly enumerating the 
benefits excluded from the reimbursed benefit coverage, or whether it may apply 
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special conditions which indirectly limit the circle of benefits reimbursed. The Court 
did not explicitly answer this in its judgement, although it made it clear that whatever 
method is used to determine the content of the benefit basket, it must be based on 
objective, non-discriminatory criteria, without reference to the origin of the treatment 
in question.663 According to the Court’s arguments, in the exact case to allow only 
treatment habitually carried out on national territory and scientific views prevailing 
in national medical circles to determine what is or is not normal will make it likely 
that Netherlands providers of treatment will always be preferred in practice.664 The 
Court also offered a possible solution to make the Dutch condition more objective 
and in compliance with EU rules by extending it in such a way that, where treatment 
is sufficiently tried and tested by international medical science,665 the authorisation 
cannot be refused on that ground.666 So no distinction is made between the treatment 
being provided in the competent Member State or outside of its territory.667 
Although this condition lacks any discriminatory implications, it also induces certain 
questions, which were left open by the Court. For example, what can be considered 
as ‘sufficiently tried and tested’; whose responsibility is it to decide about it; and 
what kind of assessment has to be used in the course of this decision-making.668 On 
top of that, the global view of ‘normality’ conveyed by the Court seems to set aside 
the disparities in the medical treatment patterns in the different Member States,669 
and theoretically implies that a Member State might be obliged to reimburse the costs 
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of a treatment which is not only not available in that country but also not accepted or 
even opposed by the healthcare professionals of the Member State concerned.670 
COUCHEIR and JORENS point out that putting the national policies of determining the 
scope of healthcare coverage into an international perspective might not only be seen 
as a threat to the autonomy of the Member States, but as “an occasion to share best 
practices, which, in the long run, could result in a converging of national health care 
baskets.”671 Although this approach is very innovative, it seems to be a bit 
overoptimistic: on the one hand, Member States react very sensitively to any actions 
which have the potential to affect their healthcare competence, and on the other hand, 
extending benefit coverage in the Member States might require serious financial 
investments. This converging is thus very much dependent on the financial potential 
of the individual Member States. Nevertheless, setting up a standardised package of 
healthcare offered across the European Union,672 which will however realistically not 
happen very soon, would be a ground-breaking achievement of the Union’s 
healthcare policy. 
Secondly, the European Court of Justice was confronted with this issue of benefit 
packages in the recent Elchinov case,673 in which the question of the method to 
determine the circle of benefits covered was raised with regard to one of the new 
Member States, namely Bulgaria.674 Although – as MURPHY noted correctly675 by 
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tartalmának kérdése (Another ECJ ruling on scheduled treatment abroad: the question of the content 
of benefit baskets). Jogesetek Magyarázata (Case Law Review), Vol 3 Issue 2, pp. 39-47; Tomislav 
SOKOL (2010): Rindal and Elchinov: A(n) (Impending) Revolution in EU Law on Patient Mobility. 
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Faculty of Law Working Paper 2010/9, 
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referring to the opinion of Advocate General Cruz Villalón676 – each question677 
referred to the Court could have been answered according to the existing case law, 
the accession to the European Union of new States with different healthcare systems, 
both in terms of their organisation and their financial resources, raises uncertainties 
about the applicability of case-law which was conceived and correspondingly 
developed in an era preceding that expansion.678  
In the case concerned, the competent national institution refused to give the patient679 
the prior authorisation on the ground that the treatment in question was not included 
in the domestic healthcare benefit basket.680 Unlike under the Dutch legislation, the 
benefits covered by the Bulgarian compulsory health insurance scheme were listed 
comprehensively and definitively in the Law on health insurance. 
Accordingly, the legal uncertainty at stake was not based on the discretionary power 
of the competent institution. Instead – despite the clear attempt of the legislature to 
set out an objective, transparent and non-discriminatory system – the lower court and 
the Supreme Administrative Court disagreed on the scope of the benefit coverage, 
namely whether one of the categories681 listed in the law included the treatment 
concerned.682 It has to be kept in mind that the outcome of this assessment is decisive 
from the Regulation’s point of view: if the treatment is theoretically covered by the 
                                                                                                                                          
Autonomy: Comment on Elchinov. European Law Review, No 4, pp. 542-557; and VAN DER MEI 
(2011). 
675
 MURPHY (2011: 543.). 
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 Opinion of AG Cruz Villalón in C-173/09 Georgi Ivanov Elchinov v Natsionalna 
zdravnoosiguritelna kasa [ECR 2010 Page I-08889], 2. 
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 Mr Elchinov, a Bulgarian citizen covered by the compulsory healthcare insurance system in 
Bulgaria, suffered from a malignant oncological disease of the right eye. He was recommended to 
undergo a specialised treatment, which was not available in his Member State of residence. Therefore, 
he requested prior authorisation to travel to Germany and receive the required medical care in a 
special clinic for eye diseases in Berlin. C-173/09 Elchinov, 10-11. 
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health insurance scheme but cannot be provided in the territory of the Member State, 
the competent institution is obliged to issue the S2 form enabling the patient to 
receive the treatment abroad. If it is not covered, the Member State has no obligation 
to finance the medical costs. 
The Bulgarian Supreme Administrative Court was of the opinion that the fact that it 
is impossible to provide the treatment in issue in Bulgaria, even though it is referred 
to in the national legislation, establishes a presumption that it is not included among 
the benefits that are lawfully payable.683 The Court of Justice held that if the list of 
reimbursed medical benefits does not expressly and precisely specify the treatment 
method applied but defines types of treatment, an application for prior authorisation 
cannot be rejected on the ground that the required treatment is not provided within 
the territory of the Member State of residence, since such a ground, if it were 
accepted, would imply an unjustified restriction on the scope of the coordination 
rules on planned medical care.684 
In my opinion, the Court – once again – went a bit too far on this point. It 
acknowledged that the national legislature took obvious efforts to create an objective, 
transparent and non-discriminatory framework, but it did not seem to respect the 
presumptive legislative intention not to cover benefits which are not provided in the 
Member State concerned and dismissed the restrictive interpretation of the national 
higher court. This extensive interpretation, however, may warn each Member State – 
especially the ones with a relatively limited healthcare budget – to formalise their 
benefit catalogues even more carefully in order to avoid the possibility that they 
might be required to pay for advanced treatments which go beyond the financial 
limits of these Member States. However, taking into account the current state of 
medicine and the rapid improvement of medical research, it is highly doubtful 
whether it is possible to define a taxative list. As NEWDICK notes, “(a) ‘positive’ or 
‘white’ list of approved treatments would need to be very responsive to advances in 
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684
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clinical and pharmaceutical developments. If the system is too slow or bureaucratic, 
it could deprive patients of beneficial new treatments available elsewhere.”685 
Moreover, the Court’s standpoint in the Elchinov judgement may motivate the 
Member States to set up negative lists and clearly indicate those benefits which are 
excluded from the benefit coverage.686 This may increase the level of legal certainty 
but decrease the level of protection, resulting in exactly the reverse effect than the 
one the Court intended to reach.687 
To sum up, the first condition of Article 20 (2) is satisfied if the treatment required is 
explicitly or implicitly included in the benefit package of the Member State of 
residence. If the result of the assessment is affirmative, the second criterion will be 
observed, namely whether the treatment required, which is proven to be covered by 
the compulsory healthcare scheme of the Member State of residence, can be provided 
within a medically justifiable time limit. 
 
(2) While the first condition attached to prior authorisation remained intact 
and Article 20 (2) of Regulation 883/2004 echoes exactly the same phrase as Article 
22 (2) of Regulation 1408/71, a remarkable change was implemented with regard to 
the second condition. As mentioned already,688 the old Regulation imposed the 
obligation of granting authorisation when the treatment required could not be given 
within the time normally necessary for obtaining the treatment in question in the 
Member State of residence taking account of the patient’s current state of health and 
the probable course of the disease.689 This rather administrative criterion, which was 
based on the impersonal, generalised, normally necessary time limit, was slightly 
rephrased in the new Regulation into a more personal medical condition based on a 
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time limit which is medically justifiable.690 The discrepancy – although it might seem 
small – is significant, as can be deducted from CORNELISSEN’s example illustrating 
the practical side: “under the […] wording of Article 22 (2) Regulation 1408/71, 
authorisation may be refused to a person requiring surgery which, if carried out 
within three months might prevent the risk of irreversible aggravation of health or 
even death, if the ‘time normally necessary for obtaining the treatment’ in question 
in the competent State is six months.”691 Under the wording of the new Regulation, 
however, the time limit is individualised taking due account of the medical 
circumstances of the person concerned. This development is also rooted in the case 
law of the European Court of Justice. 
The Court dealt with the interpretation of the second condition in numerous rulings. 
Its findings in this regard can be summarised as follows: (1) the requirement of 
medical necessity is in practice satisfied only when the same or equally effective 
treatment cannot be obtained without undue delay in the territory of the Member 
State of residence; (2) while assessing the necessity of the treatment, the national 
authorities are required to have regard to all the relevant circumstances of each 
specific case; (3) the mere existence of waiting lists in the territory of the Member 
State concerned cannot constitute a justified ground to refuse to grant prior 
authorisation. 
 
Firstly, the European Court of Justice was asked to give its opinion about the second 
condition for mandatory authorisation in the above cited Geraets-Smits and 
Peerbooms judgement,692 when it needed to interpret the Dutch requirement of 
medical necessity in the light of the Regulation. Under the legislation of the 
Netherlands, to grant authorisation allowing the assumption of the costs of a medical 
treatment provided outside of the country is subject to the condition that it is proven 
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that the insured person's state of health requires the treatment.693 In the course of the 
proceedings, it turned out that in practice this condition often appears to be 
interpreted as meaning that the provision of such treatment is not to be authorised 
unless it appears that appropriate treatment cannot be provided without undue delay 
in the Netherlands.694 However, this interpretation immediately leads to two further 
questions, namely (1) what can be considered ‘appropriate treatment’ and (2) what 
does ‘undue delay’ mean. The answers are decisive on this point, but the Court was 
reluctant to give a full interpretation of either of them. Still, it added that the 
condition concerning the necessity of the treatment is satisfied if the same or equally 
effective treatment can be obtained without undue delay.695 Furthermore, in order to 
determine whether equally effective treatment can be obtained without undue delay, 
the national authorities are required to have regard to all the circumstances of each 
specific case and to take due account not only of the patient's medical condition at 
the time when authorisation is sought but also of his past record.696  
Consequently, it can be concluded that the same or equally effective treatment is 
considered appropriate. However, this does not seem to solve the problem: neither 
guidelines were given on the interpretation of the expression ‘equally effective 
treatment’, nor was the meaning of ‘undue delay’ established. For lack of an EU-
wide interpretation, the competent Member State has to decide whether the treatment 
requested to undergo abroad is equally effective as the ones provided in its own 
territory, and has the authority to evaluate whether the patient has to wait too long for 
the treatment.697 Therefore, it is still unclear under which circumstances the 
competent institution may not refuse to grant prior authorisation: its discretionary 
power is very extensive and the right of the patient is rather uncertain. A whole series 
of Court cases have sought to clarify these matters. 
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Secondly, the Court proceeded its observation of the Dutch legislation in the Müller-
Fauré and Van Riet case,698 in which the referring court asked the Court to explain 
specifically what is meant by without undue delay and, in particular, whether that 
condition must be assessed on a strictly medical basis, regardless of the waiting time 
normally necessary for the treatment in question.699 Despite the obvious and 
expressed need for clarification, the Court once again avoided describing the notion 
of undue delay by simply repeating its own statement in the Geraets-Smits and 
Peerbooms.700 
What it did, however, is extend the list of factors that must be taken into account by 
the competent institution when determining whether the treatment which is equally 
effective for the patient can be obtained without undue delay in the territory of the 
Member State of affiliation. Besides the patient's medical condition at the time 
authorisation is sought and his/her medical history, where appropriate, also the 
degree of pain or the nature of the patient's disability which might, for example, 
make it impossible or extremely difficult for him to carry out a professional activity 
must be taken into consideration.701 By saying this, the Court peremptorily switched 
to medically justifiable time limit, which is again a considerable improvement in 
favour of the patients. Moreover, as FLEAR noted correctly, “(t)his clearly goes 
beyond an assessment of the patient’s medical need alone.”702 The fact that the 
potential effect on the patient’s employment status may be taken into consideration 
shows that the Court opts for an extensive evaluation process. Although the usage of 
the expression “for example” indicates that the list given by the Court is not 
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exhaustive, it leaves open the question what kind of other circumstances may play a 
role. 
Recently, the Petru case703 added an interesting new aspect to the interpretation of 
the second condition. The ECJ pointed out that one of the circumstances that the 
competent institution must take into account may, in a specific case, be the lack of 
medication and basic medical supplies and infrastructure.704 Although this 
circumstance clearly has the potential to make it impossible to provide healthcare 
without undue delay, the ECJ underlined that it is for the national court to determine 
whether the treatment could have been carried out in another domestic hospital in 
due time.705 In line with this logic, the ECJ gave a cautious answer to a politically 
sensitive question706 and declared that inadequate medical infrastructure can indeed 
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result in a situation in which a Member State cannot refuse to authorise planned care 
abroad, but did not go as far as to decide whether this was the case in Romania.707 
 
Thirdly, the issues adumbrated above again popped up in the Inizan708 ruling, but it 
did not facilitate the understanding of the aforementioned phrases either. The 
question what ‘undue delay’ means still remained. 
Fourthly however, an important step was taken in Watts,709 where the Court 
elucidated the relationship between the concept of undue delay and the setting up of 
waiting lists710 in the Member States. The question of waiting lists had already been 
touched upon in the Müller-Fauré and Van Riet case, where the government of the 
United Kingdom drew attention to the fact that in practice authorisation for 
treatment in another Member State is generally given in the United Kingdom when 
                                                                                                                                          
In his opinion, Member States with structural and prolonged deficiencies can deny to authorise 
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there is a delay for treatment beyond the maximum waiting times. Additionally, it 
emphasised that national waiting lists take account of the different needs of different 
categories of patients and permit the best possible allocation of hospital resources. 
The lists are flexible so that if a patient's condition suddenly deteriorates, he can be 
moved up the waiting list and treated more quickly.711 Consequently, one may 
wonder whether undue delay means a delay beyond the maximum waiting times. Can 
the Member States be obliged to determine maximum waiting times for certain types 
of treatments? If a Member State defines a maximum waiting time, does that mean 
that the non-provision of the required treatment within this period ensures the right 
for the patient to obtain the treatment abroad at the expense of his/her health 
insurance automatically? Moreover, could not the European Union itself determine a 
general maximum waiting time? 
 
The Court indicated in its Müller-Fauré and Van Riet judgement – and confirmed in 
Watts – that setting up waiting lists is not per se incompatible with Union law. It is 
part of the Member States’ autonomy concerning the organisation of their healthcare 
schemes,712 but a refusal to grant prior authorisation which is based not on fear of 
wastage resulting from hospital overcapacity but solely on the ground that there are 
waiting lists on national territory for the hospital treatment concerned, without 
account being taken of the specific circumstances attaching to the patient's medical 
condition cannot be accepted and a waiting time which is too long or abnormal 
would be more likely to serve as a ground for compulsory authorisation.713 However, 
this interpretation is still rather vague, and does not provide legal certainty, neither 
for the competent institutions nor for the patients. 
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As a consequence, in the Watts case, the Court was asked directly to shed light on 
whether the criteria for the interpretation of the phrase ‘within the time normally 
necessary for obtaining the treatment in question’ are the same as those used to 
define the term ‘without undue delay’.714 Answering the question, the Court pointed 
out again that the refusal to grant prior authorisation can be based only on an 
objective medical assessment which takes due account of all the relevant factors 
identified in the case law of the Court. Therefore, the competent institution is entitled 
to refuse the authorisation on the ground of non-satisfaction of the criterion in regard 
to waiting time only if it does not exceed the period which is acceptable in the light 
of an objective medical assessment of the clinical needs of the person concerned in 
the light of (1) his/her medical condition and (2) the history and (3) probable course 
of his/her illness, (4) the degree of pain he/she is in and/or (5) the nature of his/her 
disability at the time the authorisation is sought.715 Still, it is remarkable that – unlike 
in the Müller-Fauré and Van Riet ruling – in Watts the Court failed to make 
reference to the potential impact of the patient’s medical status to her employment 
status, which evokes the question whether factors other than the ones of a purely 
medical nature must be taken into consideration. Interestingly enough, in the 
Elchinov judgement, the reference to the impact on professional activity showed up 
again.716 
It is also clearly shown that the setting of waiting times is expected to be done 
flexibly and dynamically, so that the period initially notified to the person concerned 
may be reconsidered in the light of any deterioration in his/her state of health 
occurring after the first request for authorisation,717 as in Mrs Watt’s case. 
Furthermore, the Court firmly dismissed the UK’s arguments according to which 
such an interpretation would be liable to undermine the national competent 
authorities’ power to manage the available hospital capacity in their territory by the 
use of waiting lists, provided that the existence of such lists does not prevent the 
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taking account in each individual case of the medical circumstances and the clinical 
needs of the person concerned when he requests authorisation to receive hospital 
treatment in another Member State at the expense of the system with which he is 
registered.718 
 
To sum up, according to the rules of the Regulation as interpreted by the European 
Court of Justice a three-step assessment process can be drawn up in regard to the 
prior authorisation requirement. It is illustrated below in Table 9 infra. 
If the two criteria of Article 20 (2) BR are cumulatively satisfied, the competent 
institution has no liberty to decide whether to accord the prior authorisation, since it 
cannot fulfil its obligation to provide the requested treatment, which is included into 
the benefit package of the Member State concerned, within a medically justifiable 
time limit. 
 
Table 9: Assessment under Article 20 (2) BR 
B
en
ef
it 
co
v
er
ag
e 
Question No1: Is the treatment in question among the benefits provided for by the 
legislation in the Member State where the person concerned resides? (Article 20 
(2) BR) 
YES NO 
A
v
ai
la
bi
lit
y 
Question No2: Can the person concerned be given such 
treatment within a time limit which is medically justifiable? 
(Article 20 (2) BR) 
The first condition 
of Article 20 (2) 
BR is not met, thus 
the competent MS 
is not obliged to 
accord the 
authorisation. 
Question No2 Part1: Is the same or equally effective 
treatment available in the Member State of residence? (ECJ) 
YES NO 
W
ai
tin
g 
tim
e 
Question No2 Part2: Is the same or 
equally effective treatment available in 
the Member State of residence without 
undue delay? (ECJ) 
The conditions of 
Article 20 (2) BR 
are met, thus the 
competent MS is 
obliged to accord 
the authorisation. 
YES NO 
The second 
condition of 
Article 20 (2) BR 
is not met, thus the 
competent MS is 
not obliged to 
accord the 
authorisation. 
The conditions of 
Article 20 (2) BR 
are met, thus the 
competent MS is 
obliged to accord 
the authorisation. 
Source: the author’s own summary 
                                                 
718
 C-372/04 Watts, 75. 
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In my opinion, it could be argued that introducing a general maximum waiting time 
(hereinafter also referred to as MWT) in Union law would ensure a higher level of 
protection for the patients. That is to say, if a Member State cannot provide the 
patient, who is covered by the statutory healthcare system of that Member State, with 
the requested healthcare, which is included in the benefit package of the Member 
State in question, it fails to fulfil its obligation that is based on the legal entitlement 
of the person. Thus, the Member State is obliged to grant a permission to the said 
person to obtain the requested healthcare in another Member State, if the patient opts 
for it. 
Setting a maximum waiting time would not solve all the problems related to undue 
delay, but could possibly motivate the Member States to keep waiting times low, 
ensure timely healthcare provision719 and manage waiting lists more efficiently. In 
theory, this would require just a slight modification of the text of the Basic 
Regulation.720 However, in practice, one might suspect that Member States would 
heavily oppose the introduction of such a rule in the fear that it would considerably 
reduce their autonomy and discretionary power721 on the one hand, and on the other, 
it would require significant investments in the healthcare sector in certain Member 
States in order to achieve short waiting times. Therefore, in today’s circumstances it 
is not very likely that such an amendment would be supported by a required majority 
                                                 
719
 This issue is further dealt with in Chapter V. on the timely provision of healthcare. 
720
 The sentence the authorisation shall be accorded where the treatment in question is among the 
benefits provided for by the legislation in the Member State where the person concerned resides and 
where he/she cannot be given such treatment within a time limit which is medically justifiable, taking 
into account his/her current state of health and the probable course of his/her illness should be 
completed by adding the maximum time limit, for instance “he/she cannot be given such treatment 
within a time limit which is medically justifiable, and which is not longer than 90 days from the 
submission of the request for authorisation.” 
Of course, mainly it is not a legal issue to elaborate how long this MWT should be, but it is for the 
healthcare experts to decide what is on the one hand realistic and feasible within the European 
healthcare systems and on the other hand serves the purpose of providing patients with timely 
healthcare within the EU at the same time. In my opinion, 90 days as a maximum would meet these 
criteria. 
721
 Such a measure would clearly go beyond coordination of social security systems, which is why 
Member States might argue that the Union overreaches its competence. 
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in the Council.722 Since this initiative is of a harmonising nature and goes beyond the 
current competences of the Union in this respect,723 the introduction of a maximum 
waiting time cannot be imagined without the common support of the Member States 
themselves. 
Nevertheless, in the long run this is a desirable direction for the legislation to go into, 
since it would not only improve the social protection of migrants but would serve the 
interest of every single patient EU-wide by inducing the decrease of waiting times in 
healthcare in general. 
 
The coordination mechanism on planned care had been long in place when “a 
handful of dissatisfied patients, some seeking redress at the European Court of 
Justice by invoking the principles of free movement of goods and services”724 offered 
the Court the opportunity to change the landscape of Union legislation on planned 
care.725 As said above, in the proceedings before the Court national legislations have 
been challenged, which more or less followed the Coordination Regulations’ path, 
and the Court consistently held that the national authorisation systems constitute an 
obstacle to the free movement. 
Since the steps taken by the Court from the limited patient mobility of the 
coordination mechanism towards the ‘liberalisation of patient mobility’ within 
Europe were already outlined,726 just a few things will be underlined here again. The 
Court’s main consideration was that healthcare services are not different from any 
other services which move freely within the Union.727 Therefore, any national 
measures and legislative arrangements which hinder patients, as the recipients of 
these services,728 to obtain medical treatments abroad must be seen as a barrier to 
                                                 
722
 On the legislative procedure related to social security coordination measures, see footnote 262. 
723
 See footnote 721. 
724
 Martin MCKEE, Reinhard BUSSE, Rita BAETEN and Irene GLINOS (2013): Cross-border healthcare 
collaboration in the European Union: Placing the patient at the centre. Eurohealth, Vol 19 No 4, p. 4 
725
 On the ECJ’s approach see section III.1.3.4 on the evolution of the legislation on European cross-
border patient mobility. 
726
 See section III.1.3.4. 
727
 See footnote 316 and 317. 
728
 See footnote 318. 
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free movement729 and as breaching Union law unless properly justified.730 The main 
breakthrough of this concept was the following: whereas the basic principle of 
planned care under the coordination system was that prior authorisation from the 
competent institution was required,731 under the case law the main rule was that no 
prior authorisation could be prescribed. The cases in which the requirement of prior 
authorisation was accepted were exceptional cases where Member States could 
justify the existence of the authorisation system.732 Besides the numerous grounds of 
justification which were refused by the Court,733 there were two reasons which 
actually turned out capable of serving as a legitimate ground for restricting patient 
mobility by setting up or maintaining a prior authorisation system.734 Both of them 
were based on the necessity of planning within healthcare systems: (1) hospital 
planning735 and (2) planning concerning the use of major medical equipment.736  
Concerning planning requirements, the Court first acknowledged that the number of 
hospitals, their geographical distribution, the mode of their organisation and the 
equipment with which they are provided, and even the nature of the medical services 
                                                 
729
 See footnote 326. 
730
 On the possible grounds of justification see footnote 327. 
731
 Article 20 (1) BR: Unless otherwise provided for by this Regulation, an insured person travelling 
to another Member State with the purpose of receiving benefits in kind during the stay shall seek 
authorization from the competent institution. 
732
 Although Community law does not in principle preclude a system of prior authorisation, the 
conditions attached to the grant of such authorisation must nonetheless be justified with regard to the 
overriding considerations examined and must satisfy the requirement of proportionality. C-157/99 
Geraets-Smits and Peerbooms, 82; C-385/99 Müller-Fauré and Van Riet, 83; C-372/04 Watts, 113-
114; C-173/09 Elchinov, 41. 
The settled case law of the ECJ was confirmed by a recent order of the Court, which says that Article 
49 EC and Article 22 of Regulation (EEC) No 1408/71 [...] do not, in principle, preclude legislation 
of a Member State which makes the entitlement to full reimbursement of expenses incurred in respect 
of hospital treatment provided in another Member State subject to obtaining prior authorisation. On 
the other hand, those provisions preclude such legislation which is interpreted as excluding, in all 
cases, full reimbursement by the competent institution for hospital treatment given without prior 
authorisation. C-430/12 Elena Luca v Casa de Asigurări de Sănătate Bacău [ECR 2013 Page 00000] 
733
 See footnote 327. 
734
 The grounds of justification are summarised in Annex II. 
735
 This argument first occurred in the Geraets-Smits and Peerbooms judgement, and was then 
confirmed at several occasions. C-157/99 Geraets-Smits and Peerbooms, 76, 78-80; C-385/99 Müller-
Fauré and Van Riet, 77-81; C-56/01 Inizan, 56; C-145/03 Keller, 62; C-372/04 Watts, 108-110; C-
173/09 Elchinov, 43; C-512/08 Commission v France, 33-42. 
736
 The question of the prior authorisation requirement when the treatment is provided outside of a 
hospital environment and involves the use of major medical equipment was raised in the course of an 
infringement procedure against France. C-512/08 Commission v France. 
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which they are able to offer, are all matters for which planning must be possible. The 
possibility of planning serves two basic aims: (1) on the one hand, it seeks to achieve 
that there is sufficient and permanent access to a balanced range of high-quality 
hospital treatment in the State concerned and (2) on the other hand, it assists in 
meeting a desire to control costs and to prevent, as far as possible, any wastage of 
financial, technical and human resources.737 It is indeed a valid argument that in 
certain cases planning is not only desirable, but even inevitable in order to ensure the 
sustainability of European healthcare schemes.738 However, in which cases planning 
is truly necessary and therefore maintaining a prior authorisation system is a justified 
national measure is a highly arguable question. Not surprisingly, a discussion 
emerged from this question.739 In this respect, the Court added important points of 
clarification in its Müller-Fauré and Van Riet 740 and Commission v France741 
judgements. In the former, it concluded that the distinction between hospital services 
and non-hospital services may sometimes prove difficult to draw. In particular, 
certain services provided in a hospital environment but also capable of being 
provided by a practitioner in his surgery or in a health centre could for that reason 
be placed on the same footing as non-hospital services.742 This argumentation clearly 
shows the Court’s intention to interpret the notion of hospital treatment restrictively. 
However, it does not provide a specific ground on which a distinction can be made 
                                                 
737
 See footnote 735. 
738
 The ECJ emphasises that a borderless, uncontrolled patient flow carries the potential to jeopardise 
all the planning which goes into the system of agreements in an effort to guarantee a rationalised, 
stable, balanced and accessible supply of hospital services. C-157/99 Geraets-Smits and Peerbooms, 
81; C-385/99 Müller-Fauré and Van Riet, 82; C-372/04 Watts, 111. 
739
 It is not difficult to see that on this point, the Member States wish to stay in control and interpret 
this ground of justification widely, whereas the European Union attempts to protect or even extend 
patient’s rights by limiting the discretionary power of the national institutions. 
740
 C-385/99 Müller-Fauré and Van Riet. See footnote 343. 
741
 The baseline of the infringement procedure against France was that the Commission argued that 
the requirement of prior authorisation for the purpose of responsibility for payment by the competent 
institution for treatment available at a general practitioner’s surgery in another Member State and 
requiring the use of major medical equipment constituted a restriction of the freedom to provide 
services, whereas the French government held that the Court’s case law must be interpreted as 
allowing – for the sake of overall planning objectives – to require prior authorisation in regard to 
medical treatments calling for the use of major medical equipment outside hospital infrastructures, 
having regard to the very high costs of that equipment and to its impact on the budget of social 
security systems. C-512/08 Commission v France, 20 and 25. 
742
 C-385/99 Müller-Fauré and Van Riet, 75; C-512/08 Commission v France, 35. 
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between inpatient care, where the requirement of prior authorisation is tolerated, and 
outpatient care, where the requirement of prior authorisation cannot be justified. In 
the latter judgement, the Court accepted the arguments of France and declared that 
planning objectives might not only relate to hospital environment, but also to major 
medical equipment, regardless of the setting, hospital or otherwise, in which it is 
intended to be installed and used.743 However, once again, no further specification of 
the definition of major medical equipment was offered by the Court. Thus, although 
the legal status of border-crossing patients was strengthened by the possibility to 
obtain healthcare without prior authorisation, the lack of well-defined boundaries of 
the Member States’ discretion left patients uncertain and hesitant about which 
treatments could and could not be reimbursed when the patient was not granted 
authorisation beforehand. 
 
The Directive follows this logic of the case law by stipulating that the Member State 
of affiliation shall not make the reimbursement of costs of cross-border healthcare 
subject to prior authorisation except in cases set out in the Directive itself.744 The 
Union permits the Member States to restrict free mobility of patients by applying 
authorisation schemes within a limited scope. This limitation must be based on 
overriding reasons of general interest, such as planning requirements745 relating to 
the aim of ensuring sufficient and permanent access to a balanced range of high-
quality treatment in the Member State concerned or to the wish to control costs and 
avoid, as far as possible, any waste of financial, technical and human resources. 
It can therefore be concluded that the main principle of the Directive is that no prior 
authorisation is required. However, a few exceptions exist when the restriction of 
free movement by applying the prior authorisation requirement is lawfully justified. 
These exceptions, which grant the competent institutions the right to make the 
                                                 
743
 C-512/08 Commission v France, 37. 
744
 Article 7 (8) PMD. 
745
 Article 7 (9) PMD. On healthcare capacity planning see Rita BAETEN and Willy PALM (2011): The 
Compatibility of Health Care Capacity Planning Policies with EU Internal Market Rules. In Johan 
Willem VAN DE GRONDEN, Erika SZYSZCZAK, Ulla NEERGAARD and Markus KRAJEWSKI (eds.): 
Health Care and EU Law. The Hague: T. M. C. Asser Press, pp. 389-411. 
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reimbursement of medical costs abroad subject to prior authorisation, can be divided 
into two groups: they partly concern (1) the planning requirement746 and partly (2) 
medical quality and safety issues.747 
 
(1) The grounds for planning which already appeared in the case law of the 
Court are repeated in the Directive:748 healthcare may be subject to prior 
authorisation if (a) it involves overnight hospital accommodation of the patient in 
question for at least one night749 or (b) it requires use of highly specialised and cost-
intensive medical infrastructure or medical equipment.750 Although the grounds are 
the same, they already appear slightly more specified as when observed in the 
judgements of the Court: the Directive attempted to fine-tune these provisions. 
(a) Hospital treatments only fall within the category of justified restriction of free 
movement as far as they require the patient to stay at least one night in hospital. In 
this respect, medical protocols might be decisive, since they define those types of 
treatments which normally necessitate in-hospital stay and also suggest the 
approximate length of the stay.751 The downside of this approach is that it leaves no 
room for individually influencing factors and personal assessment, whereas it can 
easily happen that a medical intervention has diverse effects on diverse persons: one 
person might need in-hospital stay afterwards (or beforehand), whereas the other 
does not. Introducing this condition seems to answer the question whether 
ambulatory care or one-day surgery, which can be performed only in a hospital 
setting, might be subject to an authorisation requirement: they cannot unless they fall 
                                                 
746
 Article 8 (2) (a) PMD. 
747
 Article 8 (2) (b) and (c) PMD. 
748
 PENNINGS points out a tiny wording difference with less tiny consequences: whereas the case law 
referred to the two objectives of planning as cumulative aims (see footnote 735), the Directive – by 
using the word “or” in Article 7 (9) – treats them as alternatives. Thus, even one of them (e.g. the 
desire to control costs) can be enough to lawfully justify the existence of an authorisation scheme. 
PENNINGS says that “(t)he requirements of the Directive may, thus, be less strict than those of the case 
law” and “(a)s a result, the formula of the Directive can lead to legal uncertainty and incoherence 
between case law and the Directive.” PENNINGS (2011: 440.). 
749
 Article 8 (2) (a) (i) PMD. 
750
 Article 8 (2) (a) (ii) PMD. 
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 Aileen CLARKE and Rebecca ROSEN (2001): Length of stay – How short should hospital care be? 
European Journal of Public Health, Vol 11 Issue 2, pp. 166-170. 
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under the second category, requiring the usage of highly specified or cost-intensive 
medical infrastructure or medical equipment. However, one may wonder whether 
overnight hospital stay requires considerably more planning than daytime hospital 
stay. For example, if a person is duratively treated in a hospital setting but is allowed 
to spend the nights at his/her home, the above condition is not met, although it can be 
rightfully argued that this treatment requires a comparable scale of planning. 
(b) A similar flaw can be discovered in the event of the use of highly specialised and 
cost-intensive medical infrastructure or medical equipment. This category is more 
sophisticated than its predecessor in the case law, but neither the notion of highly 
specialised infrastructure or equipment, nor the notion of cost-intensive infrastructure 
or equipment are circumscribed. The question might be raised whether specification 
and cost-intensiveness can be defined according to Member States’ national 
standards taking into account that the local differences or international medical 
science must indicate which cases fall under this category as seen in Geraets-Smits 
and Peerbooms.752 It is, however, a development that – unlike in the case law – it is 
acknowledged that not only medical equipment but also necessary medical 
infrastructure, such as specialised services and facilities can constitute grounds of 
planning. 
To sum up, the aim of the legislature to make the above categories more concrete is 
more than appreciated. However, it is crucial to clearly indicate the limits of the 
Member States’ discretionary power. In my opinion, this goal has not been achieved 
by the current wording of the Directive, which is rather vague, lacks precise 
definitions, and leaves too much room for arbitrary interpretation. Uncertainty on this 
essential point of the legislation is not in favour of the border-crossing patients, and 
thus these issues demand further clarification. Notwithstanding that it does not tackle 
the above mentioned problems, it does reduce the uncertainty by obliging the 
Member States to specify the categories of healthcare the planning objectives of 
which justify the existence of the prior authorisation scheme.753 
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 See footnotes 664 and 665. 
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 Article 8 (2) PMD. 
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(2) The protection of public health by means of prior authorisation is a new 
element in the Patient Mobility Directive. The protection of public health did appear 
earlier in the case law of the Court several times as a possible ground for restricting 
patient mobility, but the Court consistently held that since the conditions for taking 
up and pursuing regulated professions have been harmonised on Community level,754 
the provision of a treatment by a healthcare provider established in another Member 
State provides guarantees equivalent to those provided by a healthcare practitioner 
established in the national territory.755 The drafters of the Directive did not seem to 
fully agree with this argument and included quality and safety reasons which can 
justify prior authorisation under the Directive’s regime. Concerns might appear both 
in relation to (a) treatments which might present a particular risk for the patient or 
the population;756 and (b) healthcare providers that might give rise to serious and 
specific concerns relating to the quality or safety of the care.757 
(a) It is true that the variety of national healthcare systems manifests itself also in the 
different approaches to certain treatments. Especially the medical interventions 
which are heatedly debated from a bioethical point of view758 are treated differently 
in the Member States of the European Union. Home birth services are a good 
example in this respect. Whereas it is rather liberally ruled in certain Member States, 
in others very strict rules apply to such situations.759 Hungary, for example, belongs 
to the latter group: intense political and legal debate has been taking place about 
whether and under which conditions a woman is legally entitled to give birth outside 
a hospital environment. The severity of the current legislation760 might drive women 
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 See footnote 141 on the mutual recognition of qualifications. 
755
 See footnote 327 on the grounds of justification which appeared in the case law. 
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 Article 8 (2) (b) PMD. 
757
 Article 8 (2) (c) PMD. 
758
 See footnote 77. 
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 On the different legislations in some of the Member States, see Eugene DECLERCQ, Raymond 
DEVRIES, Kirsi VIISAINEN, Helga B. SALVESEN and Sirpa WREDE (2002): Where to give birth? 
Politics and the Place of Birth. In Raymond DEVRIES, Sirpa WREDE, Edwin VAN TEIJLINGEN and 
Cecilia BENOIT (eds): Birth by Design: Pregnancy, Maternity Care, and Midwifery in North America 
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760
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to another Member State with a more permissible law.761 Therefore, a Member State 
with a stricter legislation could argue that the treatment concerned presents a 
particular risk for the patient or the population762 and make that treatment subject to 
prior authorisation under the scope of the Patient Mobility Directive. The Member 
States are required to officially declare which treatments are considered risky in this 
relation and make publicly available which healthcare is subject to prior 
authorisation for the purposes of this Directive.763 However, in the effort to reduce 
uncertainty, it is highly advisable to extend the obligation of prior notification 
towards the Commission to this category as well.764 
Moreover, the Member States are not only permitted to make these treatments 
subject to prior authorisation, but may also refuse to grant prior authorisation on the 
ground that the patient will be exposed with a reasonable certainty to an 
unacceptable patient-safety risk765 or the general public will be exposed with 
reasonable certainty to a substantial safety hazard as a result of the cross-border 
healthcare in question.766 It would have been helpful, though, if the legislature had 
given a hint about whom is in charge of deciding whether a safety risk is still 
acceptable767 or what is to be understood under reasonable certainty.768 
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 The same goes, for example, to palliative care and end-of-life treatments. 
762
 In the case of home birth, studies show that there is a considerably higher health risk both for the 
mother and for the newborn compared to hospital birth, so this might be a valid argument. See among 
others Ank DE JONGE, Birgit Y. VAN DER GOES, Anita C. J. RAVELLI, Marianne P. AMELINK-
VERBURG, Ben W. J. MOL, Jan G. NIJHUIS, Jacob BENNEBROEK GRAVENHORST, Simone E. 
BUITENDIJK (2009): Perinatal mortality and morbidity in a nationwide cohort of 529 688 low-risk 
planned home and hospital births. An International Journal of Obstetrics & Gynaecology, Vol 116 
Issue 9, pp. 1177–1184 and N. Meltem DAYSAL, Mircea TRANDAFIR and Reyn VAN EWIJK (2012): 
Saving lives at birth: The impact of home births on infant outcomes. Discussion Paper Series, 
Forschungsinstitut zur Zukunft der Arbeit, No. 6879. 
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 Article 8 (7) PMD. 
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 See footnote 753. 
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 Article 8 (6) (a) PMD. 
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 Article 8 (6) (b) PMD. 
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 According to Article 8 (6) (a) PMD, a clinical evaluation must take place. However, it is not 
indicated whose opinion is decisive concerning the acceptability of the safety risk. Is it the patient, 
who might be willing to take higher risks since he/she requested prior authorisation for the healthcare 
(e.g. in the case of home birth)? Is it the competent institution, which might not be willing to authorise 
any healthcare considered risky? Or is it the health practitioner, who might form an impartial 
professional opinion; however, who might not be willing to approve any treatment which possibly 
induces medical liability issues. 
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(b) The quality and safety concerns in relation to certain healthcare providers are 
more difficult to be dealt with. According to Article 3 (g) of the Patient Mobility 
Directive, a healthcare provider must be understood as any natural or legal person or 
any other entity legally providing healthcare on the territory of a Member State. 
Consequently, the following question arises: how can a healthcare provider that gives 
rise to serious and specific quality or safety concerns legally provide healthcare 
services within the European Union. To answer this question, first it must be noted 
that healthcare professions769 are regulated professions770 in the European Union and 
– as the Court has underlined771 – the rules according to which healthcare professions 
can be accessed and pursued in the territory of the European Union are harmonised. 
Thus, in my opinion, two scenarios are possible here: safety concerns that arise about 
(ba) a healthcare provider that performs his/her activity legally in the territory of a 
Member State but falls outside of the scope of Directive 36/2005772 or (bb) a 
healthcare provider that falls within the scope of the said Directive and pursues 
his/her activity legally, but does not meet certain national standards or guidelines, 
such as provisions on supervision.773 For the sake of legal certainty and in order to 
avoid the arbitrary ‘exclusion’ of healthcare providers, clear and transparent 
indicators are needed to identify which healthcare providers are considered 
unadvisable, meaning not only that the provider can be made subject to prior 
authorisation774 but that this authorisation may also be refused.775 
 
                                                                                                                                          
768
 In this case, the burden of proof lies with the competent institution which ought to justify the 
refusal of the request for prior authorisation. Yet, it is an interesting question how the presence of an 
unacceptable safety risk can be proven with a reasonable certainty. 
769
 Under the scope of Directive 2005/36, harmonised healthcare professions are: doctors of medicine, 
nurses responsible for general care, dental practitioners, veterinary surgeons, midwives and 
pharmacists. 
770
 See Article 3 (1) (a) of Directive 2005/36 on the recognition of professional qualifications. 
771
 See footnote 141 on the mutual recognition of qualifications. 
772
 A medical masseur might be a good example. 
773
 In this case, Member States are free to refuse to grant prior authorisation to the patient concerning 
healthcare provided by such a healthcare provider. Article 8 (6) (c). 
774
 Article 8 (2) (c) PMD. 
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 Article 8 (6) (c) PMD. 
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Besides the grounds of refusal mentioned above, the Directive also stipulates that 
authorisation may be lawfully refused if the requested healthcare can be provided on 
the territory of the Member State of affiliation within a time limit which is medically 
justifiable, taking into account the current state of health and the probable course of 
illness of each patient concerned.776 This provision of the Patient Mobility Directive 
fully corresponds with the relevant provision of the Coordination Regulation,777 
which was already analysed earlier in this section. Similarly, the Directive echoes the 
Regulation by adding that the Member State of affiliation may not refuse to grant 
prior authorisation when the patient is entitled to the healthcare in question, and 
when this healthcare cannot be provided on its territory within a time limit which is 
medically justifiable.778 It is actually not quite clear why the Directive repeats in 
Article 8 (6) (d) what can be deduced already from Article 8 (5).779 
 
Both routes of patient mobility apply prior authorisation schemes when a person 
intends to receive scheduled healthcare abroad. Nevertheless, whereas in the 
framework of the coordination mechanism prior approval from the competent 
institution is required, under the Patient Mobility Directive prior authorisation is 
considered an obstacle of free movement. Therefore, the scope of the justified 
application of such measures is limited by law. As can be deduced from the above 
analysis, the unique legal tools themselves contain numerous problematic points, 
such as the determination of the benefit baskets, the definition of – among others – 
the medically justifiable time limit, undue delay, highly specialised and cost-
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 Article 8 (6) (d) PMD. 
777
 Article 20 (2) BR. 
778
 Article 8 (5) PMD. The decision whether a time span is medically justifiable from an individual 
patient’s point of view must be based on an objective medical assessment of the patient’s medical 
condition, the history and probable course of the patient’s illness, the degree of the patient’s pain 
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other factors codified in the Directive can be traced in the case law. See footnote 701 and 702. 
However, unlike in the judgements of the Court, in the Directive no reference is made to the possible 
effect of the illness to the employment status of the patient. See also PENNINGS’s remark on this 
(2011: 442.). 
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 In my opinion, Article 8 (6) (d) could simply have been erased from the text, which would not have 
changed the content of the legislation. 
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intensive medical infrastructure and medical equipment, reasonable certainty and the 
specification of the conditions for introducing prior authorisation and refusing to 
grant one. The picture is even more complex if these tools are examined in an 
administrative context.  
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III.2.2.2. Administrative burden 
Without any doubts, not only the legislation on cross-border healthcare 
provision is difficult and challenging for patients. Also the related administrative 
procedures are often lengthy, time-consuming and ponderous. Through these formal 
processes, patients are confronted with the complex legal framework and they might 
be easily discouraged by the administrative burden itself or the conditions attached to 
the different forms of patient mobility. 
Therefore, the examination of the administrative conditions and procedures cannot be 
left out of this research. In this section, the processes in relation to the three various 
scenarios of European cross-border patient mobility780 are investigated. 
III.2.2.2.A. Administrative formalities when accessing healthcare in the competent 
Member State and residing outside of that Member State 
People residing outside the competent Member State need to meet certain 
administrative requirements to obtain their benefits in good order in the Member 
State of residence. First, the insured person and his/her family members have to 
register themselves at the institution of the place of residence.781 Second, they have 
to provide proof of insurance under the sickness scheme of the competent Member 
State. For this purpose, an S1 form782 has to be requested from the competent 
institution.783 This document states that the person concerned fulfils the conditions 
for entitlement to healthcare benefits in kind in accordance with the competent 
Member State’s national legislation.784 In the framework of their obligation to 
cooperate, both the competent institution and the institution of the place of residence 
                                                 
780
 See section III.2.2.1. 
781
 Article 24 (1) IR. 
782
 The S1 form is a portable document (hereinafter also referred to as PD) under the new coordination 
regime replacing the former E 106 form. A useful summary on different social security rights-related 
forms for citizens can be found on the Your Europe website: 
http://europa.eu/youreurope/citizens/work/social-security-forms/index_en.htm (10 March 2014). 
783
 Article 24 (1) IR. 
784
 See supra under section III.2.2.1.A. and JORENS et al. (2007: 31.). 
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have to inform the other one in the event of registration, change or cancellation of 
registration.785 
If insured persons or their family members wish to obtain medical treatments in the 
competent Member State, they are free to do so under the same conditions as the 
persons residing there. However, if family members of frontier workers786 or 
pensioners and their family members787 whose access to healthcare in the competent 
Member State is restricted intend to obtain planned healthcare in the competent 
Member State, they are required – under the Coordination Regulations – to request a 
prior authorisation.788 
III.2.2.2.B. Administrative formalities when obtaining necessary healthcare 
Under the traditional regime of the Coordination Regulations, in order to 
obtain necessary healthcare in a Member State other than the Member State of 
residence during a temporary stay in that Member State on the account of the 
patient’s health insurance in the competent Member State, three basic requirements 
must be met: (1) the person concerned must be entitled to sickness benefits in kind in 
the competent Member State; (2) the person concerned must be able to prove his/her 
entitlement to the foreign healthcare provider he/she intends to obtain treatment 
from; and (3) the healthcare must be obtained from a public healthcare provider. 
 
(1) Firstly, the person concerned must be entitled to sickness benefits in kind 
under the national legislation of the Member State where he/she is covered by the 
compulsory health insurance scheme.789 The formalisation of the entitlement rules is 
the sole responsibility of the Member States, although if these requirements are met, 
                                                 
785
 Article 24 (2) IR. 
786
 On the rules of access to healthcare for family members of frontier workers see section III.2.1.1. 
787
 On the rules of access to healthcare for pensioners and their family members see section 
III.2.2.1.A. 
788
 The rules on the prior authorisation procedure for planned care when residing outside the 
competent MS are discussed in section III.2.2.2.C. infra. 
789
 See footnote 534. 
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the healthcare basket provided in the Member State of stay determines the benefits 
available as necessary care during a temporary stay abroad.790 
 
(2) Secondly, the patient must be able to present a proof of entitlement to the 
sickness benefits in kind issued by the competent institution for the healthcare 
provider in the Member State of stay.791 For this purpose, the E 111 form was used 
until it was progressively – in three stages792 − replaced by the European Health 
Insurance Card.793 The aim of this action was to simplify procedures without 
changing the existing rights and obligations.794 The Administrative Commission 
published its decision aimed at introducing the European Health Insurance Card795 in 
2003, in which decision it also adopted the basic provisions concerning the 
application of the EHIC. The target of the adoption of a uniformed health insurance 
card was twofold: (a) on the one hand, the Union legislature intended to simplify the 
access to healthcare during a temporary stay abroad by introducing the EHIC initially 
in a format in which the data necessary for the provision of health care and 
reimbursement of the costs can be read with the naked eye;796 (b) on the other hand, 
                                                 
790
 See footnote 546. 
791
 Article 25 (A) (1) IR. 
792
 Paragraph 1 of the Preamble of Decision No 191 of the Administrative Commission of 18 June 
2003 concerning the replacement of forms E 111 and E 111 B by the European health insurance card. 
OJ L 276 of 27 October 2003. 
793
 The European Council decided about the replacement of the paper forms with the European Health 
Insurance Card at its Barcelona Summit in March 2002 and asked the European Commission to 
present a proposal before the Spring European Council held in March 2003. The Commission’s 
proposal was presented in the form of a communication: Communication from the Commission 
concerning the introduction of a European health insurance card. COM (2003) 73 final, 17. 02. 2003 
794
 See footnote 581. 
795
 Decision No 189 of the Administrative Commission of 18 June 2003 aimed at introducing a 
European health insurance card to replace the forms necessary for the application of Council 
Regulations (EEC) No 1408/71 and (EEC) No 574/72 as regards access to health care during a 
temporary stay in a Member State other than the competent State or the State of residence. OJ L 276 
of 27 October 2003. 
796
 Paragraph 3 of the Preamble of AC Decision 189. On the design and specifications of the European 
health insurance card see Decision No 190 of the Administrative Commission of 18 June 2003 
concerning the technical specifications of the European health insurance card (OJ L 276 of 27 October 
2003). See also the revised decisions of the Administrative Commission on these matters, namely 
Decision No S1 of the Administrative Commission of 12 June 2009 concerning the European Health 
Insurance Card (OJ C 106 of 24 April 2010) and Decision No S2 of the Administrative Commission 
of 12 June 2009 concerning the technical specifications of the European Health Insurance Card (OJ C 
106 of 24 April 2010). 
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the EU legislature wanted to ensure that the insured persons can use their right to 
healthcare benefits in kind through this card on the same terms as those applicable to 
persons insured under the legislation of the Member State of stay.797 This is the 
practical implementation of the equal treatment principle in the healthcare 
provision.798 
The EHIC is an individual plastic card799 that contains a certain set of data800 which 
can be easily recognised in any Member State and enables patients to turn directly to 
the healthcare providers in case of need for healthcare in another Member State. The 
card is issued by the competent Member State, which must also determine the 
validity period of the document.801 The card can be requested free of charge, 
although when exceptional circumstances occur such as theft, loss of the card or an 
urgent travel, and these situations prevent an EHIC from being issued, the competent 
institution must issue a provisional replacement certificate (hereinafter also referred 
to as PRC) with a limited validity period.802 
                                                 
797
 Article 25 (A)(2) IR. 
798
 See footnote 550. 
799
 Article 2 of AC Decision No S1. 
800
 Detailed in AC Decision No S2. 
801
 Article 3 of AC Decision No S1. The length of the validity periods differs widely in the Member 
States from several months (e.g. in Romania the EHIC is valid for six months) to several years (e.g. in 
Hungary EHIC is valid for three years). European Commission – MEMO/11/406: Health: getting 
ready for the holiday – always travel with your European Health Insurance Card (EHIC)? p. 2. 
http://europa.eu/rapid/pressReleasesAction.do?reference=MEMO/11/406&format=HTML&aged=0&l
anguage=EN (1 December 2011). Recently introduced changes concerning the validity periods and 
data on current validity periods can be found in the EHIC Reports. COUCHEIR (2013: 6-8.) and 
PACOLET and DE WISPELAERE (2014a: 10-11.). 
Both very short and very long validity periods can raise concerns. On the one hand, the need for a 
regular change of EHICs due to a short-term validity constitutes a relatively big administrative 
burden, whereas on the other hand, long validity increases the possibility of fraudulent usage if the 
insurance status of the person concerned changes during the time of validity. 
The national determination of the length of the validity period may also be subject to discussion, since 
in this way, the Member States can indirectly influence the length of temporary stay abroad. One 
could question why an expiry date is actually needed. In my opinion, the aim of preventing fraud and 
misuse cannot be accepted as a reason, since they should be stopped by strengthening the cooperation 
among the competent institutions and not by forcing the patients to request a new card – in some 
Member States – after just a few months. Using the analogy of the national health insurance cards, the 
EHIC could be issued for an unlimited period of time and if any changes occur in the insurance status 
of the patient, the institutions involved should have the obligation to inform each other as they are 
obliged to do so under the validity period. Article 24 (2) IR. 
802
 Article 5 of AC Decision No S1. 
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The fact that the only proof of entitlement to sickness benefits in kind is the EHIC 
may raise concerns. Unlike on national level, where the existence of healthcare 
entitlements can be checked in some kind of database,803 on European level no such 
controlling mechanism is in place. The provider to whom an EHIC is presented is 
bound by Union legislation – if the criteria are met – to provide the patient with 
necessary care, lacking any means to check the entitlement. This might lead to the 
fraudulent consumption of healthcare services and legal disputes in relation to the 
reimbursement of the costs of these services. Although it does not seem realistic 
nowadays, in the long run it would be highly desired to set up a European database, 
an online verification system (maybe as an integral part of the EESSI)804 which 
would enable providers to check the patients’ social security status, and this way 
prevent the misuse of the EHIC procedure.805 
 
(3) Thirdly, the costs of necessary care are reimbursed only if the healthcare 
was provided by a public healthcare provider,806 meaning that under the 
Regulation’s regime, reimbursement cannot be claimed for medical treatment 
provided by private healthcare providers functioning beyond the scope of the public 
healthcare system.807 This restriction can very well be seen as a budget control tool: 
the Member States intend to avoid being obliged to reimburse the definitely higher 
                                                 
803
 For instance in Hungary, a colour code system was introduced in relation to entitlement checks. 
When a patient presents his/her national social security card (TAJ kártya) to a healthcare provider, the 
provider is obliged to check his/her social security status in the online database. If the system gives a 
green signal, it means that the card is valid and the social security status of the patient is settled 
(rendezett). A red signal is received when – despite the card being valid – there is a problem regarding 
the patient’s social security status (nem rendezett). A blue signal is for those who became insured in 
another country, making their card temporarily invalid (átmenetileg érvénytelen). Brown is for those 
whose card is deemed invalid for some other reason. Országos Egészségbiztosítási Pénztár (2011): 
Tájékoztató a jogviszony-ellenırzésrıl. 
http://www.oep.hu/pls/portal/docs/PAGE/SZAKMA/OEPHUSZAK_EUSZOLG/JVELL_SZOLG/TA
JEKOZTATO-JOGVISZONYELLENORZESROL4.PDF (13 March 2014), pp. 6-7. 
804
 On EESSI, see footnote 279 and section V.1.2. infra. 
805
 In this respect, work has been in progress on EU level for years now. The NETC@RDS for e-EHIC 
ID project aims at enabling the health practitioners to check foreign patients’ entitlement to health 
care. http://netcards-project.com/web/frontpage (13 March 2014). See also COM (2003) 73, p. 8. 
806
 In most of the cases this implies that the provider has a contract with the responsible institution of 
the MS of stay. 
807
 However, these costs can be reimbursed under the PMD’s regime. Further details on the inclusion 
of private providers can be found in this section infra. 
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private charges. By doing so, they do reduce patients’ freedom of choice. What is 
worse is that patients do not always seem aware that they can expect their medical 
costs being reimbursed under the Regulation only if they obtain treatment at a public 
provider. In this respect, I share the opinion of the German healthcare insurance 
institutions, which suggest an easy way to tackle this source of misunderstandings: 
each healthcare provider that functions under the scope of the Regulation and thus 
accepts the EHIC in the course of providing necessary care, should be obliged to 
display an EU-wide, universal, easily recognisable symbol in their entrance area.808 I 
share the opinion that a similar scheme could be followed as for credit card symbols: 
it is nowadays most common that restaurants, bars and hotels indicate somewhere 
around their entrance which types of credit cards are accepted for payment.809 This 
practice results in a clear situation on both sides and prevents later difficulties. A 
similar solution could be applied to the EHIC. Moreover, it would not require any 
considerable investments, but would completely solve the above mentioned problem 
and certainly improve patients’ feeling of certainty in such situations. 
 
In recent years, the EHIC grew to be a very important and useful tool in the Union’s 
healthcare policy. Data show that more than 190 million EHICs are currently in 
circulation,810 which makes the EHIC one of the most visible EU tools for EU 
citizens and “surely the most well-known tool for healthcare abroad.”811 
Nevertheless, the practical functioning of the EHIC remains a subject of constant 
discussion and many problems of ill-application are reported.812 The main problems 
can be grouped into three categories, namely (1) improper usage of the EHIC by 
patients; (2) non-acceptance of the EHIC by healthcare providers in the Member 
State of stay; and (3) invoice rejection based on the usage of the EHIC by competent 
institutions. 
                                                 
808
 JORENS and LHERNOULD (2013: 29.) and COUCHEIR (2013: 25.). 
809
 See also point 39 of EP – IMCO (2007). 
810
 Taking into account the PRCs as well, together they make more than 194 million. COUCHEIR 
(2013: 5.). 
811
 LHERNOULD (2014: 184.). 
812
 JORENS and LHERNOULD (2013: 29.). 
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(1) The inappropriate or fraudulent use of the EHIC is not a widespread 
problem. Rarely did cases occur in which the EHIC was used to obtain planned care, 
the treatment predated the issue of the EHIC or the EHIC was not used by the 
insured person to whom the EHIC was issued.813 
(2) However, it is a more frequent problem that healthcare providers refuse to 
accept the EHIC presented to them or to follow the procedure applicable to the 
provision of necessary care. The reasons behind this are multifarious. On the one 
hand, illegitimate refusals are for example based on (a) a lack of knowledge 
regarding the EHIC and its procedures; (b) concerns or reluctance regarding extra 
paper work and red tape associated with the EHIC814 and (c) concerns regarding late 
or non-payment by the competent institution;815 on the other hand, legitimate refusals 
are based on the fact that one or more of the above conditions to use the EHIC to 
obtain healthcare abroad are not met, especially when (a) the patient turns to a 
private, non-contracted provider that falls outside of the scope of EHIC procedures or 
(b) the patient aims to obtain planned care instead of necessary care. 
(3) Invoice rejections are not unknown either. Once again, “(a) multitude of 
reasons are reported as to why countries fail to accept forms E125816 or SED S080817 
for treatment obtained by their insured persons.”818 Most often the problems occur 
either in relation to the use of the EHIC819 or the invoice.820 
 
                                                 
813
 COUCHEIR (2013: 18.). 
814
 Providers often prefer private insurance over the EHIC or refer foreign patients to private 
providers. Neither of these practices comply with EU law. 
815
 COUCHEIR (2013: 19.). 
816
 E125 is a paper-based form, an individual statement of the costs of the medical treatment a person 
received in another Member State. Although E-forms were abolished by the new set of Coordination 
Regulations, they are still in use in several Member States. 
817
 SED is the abbreviation for structured electronic document. SEDs were designed to replace the 
former E-forms and make communication of data between institutions easier and more efficient. SED 
S080 serves as a replacement of E125 and is used for claiming reimbursement. 
818
 COUCHEIR (2013: 23.). 
819
 The cases of improper use of the EHIC were already mentioned in this section supra. 
820
 If, for instance, the form is incomplete or completed incorrectly. COUCHEIR (2013: 23.). 
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In my opinion, the main risk beyond these practices is that they hold a significant 
potential to undermine the public trust towards the EHIC itself821 and towards EU 
tools in general. Therefore, it is very important to pay due attention to such claims 
and to develop techniques which are able to tackle the most typical problems. In 
general, better controlling and monitoring mechanisms should be introduced both on 
the national and European level. The claims coming either from patients, providers 
or competent institutions should be promptly investigated and if deemed necessary, 
legal action should be taken against any person or entity who may not comply with 
Union legislation. Moreover, further active, awareness-raising initiatives should be 
carried out both among patients and healthcare providers.822 Although “many 
countries stress that information is continuously kept available through a variety of 
channels,”823 the above mentioned problems show that more active measures should 
be implemented. In my view, this is a shared responsibility of the Member States824 
and the Union,825 where best practices should be exchanged. The problems analysed 
above and some possible solutions suggested are summarised in Table 10 infra. 
  
                                                 
821
 COUCHEIR (2013: 3, 20.). For instance, the notorious non-acceptance practices of South-European 
touristic areas were very bad marketing for the EHIC. See among others Teresa HUNTER (2013): 
Holidaymakers warned as Spain blocks EHIC usage. The Telegraph, 31 Mar 2013, 
http://www.telegraph.co.uk/finance/personalfinance/insurance/travel/9960030/Holidaymakers-
warned-as-Spain-blocks-EHIC-usage.html (2 April 2013) and Harriet MEYER (2013): Spain's Ehic 
refusal prompts legal action from European Commission. The Guardian, 30 May 2013, 
http://www.theguardian.com/money/2013/may/30/spain-ehic-refusal-european-commission (2 April 
2014). 
822
 Most countries do not take active measures to raise awareness concerning the EHIC neither among 
patients nor among providers. COUCHEIR (2013: 12-13.). See also PACOLET and DE WISPELAERE 
(2014a: 15-18.). 
823
 COUCHEIR (2013: 12.). 
824
 See footnote 587. 
825
 The European Commission has taken serious efforts to spread information on and promote the 
EHIC: (1) it launched an online campaign with videos which were published on the most common 
video sharing sites (http://ec.europa.eu/social/main.jsp?catId=559&langId=en&furtherVideos=yes), 
(2) a smartphone application was designed, available in 24 languages, which provides a guide on how 
to use the EHIC in the 32 countries and includes general information about the card, emergency phone 
numbers, covered treatments and costs, how to claim reimbursement and who to contact if you have 
lost your card (http://ec.europa.eu/social/main.jsp?catId=559&langId=en); (3) it continuously 
provides information in the form of different leaflets, booklets, press releases and (4) through its 
website (http://ec.europa.eu/social/main.jsp?catId=559&langId=en). 
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Table 10: Ill-application of the European Health Insurance Card 
Nature of ill-application Examples of ill-application Possible solutions to tackle ill-application 
improper 
usage of 
the EHIC 
by patients 
patient 
acting in 
good faith 
the validity period of the EHIC 
expired 
awareness-raising among patients in various 
forms (e.g. through general practitioners, 
media) 
unaware of the legislation, the 
patient intends to obtain 
planned care with the EHIC 
not covered by the healthcare 
scheme of the MS that issued 
the EHIC 
facilitating more efficient inter-institutional 
communication 
patient 
acting 
maliciously 
(fraudulent 
usage of 
the EHIC) 
the treatment predates the issue 
of the EHIC 
indicating the starting date of the validity/ 
date of issue on the EHIC 
the patient maliciously intends 
to obtain planned care with the 
EHIC 
developing controlling and monitoring 
mechanisms and taking legal steps if 
necessary 
usage of fake, forged EHIC 
the EHIC is used by someone 
other than the person it was 
issued to 
non-
acceptance 
of the 
EHIC by 
healthcare 
providers 
illegitimate 
practices of 
non-
acceptance 
lack of knowledge about EHIC 
and its procedures 
awareness-raising among healthcare providers 
in various forms (e.g. in the framework of 
general healthcare education, specialised 
trainings, journals, circular letters) 
concerns regarding extra paper 
work and red tape 
improving administrative procedures 
concerns regarding late or non-
payment 
improving cooperation between competent 
institutions, speeding up reimbursement 
mechanisms by more efficient inter-
institutional communication, taking legal 
steps in the event of delayed or non-payment 
legitimate 
practices of 
non-
acceptance 
private provider applying an EU-wide, universal symbol to 
providers that accept EHIC 
requested healthcare falls 
outside of the notion of 
necessary care 
providing clearer guidelines on the scope of 
necessary care826 
usage of invalid EHIC  
invoice 
refusal by 
competent 
institutions 
EHIC 
related 
problems 
improper use of the EHIC (see 
supra) 
 
invoice 
related 
problems 
incomplete or incorrectly 
completed document 
facilitating more efficient inter-institutional 
communication 
Source: the author’s own summary 
 
                                                 
826
 On the notion of necessary care, see section III.2.2.1.B. 
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Although I firmly believe that the EHIC holds great opportunities, the EU is far from 
using its full potential. It seems to me that the expectations about the EHIC are only 
partly met so far and that there is still a long way to go to its full implementation. 
The replacement of the paper-based E-forms827 with the EHIC should be considered 
a first step. A second step would be an improved version of the EHIC which is able 
to electronically store healthcare data safely,828 not mentioning that the original idea 
was to combine the EHIC with the national health insurance cards.829 This also has 
not happened yet in many countries, although in the long run it could replace these 
national cards.830 
I share the opinion that the ‘electronification’ of the EHIC is the direction in which 
the European Union should move towards.831 The EHIC could function as an ‘EU 
medical passport’ (1) incorporating both national and European healthcare rights of 
the person concerned, (2) enabling healthcare providers to verify his/her entitlements 
and (3) storing medical data. However, it must be understood that the 
implementation of such a system requires considerable future investments and raises 
numerous problems to deal with.832 
 
Under the Directive’s regime, from the three above detailed conditions only one 
remained, namely that costs are only reimbursed if the healthcare in question is 
among the benefits to which the insured person is entitled in the Member State of 
affiliation.833 Subsequently, Member States are not obliged to reimburse the costs of 
treatments which are not covered by or expressly excluded from the benefit basket of 
the Member State of affiliation. It must be pointed out though, that this is not entirely 
                                                 
827
 The following E-forms were progressively replaced: E111 (for holidays), E128 (for posting), E110 
(for international road transport), E128 (for study) and E119 (for job seeking). COM (2003) 73, p. 4. 
828
 COM (2003) 73, p. 5. 
829
 COM (2003) 73, p. 12. 
830
 The EHIC carries a free area which is an area located on the reverse side of the European card 
and available for national purposes. Point 3.3.4. of Annex 1 to AC Decision S2. This free area could 
be used to integrate the national healthcare card into the EHIC. 
831
 COM (2003) 73, pp. 15-16. 
832
 Among others – as each application where ICT is involved – it raises serious concerns regarding 
data protection and confidentiality of sensitive medical data. This issue is further dealt with in Chapter 
V. 
833
 Article 7 (1) PMD. 
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the same condition as in the Regulation, because when necessary care is received 
under the coordination mechanism, the rules on the benefit coverage of the Member 
State of treatment apply.834 It is indeed the competent Member State which defines 
whether or not the person is entitled to healthcare services under its own legislation, 
but if he/she is and obtains occasional care in another Member State, the available 
benefits are defined by the legislation of the latter country.835 The Directive’s 
provision is not necessarily disadvantageous for the patient. Yet, he/she must be 
aware that if he/she obtains a medical treatment which is normally provided in the 
Member State of stay as a benefit included into its benefit package but is not covered 
by the benefit package of the Member State of affiliation, reimbursement cannot be 
claimed under the Directive. 
Unlike under the Regulation, the patients are not required to present a proof of their 
entitlement to healthcare services to the healthcare providers, since the healthcare 
provider is no longer interested whether the patient’s social security status checks 
out. The provider receives the full payment for the treatment from the patient, so it 
does not participate in the posterior reimbursement procedure between the patient 
and the competent institution. If the patient proves not to be entitled to the healthcare 
obtained, on the ground of Article 7 (1) of the Patient Mobility Directive the 
competent institution can legitimately refuse to reimburse the medical costs, which in 
the end remain at the expense of the patient. 
Similarly, the restriction regarding the accessible providers is not applicable either. 
The Directive covers both public and private providers, which obviously extends the 
patients’ possibility to choose. Therefore, this can be seen as a beneficial 
development from the patients’ point of view.836 However, some providers have 
                                                 
834
 According to the full integration principle, the person is treated as though he/she were insured 
under the legislation of the MS of stay. Article 19 (1) BR and Article 25 (A) (3) IR. 
835
 This issue is dealt with in details in section III.2.2.1.A. 
836
 However beneficial the inclusion of private providers is, it raises a serious concern in relation to 
equal treatment and might result in reverse discrimination. The problem can be illustrated with the 
example of Hungary. The Hungarian national legislation is not quite clear about whether Hungarian 
patients are entitled to obtain necessary care at non-contracted providers in another Member State 
under the Directive’s regime. One could argue that the Hungarian health insurance scheme does not 
cover treatments at private providers within the country (Article 9 of Act LXXXIII of 1997 on 
Compulsory Health Insurance hereinafter also referred to as Ebtv.). It can thus do the same when the 
Gabriella BERKI: Cross-border patient mobility: The legal framework of obtaining 
healthcare abroad within the European Union – a patients’ perspective 
191 
 
already been reported to abuse the extended opportunities offered by the Directive, 
inviting patients with an EHIC to pay upfront (even though domestic patients do not 
pay on the spot) or directing them to private providers instead of public ones which 
function under the scope of the Regulation.837 These practices are illegitimate and do 
not serve the interest of the patients. Therefore, such cases should be notified to the 
responsible authorities that can take the necessary measures to prevent such cases 
from happening again. 
 
At the same time, another condition popped up – rather surprisingly – which has not 
been applicable to necessary care under the Regulation, namely the requirement of 
prior authorisation. Since the Directive does not make a distinction between planned 
and unplanned care, but covers them both under the notion of cross-border 
healthcare,838 it must be deduced that all the conditions included in the Directive are 
applicable to both types. This has a fully illogical result regarding the relationship 
between necessary care and the authorisation requirement. As mentioned above,839 
the Directive permits Member States to provide for a system of prior authorisation 
for the reimbursement of costs of cross-border healthcare840 if it is justified by 
overriding reasons of general interest.841 However, what seems to be an acceptable 
                                                                                                                                          
provider is established in another Member State. However, the Directive is univocal on the point that 
the Member State of affiliation shall ensure the costs incurred by an insured person who receives 
cross-border healthcare are reimbursed, if the healthcare in question is among the benefits to which 
the insured person is entitled in the Member State of affiliation. (Article 7 (1) PMD). So the counter-
argument is that it is the treatment in question which decides whether the costs must be reimbursed, 
not the status of the provider. The current national legislation accepts the latter argument, because it 
provides that if an insured person obtains unplanned, medically necessary treatment at a provider that 
does not fall under the scope of the Regulations but is established within the European Union, the 
costs must be reimbursed (Article 8 (1) of Governmental Decree No 340/2013). Nevertheless, this 
right of the patients is neither expressly declared in the national legislation, nor communicated to the 
public. 
In my opinion, this constitutes reserve discrimination, where non-mobile patients enjoy a lower level 
of social protection, since their domestic private medical expenses are not reimbursed, than mobile 
patients, whose private medical expenses, which occurred abroad, are (at least partly) reimbursed. On 
reverse discrimination see footnote 1022 infra. 
837
 COUCHEIR (2013: 20.). 
838
 This issue is dealt with in section III.2.2.1.B. See also footnote 616. 
839
 This issue is dealt with in section III.2.2.1.C. 
840
 Article 8 (1) PMD. 
841
 Article 7 (9) PMD. 
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practice in relation to planned care results in an unrealistic legal scenario in relation 
to occasional care. The very notion of necessary care is based on the fact that in such 
cases there is neither time nor opportunity to request prior authorisation, since the 
patient does not have the intention to consume healthcare services before the need 
occurs. How lifelike would it be to expect a patient who – for instance – suffered a 
ski accident or fell ill during a three-day conference trip to request prior authorisation 
and wait for the prior authorisation to be granted before the provision of healthcare? 
Of course, this situation appears only if healthcare is provided under the Directive’s 
regime and is subject to prior authorisation, such as a treatment by a private provider 
involving overnight hospital accommodation. Nevertheless, the Hungarian delegation 
expressly addressed this question in the Administrative Commission, and received 
the answer that treatment should be reimbursed if it becomes necessary during a 
temporary stay and prior authorisation cannot be requested.842 It is true that the 
interpretation given by the Secretariat of the Administrative Commission is perfectly 
logical and realistic, but not in line with the current wording of the Directive. Since 
the interpretation of the Administrative Commission is not binding for the Member 
States, in theory it would be possible that a Member State refuses to reimburse the 
costs of necessary care obtained without a prior authorisation. 
Table 11 infra shows the discrepancies of the administrative conditions between the 
Regulation’s and the Directive’s provisions when obtaining unplanned care. 
  
                                                 
842
 Administrative Commission for the Coordination of Social Security Services (2011): Minutes of 
the Working Party of the Administrative Commission on Patients’ mobility. AC 332/11, 4 October 
2011. 
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Table 11: Administrative formalities related to unplanned care 
Administrative 
condition Coordination Regulation Patient Mobility Directive 
(1) entitlement to 
healthcare 
services 
  
the patient must be entitled to 
healthcare services under the 
legislation of the competent MS 
the patient must be entitled to 
healthcare services under the 
legislation of the competent MS 
AND 
the healthcare must be among the 
benefits provided by the MS of 
affiliation 
(2) presentation 
of proof of 
entitlement to 
healthcare 
services to the 
healthcare 
provider 
  
the patient must hold an EHIC or a 
PRC 
no need to present proof of 
entitlement 
(3) restriction on 
the accessible 
healthcare 
providers 
  
only public providers are covered both public and private providers 
are covered 
(4) prior 
authorisation 
  
no need to request PA 
in theory, MSs can refuse to 
reimburse the costs of treatments 
subject to PA, but obtained as 
necessary care without a PA 
Source: the author’s own summary, based on the legislation 
 
If these conditions are fulfilled, (part of) the medical expenses must be borne by the 
Member State of affiliation in accordance with the rules and procedures detailed 
infra in Chapter IV. 
III.2.2.2.C. Administrative formalities when obtaining planned healthcare 
As the Member States’ entitlement to require prior authorisation regarding 
planned care has already been analysed,843 in this section those rules are highlighted 
which are applicable to the procedures through which authorisations are granted or 
                                                 
843
 See section III.2.2.1.C. 
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requests refused. Here as well, an evolution of legislation can be observed, since (1) 
first only the Regulation’s authorisation procedure existed, (2) subsequently certain 
points of which were interpreted and clarified by the European Court of Justice and 
certain requirements regarding these procedures were stressed, and (3) then the 
Directive created its own, separate authorisation system applicable to cross-border 
healthcare in general and codified the case law of the Court as well. 
 
(1) The Coordination Regulation provides that an insured person travelling to 
another Member State with the purpose of receiving benefits in kind during the stay 
shall seek authorisation from the competent institution.844 Notably, the competent 
institution is bound to issue the requested permission, if two well-known conditions 
are met, namely that (a) the treatment is included in the benefit package provided for 
by the Member State of residence and that (b) the said treatment cannot be provided 
in this country within a medically justifiable time limit.845 
While limiting the discretionary power of the competent institutions in terms of 
refusing to issue prior authorisation, Article 20 (2) of the Basic Regulation does not 
in any sense intend to prevent the Member States from entitling their citizens to get 
reimbursed for medical costs incurred abroad even if the criteria referred to in that 
article are not met. As the Court repeatedly confirmed, the sole purpose of that 
provision is to identify the circumstances in which the competent national institution 
is precluded from refusing authorisation sought on the basis of the Regulation. That 
provision is not designed to limit the circumstances in which such authorisation may 
be granted. It follows that, where permission is granted on the basis of a national 
rule which provides that authorisation is to be granted where it is established that 
hospital treatment can be provided under better medical conditions abroad, such 
permission constitutes an authorisation within the meaning of the Regulation.846 This 
provision basically indicates that the Member States are free to authorise treatments 
                                                 
844
 Article 20 (1) BR. 
845
 Article 20 (2) BR. These criteria are dealt with in section III.2.2.1.C supra. 
846
 C-368/98 Vanbraekel, 31; C-56/01 Inizan, 41, 50; C-173/09 Elchinov, 39, 53. 
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abroad even if – lacking the fulfilment of the said conditions – they are not legally 
obliged to do so.847 
Concerning the prior authorisation scheme of the coordination mechanism, which in 
practice materialises into the issuing of the so-called S2 form,848 the Court defined 
some minimum requirements in its case law. 
 
(2) Firstly, the Court pinpointed that a scheme of prior authorisation cannot 
legitimise discretionary decisions taken by the national authorities which are liable 
to negate the effectiveness of provisions of Community law.849 Therefore, the 
administrative procedure must be based (a) on objective, non-discriminatory criteria 
which are known in advance,850 in such a way as to circumscribe the exercise of the 
national authorities' discretion, so that it is not used arbitrarily;851 and (b) on a 
procedural system which is easily accessible and capable of ensuring that a request 
for authorisation will be dealt with objectively and impartially within a reasonable 
time and refusals to grant authorisation must also be capable of being challenged in 
judicial or quasi-judicial proceedings.852 Furthermore, (c) refusals to grant 
                                                 
847
 On the different practices of the Member States see KESTELOOT et al. (1995: 47-48); COUCHEIR 
and JORENS (2005: 22-23.); HAJDÚ József (2008): Cross border health care under the 1408/71 EC 
Regulation. Studia Juridica Caroliensia, Vol 3, Károli Gáspár Református Egyetem Állam- és 
Jogtudományi Kar, Budapest and VAN DER MEI (2011: 1301.). 
848
 The S2 form is a PD under the new Regulation, which replaced the paper-based E 112 form but 
continued to function as a proof of entitlement to scheduled treatment abroad. According to Article 26 
(A) (1) IR, for the purposes of the application of Article 20(1) BR, the insured person shall present 
this document issued by the competent institution to the institution of the place of stay. The ECJ also 
confirmed in Keller, that forms E 111 and E 112 are intended to assure the institution of the Member 
State of stay and the doctors authorised by that institution that the holders of those forms are entitled 
to receive in that Member State, during the period specified in the form, treatment whose cost will be 
borne by the competent institution. C-145/03 Keller, 49. 
849
 Joined Cases C-286/82 and C-26/83 Luisi and Carbone, 34; Joined Cases C-358/93 and C-416/93 
Bordessa and Others, 25; Joined Cases C-163/94, C-165/94 and C-250/94 Sanz de Lera and Others, 
25; C-205/99 Analir and Others, 37; C-157/99 Geraets-Smits and Peerbooms, 90; C-385/99 Müller-
Fauré and Van Riet, 84; C-372/04 Watts, 115. 
850
 Article 22 (1) IR lay the charge on the Member States to ensure that any necessary information is 
made available to insured persons regarding the procedures and conditions for the granting of 
benefits in kind. 
851
 C-205/99 Analir and Others, 38; C-157/99 Geraets-Smits and Peerbooms, 90; C-385/99 Müller-
Fauré and Van Riet, 85; C-56/01 Inizan, 57; C-372/04 Watts, 116;C-173/09 Elchinov, 44; C-512/08 
Commission v France, 43. 
852
 C-157/99 Geraets-Smits and Peerbooms, 90; C-56/01 Inizan, 48, 57; C-372/04 Watts, 116; C-
512/08 Commission v France, 43. 
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authorisation, or the advice on which such refusals may be based, must refer to the 
specific provisions on which they are based and be properly reasoned in accordance 
with them. Likewise, courts or tribunals hearing actions against such refusals must 
be able to seek the advice of wholly objective and impartial independent experts.853 
Each of these requirements (which are summarised in Table 12 infra) aim to limit the 
Member States’ discretionary power, to guarantee an impartial and objective 
evaluation of the requests and to ensure transparency of the procedures in order to 
strengthen the patients’ feeling that they are not exposed to an uncontrollable, 
untraceable bureaucratic mechanism. However, some of the requirements are rather 
vaguely phrased and may thus not have the desired result. For instance, the criterion 
which says that the factors assessed in the authorisation procedure are to be known in 
advance does not concretise how or by means of what platform and where this 
information must be published or how much in advance this has to be communicated 
towards the insured persons.854 Similarly, it is not quite clear what can be considered 
reasonable time concerning the decision-making. It is certainly left to the Member 
States to define their administrative procedures and the processing times, but – 
similarly to what was suggested in relation to the notion of the medically justifiable 
time limit855 – it would increase the level of legal certainty in favour of the patients, 
if an EU-wide maximum processing time (hereinafter also referred to as MPT) was 
introduced. 
  
                                                 
853
 C-56/01 Inizan, 49, 57; C-372/04 Watts, 117. 
854
 One may raise the question, for example, whether it is appropriate to inform the insured person 
about these rules only right before he/she submits his/her request for a treatment abroad. 
855
 On the introduction of MWT, see section III.2.2.1.C. 
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Table 12: Requirements concerning a prior administrative authorisation scheme in accordance with 
the case law of the European Court of Justice 
(1) Requirements concerning the criteria of 
the assessment 
objective, non-discriminatory 
known in advance 
capable of preventing arbitrary decisions 
(2) Requirements concerning the procedural 
system 
easily accessible 
capable of ensuring objectivity and impartiality 
capable of ensuring a decision within a 
reasonable time 
capable of being challenged in judicial or 
quasi-judicial proceedings. 
(3) Requirements concerning administrative 
decisions and courts or tribunal hearing 
actions 
must refer to the specific provisions on which 
they are based 
must be properly reasoned 
Source: the author’s own summary 
 
In principle, the competent institution is responsible for assessing all the relevant 
information in each case and for deciding about the provision of prior authorisation. 
This rule is completely reasonable taking into account that the competent institution 
has to bear the costs of the scheduled treatment.856 However, there is an exception 
when the institution of the place of residence plays a significant role in this 
procedure, namely if the insured person does not reside in the competent Member 
State and is willing to obtain treatment in a third Member State. 
In this case, the person concerned has to request the authorisation from the institution 
of the place of stay, which certifies whether the conditions set out in the second 
sentence of Article 20 (2) BR are met in its own territory. At the same time, the 
request has to be forwarded to the competent institution without delay and this 
institution decides whether or not to grant the authorisation. It may refuse to grant the 
authorisation (1) if the said conditions are not met in the Member State of residence 
or (2) if the competent Member State itself can provide the required treatment within 
a medically justifiable time limit.857 Since this process involves lengthy 
administrative decision-making in two Member States, it can be – in practice – 
                                                 
856
 Article 26 (A) (1) IR. 
857
 Article 26 (A) (2) IR. On the issue of the medically justifiable time limit, see section III.2.2.1.C. 
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highly time-consuming, which is very likely to be disadvantageous for the patient in 
need of medical care. Therefore, the Union legislature implemented two provisions 
in favour of the patient to ensure the timely provision of the treatment. (1) Firstly, in 
the absence of a reply within the deadlines set by its national legislation, the 
authorisation shall be considered to have been granted by the competent 
institution.858 (2) Secondly, if the patient needs urgent vitally necessary treatment, 
and the authorisation cannot be refused in accordance with the second sentence of 
Article 20 (2) BR, the authorisation shall be granted by the institution of the place of 
residence on behalf of the competent institution, which shall be immediately 
informed by the institution of the place of residence.859  
Both solutions seek to avoid that the patient needs to wait for an administrative 
decision for an unreasonably long time. The first solution approximates to my idea 
on guaranteeing legal certainty for patients by setting a deadline or maximum 
processing time for administrative decision-making. Yet, instead of national 
processing times, I support the introduction of a universal, European deadline set out 
by the Regulation. The second solution was inspired by the Keller case,860 which is 
detailed infra. 
 
The administrative procedure can result either in granting the authorisation or in 
refusing the request for authorisation. However, after an authorisation has been 
granted, another crucial issue is the scope of the authorisation, namely where the 
limits lie of the entitlement covered by the authorisation issued by the competent 
                                                 
858
 Article 26 (A) (2) IR. 
859
 Article 26 (A) (3) IR. 
860
 C-145/03 Heirs of Annette Keller v Instituto Nacional de la Seguridad Social (INSS) [ECR 2005 
Page I-02529] The case concerned a German national, who resided in Spain and was affiliated to the 
Spanish healthcare system. While on a temporary visit in Germany, she was hospitalised and 
diagnosed with a malignant tumour, sufficiently serious to be likely to cause her death at any time. 
Since she wished to be able to continue receiving the medical treatment necessitated by the condition 
affecting her in Germany, Ms Keller requested authorisation from the Spanish competent institution. 
The authorisation was issued to her, because – taken due account to the serious nature of her state of 
health – a transfer to Spain was not advisable. Following numerous examinations and a thorough 
analysis of the various possibilities of treatment available, the doctors of the German hospital 
considered that, in view of its extremely delicate nature and the special expertise it required, the 
surgical operation which was immediately and vitally necessary for Ms Keller could only be 
performed in a specialised clinic in Switzerland. 
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Member State. The Keller case also served as a proper opportunity for the Court to 
take its stand on this question. In this case, the patient, who was entitled by the 
competent institution to receive medical care in Germany, was transferred and 
operated on in Switzerland due to the decision of the German doctors. The competent 
institution was reluctant to bear the costs of the treatment in the latter country, 
because in its opinion medical treatment provided in a non-member country would 
have required express permission, so the authorisation issued did not cover such an 
arrangement.861 The Court proved its commitment to the principle of shared 
responsibilities. From this principle it follows that by issuing a prior authorisation, 
the competent institution is dependent on the decision of the doctors authorised by 
the institution of the Member State of stay. They are called on to treat the insured 
person in that country, and the competent institution is obliged to accept and 
recognise the findings and choices of treatment made by them.862 Since the doctors 
established in the Member State of stay are clearly best placed to assess the state of 
health of the person concerned and the immediate treatment required by that state,863 
they are free to choose the treatment they find the most appropriate in accordance 
with the current state of medical knowledge, which also includes the possibility to 
choose to transfer the patient to another state where the treatment required can be 
provided.864 In this regard, it is not relevant whether that state is one of the Member 
States of the European Union.865 At the same time, the institution of the place of stay 
must keep the competent institution informed and provide it with the relevant data if 
                                                 
861
 C-145/03 Keller, 19. One may wonder though, whether the situation would have been different if 
Ms Keller had been operated on in another Member State. In my opinion, this was a very weak 
argument from the competent Member State. 
862
 C-145/03 Keller, 50. This can be considered as a confirmation of a finding which showed up 
several times in the case law of the ECJ: see by analogy, in the context of medical findings concerning 
the incapacity for work, C-22/86 Giuseppe Rindone v Allgemeine Ortskrankenkasse Bad Urach-
Münsingen [ECR 1987 Page 01339], 15; C-45/90 Alberto Paletta (I) and others v Brennet AG [ECR 
1992 Page I-03423], 28 and C-206/94 Brennet AG v Vittorio Paletta (II) [ECR 1996 Page I-02357], 
24-28. 
863
 C-145/03 Keller, 51. 
864
 C-145/03 Keller, 54. 
865
 C-145/03 Keller, 55. 
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it appears medically appropriate to supplement the treatment covered by the existing 
authorisation.866 
 
Although according to the settled case law the person concerned, provided with a 
prior authorisation, cannot be required to return to the competent Member State to 
undergo a medical examination there, when doctors authorised by the institution of 
the Member State of stay consider that his/her state of health requires urgent vitally 
necessary treatment,867 the competent institution must retain the right – at any time 
during the procedure granting the authorisation – to have the insured person 
examined by a doctor of its own choice in the Member State of stay or residence.868 
The latter issue opens up the question of fraud and abuse: what possibilities does the 
competent institution have if doubts are raised in relation to the medical findings on 
which the administrative decision is based. The Court dealt with the matter of abuse 
in its Paletta judgements.869 In Paletta I, the Court ruled that the competent 
institution is bound in fact and in law by the medical findings made by the institution 
of the place of residence or temporary residence, when it does not have the person 
concerned examined by a doctor of its choice, as it may do under the Coordination 
Regulations.870 This implies that if the competent institution does not exercise its 
right offered by the Regulations, it must rely on the institution of the place of stay or 
residence. However, as pointed out in this case, sometimes the competent institution 
is simply not able to make good use of this possibility,871 because it might not be 
aware of the insured person’s exact place of stay and even if it does know, the 
competent institution might not have any consultant doctor in the given area. 
                                                 
866
 Article 26 A (5) IR. 
867
 C-22/86 Rindone, 21; C-145/03 Keller, 56. 
868
 Article 26 A (4) IR. 
869
 C-45/90 Alberto Paletta (I) and others v Brennet AG [ECR 1992 Page I-03423] and C-206/94 
Brennet AG v Vittorio Paletta (II) [ECR 1996 Page I-02357]. Both decisions concerned the members 
of an Italian family who were employed in Germany and reported to have fallen sick while on a leave 
in another country. The competent institution (that happened to be their employer in this case) refused 
to provide benefits on the ground that it did not consider itself bound by the medical findings made 
abroad the veracity of which it had serious reasons to doubt. C-45/90 Paletta I, 2-4. 
870
 C-45/90 Paletta I, 28. See also C-22/86 Rindone, 15. 
871
 C-45/90 Paletta I, 26. This statement is all the more valid when the competent institution is not a 
social security authority, but an employer. 
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Nevertheless, when its opinion on fraudulent use of the coordination rules was 
expressly asked for in Paletta II, the Court reminded that Community law cannot be 
relied on for the purposes of abuse or fraud.872 If reasonable doubts are raised in 
relation to the veracity of the facts on which a prior authorisation is based, the 
Member States involved must cooperate in accordance with the procedure set out by 
Article 5 of the Implementing Regulation. Therefore, in order to fight and prevent 
fraud and abuse, it is essential that the competent institutions in the various Member 
States have direct contacts and support each other. 
 
If the competent institution refuses to provide the patient with a prior authorisation, 
the patient has the right to challenge the decision. The outcome of the review is 
either that the administrative decision of the first instance is affirmed and the 
authorisation denied, or that as a result of new facts (e.g. a deterioration in the 
claimant’s health status) or due to the re-assessment of the situation, the authorisation 
is granted. In this respect, the question had to be answered how it should be 
evaluated if the patient – after the refusal – in the meantime underwent the desired 
treatment abroad without an authorisation. The Vanbraekel case873 shed light on the 
Court’s position – among others – on post factum authorisation. Both here and in the 
Elchinov judgement,874 where the question appeared again, the Court firmly held that 
where the request of an insured person for authorisation has been refused by the 
competent institution and it is subsequently established, either by the competent 
institution itself or by a court decision, that that refusal was unjustified, that person 
is entitled to be reimbursed directly by the competent institution in an amount 
equivalent to that which it would ordinarily have borne if authorisation had been 
                                                 
872
 C-206/94 Paletta (II), 24. See also, in particular, (1) regarding the freedom to provide services, C-
33/74 van Binsbergen, 13; and C-23/93 TV10 SA v Commissariaat voor de Media [ECR 1994 Page I-
04795], 21; (2) regarding the free movement of goods, C-229/83 Association des Centres distributeurs 
Édouard Leclerc and others v SARL "Au blé vert" and others [ECR 1985 Page 00001], 27; (3) 
regarding the freedom of movement for workers, C-39/86 Sylvie Lair v Universität Hannover [ECR 
1988 Page 03161], 43; (3) and regarding the Common Agricultural Policy, C-8/92 General Milk 
Products v Hauptzollamt Hamburg-Jonas [ECR 1993 Page I-00779], 21. 
873
 See footnote 333. 
874
 See footnote 679. 
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properly granted in the first place.875 This case law provides the patients with the 
certainty that if they fulfil the conditions for planned care required by the Regulation, 
they are entitled to the permission and as a consequence to be reimbursed according 
to the coordination regime even if the competent authorisation refuses their 
authorisation first. However, as said above,876 due to several loopholes 
accompanying the conditions for planned care (e.g. unclearly defined benefit 
coverage or dilemmas in relation to the medically justifiable time limit), it is often 
not easy for the patients to guess whether they might fulfil the requirements. This 
way, obtaining treatment abroad without an authorisation in the hope that the 
authorisation will be granted a posteriori holds the risk that if the permission is not 
granted after all, the financial burden remains on the patient unless he/she can claim 
reimbursement under the Patient Mobility Directive. 
Most of the rules laid down by the Court were codified in the Patient Mobility 
Directive. At the same time, the Directive created its own, genuine authorisation 
system. 
 
(3) Interestingly enough, the authorisation scheme of the Patient Mobility 
Directive grew out of the idea that prior authorisation cannot be required in relation 
to healthcare services, because it constitutes a barrier to free movement.877 Soon it 
became clear though, that in certain cases prior authorisation is a necessary and 
justified measure, on the one hand because an uncontrollable patient flow has the 
potential to jeopardise healthcare planning and thus result in wastage of financial, 
technical and human resources and endanger the Member States’ healthcare systems 
                                                 
875
 C-368/98 Vanbraekel, 34; C-326/00 Ioannidis, 61; C-8/02 Leichtle, 55; C-145/03 Keller, 69; C-
173/09 Elchinov, 48. See also Anne Pieter VAN DER MEI (2002): Cross-Border Access to Health Care 
within the European Union: Some Reflections on Geraets-Smits and Peerbooms and Vanbraekel. 
Maastricht Journal of European and Comparative Law, Vol 9 Issue 2, p. 211. 
876
 On the conditions concerning planned care, see section III.2.2.1.C. 
877
 See footnote 326. See also Recital 38 of the Preamble of the Patient Mobility Directive and Article 
7 (8) PMD. 
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in general;878 and on the other hand because in some cases the patient’s safety is at 
stake.879 
The grounds of justification880 and the possible reasons for refusal881 are not analysed 
here again. The focus is set on the procedural requirements included in the Directive, 
which provides that the system of prior authorisation, including the criteria and the 
application of those criteria, and individual decisions of refusal to grant prior 
authorisation, shall be restricted to what is necessary and proportionate to the 
objective to be achieved, and may not constitute a means of arbitrary discrimination 
or an unjustified obstacle to the free movement of patients.882 It is apparent from the 
wording of the Directive that its aim is to limit the scope of prior authorisation 
schemes as much as possible. Whereas the European institutions tend to focus on 
keeping the requirement of authorisation as an ultima ratio, the Member States 
consider it as one of the last remaining fastnesses to protect their healthcare 
systems.883 The Member States might therefore implement the Directive in a way 
which allows them to use prior authorisation schemes permitted by the Directive to 
their full potential. Whether these measures will be accepted as necessary and 
proportionate884 is a question for the future. In regard to this, one may ask whether all 
the national measures which make healthcare subject to prior authorisation based on 
one of the justifying reasons incorporated in the Directive should necessarily be seen 
                                                 
878
 On the justification of prior authorisation schemes, see section III.2.2.1.C. See also Recital 40 of 
the Preamble of the Patient Mobility Directive. 
879
 Recital 43 of the Preamble of the Patient Mobility Directive. 
880
 Article 8 (2) PMD. This issue is detailed in section III.2.2.1.C. 
881
 Article 8 (6) PMD. This issue is detailed in section III.2.2.1.C. 
882
 Article 8 (1) PMD. 
883
 It can also be said that prior authorisation is looked at as a “means of restricting, or at least 
rationalizing, “exodus” from the national welfare system towards other Member States’ facilities.” 
Vassilis HATZOPOULOS and Thien Uyen DO (2006): The case law of the ECJ concerning the free 
provision of services: 2000-2005. Common Market Law Review, Vol 43, p. 941. 
884
 The requirement of the necessity and proportionality of the restricting measures is also rooted in 
the case law of the ECJ, which on several occasions held that the conditions attached to the grant of 
an authorisation must satisfy the requirement of proportionality [C-157/99 Geraets-Smits and 
Peerbooms, 82; C-385/99 Müller-Fauré and Van Riet, 83; C-372/04 Watts, 113-114; C-173/09 
Elchinov, 41] and that they must not exceed what is objectively necessary for that purpose and that 
the same result cannot be achieved by less restrictive rules [C-205/84 Commission v Germany, 29; C-
180/89 Commission v Italy, 18; C-106/91 Ramrath, 31; C-157/99 Geraets-Smits and Peerbooms, 75; 
C-385/99 Müller-Fauré and Van Riet, 68; C-8/02 Leichtle, 43; C-372/04 Watts, 106; C-444/05 
Stamatelaki, 34; C-173/09 Elchinov, 44]. 
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as proportionate. Are there really no less restrictive measures that can be applied 
which are able to achieve the objectives in a similar way? For instance, could a prior 
notification system885 not fulfil the same role? In a possible prior notification system 
the patient could unilaterally inform both the competent institution and the institution 
where he/she intends to obtain the treatment. This way both institutions could reckon 
with this need in their planning,886 and if concerns arise regarding to the protection of 
public health,887 the competent institution would be in charge of informing the 
patient about the risk, who would be free to consider whether he/she is willing to 
take the risk or not. 
The provisions which say that the administrative procedures shall be based on 
objective, non-discriminatory criteria888 and that they shall be easily accessible and 
capable of ensuring objectivity and impartiality889 are true reflections of the case 
law.890 Similarly, nothing new is added to the requirement that the decisions resulting 
from these procedures must be properly reasoned, subject to review and capable of 
being challenged in judicial proceedings.891 
However, an interesting new element is that the Directive expressly imposes the 
obligation on the Member States to deal with the requests for cross-border healthcare 
within a reasonable period of time. Moreover, these national standards of time must 
be made public in advance.892 Nevertheless, the problem is that this rule requires that 
the requests are – as the Directive phrases it – dealt with, not decided about within 
this timeframe. This difference is apparently not just a matter of word choice, but 
sets a deadline for the start of the administrative procedure, not for the end of it. Of 
course, it is important for patients to know that their requests enter the evaluation 
phase in due time, but it is even more important to know when they can expect the 
                                                 
885
 The idea of a prior notification system is included in the Directive, but only as a voluntary option 
to receive in return a written confirmation of the amount to be reimbursed. Article 9 (5) PMD. 
886
 Justifying reasons based on planning are included in Article 8 (2) (a) PMD. 
887
 Justifying reasons based on the protection of public health are included in Article 8 (2) (b)-(c) 
PMD. 
888
 Article 9 (1) PMD. 
889
 Article 9 (2) PMD. 
890
 See footnotes 850-852 and Table 13 supra. 
891
 Article 9 (4) PMD. See also footnote 853. 
892
 Article 9 (3) PMD. 
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result on which the reimbursement of medical costs depends. As I already 
mentioned, the introduction of a universal maximum processing time could greatly 
contribute to the protection of patients’ rights.893 
It is worth noting that the Directive requires the Member States to take into account 
three factors when considering a request, namely (a) the specific medical 
condition,894 (b) the urgency and (c) individual circumstances.895 It is most evident 
that the patient’s state of health influences the decision as well as the timeliness of 
the treatment. However, no reference is made to what those individual circumstances 
are that have to be assessed. They could be a whole range of things, such as the 
medical history, the refusal of former requests, the ability to carry out a professional 
activity or even non-health-related determinants. On this point, the Member States 
are free to decide which circumstances they want to include into their implementing 
laws. 
The above mentioned procedural requirements are categorised in Table 13 infra. 
 
Table 13: Requirements concerning a prior administrative authorisation scheme in accordance with 
the Patient Mobility Directive 
(1) Requirements concerning the 
system of PA in general 
necessary 
proportionate 
may not constitute a means of arbitrary discrimination 
may not constitute an unjustified obstacle to the free 
movement of patients 
(2) Requirements concerning the 
criteria of the assessment 
objective, non-discriminatory 
necessary and proportionate 
(3) Requirements concerning the 
procedural system 
easily accessible 
related information publicly available at the appropriate level 
capable of ensuring objectivity and impartiality 
requests must be dealt within a reasonable period of time 
the specific medical condition, the urgency and individual 
circumstances must be taken into account 
(4) Requirements concerning 
administrative decisions 
must be properly reasoned 
must be subject to review 
capable of being challenged in judicial proceedings 
Source: the author’s own summary 
                                                 
893
 See the idea of MPT earlier in this section. 
894
 Article 9 (3) (a) PMD. 
895
 Article 9 (3) (b) PMD. 
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There is an exceptional rule applicable to patients with rare diseases.896 When a 
patient affected, or suspected of being affected, by a rare disease applies for prior 
authorization, a clinical evaluation may be carried out by experts in that field.897 
Since one of the specificities of rare diseases is the scarcity of relevant knowledge 
and expertise,898 it is possible that there are no experts in the Member State of 
affiliation who are familiar with the rare disease in question, in which case it is 
highly advisable899 to seek scientific opinion in another Member State. In the course 
of this exercise, the newly invented European reference networks900 are supposed to 
play a significant role in the future.901 Through these provisions, the European Union 
took a small, but important step towards ensuring effective and efficient recognition, 
prevention, diagnosis, treatment, care, and research for rare diseases in Europe.902 
 
It must be admitted that the case law compliant codification of the procedural 
safeguards is indeed a step forward. However, the Directive does not do much more 
than that: it does not go “beyond the existing precedents in recognising additional 
rights for the patient.”903 Quite the contrary, by creating an authorisation mechanism 
parallel with the Coordination Regulations, it makes the European legal framework 
on cross-border patient mobility even more difficult to handle for the patients. Some 
potential sources of difficulties hiding in the legislation are scrutinised in the next 
section.  
                                                 
896
 Rare diseases are those that meet a prevalence threshold of not more than five affected persons per 
10000, in line with Regulation (EC) No 141/2000 of the European Parliament and of the Council of 
16 December 1999 on orphan medicinal products, and they are all serious, chronic and often life 
threatening. Recital 55 of the Preamble of the Patient Mobility Directive. 
897
 Article 8 (4) PMD. 
898
 European Commission: Communication from the Commission to the European Parliament, the 
Council, the European Economic and Social Committee and the Committee of the Regions on Rare 
Diseases: Europe's challenges. COM (2008) 679 final, 11. 11. 2008, p. 2. 
899
 It is not phrased in the Directive as an obligation, but rather as an opportunity for the Member 
States. 
900
 On the provisions related to European reference networks, see Article 12 PMD. 
901
 Article 13 (a) PMD. 
902
 COM (2008) 679 final, p. 3. 
903
 Stephanie DE LA ROSA (2012): The Directive on Cross-Border Healthcare or the art of codifying 
complex case law. Common Market Law Review, Vol 49, p. 34. 
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III.2.2.3. The complexity of the recent legal tools simultaneously applicable on 
European cross-border patient mobility 
What patients are likely to find very confusing about the Union’s legislation 
on cross-border patient mobility is that different legal tools (partly) cover the same 
issues (such as authorisation and reimbursement) and apply different rules to the 
same issues under their own, individual regimes. In the absence of a well-defined 
hierarchy among the simultaneously applicable legal institutions, patients can get lost 
easily in the labyrinth of legal provisions. This section aims to mark some of the 
main crossroads of this maze and attempts to offer an itinerary to find your way 
through. 
Many of the issues which are shared by or differ in the Regulations and the Directive 
were already discussed in the above sections. Therefore, here a comparative 
approach is used to highlight the discrepancies of the different legal tracks.904 Four 
(plus one) criteria of comparison are taken into account infra in this section, namely 
(1) objective and legal basis, (2) scope, (3) approach towards authorisation schemes 
and (4) administrative procedure. (5) The difference between the reimbursement 
regimes is touched upon only briefly, because their in-depth analysis is carried out in 
a separate chapter.905 After the comparison the relationship of the two pillars of 
patient mobility are examined. 
 
(1) As already said,906 the mechanisms of the Coordination Regulations and 
the Patient Mobility Directive, which is based on the case law of the Court, emerged 
from different ideas, and are thus rooted in different legal bases. Whereas (a) the 
Coordination Regulations were adopted in accordance with Article 48 of the 
                                                 
904
 The main focus is certainly on the differences between the Coordination Regulations and the 
Patient Mobility Directive, but reference is made also to those points where the Directive diverges 
from the case law. 
905
 On the financial regimes, see Chapter IV. 
906
 On the co-existence of different legal tools in the field of European cross-border patient mobility, 
see section III.1.3.4. 
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Treaty907 to enhance the free movement of workers and to ensure that they do not 
lose social entitlements while using their right to move freely within the Union,908 (b) 
the baseline for both the case law and the Patient Mobility Directive has been that 
healthcare constitutes a service within the meaning of the Treaty909 and therefore any 
restriction of healthcare provision is considered a barrier of the free movement of 
services910 unless properly justified.911 Both the underlying logic and the legislative 
competence are different in the two fields. 
While analysing questions that fall under the broad scope of healthcare, a principle 
that cannot be overlooked is that the organisation and the delivery of healthcare in 
the European Union primarily belong to the responsibility of the Member States.912 
Therefore, each time a European legal tool is dealt with, the question will be posed 
whether the Union has the legislative power to rule the field concerned. 
(a) The competence question is rather simple to answer for the Coordination 
Regulations where the Treaty expressly assigns the legislative bodies of the Union to 
adopt measures in the field of social security as are necessary to provide freedom of 
movement for workers.913 The Regulations target to ensure access to healthcare for 
insured persons in various situations914 through the logic of coordination,915 and thus 
lacks the slightest attempt to intervene into the Member States’ national social 
security legislations. Instead, it provides supranational rules which connect the 
national systems. This mechanism undoubtedly facilitates the free movement of 
persons in today’s Europe and has great contributions for border-crossing patients as 
well. However, it does not necessarily cover each cross-border patient movement916 
and limits the patient flow by posing rather rigid conditions to be met.917 
                                                 
907
 Article 48 TFEU was numbered as Article 42 TEC and was originally codified as Article 51 in the 
Treaty of Rome. See also footnote 260. 
908
 On the aim of the coordination of social security schemes within the EU, see section III.1.3.3. 
909
 See footnote 325. 
910
 See footnote 326. 
911
 See footnote 327. 
912
 Article 168 (7) TFEU. See also footnote 245-246 and 256. 
913
 Article 48 TFEU. 
914
 On the various legal scenarios, see section III.2.2.1. 
915
 On the coordination as a legislative mechanism, see section III.1.3.1. 
916
 One of its defects is that private healthcare provision falls outside of its scope. 
917
 These conditions are dealt with in detail in section III.2.2.1. 
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(b) For the Directive, the answer to this question is less clear-cut. The Directive itself 
refers to two different provisions of the Treaty as its legal bases. On the one hand, it 
points at Article 114 on the approximation of laws, which provides the EU 
institutions with a permission to adopt measures for the approximation of the 
provisions laid down by law, regulation or administrative action in Member States 
which have as their object the establishment and functioning of the internal 
market.918 This provision is a clear reflection of the revolutionary innovation of the 
patient mobility case law, which puts healthcare services in the territory of the free 
movement of services.919 The question whether healthcare can be considered a 
service under Union law has triggered heated discussions both on political and 
academic level.920 Among the various components of this debate, there is also an 
aspect related to legislative competence. Whereas in the field of social security the 
latitude of the Union is limited to coordination measures, in the field of service 
provision it is allowed to harmonise national rules. Not surprisingly, the Member 
States did react very negatively to the activist approach of the Court921 and labelled 
                                                 
918
 Article 114 (1) TFEU. 
919
 On the approach of the Court, see section III.1.3.4., especially footnote 302. The Directive itself 
argues that Article 114 is the appropriate legal basis since the majority of the provisions of this 
Directive aim to improve the functioning of the internal market and the free movement of goods, 
persons and services. Recital 2 of the Preamble of the Patient Mobility Directive. The Directive also 
adds that while recognising their specific nature, all types of medical care fall within the scope of the 
TFEU. Recital 6 of the Preamble of the Patient Mobility Directive. 
920
 There has not been a full agreement on whether the special characteristics of healthcare services lift 
them out of the circle of services of an economic nature. See footnote 20. Even within the Court, there 
have been different views. A good example is AG Ruiz-Jarabo Colomer’s opinion in Geraets-Smits 
and Peerbooms, who went as far as to question whether the treatment provided by medical 
practitioners and health-care institutions may be regarded as a service within the meaning of the 
Treaty, in view of the fact that the person for whom the service is provided does not receive it in 
return for remuneration. Opinion of AG Ruiz-Jarabo Colomer delivered on 18 May 2000 in C-157/99 
B.S.M. Geraets-Smits v Stichting Ziekenfonds VGZ and H.T.M. Peerbooms v Stichting CZ Groep 
Zorgverzekeringen, 26. 
On the same day another AG opinion was delivered in Vanbraekel. Similarly to AG Ruiz-Jarabo 
Colomer, AG Saggio – in conjunction with the opposing governments – argued that the findings in the 
C-263/86 Humbel case in relation to publicly funded education should be applied to public healthcare 
schemes and services which, on the one hand, are an integral part of the public health-care system, in 
the sense that they are established and organised by the State, and, on the other hand, are financed by 
public funds, must be excluded from the provisions on freedom of movement. Opinion of AG Saggio 
delivered on 18 May 2000 in C-368/98 Abdon Vanbraekel and Others v Alliance nationale des 
mutualités chrétiennes, 21. 
921
 The preoccupation of the Member States can “be appreciated by the fact that all the (old) Member 
States have occasionally intervened in the proceedings before the Court in this field, and essentially 
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the patient mobility case law as an “unwarranted incursion into Member State’s 
autonomy to organise their social security system.”922 So although both the case 
law923 and the Directive924 confirm that they do respect the Member States’ national 
competencies in organising and delivering healthcare, they very likely erode the 
national health powers by extending Union competence beyond the boundaries of 
national healthcare legislations. 
The Directive also refers to Article 168 of the Treaty on public health. In my opinion, 
this is where the Patient Mobility Directive’s true added value for patients lies. It 
exceeds the ‘hard core’ social security topics such as access to healthcare and 
financing, and takes some – maybe a little dispirited – steps towards the creation of a 
‘common healthcare area’ within the European Union. Although there is still a long 
way to go in order to achieve the latter, the initiatives, such as the creation of 
European reference networks,925 the recognition of prescriptions926 and cooperation 
on eHealth innovations,927 are heading into a right direction. However, the European 
institutions do not have very powerful entitlements in most of these matters, so their 
action is mainly limited to supporting national activities and to facilitating 
cooperation. As a consequence, although many of these provisions can be considered 
                                                                                                                                          
with positions opposed to those finally adopted by the Court.” HATZOPOULOS and DO (2006: 937.). 
OBERMAIER supports this statement with numbers: he counted in total 74 observations from the 
Member States in the first ten patient mobility cases. Andreas J. OBERMAIER (2008): Fine-tuning the 
Jurisprudence: The ECJ’s Judicial Activism and Self-restraint. Institute for European Integration 
Research, Working Paper No. 02/2008, http://eif.univie.ac.at/downloads/workingpapers/wp2008-
02.pdf (21 March 2014), p. 24. 
922
 MURPHY (2011: 552.) See similarly KACZOROWSKA (2006: 352) “The issue arises whether the 
Court of Justice, when it decided that medical services provided in the context of national social 
security schemes were within the scope of Articles 49 and 50 EC, extended the scope of the 
fundamental principles of the internal market beyond acceptable limits, and thus encroached on the 
sovereign powers enjoyed by Member States.” 
923
 See footnote 323. 
924
 Article 1 (1) PMD. 
925
 Article 12 PMD. 
926
 Article 11 PMD. See on this issue Rita BAETEN and Lorena SAN MIGUEL (2013): Cross-border 
recognition of medicines prescriptions: Results from a mystery shopping experiment. Eurohealth, Vol 
19 No 4 . 
927
 Article 14 PMD. 
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innovative and valuable, they cannot be expected to ensure prompt benefits on the 
patients’ side.928 
As a conclusion, it is worth underlining that whereas the Social Security 
Coordination Regulations do not intend to achieve more than ensuring smooth access 
to healthcare for those who practice their right to move freely within the Union, the 
Patient Mobility Directive ‘engages into a competition’ with the Regulations in the 
social security issues by stating that patients must be considered as recipients of 
services on the common market. Yet, it also regulates some public health issues to 
enhance cross-border care which are not touched by the Regulations. 
 
 (2) The former point already shed light on the fact that the scope of the two 
tools is different. The Coordination Regulations cover the whole spectrum of social 
security, not only healthcare benefits, whereas besides individual healthcare matters 
the Directive infiltrates public health as well. The point is that the two instruments 
have a common zone which they share and both impose rules on. However, they do 
so according to different philosophies, in different ways. Therefore, it is important to 
clarify where the borders lie within this shared area. Concerning the scope, two 
factors can be identified which are regulated differently, namely (a) to which type of 
healthcare the legal tools apply and (b) to which healthcare providers the legal tools 
apply. 
(a) The Regulations coordinate – among other social security branches929 – sickness 
benefits both in cash and in kind. Concerning healthcare, however, their scope 
focuses on three situations, namely when insured persons reside outside of the 
country where they are covered by the national healthcare scheme,930 when insured 
                                                 
928
 This is not true for all of the public health provisions in the Directive. For instance, the obligation 
of the Member States to ensure that prescriptions issued in another Member State are recognised 
results in an instant development to patients’ social protection. Article 11 PMD. In order to ensure the 
uniform application of this provision of the Patient Mobility Directive, another Directive was adopted, 
namely Commission Implementing Directive 2012/52/EU of 20 December 2012 laying down 
measures to facilitate the recognition of medical prescriptions issued in another Member State. OJ L 
356 of 22 December 2012. See Dirk VAN DEN STEEN (2013): Cross-border health care: Common 
rules on medical prescriptions when travelling to another EU country. Eurohealth, Vol 19 No 4. 
929
 See footnote 288. 
930
 Article 17-18 BR, Article 24 IR. 
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persons temporarily stay outside of the country where they are covered,931 and when 
insured persons travel into another Member State with the express purpose to receive 
healthcare in that country.932 The Directive, however – as its title shows – deals 
solely with cross-border healthcare, meaning that neither other social security 
benefits, nor cash benefits are dealt with. The Directive intends to break with the 
strict – and not always clear933 – categorisation of the Regulations and thus imposes 
rules on cross-border healthcare934 in general.935 This implies that the same rules 
govern all of the above mentioned situations, since each healthcare provision is 
considered service provision within the Union legislation. This might seem as 
providing greater freedom for the patients, but as shown supra, applying the same 
rules for instance to planned and unplanned care might result in controversial 
situations.936  
(b) A similar difference of approach can be seen also in relation to the question 
which healthcare providers are covered by the different legal tools: the Regulations 
are more restrictive than the Directive, which intends to broaden the scope. Whereas 
under the Coordination Regulations healthcare can be received only from providers 
within the statutory system,937 the Patient Mobility Directive requires the Member 
States to reimburse medical costs occurred both at private and public providers.938 
This is also an important development in patients’ protection, since before the 
adoption of the Directive they could not expect any reimbursement for treatments 
obtained outside the public system. This is thus one of the scenarios where the 
Directive is obviously more advantageous for the patient than the Regulations. 
                                                 
931
 Article 19 BR, Article 25 IR. 
932
 Article 20 BR, Article 26 IR. 
933
 On the problematic cases related to the distinction between necessary care and planned care, see 
section III.2.2.1.B. 
934
 On the definition of cross-border healthcare, see footnote 135. 
935
 It must be noted, though, that certain health-related services are expressly excluded from the 
material scope of the Patient Mobility Directive, such as long-term care, organ transplantation and 
vaccinations. Article 1 (3) PMD. 
936
 See the relation of necessary care and prior authorisation under the Directive in section III.2.2.2.B. 
937
 PENNINGS (2011:426.). 
938
 Article 1 (2) PMD. 
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To sum up, while both planned and unplanned care are covered by both instruments, 
healthcare provided by non-contracted healthcare providers is covered only by the 
Patient Mobility Directive. 
 
 (3) One of the most visible discrepancies between the two tracks of patient 
mobility is their relation to prior authorisation for medical treatments. The issue of 
authorisation was indeed the crucial point when the Court departed from the 
Regulations towards a new path of patient mobility, which does not require prior 
authorisation for health services. The Court has never asseverated that the Regulation 
itself restricts the freedom of service provision. Nevertheless, in the Kohll 
judgement939 it declared a national legislation – which was in line with the 
Regulation940 – being in violation of Community law by making the reimbursement 
of the costs of a health service subject to prior authorisation.941 
This duplicity still exists. Whereas the principle of the Coordination Regulation is 
that planned healthcare abroad must be approved by the competent institution,942 the 
Directive – in conformity with the case law – is driven by the idea that authorisation 
is required only in exceptional cases listed in the Directive.943 These exceptions, 
which must be interpreted restrictively, concern situations in which overriding 
reasons of general interest, such as planning objectives and the protection of public 
health, justify the limitation of the free movement of services.944 
The legal tools concur on the point that a request for prior authorisation cannot be 
refused (or must be issued) when two criteria are conjunctively met, namely that the 
patient is entitled to the healthcare in question and that it cannot be provided to 
him/her in a medically justifiable time limit.945 A slight difference is that whereas the 
Regulation takes the benefit basket of the Member State of residence as a basis to 
decide whether the patient is entitled to the treatment concerned, the Directive refers 
                                                 
939
 See footnote 303. 
940
 C-158/96 Kohll, 25. See also footnotes 614 and 615. 
941
 C-158/96 Kohll, 54. 
942
 Article 20 (1) BR. 
943
 Article 8 (2) PMD. 
944
 See section III.2.2.1.C. 
945
 Article 20 (2) BR and Article 8 (5) PMD. 
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to the benefit package of the Member State of affiliation, which is not necessarily the 
Member State of residence. Also, the Directive – codifying the case law – describes a 
longer list of factors which must be taken into account when assessing the length of 
the medically justifiable time limit.946 However, the exact definition of medically 
justifiable time limit is still lacking, which leaves room for different interpretations 
on the Member States’ side. Introducing a universal maximum waiting time would 
therefore considerably decrease national discretion on this point. 
 
(4) The main source of complexity with regard to the administrative 
procedures is that both the Regulations and the Directive have their separate 
procedures, with their own set of administrative requirements, documents to fill in 
and attach, and administrative steps to follow. It is very crucial for patients to be 
aware of all the relevant information on the procedures themselves, their entitlements 
under the two legal tools and the implications of the outcomes of these procedures. 
For instance, it is of utmost importance to inform the patient what the difference is 
between being granted prior authorisation under the Regulations or under the 
Directive. 
First of all, the Member States were not obliged but permitted to introduce a prior 
authorisation procedure for treatments obtained in accordance with the Patient 
Mobility Directive. This means that those Member States which opted for no 
authorisation scheme947 had to set up a reimbursement procedure only when 
implementing the Directive. However, those countries which chose to use the 
opportunity to restrict patient movements had to decide on the new authorisation 
system. In its Guidance note,948 the Commission suggested to the Member States to 
consider whether they wish to create one unified system of prior authorisation, which 
                                                 
946
 See under section III.2.2.1.C. Moreover, the Directive regulates legitimate reasons of refusal which 
are not included in the Regulations. 
947
 For instance, the Czech Republic decided not to set up an authorisation procedure when 
implementing the Directive. On the Czech implementation, see the presentation of Sarka POLAKOVA 
at AIM Cross-Border Healthcare Workshop. See footnote 522. 
948
 See footnote 562. 
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deals with requests for authorisation under both the Regulations and the Directive, 
or whether they have two separate systems.949  
In my opinion, the patients’ best interest is to have an administrative procedure 
which is easily accessible, quick, transparent and as simple as possible. Therefore, I 
would support the introduction of an integrated administrative scheme, in which the 
patients can get all the necessary information and can make all the necessary 
arrangements at the same time. I think that the national contact points, which have 
been designed to provide patients with information about cross-border healthcare, are 
the best positioned to play the main role in this integrated system and act as 
mediators between the patient and the other parties (insurers, providers) involved. A 
unified authorisation system would enable the patients to benefit from the most 
advantageous option to obtain healthcare abroad. Similarly, from the patients’ point 
of view it would be highly desirable to define a universal maximum procedural time, 
which would set a limit to the circuitous administrative processes. 
 
(5) The enumeration of the differences between the various paths of patient 
mobility and of the sources of complicacy would not be complete without referring 
briefly to the discrepancy between the reimbursement regimes. Since the regimes are 
analysed in the next chapter, the main point I would like to highlight here is that both 
the level and the mechanism of reimbursement are genuinely different in the 
Regulations and in the Directive. Whereas – in principle – the Regulations offer a 
reimbursement of medical costs up to the level of the costs in the Member State of 
treatment and prioritise inter-institutional reimbursement, under the Directive 
reimbursement can be claimed up to the level of cost coverage in the Member State 
of affiliation and patients need to advance the medical costs. Thus, the latter might 
put a considerable financial burden on the patient, who must be aware of the nature 
of reimbursement in advance. 
 
                                                 
949
 AC 246/12, p. 8. 
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After this comparison, which is briefly summarised in Table 14 infra, the following 
question presents itself: how do these pieces of the legislative puzzle fit together? 
What is the current relationship of the two (plus one)950 pillars of patient mobility, 
and how could it be developed in favour of the patients? 
Instead of stating that the Regulation is inconsistent with the Treaty, the Court 
emphasised in its case law that the mechanisms included in the Regulations and in 
the case law complement each other. This attitude can be seen in the Directive as 
well, which unambiguously states in its Preamble that for patients the two systems 
should be coherent; either this Directive applies or the Union regulations on the 
coordination of social security systems apply.951  
When observing the current relationship of the Regulations and the Directive, Article 
2 (m) of the Directive should be taken as a starting point, which indicates that the 
Directive should apply without prejudice to the Coordination Regulations. This 
implies that they are parallelly applicable and that there is no priority between them. 
One may wonder, though, whether it is good that there is no hierarchy between the 
two instruments. From the patients’ point of view, the order of priority is rather 
simple, since if the conditions of the Regulations are met, more favourable rules 
apply both to the level and to the mechanism of reimbursement. This fact is – at least 
partly – acknowledged by the Directive, which provides that with regard to requests 
for prior authorisation made by an insured person with a view to receiving cross-
border healthcare, the Member State of affiliation shall ascertain whether the 
conditions laid down in the Coordination Regulation have been met. Where those 
conditions are met, the prior authorisation shall be granted pursuant to that 
Regulation unless the patient requests otherwise.952 It is worth pointing out that this 
provision looked slightly different in the Commission’s original proposal. It was 
                                                 
950
 It must be kept in mind that despite the Directive’s intention to codify the case law, the case law 
still exists, is applicable and is expected to be developed by the Court in the future. PENNINGS warns 
that „the risk exists that the Directive will be overruled by new case law […] since there are 
differences between the approach of the Court and the Directive.” PENNINGS (2011: 436.). Similarly, 
MURPHY is on the opinion that „the case law of the CJEU will continue to be of relevance for 
„mobile” patients.” MURPHY (2011: 557.). 
951
 Recital 30 of the Preamble of the Patient Mobility Directive. 
952
 Article 8 (3) PMD. 
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phrased as follows: when the circumstances under which an authorisation to go to 
another Member State in order to receive appropriate treatment under the 
Coordination Regulation must be granted are met, the provisions of that Regulation 
shall apply and the provisions of this Directive shall not apply.953 To my 
understanding, there are two points where the change of the wording adversely 
affects the patients.  
(1) On the one hand, the current wording of the Directive refers to requests 
for prior authorisation made by an insured person, indicating that if the request is 
not submitted in advance, like in the case of necessary care954 or post-factum 
authorisation,955 there is no obligation to apply the more beneficial rules of the 
Regulation. 
(2) On the other hand, the adopted version of the Directive puts the choice 
into the hands of the patients by saying that the rules of the Regulation must be 
applied unless the patient requests otherwise. This provision would be fully 
acceptable if patients could be expected to act as informed customers, one hundred 
per cent aware of their entitlements, possibilities, options to choose from and the 
consequences of their choice. Can this be expected from today’s cross-border 
patients in the current circumstances? Doubts can be raised here.956 Moreover, one 
might wonder in which case it would be more advantageous to apply the Directive’s 
regime, if the Regulation can be applied too. If the Regulation cannot be applied, 
then of course the Directive might offer a solution for the patient, but if the insured 
person is entitled under both legal instruments, I see no reason why not to pinpoint 
that the Regulation has an absolute priority as it is more beneficial for the patient. 
This does not exclude that the patients could still be provided with the right to 
expressly refuse to use the Regulation’s mechanism for instance in the case of 
planned outpatient care, which can be obtained without prior authorisation in 
                                                 
953
 Article 3 (2) of the Proposal for the Patient Mobility Directive, COM (2008) 414. 
954
 See section III.2.2.2.B. 
955
 See section III.2.2.2.C. 
956
 JORENS and LHERNOULD (2013: 30.). 
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accordance with the Directive, if they confirm that they are aware of the implications 
of this decision on their entitlements. 
 
Table 14: Discrepancies between the simultaneously existing mechanisms of European cross-border 
patient mobility 
 Coordination Regulations Patient Mobility Directive 
Legal base Article 48 TFEU (ex Article 42 TEC) in 
the framework of free movement of 
workers 
Article 114 TFEU (ex Article 95 TEC) 
on the approximation of laws in the 
field of the functioning of the internal 
market 
Article 168 TFEU (ex Article 152 TEC) 
on public health 
Material scope sickness benefits in kind in various 
legal scenarios 
cross-border healthcare (long-term care, 
organ transplantation and vaccination 
programmes against infectious diseases 
are expressly excluded) 
providers within the statutory system providers within and outside of the 
statutory system 
Approach 
towards 
authorisation 
in the case of planned care, PA must 
always be requested 
compulsory grant of authorisation: if 
the benefit is included in the benefit 
package of the MS of residence, but 
cannot be provided within a medically 
justifiable time limit 
principle: cross-border healthcare 
cannot be made subject to PA 
exception: PA scheme justified by an 
overriding reason of general interest 
refusal may be based on justified 
reasons listed in the PMD, among 
which a request can be refused if the 
benefit is included in the benefit 
package of the Member State of 
affiliation and can be provided within a 
medically justifiable time limit 
Administrative 
procedures 
separate or unified authorisation procedures 
(in certain MSs no authorisation procedures under the Directive’s regime) 
Reimbursement 
mechanism 
reimbursement up to the level of cost 
coverage in the MS of treatment 
complemented, where appropriate, up 
to the level of cost coverage in 
competent MS 
inter-institutional reimbursement 
reimbursement up to the level of cost 
coverage in the MS of affiliation 
patients advance the costs 
The current 
relationship 
between the 
Regulations 
and the 
Directive 
no clear priority between the Regulations and the Directive 
With regard to requests for prior authorisation made by an insured person with a 
view to receiving cross-border healthcare, the Member State of affiliation shall 
ascertain whether the conditions laid down in the Coordination Regulation have 
been met. Where those conditions are met, the prior authorisation shall be granted 
pursuant to that Regulation unless the patient requests otherwise. 
Source: the author’s own summary 
 
As to the possible further development of the legal framework on European patient 
mobility, I firmly believe that the duplicity of the legislation must be ceased, since – 
for now – it is a very complex structure, where the interrelations of the legal tools are 
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challenging to handle both for the patients and for the other participants (healthcare 
authorities, insurers, providers etc). In my opinion, there are two options to deal with 
this problem. 
 (1) A less radical solution is what was suggested above and which is basically 
what the Commission originally intended to codify into the Directive, namely that 
with rather small changes a clear hierarchy could be established which focuses on the 
patient’s best interest and obliges the Member States to automatically apply the more 
beneficial provisions of patient mobility from the patients’ point of view.957 
 (2) However, in my opinion, a more drastic change is needed and one set of 
rules should be applicable to European border-crossing patient movements, 
implemented into one single legal instrument. The rules, which are currently 
included in various legislative instruments, are not to be evaluated separately, since 
they aim to regulate the same phenomenon. My idea is to genuinely simplify this 
system by erasing each and every overlapping issue from the Patient Mobility 
Directive and incorporating them into the Coordination Regulations.958 Nevertheless, 
the Directive should remain and further concretise the public health aspects of patient 
mobility; those would not interfere in the Regulation rules. 
 
In my view, the integrated patient mobility legislation should synthesise the high 
level of protection provided by the Regulations and the more liberal approach of the 
Directive. The establishment of the integrated system in the framework of the 
Regulations would solve the problem of diverse transposition in the various Member 
States and enable the European institutions to monitor the application of the rules 
more easily. Last, but not least, a mono-track system – especially if combined with 
an accessible and patient-friendly network of national contact points – would 
                                                 
957
 See also PENNINGS (2011: 446-447.). 
958
 The core of this idea is not a recent one. The inclusion of the case law into the Coordination 
Regulations occurred both when the new set of Regulations was drafted (See section III.1.3.4., 
especially footnotes 357 and 358.) and after healthcare services were excluded from the Services 
Directive. See WISMAR et al. (2011b: 5-6.) The attempts failed and left room for the adoption of the 
Patient Mobility Directive. The idea appeared also in course of the dialogue in the Administrative 
Commission. AC 332/11, p. 6. 
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significantly decrease the legal uncertainty and administrative burden on the patients’ 
side.959 
  
                                                 
959
 The idea of an integrated legal and financial system is elaborated as a part of my de lege ferenda 
suggestions in Chapter VI. 
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III.2.3. Conclusion 
It was already affirmed that European patients are legally entitled to receive 
medical treatment outside of the Member State of residence within the EU, if they 
fulfil certain conditions required by EU legislation. The main finding of this 
extensive subchapter on the realisation of access to healthcare across borders is that 
although the right to cross-border care is granted, in practice European patients 
encounter serious difficulties when they intend to exercise this right. 
 
While mapping the current obstacles of cross-border patient movements, two areas of 
hurdles were identified, namely practical complications (geographical distance, a 
language gap and a lack of information) on the one hand, and legal complications 
(legal complexity and administrative burden) on the other. 
Concerning the obstacles of a non-legal nature, it was concluded that the need to 
have access to the nearest healthcare provider is mostly satisfied by cross-border 
contracting techniques and an increasing number of cross-border cooperation, and 
this trend should be continued. A solution for the matter of the language barrier is 
currently lacking, since the problem is not even addressed on European level, thus 
both the burden and the costs in relation to translation and interpretation lies with the 
patients. The patients’ information rights were strengthened by the Patient Mobility 
Directive, but collecting all the relevant information a border-crossing patient might 
need still constitutes a challenge. Whereas the language barrier demands an original 
solution on Union level, the patients’ awareness could be effectively raised by 
empowering the network of national contact points and using their potential more 
efficiently. 
Concerning the obstacles of a legal nature, it was found that the different legal routes 
based on different legal bases have been functioning next to each other for numerous 
years and the joint application of these systems continued to raise questions. 
Although years of political debate and public consultation lead to the adoption of a 
new piece of legislation, the Patient Mobility Directive was rightfully designated to 
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be “one of the most controversial pieces of European healthcare legislation in recent 
years,”960 which left many questions unanswered. I would even go so far as saying 
that it raised some additional questions. I see the solution to the core of this problem 
in a pair of interrelated arrangements. On the one hand, the more patient-friendly 
coordination mechanism is to be strengthened and liberalised by opening up the 
system for private providers as well and by reinforcing the monitoring of the 
application of the Regulations’ rules. On the other hand, the duplicity of the 
legislation is to be ceased by erasing the overlapping social security issues from the 
Directive, which would keep governing the – rather innovative, but still improvable – 
public health-related questions of cross-border healthcare, while the social security 
issues would be united under the scope of the Coordination Regulations. The one-
track system would not only bring transparency and simplicity, but would take due 
account of the patient’s best interest by insuring timely administrative decisions 
based on an objective assessment of clear legal conditions. 
 
In the next two, shorter chapters two further fields of potential problems are 
scrutinised briefly, namely the financing of cross-border healthcare and the issue of 
the timely provision of healthcare. 
  
                                                 
960
 JELFS and BAETEN (2011: 8, 30.). 
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IV. FINANCING MEDICAL TREATMENT ABROAD 
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Financing healthcare is one of the main concerns of patients.961 Therefore, 
special attention must be paid to the financial aspect of cross-border patient 
movements. Although financing can be seen as another practical obstacle (namely 
the financial affordability of cross-border healthcare) and the legislation of the 
reimbursement schemes as another legal obstacle (namely the accessibility of 
reimbursement for cross-border medical costs), the dedication of a brief but separate 
chapter to these issues aims to emphasise their utmost importance in patients’ 
decisions. 
In this chapter, the main question to be answered is how cross-border medical 
treatments can be financed based on the healthcare entitlements of the patients in the 
Member State of affiliation. 
 
As described above, in this chapter, three of the research questions962 are 
investigated: 
(1) Which alternatives do European patients have to cover the costs of medical 
treatment abroad? 
(2) Which conditions must be met in order to guarantee that cross-border 
healthcare is covered by the patient’s health insurance? How can the patients 
get reimbursed under the current legal mechanisms in the European Union? 
(3) How might the financial regimes affect European patient movements? 
  
                                                 
961
 According to a recent survey that was monitoring the reasons behind unmet needs for healthcare 
within the European Union, “(i)n the EU27, on average, 30% of those reporting an unmet need for 
medical treatment or examination referred to the cost of the examination ot treatment as the reason 
for this. […] Significantly more people in the EU12 cited costs as the reason (40%) than in the EU15 
(25%). In almost half of Member States (13 out of 27), the cost of treatment was the most important 
single reason for unmet need and in 9 of them (Belgium, Greece, Italy, Portugal, Ireland, Bulgaria, 
Cyprus, Latvia and Romania) around half or more referred to this as the main reason. In Romania 
almost three-quarters of those with an unmet need cited the treatment being too costly.” WARD and 
OZDEMIR (2012: 9-10.). 
962
 See section I.2. 
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IV.1. FINANCIAL ARRANGEMENTS AS A MATTER OF CONCERN IN CROSS-
BORDER HEALTHCARE SITUATIONS 
 When a patient receives healthcare in his/her ‘normal setting’, in the Member 
State where he/she resides, and is familiar with the healthcare system and aware of 
the basic functioning of that system, he/she is more or less confident about when, 
how much and under what procedure he/she may expect to need to pay for 
healthcare. However, healthcare financing structures, as well as healthcare systems in 
general,963 vary greatly between the various Member States of the Union.964 
Consequently, if the patient obtains healthcare abroad, the question of financing 
instantly pops up. At the same time, the level of medical costs and especially cost-
sharing arrangements can motivate patients to obtain healthcare in another country965 
where the prices imposed on patients are more beneficial.966 
 
There are numerous methods of financing medical costs which might play a role in 
cross-border situations. Below, the following such methods are further scrutinised: 
(1) out-of-pocket payments, (2) payments through specialised insurance for 
travelling purposes and (3) payments through healthcare schemes. 
                                                 
963
 See footnote 258. 
964
 On general models of healthcare financing, see KARNER (2008). On healthcare financing in the 
Member States of the European Union, see among others Manfred HUBER (1998): Health Care 
Financing in European Union Member States. An Initial Perspective Based on Recent OECD Work on 
Overall Social Trends. In Reiner LEIDL (ed.): Health Care and its Financing in the Single European 
Market. Amsterdam: IOS Press, pp. 59-71 and Sarah THOMSON, Thomas FOUBISTER and Elias 
MOSSIALOS (2009): Financing health care in the European Union: Challenges and policy responses. 
Copenhagen: World Health Organization, pp. 23-48. The examination of the different financing 
schemes is beyond the scope of this dissertation. 
965
 On the determinants of cross-border patient movements, see section II.1.2. supra. 
966
 “Cost-sharing […] is an important consideration for patients […]; predictably, patients’ cost-
sharing requirements are given as a reason for the existence of cross border arrangements only in a 
handful of ‘other arrangements’, e.g. where providers attract patients from other countries where the 
services in question require significant cost-sharing and where providers can offer them considerably 
cheaper than in the home country (prime example: dental care in Hungary for patients from Austria). 
Policy-makers need to be aware that such a diversion of care to other countries may increase 
inequities as those most suffering from cost-sharing can often not afford travel costs.” BUSSE et al. 
(2006: 5). 
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(1) Out-of-pocket payments should be understood as those situations where 
the patient uses his/her own financial means to pay for healthcare services abroad 
without the perspective of reimbursement. This usually is the case if the patient lacks 
healthcare coverage within a statutory system or intends to ‘buy’ a medical treatment 
which is not included in the benefit basket provided for by the competent Member 
State (e.g. dental treatments, cosmetic surgical interventions).967 These patients are 
certainly free to receive the treatment of their choice in the Member State of their 
choice if the treatment requested is available in that country.968 Since this healthcare 
service consumption is independent from the social security coverage, neither the 
Coordination Regulations, nor the social security provisions of the Patient Mobility 
Directive apply. However, these patients can also benefit from those provisions of 
the Directive which affect cross-border patients in general, such as rules on 
information rights and Member States’ responsibilities969 or cross-border 
cooperation.970 
 
 (2) Travellers’ insurance is a unique combination of insurance services971 
designed especially for travelling purposes. Since these insurance constructions 
usually contain a medical coverage element, they can also be considered as an 
alternative to finance healthcare costs abroad, although they only cover the costs of 
necessary treatments. The exact scope and level of healthcare coverage is specified in 
the insurance contract itself. 
Compared to the current solutions of the European legislation for reimbursement of 
necessary care, travellers’ insurance has the advantage that it may offer a broader 
                                                 
967
 For these purposes voluntary health insurance schemes may also serve as a satisfying solution. On 
private health insurance, see among others Alan MAYNARD and Anna DIXON (2002): Private health 
insurance and medical savings accounts: theory and experience. In MOSSIALOS et al. (2002) and Elias 
MOSSIALOS and Sara M. S. THOMSON (2002): Voluntary health insurance in the European Union. In 
MOSSIALOS et al. (2002). The examination of the private health insurance schemes is beyond the 
scope of this dissertation. 
968
 On the issue of availability, see section II.1.2. supra. 
969
 Chapter II PMD. 
970
 Chapter IV PMD. 
971
 Most travellers’ insurance packages include – for instance – emergency medical and evacuation 
assistance, non-stop assistance service, and cover the costs of lost, stolen or damaged baggage, 
cancellation and travel delay, and legal and funeral expenses. 
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scale of services than the patient’s health insurance. For example, numerous health 
insurance schemes exclude benefits for health injuries related to extreme sports from 
their scope,972 which would leave the patient unprotected against such risks. An 
appropriate travellers’ insurance on the other hand can fill this gap. Furthermore, this 
private insurance can provide coverage in the event of an EHIC refusal,973 a 
requirement of co-payment or the usage of private medical facilities. Consequently, 
the role of travellers’ insurance – although mostly supplementary – is important for 
European cross-border patients. 
 
(3) Healthcare schemes all over Europe – irrespective of how they are 
organised and financed974 – do have extraterritorial elements such as the 
reimbursement of costs of healthcare obtained abroad.975 However, within the 
framework of European legislation, each Member State applies different rules on 
cost coverage for cross-border medical care. Therefore, the next section aims to 
discuss those common rules which impose a universal reimbursement obligation on 
the Member States. 
  
                                                 
972
 This is the case – among others – in Hungary. In 2007, a new law implemented a – heavily 
attacked – provision into the Ebtv., resulting in the exclusion of any benefits provided in connection to 
accidents which occurred in the course of extreme sport activities from statutory healthcare financing. 
Article 18 (6) (e) Ebtv. 
973
 On the refusal of EHICs, see section III.2.2.2.B. 
974
 On the categorisation of European healthcare schemes, see footnote 258. 
975
 On the matter of territoriality, see section III.1.3. 
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IV.2. REIMBURSEMENT MECHANISMS FOR CROSS-BORDER 
HEALTHCARE COSTS UNDER CURRENT EUROPEAN LEGISLATION 
It is an old, well-known (and proven) cliché that money makes the world go 
round. This is equally true for healthcare systems: healthcare budgets constitute a 
fundamental unit of national budgets,976 so anything which has the potential to 
genuinely affect healthcare expenditures, is a politically sensitive area. Not 
surprisingly, when the first cases of cross-border patient mobility ended up before the 
European Court of Justice,977 the Member States did not hold back from expressing 
their concerns about the correspondence between free patient movements and 
possibly increasing healthcare costs, which holds the risk of seriously undermining 
the financial balance of the social security system.978 The Court eased the tension by 
introducing a new reimbursement regime which gradually differs from the 
Coordination Regulations’ financing mechanism and has no effect on the financing 
or balance of the social security system.979 This dichotomy still exists, since the 
Court’s solution lives on in the Patient Mobility Directive. However, it must be 
recognised that “the demarcation line between these two systems of legislation 
appears to have been blurred by the Community legislature”980 since certain findings 
of the Court made their way into the Regulations. 
Nevertheless, the distinctness of the financing mechanisms under the different legal 
tools profoundly defines the patients’ legal status and their capacity and willingness 
                                                 
976
 On recent data on national healthcare expenditure, see Eurostat (2013): European social statistics. 
2013 edition. Luxembourg: Publications Office of the European Union, 
http://epp.eurostat.ec.europa.eu/cache/ITY_OFFPUB/KS-FP-13-001/EN/KS-FP-13-001-EN.PDF (2 
April 2014), pp. 88-91. 
977
 See section III.1.3.4. 
978
 C-120/95 Decker, 39-40; C-158/96 Kohll, 38-42. On the same matter, see also C-368/98 
Vanbraekel, 47; C-157/99 Geraets-Smits and Peerbooms, 72; C-385/99 Müller-Fauré and Van Riet, 
73-74; C-145/03 Keller, 68; C-372/04 Watts, 103; C-444/05 Stamatelaki, 30; C-173/09 Elchinov, 42; 
C-490/09 Commission v Luxemburg, 43. 
979
 Ibid. 
980
 Opinion of AG Mergozzi in C-211/08 European Commission v Kingdom of Spain [ECR 2010 
Page I-05267], 71. 
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to use their cross-border healthcare rights, making it reasonable to examine those two 
reimbursement systems alongside the case law. 
IV.2.1. The financial regime of the Coordination Regulations 
The basic idea behind the Coordination Regulations is to protect the European 
migrants’ acquired social rights and facilitate their free movement within the Union. 
In order to fulfil this mission in the field of cross-border healthcare, the Regulations 
are based on the principle that the costs of medical treatments provided by the 
Member State of residence or of temporary stay must be fully reimbursed by the 
competent Member State.981 Notably, notwithstanding that the health contributions 
were paid in accordance with the legislation of the competent Member State, since 
the hosting Member State’s rules apply to the healthcare provision,982 the costs are 
calculated in accordance with the tariffs of the latter country.983 
 
The reimbursement procedure between the institutions involved can take place in 
various forms, namely (1) reimbursement based on actual costs, (2) reimbursement 
based on fixed amounts (lump-sum) 984 and (3) a mutual waiver agreement.985 
(1) Firstly, the financial transfer can be based on proof of the actual 
expenditure as shown in the accounts of the institution that provided the healthcare 
benefits in kind.986 This claim for a refund must be introduced to the debtor Member 
State (competent Member State) within 12 months of the end of the calendar half-
                                                 
981
 Article 35 (1) BR. See also Paragraph 1 of the Preamble of Decision No S4 of the Administrative 
Commission for the Coordination of Social Security Systems of 2 October 2009 concerning refund 
procedures for the implementation of Articles 35 and 41 of Regulation (EC) No 883/2004 of the 
European Parliament and of the Council. OJ C 106 of 24 April 2010. 
This has been repeatedly confirmed also by the Court. See C-368/98 Vanbraekel, 33; C-56/01 Inizan, 
20; C-145/03 Keller, 66; C-372/04 Watts, 126. 
982
 Article 17, 19 (1), 20 (2) BR. 
983
 See footnote 544. 
When a MS imposes relatively low health contributions and is obliged to pay the bill of a medical 
treatment provided in a MS with high medical costs, this can mean a serious burden for the health 
financing system of the former state. 
984
 Article 35 (2) BR. 
985
 Article 35 (3) BR. See also C-326/00 Ioannidis, 54. 
986
 Article 62 (1) IR. 
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year during which those claims were recorded in the accounts of the creditor 
institution (in the Member State of the healthcare provision).987 In principle, the 
claims must be paid within 18 months of the end of the month during which they were 
introduced to the institution of the debtor Member State.988 It must be underlined at 
this point that higher rates than those applicable to the benefits concerned in the 
Member State of treatment may not be taken into account in the reimbursement.989 
This rule is another reflection of the ever-present equal treatment principle.990 
(2) Secondly, if the first method is not appropriate,991 reimbursement can be 
made on the basis of fixed amounts.992 In this case, the inventory shall be presented 
to the debtor Member State by the end of the year following the reference year, and 
the claims based on this inventory shall be introduced as soon as possible following 
the publication in the Official Journal of the European Union of the annual fixed 
amounts per person, but latest within the 12-month period following the month 
during which the average costs for the year concerned were published.993 Here as 
well, the claim must be paid to the creditor by the debtor within 18 months of the end 
of the month during which it was introduced.994 
(3) Thirdly, the Regulation allows the Member States to agree on any other 
method of reimbursement or the institutions involved can even mutually waive all 
reimbursements coming under their jurisdiction.995 
 
Although claims for reimbursement between the Member States concerned have to 
be made as promptly as possible, similarly the Member States are obliged to 
reimburse claims as soon as possible.996 It can be deduced from the above time 
                                                 
987
 Article 67 (1) IR, see also Article 1 of AC Decision S4. 
988
 Article 67 (5) IR, see also Article 1 of AC Decision S4. 
989
 Article 62 (3) IR. 
990
 See footnote 550. 
991
 The Member States claiming the reimbursement of the cost of benefits in kind on the basis of fixed 
amounts are the following: Ireland, Spain, Cyprus, the Netherlands, Portugal, Finland, Sweden and the 
United Kingdom. This list can be found in Annex III IR. 
992
 Article 35 (2) BR. 
993
 Article 67 (2) IR, see also Article 6 of AC Decision S4. 
994
 See footnote 988. 
995
 Article 35 (3) BR. 
996
 Article 66 (1) IR. 
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limits, that even if the institutions meet the deadlines set up by the Regulations,997 the 
procedures are very lengthy; 998 it can easily take years before a claim is settled. This 
problem – although it mostly manifests itself between the institutions – has an 
adverse effect on patients as well. They are the innocent third party here suffering the 
consequences of the system malfunctioning. Delayed payments and non-payments 
might drive providers to behaviour that is not compliant with EU law, such as not 
accepting EHICs and inviting patients to pay the invoice directly999 instead of a 
posterior reimbursement by the debtor institute. These practices not only diminish 
the patients’ rights but endanger the fruitful cooperation between the Member States 
and – in the long run – question the sustainability of the coordination mechanism.  
In my view, the only way to reverse this tendency is to urge – if needed to pressurise 
– the competent institutions to settle the claims more promptly, without delay and to 
monitor the application of the Regulations’ rules more closely. 
 
On the one hand, the implementation of the equal treatment principle guarantees 
equal rights for migrants compared to the nationals of the State of the treatment as 
though they were insured there.1000 On the other hand, however, it creates equal 
obligations.1001 Thus, if the nationals bear or advance all medical expenses or a 
certain part of them in the Member State of treatment, this legislation applies to the 
migrants as well; so they are also obliged to pay for the treatment in question. This 
might be especially unusual and unfavourable for those who are insured in a benefit-
in-kind system, where they obtain the treatments free of charge. They may find 
                                                 
997
 If the creditor does not meet the deadline to introduce the claim, the claim will not be considered 
(Article 67 (5) IR), whereas if the debtor does not meet the deadline to pay the claim, interest can be 
charged by the creditor (Article 68 (1) IR). 
998
 In the Proposal for the Implementing Regulation, the Commission stood up for the setting of 
shorter deadlines, but due to the requirement of unanimity in the Council, those suggestions failed in 
the course of the negotiations. See European Commission: Proposal for a Regulation of the European 
parliament and of the Council laying down the procedure for implementing Regulation (EC) No 
883/2004 on the coordination of social security systems. COM (2006) 16 final, 31. 01. 2006, Article 
66 on pp. 43-44. 
999
 On the ill-application of the EHIC, see section III.2.2.2.B. and especially footnote 815 and Table 
10. 
1000
 On the full integration idea, see footnote 550. 
1001
 Article 4 BR. 
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themselves in a highly uncomfortable situation if they do not get a line on the local 
system applied in the Member State of stay in advance. Therefore, it is very 
important that both the Member States and the European institutions use all possible 
ways and tools at their disposal to raise patients’ awareness of their rights and 
obligations.1002 
 
Although the basic full reimbursement principle is the same,1003 the Regulations 
provide special procedural rules on reimbursement for (1) necessary care and (2) 
planned care. These are briefly outlined hereinafter. 
 
 (1) In the above mentioned situation, when the patient has actually borne the 
costs of all or part of the necessary healthcare services during a temporary stay, and 
the legislation of the Member State of stay enables the reimbursement of those costs, 
the patient has two options to meet the medical expenses: the insured person may (a) 
claim reimbursement at the institution of the place of stay,1004 or (b) send an 
application for reimbursement directly to the competent institution.1005 In both cases 
the costs have to be reimbursed directly to the person concerned in accordance with 
the rates laid down by the legislation of the Member State of stay1006 and without 
exceeding the total cost of the care borne by the patient.1007 The possibility to claim 
reimbursement at the institute of the place of stay is an especially beneficial rule 
from the patients’ point of view, because it can considerably shorten the time before 
the patient receives the reimbursement. In contrast, if the request is submitted to the 
                                                 
1002
 On the information rights of patients, see section III.2.1.3. 
1003
 See footnote 981. 
1004
 Article 25 (B)(4) IR. 
1005
 Article 25 (B)(5) IR. 
1006
 It is doubtful, though, whether the competent institutions really refund occasional care 
accordingly. For instance, the trESS European Report 2013 shed light on a Belgian practice which – 
in certain cases – “deprives insured persons of the possibility to obtain reimbursement in accordance 
with the legislation of the country of stay;” it is thus not “in keeping with the provisions of the 
Coordination Regulations.” JORENS and LHERNOULD (2013: 29.). 
1007
 Article 25 (B)(8) IR. If the patient agrees or if the MS of stay does not provide for reimbursement 
in the case concerned, the competent institution may undertake the reimbursement of the costs 
incurred within the limits of and under the conditions of the reimbursement rates laid down in its 
legislation. Article 25 (B) (6)-(7). 
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competent institution, the coordination arrangements between the institutions in the 
different Member States which aim at defining the amount of the reimbursement 
might take longer. However, the patient might prefer to take the necessary 
administrative steps in the competent Member State, where he/she is more familiar 
and thus comfortable with the system. 
Furthermore, in the case of substantial expenditure, the Implementing Regulation 
offers the legal opportunity to request an appropriate advance from the competent 
institution.1008 It is nevertheless problematic that no guidelines are given in the 
legislation about what should be considered substantial expenditure, and that the 
institutions are not obliged to provide an advance, but are free to do so. 
Nevertheless, the above mentioned provisions do not change the fact that the 
competent institution must fully reimburse all the costs incurred in the institution 
providing the healthcare1009 in accordance with the procedure detailed supra. 
 
 (2) Concerning the reimbursement of the costs of scheduled treatment, the 
Implementing Regulation took over two remarkable points from the case law. It 
implemented (a) on the one hand the so-called Vanbraekel supplement and (b) on the 
other hand the obligation to reimburse ancillary costs. 
(a) In the Vanbraekel judgement1010 the applicable tariffs were the focus, since in this 
case, the tariffs applied by the Member State of treatment (France) were lower than 
the ones in the Member State of affiliation (Belgium).1011 Consequently, the question 
was raised which scheme had to be applied as a basis for the calculation of the 
amount reimbursed and whether the patient can also claim extra reimbursement to 
cover the difference between the two systems.1012 Although the then rules of the 
Coordination Regulations did not have the further effect of requiring such additional 
reimbursement;1013 from the Treaty rules on the free movement of services the Court 
                                                 
1008
 Article 25 (B)(9) IR. 
1009
 Article 35 BR and Article 62 IR. 
1010
 See footnote 333. 
1011
 C-368/98 Vanbraekel, 17. 
1012
 C-368/98 Vanbraekel, 35. 
1013
 C-368/98 Vanbraekel, 37. 
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deduced that the fact that a person has a lower level of cover when he receives 
hospital treatment in another Member State than when he undergoes the same 
treatment in the Member State in which he is insured may deter, or even prevent, that 
person from applying to providers of medical services established in other Member 
States and constitutes, both for insured persons and for service providers, a barrier 
to freedom to provide services.1014 Since such additional reimbursement does not 
impose any additional financial burden on the competent Member State and thus 
cannot be liable to have a significant effect on the financing of the social security 
system, the restriction of the free movement of services cannot be properly 
justified.1015 Consequently, the Court held that additional reimbursement covering 
the difference must be granted to the insured person by the competent institution.1016 
This finding of the Court was codified in Article 26 (B) (7) of the Implementing 
Regulation, which is rather unexpected taking into account that the Court made this 
conclusion by interpreting the rules on freedom of services and that the Member 
States had been reluctant to incorporate the case law into the Regulations.1017 
Therefore, this rule seems a bit extraneous in the Coordination Regulation, which 
serves to facilitate the free movement of persons. Even if the difference of legal 
bases1018 is set aside, the nature of this provision remains controversial. On the one 
hand, as VAN DER MEI says, the right to additional reimbursement “must be 
welcomed, because it promotes cross-border access to health care without imposing 
any additional financial burden on Member States and their sickness funds.”1019 On 
the other hand, though, the provision of the Vanbraekel supplement breaks with the 
full integration theory1020 of the Regulations and does thus not comply with the 
principle of equal treatment.1021 As pointed out earlier in this section, the principle of 
equal treatment implies that both the rights and obligations of migrant persons and 
                                                 
1014
 C-368/98 Vanbraekel, 45. 
1015
 C-368/98 Vanbraekel, 52. 
1016
 C-368/98 Vanbraekel, 53. See also C-173/09 Elchinov, 78; C-512/08 Commission v France, 51. 
1017
 On this matter, see section III.1.3.4. and especially footnote 349. 
1018
 On the difference of legal bases, see section III.2.2.3. 
1019
 VAN DER MEI (2002: 212). 
1020
 See footnote 550. 
1021
 See footnote 550 and 1001. 
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nationals of the Member State concerned are equal. Under the current Union 
legislation, the right to additional reimbursement enables cross-border patients to 
receive a refund for co-payments if the level of the cost coverage is higher in their 
Member State of insurance, whereas the domestic patients in the Member State of 
stay cannot claim reimbursement for those expenses. As a result, reverse 
discrimination occurs,1022 because the migrants are in a more favourable situation 
than non-migrants. Moreover, even within the group of migrants, there is a difference 
between the legal status of persons obtaining planned care abroad who have the right 
to additional reimbursement and of persons receiving occasional care abroad to 
whom the Regulation does not grant the right to additional reimbursement.1023 
 
(b) When obtaining medical treatment outside of the patient’s catchment area, the 
incurred costs exceed the stricto sensu medical costs; the patient must also reckon 
with the expenses related to travelling and accommodation, not only for him/herself 
but also for the accompanying persons if there are any. As a result, the Court was 
asked in the Leichtle case1024 how the Member States should treat these costs with 
                                                 
1022
 There is reverse discrimination when non-mobile patients enjoy a lower level of social protection 
than mobile patients. How could this unfair situation be solved? Of course, national law must comply 
with Union law, so eroding the rights of cross-border patients is not an option. A fair and legally 
correct solution could be “to upgrade the legal position” of the “sedentary” patients to match that of 
mobile ones or to reconsider the Union law provision in question. See RENNUY (2011: 316.). 
1023
 See also PENNINGS (2011: 435.). 
In its judgement in C-211/08 Commission v Spain, the Court acknowledged that the cases of 
unscheduled and scheduled treatment must be distinguished in this respect. (58, 60) The Court points 
out in its reasoning that the patient – in many cases, when the need for healthcare arises unexpectedly 
– is not in the position to compare the medical costs of the two Member States involved and the 
circumstances leave no alternative but to provide the insured person with hospital treatment in the 
Member State of stay. (64) The Court agrees with the Commission’s argument that in certain cases the 
deterioration in the insured person’s health during a temporary stay in another Member State is not 
such as to deprive him or her of the choice between going to hospital in that state and an early return 
to the state of affiliation to receive the necessary hospital treatment there. (66) Nevertheless, it held 
that the non-provision of complementary reimbursement in case of unplanned care (as it was the case 
in the Spanish legislation) is not regarded as a restriction on cross-border healthcare services, and so it 
does not breach EU law. (72) 
1024
 Case C-8/02 Ludwig Leichtle v Bundesanstalt für Arbeit [ECR 2004 Page I-02641]. 
Mr Ludwig Leichtle, a German civil servant, requested confirmation from the competent institution 
that the expenditure associated with a health cure which he proposed to take at Ischia, in Italy, would 
be covered. His request was rejected on the ground that the care provided in Italy did not offer much 
greater prospects of success than the health cures available in Germany. Mr Leichtle underwent the 
thermal cure anyway and brought a legal action against the decision of the competent institution. 
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regard to cross-border patient movements. The Court confirmed that expenditure in 
connection with board and lodging can be regarded as forming an integral part of 
the health cure itself1025 and that although ancillary costs, such as travel costs and 
visitor’s tax are not medical in character, and are not as a rule paid to health care 
providers, they none the less appear to be inextricably linked to the cure itself.1026 
Still, it cannot be inferred from these findings that the competent institution is 
required to reimburse these additional expenses in each case; the Court lays down a 
duty to apply the equal treatment principle and to grant reimbursement if such duty 
exists when these costs arise from movements within the Member State.1027 The 
Implementing Regulation echoes this rule in Article 26 (C) (8), imposing the 
obligation on the competent institutions to assume the costs of travel and stay which 
are inseparable from the treatment of the insured person both for that person and for 
the accompanying person, if the national legislation provides for the reimbursement 
of such costs. 
 
To sum up,1028 the Coordination Regulations’ financial regime is built upon the 
principle of full reimbursement between the institutions involved. As a rule, the 
patient cannot be required to advance the medical costs unless the nationals of the 
Member State of stay do the same. In the latter case, reimbursement can be claimed 
either in the Member State of treatment or the competent Member State. The 
institutions of the Member States must cooperate closely and settle the claims as 
quickly as possible. This, however, is often not the case, which recoils on the patients 
themselves as well.  
                                                                                                                                          
See on this case, André DEN EXTER (2005): Patient Mobility in European Union: Health Spas in 
Ischia, Italy. Croatian Medical Journal, Vol 46 Issue 2, pp. 197-200. 
1025
 Case C-8/02 Leichtle, 33. 
1026
 Case C-8/02 Leichtle, 35. 
1027
 C-372/04 Watts, 139-140; C-466/04 Acereda Herrera, 38. 
1028
 The basic points of the different financial regimes are compared in Table 15 infra. 
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IV.2.2. The financial regime of the Patient Mobility Directive 
As a result of the interpretation of the Treaty rules on the free movement of 
services, the reimbursement of medical costs in relation to cross-border healthcare 
has always stood on a different footing than the Coordination Regulations. Already 
in the first judgements, the Court insisted that reimbursement must be provided in 
accordance with the tariffs of the State of insurance; this way, cross-border patient 
movements – even if they were not authorised in advance – have no effect on the 
financial equilibrium of the Member State concerned.1029 
The Patient Mobility Directive follows the same approach and provides that the costs 
of cross-border healthcare shall be reimbursed or paid directly by the Member State 
of affiliation up to the level of costs that would have been assumed by the Member 
State of affiliation, had this healthcare been provided in its territory without 
exceeding the actual costs of healthcare received.1030 This rule, however, does not in 
any sense prevent the Member State of affiliation from reimbursing the full cost of 
the treatment, if it exceeds the level of reimbursement calculated on the basis of 
domestic tariffs.1031 If the Member States use this opportunity and transpose the 
Directive accordingly, it is a real advantage for border-crossing patients. If not, 
however, this financing mechanism proves to be less attractive for patients who come 
from countries with relatively low tariffs and intend to obtain healthcare in a Member 
State with higher medical prices, because the difference between the incurred costs 
and the reimbursed costs remains at the expense of the patient.1032 
 
In regard to the ancillary costs, the Patient Mobility Directive (1) partly erodes, (2) 
partly upgrades patients’ legal status in comparison to the case law. (1) On the one 
hand, not making it obligatory to reimburse those costs inextricably linked to the 
                                                 
1029
 See footnote 978. 
1030
 Article 7 (4) PMD. Reimbursement may never lead to the enrichment of the patient. 
1031
 Article 7 (4) PMD. See also C-120/95 Decker, 29; C-158/96 Kohll, 27; C-368/98 Vanbraekel, 36; 
C-56/01 Inizan, 19; C-466/04 Acereda Herrera, 34. 
1032
 “Some reports express concerns about the flow of patients between countries with ‘high fees’ and 
countries with ‘low fees’ and towards countries providing excellent medical care.” JORENS and 
LHERNOULD (2013: 30.). 
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treatment abroad can be seen as a step backwards; whereas (2) on the other hand, 
extending the scope of the reimbursement of additional costs to persons obtaining 
necessary care, and expressly including the extra costs which persons with 
disabilities might incur due to one or more disabilities when receiving cross-border 
healthcare1033 are relevant improvements. Still, the lack of a compulsory nature 
results in a very vague guarantee for the patients, which is not in line with the case 
law of the Court. This is one of those critical points of the Directive which 
apparently do not comply with the findings of the Court1034 and can thus be easily 
overruled by new case law.1035 For example, if a Member State provides 
reimbursement for travel costs in accordance with its national law to patients 
travelling for treatment within the country, the case law – on the ground of equal 
treatment – imposes the obligation to do the same if the travel is related to cross-
border healthcare.1036 As a result, if this Member State – while implementing the 
Directive – did choose not to reimburse ancillary costs, as it has the freedom to 
decide so, the patient can challenge this provision in a judicial proceeding. 
In my opinion, the wording of Article 7 (4) of the Directive concerning the 
reimbursement of additional costs is incorrect and should be altered and expressly 
guarantee the equal treatment of domestic and cross-border patients, similar to the 
corresponding article of the Coordination Regulations.1037 Even more so, since the 
next paragraph of the same article allows the Member States to adopt provisions in 
accordance with the TFEU aimed at ensuring that patients enjoy the same rights 
when receiving cross-border healthcare as they would have enjoyed if they had 
received healthcare in a comparable situation in the Member State of affiliation. 
However, this provision also only gives the Member States permission instead of 
                                                 
1033
 The European Parliament demanded in its first reading of the Proposal to make this provision 
mandatory, but it was not supported by the Council. See Article 6 (3) of European Parliament: 
European Parliament legislative resolution of 23 April 2009 on the proposal for a directive of the 
European Parliament and of the Council on the application of patients' rights in cross-border 
healthcare. P6_TA (2009) 0286, 23. 04. 2009. 
1034
 See footnote 1027. 
1035
 See footnote 950. 
1036
 See section IV.2.1. and especially footnote 1027. 
1037
 Article 26 (C) (8) IR. 
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imposing the obligation on them to apply the principle of equal treatment with 
domestic patients. 
In my view, the two dimensions of equal treatment are equally important and should 
be safeguarded by European legislation, by the Patient Mobility Directive in this 
case. Whereas (1) the non-discrimination between domestic patients and patients 
coming from other Member States is satisfyingly ensured in the Directive,1038 (2) the 
equal treatment between patients obtaining domestic healthcare services and those 
who share the same nationality but use their cross-border healthcare rights is left to 
the discretion of the Member States. This aspect of non-discrimination should be 
improved further. 
 
The principle of equal treatment plays a crucial role in the Directive’s financing 
mechanism for two reasons: it is applied both in relation to (1) the chargeable 
healthcare fees and (2) the eligibility criteria and administrative formalities. 
(1) Besides the above mentioned general requirement of non-
discrimination,1039 the Directive specifies that Member States shall ensure that the 
healthcare providers on their territory apply the same scale of fees for healthcare for 
patients from other Member States, as for domestic patients in a comparable medical 
situation, or that they charge a price calculated according to objective, non-
discriminatory criteria if there is no comparable price for domestic patients.1040 This 
rule undoubtedly offers cross-border patients an important guarantee that they cannot 
be required to pay higher healthcare fees than the nationals of the Member State 
                                                 
1038
 The principle of non-discrimination with regard to nationality shall be applied to patients from 
other Member States. Article 4 (3) PMD. 
However, there is one exception to the general application of non-discrimination on the ground of 
nationality, namely Member States are free to adopt measures regarding access to treatment aimed at 
fulfilling their fundamental responsibility to ensure sufficient and permanent access to healthcare 
within their territory if those measures are justified by overriding reasons of general interest. This 
provision opens up the door for restricting arrangements based on rather vaguely defined arguments, 
so that even the wish to control costs might be enough to reason such a limitation. See footnote 748. 
However, the Member States’ latitude is narrowed down by the requirements that such measures shall 
be limited to what is (1) necessary and (2) proportionate and (3) may not constitute a means of 
arbitrary discrimination and (4) shall be made publicly available in advance. 
1039
 See footnote 1038. 
1040
 Article 4 (4) PMD. This provision does not deprive the healthcare providers of the right to set their 
own prices, as long as they do it without discriminating against foreign patients. 
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where they obtain a treatment.1041 However, the phrasing of this provision evokes 
some questions, such as (a) what the expression ‘in a comparable medical situation’ 
means and (b) how the Member States can monitor and enforce the application of 
this rule. 
(a) From the point of view of the Directive’s financial regime it is a fundamental 
question whether there is a price list for medical treatments calculated in advance. If 
there is, the fees applicable to domestic patients can be invoiced to cross-border 
patients, if they are in a comparable medical situation. One may wonder whether this 
implies that they should have the same diagnoses or whether they can only be 
considered being in a comparable medical situation if they receive exactly the same 
treatment. At the same time, the price a domestic patient is required to pay does not 
only necessarily depend on his/her medical status but also on his/her insurance status 
and entitlements. How could this be taken into account while calculating the price for 
cross-border patients? Should foreign patients be treated as uninsured domestic 
patients? If there are different scales for domestic patients, can foreign patients be 
automatically charged the highest one? Since the healthcare financing systems are 
highly different in the Member States of the Union, it is far from simple to create a 
harmonised reimbursement system for medical costs. In this respect, the obligation to 
apply the principle of non-discrimination between domestic and foreign patients is a 
good first step, but the issue in question calls for further elaboration.1042 
If there is no price list for domestic patients, then the only requirement is that the 
calculation of the fee must be based on objective and non-discriminatory criteria.1043 
                                                 
1041
 PENNINGS (2012: 445.) This can also be seen as codification of the Court’s findings, since in C-
411/98 Ferlini, the Court declared that the unilateral application to patients not affiliated to the 
domestic healthcare schemes of scales of fees for medical care (which in this case occurred in relation 
to the birth of Mr Ferlini’s child in Luxembourg, who was employed by the European Commission, 
thus – together with his family – affiliated to the Joint Scheme) which are higher than those applicable 
to residents affiliated to the national social security scheme constitutes discrimination on the ground 
of nationality prohibited under the provisions of the Treaty, in the absence of objective justification in 
this respect. C-411/98 Angelo Ferlini v Centre hospitalier de Luxembourg [ECR 2000 Page I-08081], 
62. See also STRBAN (2013: 399.). 
1042
 Interestingly enough, the Guidance note of the Commission (AC 246/12) does not even touch 
upon this subject. 
1043
 Article 4 (4) PMD. 
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(b) Another concern is whether the same-tariff rule can be enforced in practice. In 
the case of contracted providers, putting a monitoring system into operation should 
be possible. However, it is still doubtful “whether healthcare providers will be 
willing to charge lower prices (negotiated with home health insurance providers) for 
non-referred cross-border patients.”1044 Monitoring the pricing policy of private, 
non-contracted providers seems to be even more challenging. 
If each provider could be required to publish a list of prices of the treatments it 
provides, that would clarify this question and would allow patients to calculate the 
fee they can expect. However, setting up such a list might prove to be difficult in 
certain healthcare schemes.1045 Nevertheless, even if there is not an exhaustive list of 
medical fees, Member States shall have a transparent mechanism for calculation of 
costs of cross-border healthcare that are to be reimbursed to the insured person by 
the Member State of affiliation.1046 Furthermore, the cost calculation mechanism 
shall be based on objective, non-discriminatory criteria known in advance and 
applied at the relevant administrative level.1047 
 
 (2) Whereas the same-tariff rule is related to non-discrimination between 
foreign and domestic patients, the issue of equality of eligibility criteria and 
administrative formalities again concerns the other dimension of equal treatment, 
namely between patients affiliated to the same Member States using their cross-
border healthcare rights and the ones who are not using them. The Directive 
authorises the Member States to make the reimbursement of medical costs subject to 
the same conditions, criteria of eligibility and regulatory and administrative 
                                                 
1044
 STRBAN (2013: 399.). 
1045
 On the one hand, also under the Regulation’s regime, healthcare providers – irrespective of 
operating within a reimbursement, a benefit-in-kind or a national health service type of system – have 
introduced claims indicating the price of the treatments provided for cross-border patients. So – in 
theory – it is not impossible to set up such kind of price lists. On the other hand, the reimbursement 
mechanism within the coordination system is different from the one in the Directive and is not always 
based on the actual expenditures. On this matter, see section IV.2.1. See also PENNINGS (2012: 443-
444.). 
1046
 Article 7 (6) PMD. 
1047
 Ibid. It is up to the Member State of affiliation to determine whether reimbursement is provided at 
a national, regional or national level. Article 7 (3) PMD. 
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formalities as they would impose if the healthcare were provided in their 
territory.1048 The fulfilment of eligibility criteria and certain administrative 
formalities, such as a gatekeeping scheme, functions in many countries. What the 
Directive says is that in order to get reimbursement border-crossing patients might be 
required to go through all the same steps when obtaining healthcare abroad as they 
would when receiving the healthcare in the Member State concerned. For instance, if 
there is a referral system in place in the Member State of affiliation, patients need to 
be able to present a referral. Otherwise reimbursement can be legitimately denied on 
the ground of non-fulfilment of the administrative formalities. These conditions and 
formalities must nevertheless be non-discriminatory and must not constitute an 
obstacle to free movement.1049 
Although as a main rule, under the Directive’s regime, patients are required to pay 
for the medical treatments upfront, the Directive nevertheless offers the possibility 
for the Member States to choose to apply the mechanisms of financial compensation 
between the competent institutions as provided for by Regulation (EC) No 
883/2004.1050 If a Member State decides not to use the Regulations’ reimbursement 
mechanisms, it is then required to ensure that patients receive reimbursement 
without undue delay.1051 In my opinion, this provision is very unclear and cannot 
safeguard patients’ right to a timely reimbursement. It would be all the more 
desirable to fix a maximum – appropriately short and enforceable – deadline for 
reimbursement to avoid legal uncertainty and diverse national implementation. At the 
same time, for the sake of clarity and a speedy settling of claims, a deadline should 
be set also for the patients for introducing the claim to the Member State of 
affiliation. 
 
The conclusion can be drawn that the Directive followed the tracks of the case law of 
the Court and introduced a reimbursement system which enables border-crossing 
                                                 
1048
 Article 7 (7) PMD. 
1049
 Ibid. See STRBAN (2013: 400.). 
1050
 Article 9 (5) PMD. 
1051
 Ibid. 
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patients to claim reimbursement – in principle – up to the level of domestic tariffs in 
the Member State of affiliation, while they pay the same scale of medical fees as the 
patients affiliated to the Member State of treatment. Under the Directive’s regime, 
the patient advances the medical costs. 
This concisely summarised financing mechanism shows some gradual differences in 
comparison with the Coordination Regulation. Therefore, the next section is 
dedicated to a brief critical analysis of their discrepancies from the patients’ point of 
view. 
IV.2.3. European reimbursement regimes as an obstacle to cross-border patient 
mobility 
As already discussed, the Coordination Regulations and the Patient Mobility 
Directive substantially differ from each other.1052 One of the most outstanding 
differences is the financing of cross-border medical treatments (these differences are 
outlined in Table 15 infra). After the examination of both instruments’ 
reimbursement mechanisms,1053 it can be concluded that the most relevant 
discrepancies between the two routes of patient mobility concern (1) the level of 
reimbursement and (2) the mechanism of reimbursement.1054 
 
 (1) The level of reimbursement is basically dependent on which tariffs are 
applied when calculating the reimbursement. According to the coordination rules – 
on the ground of the full integration principle, namely that foreign patients must be 
treated as if they were insured in the Member State of treatment – the rules of the 
Member State of treatment apply, including the rules on the calculation of medical 
fees. Hence, in principle the healthcare costs incurred abroad are fully covered. 
                                                 
1052
 See section III.2.2.3. 
1053
 See sections IV.2.1. and IV.2.2. 
1054
 The financing mechanisms are not analysed in detail again; only the main differences are pointed 
out. 
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However, the Directive’s financing mechanism is based on the idea that the 
reimbursement of cross-border healthcare costs may not affect the financial balance 
of the Member State of affiliation. Patients can thus claim reimbursement up to the 
level of domestic tariffs in that country. If the actual costs exceed this amount, the 
Member States cannot be obliged to bear the difference, which therefore remains at 
the expense of the patient. 
 (2) Concerning the mechanism of reimbursement, whereas the Regulations 
primarily require the institutions involved to settle the claim for reimbursement 
between each other without the patient needing to advance the costs of the treatment, 
under the Directive, the patient is invited by the healthcare provider to pay the 
invoice upfront, after which he/she can claim posterior reimbursement from the 
Member State of affiliation. 
From the patients’ point of view, both characteristics are more beneficial under the 
Regulations, and the less favourable financial scheme of the Directive has the 
potential to prevent patients from using their rights conferred on them by the 
Directive. 
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Table 15: Differences in financing of cross-border medical treatments 
 Under the Regulations’ regime Under the Directive’s regime 
N
ec
es
sa
ry
 
ca
re
 
Reimbursement in accordance with the tariffs 
applied by the MS of treatment (except non-
reimbursable local co-payments the nationals of the 
MS of treatment are also obliged to pay) 
Main principle: reimbursement between 
institutions: the patient does not need to advance 
the costs (except the co-payments which remain at 
his/her expense) unless the MS of treatment 
operates a reimbursement system 
If the patient advances the costs, reimbursement can 
be claimed either from the institution in the MS of 
stay or from the competent institution. 
Reimbursement in accordance 
with the tariffs applied by the MS 
of affiliation 
If there is a difference between 
the actual costs (the tariffs of the 
MS of treatment – the same scale 
of fees must be applied as to 
domestic patients) and the 
reimbursed costs (the tariffs of 
the MS of affiliation), those costs 
remain at the expense of the 
patient, unless the MS of 
affiliation opts to refund the 
whole amount. 
Main principle: the patient 
advances the costs 
Ancillary costs might be 
reimbursed if the MS of 
affiliation opts for that, but there 
is no obligation. 
Pl
an
n
ed
 
ca
re
 
Tr
ea
tm
en
t s
u
bje
ct
 
to
 
PA
 
PA
 
gr
an
te
d 
In principle, reimbursement in accordance with the 
tariffs applied by the MS of treatment, but 
additional reimbursement can be claimed if the cost 
coverage is higher in the competent MS 
If ancillary costs are reimbursed when arisen from 
domestic patient movement, they must be 
reimbursed in the event of obtained planned 
treatment abroad as well. 
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Regulations (unless the refusal of the request for 
PA is deemed unlawful a posteriori). 
Medical costs are not covered by 
the Patient Mobility Directive 
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to
 
PA
 
 Reimbursement in accordance 
with the tariffs applied by the MS 
of affiliation (see above) 
Source: the author’s own summary 
 
The non-patient-friendly features of the financing system, such as a possible 
financial burden due to a cost difference and a requirement of advancing medical 
costs, were accompanied by concerns already before the adoption of the Patient 
Mobility Directive. VAN DER MEI raised the question shortly after the Kohll and 
Decker judgements and it is still valid today: “The Court has accepted that insurance 
organs may reimburse the costs of 'foreign' medical products or services in 
accordance with their own reimbursement rates. The difference between the price in 
other Member States and the national reimbursement rates is to be paid by the 
patient himself. Especially in case of rather expensive products or types of treatment, 
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the financial burden on the patient could be considerable. The danger exists that 
'better off' patients will benefit more from Decker and Kohll than the patients with 
relatively low incomes. Public health insurance schemes are aimed at guaranteeing 
all residents regardless of their financial status equality of access to medical care. In 
the State of residence this equality is largely guaranteed, but should not the same 
apply to the access to medical care in other Member States?”1055 
The risk indeed exists that the Patient Mobility Directive exacerbates pro-rich 
inequality, because it is “likely to disproportionately benefit wealthy and well 
informed patients.”1056 So the following question arises: how can equal access to 
cross-border healthcare be ensured – independently from the financial capacity of the 
individual patients?1057 
 
The European Parliament, which acted as an advocate of patients’ rights throughout 
the negotiations of the proposal for the Directive,1058 also articulated its concerns in 
relation to the financing mechanism1059 and suggested two possible solutions to 
ensure direct payment from the patients’ funder to the healthcare provider, namely 
(1) the introduction of a voucher system and (2) the establishment of a central 
clearing house. 
(1) With the voucher system, the intention was to provide cross-border 
patients with a tool which they can practically take with them and present to the 
healthcare provider in the Member State of treatment as a guarantee for 
                                                 
1055
 VAN DER MEI (1998: 297.). 
1056
 LEGIDO-QUIGLEY et al. (2011b: 366.). 
1057
 The recent Petru judgement – however not interpreting the Directive but the Coordination 
Regulation – can be used as a way of illustration: Mrs Petru’s German hospital treatment did cost 
around 18,000 euros. (See footnote 703.). One may raise the question how many patients might be in 
the position to advance such an amount of money in a country where the minimum wage is hardly 
more than 200 euros (in 2014, the minimum wage in Romania is 900 lei). 
1058
 See footnote 379. 
1059
 When we say the policy should be about patients with needs, not patients with means, we should 
make it clear we do not wish to see patients having to travel, clutching cash or credit card to pay 
upfront for often expensive in-hospital treatment. European Parliament – Committee on the 
Environment, Public Health and Food Safety (2009): Report on the proposal for a directive of the 
European Parliament and of the Council on the application of patients' rights in cross-border 
healthcare. 3 April 2009, A6-0233/2009, 
http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A6-2009-
233&language=EN (8 April 2014), p. 76. 
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reimbursement from the Member State of affiliation. This option very much 
resembles the system of the Regulations under which patients must present either 
their EHIC, for necessary care,1060 or an S2 form issued to them, for scheduled 
care,1061 as a proof of entitlement which can be seen as a ‘promissory note’ from the 
competent institution. The voucher system would have imposed a considerable 
additional administrative burden both on the patients themselves and on the national 
healthcare administrations. Moreover, the preliminary administrative steps necessary 
for the usage of vouchers would nullify the very aim of the Directive, which is to 
offer the possibility to obtain cross-border healthcare without authorisation or any 
other prior administrative arrangements. The Council did reject the creation of a 
voucher system. Still, an imprint of this proposition remained in the Directive in the 
form of a voluntary system of prior notification, in return for which the patient 
receives a written confirmation of the amount to be reimbursed on the basis of an 
estimate.1062 So this confirmation does not target the healthcare provider as was the 
idea with the voucher system, but instead gives an indication to the patient what 
he/she can expect financially. 
 (2) Another proposal was to put in place a system of direct reimbursement 
through a Central Clearing House to manage the cross-border, cross-currency, 
cross-system (Beveridge/Bismark) complications.1063 Since the details of this idea 
were not worked out because of the rejection by the Council, it is unclear how this 
institution would have been constructed and functioned. 
It is remarkable anyway that a European institution suggested to operate a separate 
institution with the purpose of managing cross-border healthcare issues. The creation 
of a central body could indeed facilitate the cooperation between the national contact 
points and could serve as a central base of knowledge and information on cross-
border healthcare.1064 
 
                                                 
1060
 See section III.2.2.2.B. 
1061
 See section III.2.2.2.C. 
1062
 Article 9 (5) PMD. 
1063
 EP – ENVI (2009: 76.). 
1064
 The idea of a central institution for cross-border healthcare is elaborated in Chapter VI. 
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Since neither of the Parliament’s proposals made it through the filter of the Council, 
the current wording of the Directive does not offer any solid solution to tackle the 
price difference and the upfront payment in order to provide greater equality and 
equal access to cross-border healthcare. The lack of a compensation mechanism 
affects particularly adversely the patients with low incomes affiliated to a healthcare 
scheme with relatively low tariffs.1065 These patients are basically deprived of their 
cross-border healthcare rights on an economic ground, because they can neither 
afford to advance a considerable amount of money, nor bear the cost difference 
between the tariffs of their own Member State and another Member State with a 
higher scale of medical fees. Therefore, there is an urgent need to address this 
problem. 
In my view, unifying the Regulations’ and the Directive’s systems as proposed 
supra1066 might solve these problems, since under the integrated system the 
Regulations’ inter-institutional reimbursement mechanism should be applied and an 
additional compensation scheme could be put in place.1067  
                                                 
1065
 In my opinion, this situation can easily result in a rather one-sided European patient mobility 
phenomenon from the Western countries to the Eastern countries, which – despite the considerably 
lower prices – do offer good quality healthcare services. 
1066
 See section III.2.2.3. 
1067
 The idea of an integrated legal and financial system is elaborated in Chapter VI. 
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IV.3. CONCLUSIONS 
Financing cross-border healthcare is likely to be troublesome for patients. Out 
of the two simultaneously functioning reimbursement mechanisms, the one included 
in the Coordination Regulations has evident advantages compared to the one in the 
Patient Mobility Directive. 
The Directive’s financing system fails to tackle both the problem of financial 
affordability since it evokes the risk of expenses remaining on the patients’ side and 
the requirement of advancing medical costs, and the problem of accessibility of 
reimbursement schemes since reimbursement is often subject to the fulfilment of 
various legal conditions, the scope and level of reimbursement can be strictly limited 
and the timeliness of the reimbursement is not ensured. 
 
Although the Regulations’ system is far from flawless either, it is in the interest of 
the patient to apply an inter-institutional reimbursement system, where they are not 
required to advance the costs of medical treatment abroad; the coordination 
mechanism’s financing process should thus be strengthened in order to ensure equal 
access to cross-border healthcare.  
I cannot agree more with CHAYTOR, who emphasises that “(a)ction to tackle health 
inequalities is vital, not least because they have significant social and economic costs 
to both individuals and wider society.”1068 
  
                                                 
1068
 Sarah CHAYTOR (2012): Future of Healthcare in Europe – Meeting future challenges: Key issues 
in context. UCL Policy Briefing, January 2012, http://www.ucl.ac.uk/european-institute/events-
view/reviews/healthcare/FHE-print.pdf (10 April 2014), p. 2. 
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V. THE TIMELY PROVISION OF HEALTHCARE AND EHEALTH 
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As the pressure on healthcare systems all over Europe is expected to increase 
due to demographic changes,1069 the timely provision of healthcare will continue to 
constitute a challenge in the 21st century. Therefore, it is of utmost importance to 
make the healthcare schemes capable of integrating the new methods and 
technologies in order to prevent waiting times from skyrocketing, and to enhance 
healthcare efficiency and thus patients’ lives.1070 
Information and communication technologies open up a whole new dimension for 
healthcare provision, also across borders. eHealth applications hold the potential to 
save time and money for border-crossing patients, shorten waiting lists, make 
healthcare communication and access to information easier and even replace the need 
to travel with service provision at a distance. However, the many-sided benefits of 
ICT in healthcare are shadowed by fears, uncertainties and challenges which have to 
be addressed and overcome.1071 
In this brief chapter, without the claim of completeness,1072 the main advantages and 
the main hazards of eHealth applications in cross-border patient mobility situations 
are enlightened, in the effort to answer the question how eHealth applications can 
contribute to European cross-border patient mobility.1073 
  
                                                 
1069
 Michael MARMOT, Ruth BELL and Peter GOLDBLATT (2012): Future of health care in Europe – a 
social determinants perspective. In Uta STAIGER and Sarah CHAYTOR (ed.): The Future of Healthcare 
in Europe. http://www.ucl.ac.uk/european-institute/events-
view/reviews/healthcare/FHE_FINAL_online.pdf (10 April 2014), p. 8. 
1070
 As it is phrased in the EU’s digital agenda, across Europe, public health systems are facing 
shrinking budgets and increased demand. Yet in times of austerity, ICT can be our most powerful ally 
to maintain cost efficient and high quality care. http://ec.europa.eu/digital-agenda/en/innovative-
healthcare-21st-century (10 April 2014). 
1071
 On this topic, see also BERKI Gabriella (2010): Online gyógyulás – Az e-egészségügy megoldatlan 
jogi problémái (Recovering online: some unsolved legal problems concerning eHealth) Munkaügyi 
Szemle (Labour Relations Review) 2010, Issue 4, pp. 30-34. 
RYNNING summarises the double-faced nature of eHealth applications very aptly when she says “e-
Health development has the potential to improve individualised care, access and patient safety, while 
at the same time lowering costs and facilitating coordination of different services and care providers. 
However, new technology may also involve new risks and require careful evaluation of many different 
aspects, in order to be successfully implemented.” RYNNING (2008: 302.). 
1072
 This dissertation does not aim to analyse each aspect of eHealth, it focuses only on the usage of 
ICT in relation to cross-border patient movements. 
1073
 See the research questions in section I.2. 
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V.1. THE POTENTIAL OF ICT APPLICATIONS IN EUROPEAN CROSS-
BORDER PATIENT MOBILITY 
The European Union and the European institutions themselves are determined 
to facilitate the timely provision of healthcare within the Union. While the European 
Court of Justice paved the path to patients’ right to timely healthcare provision by 
confirming their entitlement to authorisation for treatment abroad if it cannot be 
provided in their country within a medically justifiable time limit,1074 the 
Commission has been engaged in speeding up both the access to cross-border 
healthcare provision and the administrative procedures attached. As a result, both the 
Regulation and the Directive rely on the application of modern information and 
communication technologies in some way. Before discussing these rules, it seems 
necessary to delineate the key concepts in this field. 
V.1.1. The conceptual basics of eHealth 
eHealth is an umbrella term1075 which covers any technologies involving the 
use of ICT in health products, services and processes combined with organisational 
change in healthcare systems and new skills, in order to improve health of citizens, 
efficiency and productivity in healthcare delivery, and the economic and social value 
                                                 
1074
 On the case law of the Court in regard to the medically justifiable time limit, see section 
III.2.2.1.C. 
1075
 Although the phenomenon is not quite new and the use of ICT in healthcare and clinical sciences 
is well established, the term ’eHealth’ appeared only at the very end of the 20th century. Petra 
WILSON, Christine LEITNER and Antoinette MOUSSALLI (2004): Mapping the Potential of EHealth: 
Empowering the Citizen through EHealth Tools and Services. Maastricht: European Institute of Public 
Administration. http://www.epractice.eu/files/download/awards/D12_Award3_ResearchReport.pdf 
(13 April 2014), p. 7. 
EYSENBACH extends the notion of eHealth by saying that “e-health is an emerging field in the 
intersection of medical informatics, public health and business, referring to health services and 
information delivered or enhanced through the Internet and related technologies. In a broader sense, 
the term characterizes not only a technical development, but also a state-of-mind, a way of thinking, 
an attitude, and a commitment for networked, global thinking, to improve health care locally, 
regionally, and worldwide by using information and communication technology.” Gunther 
EYSENBACH (2001): What is e-health? Journal of Medical Internet Research, Vol 3 No 2, 
http://www.jmir.org/2001/2/e20/ (13 April 2014). 
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of health. eHealth covers the interaction between (1) patients and health-service 
providers, (2) institution-to-institution transmission of data, or peer-to-peer 
communication between (3) patients and/or (4) health professionals.1076 
Consequently, the wide notion of eHealth comprises a big spectrum of services 
which affect the whole range of healthcare provision. Whereas the Commission’s 
above definition of eHealth approaches the field from the participants’ side, CALLENS 
focuses on the function and distinguishes four interrelated categories of applications, 
namely (1) clinical information systems; (2) telemedicine and telecare; (3) health 
information networks, distributed electronic health record systems and associated 
services such as e-prescriptions or e-referrals; and (4) secondary usage of non-
clinical systems such as specialised systems for researchers, or support systems such 
as billing systems.1077 With the integration of these two aspects, the result is a matrix 
which illustrates the great variety of eHealth applications, as can be seen in Table 16 
infra. 
 
Table 16: eHealth applications 
Functions Clinical 
information 
systems 
Telemedicine and 
telecare 
Health information 
networks 
Non-clinical 
systems 
Participants 
Patient-to-
provider 
interaction 
e.g. electronic 
record of the 
patient's medical 
history 
e.g. telemonitoring 
telepsychiatry 
remote patient 
management 
- e.g. billing 
system 
Institution-to-
institution 
interaction 
- - e.g. distributed health 
record systems 
e-prescriptions 
e-referrals 
e.g. billing 
system 
Patient-to-patient 
interaction 
- - e.g. online patient 
forums 
- 
Healthcare 
professional-to-
healthcare 
professional 
interaction 
 e.g. teleconsultation 
teleradiology 
telesurgery 
telescreening 
e.g. distributed health 
record systems 
e-prescriptions 
e-referrals 
e.g. specialised 
systems for 
researchers 
Source: the author’s own summary, based on COM (2012) 736 and CALLENS (2010) 
                                                 
1076
 European Commission: Communication from the Commission to the European Parliament, the 
Council, the European Economic and Social Committee and the Committee of the Regions – eHealth 
Action Plan 2012-2020 - Innovative healthcare for the 21st century. COM (2012) 736 final, 6. 12. 
2012, p. 3. 
1077
 Stefaan CALLENS (2010): The EU legal framework on e-health. In Mossialos et al. 2010, pp. 561-
562. 
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From the border-crossing patients’ point of view, two functions of eHealth are 
especially relevant: ICT involvement can be a tool both of (1) information gaining 
and sharing and (2) remote healthcare service provision. 
 (1) John NAISBITT1078 is credited with the visionary thought that “the new 
source of power is not money in the hands of a few but information in the hands of 
many.”1079 It was already shown supra how essential it is for patients to have 
comprehensive, reliable information on each aspect of cross-border healthcare.1080 As 
the internet grew to be the biggest search engine of health-related information in the 
past decades,1081 it became an emerging consideration to provide patients with 
correct and up-to-date information on online medical platforms. The World Wide 
Web offers the possibility for healthcare authorities and healthcare providers to 
disseminate information on a broad range of topics through their websites, for 
healthcare professionals to give advice on different forums and keep contact with 
their patients, and for patients to seek information and share their knowledge and 
experience. Whereas the internet has numerous beneficial features1082 and 
undoubtedly contributes to empowering patients to take a more active role in their 
                                                 
1078
 American author and public speaker in the area of futures studies. 
1079
 Quoted by BALL and LILLIS. Marion J. BALL and Jennifer LILLIS (2001): E-health: transforming 
the physician/patient relationship. International Journal of Medical Informatics, Vol 61, p. 1. 
1080
 On this subject, see section III.2.1.3. 
1081
 Numerous studies show that “the use of the internet as a source of medical information has 
become increasingly popular.” See among others Ben S. GERBER and Arnold R. EISER (2001): The 
Patient-Physician Relationship in the Internet Age: Future Prospects and the Research Agenda. 
Journal of Medical Internet Research, Vol 3 No 2, http://www.jmir.org/2001/2/e15/ (11 April 2014); 
Joseph A. DIAZ, Rebecca A. GRIFFITH, James J. NG, Steven E. REINERT, Peter D. FRIEDMANN and 
Anne W. MOULTON (2002): Patient’s Use of the Internet for Medical Information. Journal of General 
Internal Medicine, Vol 17 Issue 3, p. 180; Sheila R. COTTON and Sipi S. GUPTA (2004): 
Characteristics of online and offline health information seekers and factors that discriminate between 
them. Social Science & Medicine, Vol 59, pp. 1795-1796; Nicola J. GRAY, Jonathan D. KLEIN, Peter 
R. NOYCE, Tracy S. SESSELBERG and Judith A. CANTRILL (2005): Health information-seeking 
behaviour in adolescence: the place of the internet. Social Science & Medicine, Vol 60, p. 1467 and 
Natalia PLETNEVA and Alejandro VARGAS (2011): Requirements for the general public health search. 
http://www.hon.ch/Global/pdf/Khresmoi/KHRESMOI_general_public_survey_report.pdf (11 April 
2014), pp. 6-7 and pp. 17-18. 
1082
 Among the advantages, COTTON and GUPTA mention that the internet “affords individuals 
privacy, immediacy, convenience, anonymity, a wide variety of information, and a variety of 
perspectives on the same topic.” COTTON and GUPTA (2004: 1797) Furthermore, PLETNEVA and 
VARGAS emphasise that “(o)nline health surfing can be very beneficial for the novice users in terms of 
feelings of reassurance, confidence and relief.” PLETNEVA and VARGAS (2011: 7.). 
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healthcare1083 and to raising their awareness, it certainly has its drawbacks.1084 One 
of the main concerns relates to the credibility of the websites,1085 the quality of which 
is often questionable. Online contents can be not only wrong, outdated or misleading 
but even harmful for patients who rely on them.1086 Therefore, it would be crucial to 
ensure the accuracy of medical information. 
In my opinion, the European Union should develop a verification system for medical 
website content with an easily recognisable emblem. This way patients – whether 
border-crossing or not – would know at first glance that the quality of the 
information has been verified and reliable. This measure could be a big leap in 
building public confidence in eHealth.1087 
 
 (2) Another field of eHealth which holds great potential (also) for border-
crossing patients, is telemedicine.1088 Telemedicine is a complex area of remote 
healthcare service provision, which encompasses a wide variety of services.1089 The 
common characteristic of telemedicine applications – as opposed to traditional 
healthcare – is that they do not require the physical presence of the parties involved 
(typically the patient and the healthcare provider) at the same place at the same time 
and that they involve the usage of an intermediary ICT tool instead of direct 
                                                 
1083
 See among others BALL and LILLIS (2001: 2.) and GERBER and EISER (2001). 
1084
 Privacy and anonymity are often mentioned as key issues, but information overload, contradictory 
information, the use of overly technical language, the lack of user friendliness, a constant 
changeability and questionable trustfulness of information can also discourage patients. COTTON and 
GUPTA (2004: 1797). 
1085
 On trust in online content such as medical websites, see Ardion BELDAD, Menno DE JONG, 
Michaël STEEHOUDER (2010): How shall I trust the faceless and the intangible? A literature review on 
the antecedents of online trust. Computers in Human Behavior, Vol 26, pp. 857–869. 
1086
 PLETNEVA and VARGAS (2011: 7.). 
There is a recent phenomenon called cyberhondria, which describes the case of “unfounded escalation 
of concerns about common symptomatology, based on the review of search results and literature on 
the Web.” Ryen W. WHITE and Eric HORVITZ (2008): Cyberchondria: Studies of the Escalation of 
Medical Concerns in Web Search. Microsoft Research, http://research.microsoft.com/pubs/76529/TR-
2008-178.pdf (11 April 2014), p. 1. 
1087
 COM (2008) 689, p. 7. 
1088
 See footnote 142. 
1089
 The Commission enumerates (1) teleradiology, (2) telepathology, (3) teledermatology, (4) 
teleconsultation, (5) telemonitoring, (6) telesurgery, (7) teleophtalmology, (8) call centres and online 
information centres for patients, (9) remote consultation and e-visits and (10) videoconferences 
between health professionals. COM (2008) 689, p. 3. 
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interaction. Telemedicine cannot only complete traditional medical treatments, but 
can save patients from travelling long distances – sometimes across borders. Medical 
teleconsultation and telediagnostic services can considerably speed up (cross-border) 
healthcare, help to shorten waiting times and optimise the use of resources.1090 
However, the shift in the patient-provider relationship, and the lack or the significant 
decrease of personal contact together with the application of information and 
communication technologies raise a series of questions, which have to be satisfyingly 
answered in order to build a safe and patient-friendly eHealth environment in the 
European Union. These problems are addressed infra.1091 
V.1.2. ICT under the scope of the Coordination Regulations 
The European Commission has been taking serious efforts to ‘bring Europe 
closer to its citizens’. While doing so, it uses – to a certain extent – the potential that 
ICT offers.1092 The field of social security coordination is not an exception: 
comprehensive information can be gathered from the website of the Directorate 
General Employment, Social Affairs and Inclusion.1093 In recent years, the 
Commission lays special emphasis on awareness-raising through online tools. Two 
outstanding examples related to patient mobility are (1) the online campaign on the 
EHIC in the course of which short video clips were published with clear information 
– often in a humorous way – on healthcare provision abroad;1094 and (2) the EHIC 
application for smartphones.1095 
                                                 
1090
 COM (2008) 689, p. 2. 
1091
 See section V.2. 
1092
 For example, it operates informative websites on its activities, and uses video sharing portals and 
social media as well. See footnote 825. 
1093
 http://ec.europa.eu/social/main.jsp?langId=en&catId=849 (11 April 2014). 
1094
 Examples of the video campaign can be found under the next links: 
http://ec.europa.eu/social/main.jsp?catId=702&langId=en&videosId=2526&vl=en&furtherVideos=ye
s (11 April 2014); 
http://ec.europa.eu/social/main.jsp?catId=702&langId=en&videosId=2121&vl=en&furtherVideos=ye
s (11 April 2014). 
1095
 http://ec.europa.eu/social/main.jsp?catId=559 (11 April 2014). See footnote 825. 
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However, one of the most far-reaching and ambitious pledges of the Union 
concerning the modernisation of the coordination mechanism is the creation of 
EESSI.1096 EESSI is an IT system that aims to help social security bodies across the 
Union in exchanging information more rapidly and securely. By computerising the 
application of European law on social security coordination and replacing paper-
based E-forms with electronic documents,1097 it is expected to shorten processing 
times and speed up both the settlement of claims and the calculation and payment of 
benefits.1098 Throughout the implementation of EESSI, numerous technical and 
organisational difficulties have occurred, which resulted in the continuous 
postponement of the operational deadline.1099 Nevertheless, once it functions, the 
electronic exchange of data will bring benefits to border-crossing patients as well. 
V.1.3. ICT under the scope of the Patient Mobility Directive 
The Proposal for the Patient Mobility Directive referred to eHealth as a mode 
of supply of growing importance.1100 Still, the actual ICT-related outcome of the 
Directive is rather limited. There are basically four points where ICT has an impact 
on the implementation of the Directive, namely (1) the information providing 
obligation of the National Contact Points, (2) the electronic healthcare record, (3) the 
recognition of prescriptions and (4) the provisions specifically concerning eHealth. 
 
 (1) Currently, the National Contact Points are the main sources of information 
on cross-border healthcare.1101 In order to fulfil their function, they should be easily 
                                                 
1096
 Article 4 (2) IR. See also footnote 279. 
1097
 See footnote 817. 
1098
 http://ec.europa.eu/social/main.jsp?catId=869 (11 April 2014). 
1099
 See Administrative Commission Decision No E4 of  13 March 2014concerning the transitional 
period as defined in Article 95 of Regulation (EC) No 987/2009 of the European Parliament and of the 
Council. OJ C 152 of 20 May 2014. 
1100
 COM (2008) 414, p. 20. 
1101
 See section III.2.1.3. 
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approachable in various forms, including online forms as well.1102 Similarly, the 
information they are designated to provide shall be easily accessible and shall be 
made available by electronic means and in formats accessible to people with 
disabilities.1103 Since the Union legislation encourages border-crossing patients to 
put their trust into the Contact Points, they can be demanded to provide accurate 
information. Besides promptly replying to concrete requests for information from the 
patients, they must also maintain a frequently updated website with comprehensive 
and reliable content. If a National Contact Point fails to meet these requirements, the 
Member State will be considered as not complying with its obligation under the 
Directive.1104 
 (2) Granting the right to patients to a written or electronic medical record1105 
of the treatment obtained abroad, or access to at least a copy of this record1106 is a 
significant step towards ensuring continuity of treatment across borders. This 
provision does not require the Member States to provide the data in electronic 
format, but most likely even paper-based medical documents issued for the patients 
are produced from electronically secured data.1107 Consequently, this issue provokes 
the question how the safety of electronic medical data is guaranteed in the European 
Union. As already mentioned, privacy is a major concern of patients.1108 Therefore, 
                                                 
1102
 Although not specified in the Directive, NCPs can be expected to offer the possibility to contact 
them via phone, e-mail, traditional mail, through their website and personally as well. 
1103
 Article 6 (5) PMD. 
1104
 See Article 6 (1) PMD. 
1105
 The appearance of electronic medical record systems at the beginning of the 1970s signalled the 
start of computerisation in healthcare. It has advanced rapidly in the internet era and today, in most of 
the developed countries electronic medical record systems pushed the traditional paper-based medical 
files into the background. BERKI (2010: 30.). See also WILSON et al. (2004: 7.). 
1106
 Article 4 (2) (f) PMD. See also footnote 424. See on the importance of discharge summaries 
Cécile KNAI, Katharine FOOTMAN, Ketevan GLONTI and Emily WARREN (2013): The role of 
discharge summaries in improving continuity of care across borders. Eurohealth, Vol 19 No 4. 
1107
 At the end of 2013, new guidelines were adopted on the electronic exchange of basic healthcare 
information. The exchange of basic information serves two aims. On the one hand, patients can have a 
summary of their electronic health record when visiting another EU country; and on the other hand, 
the doctor treating the patient can have an electronic overview of a basic set of administrative data 
(such as details of the healthcare provider in the home country and the insurance status of the patient) 
and medical information (such as allergies, vaccinations and recent surgical procedures). 
https://ec.europa.eu/digital-agenda/en/news/eu-takes-major-step-improve-cross-border-care (13 April 
2014). The guidelines themselves can be found under the following link: 
http://ec.europa.eu/health/ehealth/docs/guidelines_patient_summary_en.pdf (13 April 2014). 
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 See footnote 1084. 
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the legal protection of their sensitive data, the storage, the processing, the (cross-
border) transmission and access to them must be satisfyingly ensured.1109 The main 
legal tools for this are Directive 95/46/EC1110 and Directive 2002/58/EC.1111 
Directive 95/46/EC establishes the right to process sensitive data where processing of 
the data is required for the purposes of preventive medicine, medical diagnosis, the 
provision of care or treatment or the management of health-care services, and where 
those data are processed by a health professional subject under national law or rules 
established by national competent bodies to the obligation of professional secrecy or 
by another person also subject to an equivalent obligation of secrecy.1112 Since the 
free movement of medical data across borders is a precondition of the further 
development of cross-border patient mobility, it must be strictly controlled whether 
the Member States and the national organs dealing with electronic medical data do 
appropriately safeguard these data. 
 (3) Another field where ICT can be expected to forge ahead in the coming 
years is the e-prescription applications.1113 In the framework of cooperation between 
the Member States, the Directive expressly confirms that in order to facilitate the 
implementation of the provisions on the recognition of prescriptions issued in 
                                                 
1109
 Recital 25 of the Preamble of the Patient Mobility Directive underlines that the right to the 
protection of personal data is a fundamental right recognized by Article 8 of the CFREU. 
1110
 Directive 95/46/EC of the European Parliament and of the Council of 24 October 1995 on the 
protection of individuals with regard to the processing of personal data and on the free movement of 
such data. OJ L 281 of 23 November 1995. 
1111
 Directive 2002/58/EC of the European Parliament and of the Council of 12 July 2002 concerning 
the processing of personal data and the protection of privacy in the electronic communications sector 
(Directive on privacy and electronic communications). OJ L 201 of 31 July 2002. 
1112
 Article 8 (3) of Directive 95/46/EC. 
1113
 Electronic prescription systems create a direct – electronic – link between the prescriber and the 
dispenser and transmit the prescription information. On issues related to e-prescription, see among 
others Edward BALL, David W. CHADWICK and Darren MUNDY (2003): Patient Privacy in Electronic 
Prescription Transfer. IEEE Security & Privacy, Vol 1 Issue 2 and Albert BOONSTRA, David BODDY 
and Moira FISCHBACHER (2004): The limited acceptance of an electronic prescription system by 
general practitioners: reasons and practical implications. New Technology, Work and Employment, 
Vol 19 Issue 2. 
In developing cross-border e-prescription systems, the epSOS project is a pioneer, which concentrates 
on developing a practical eHealth framework and ICT infrastructure that enables secure access to 
patient health information among different European healthcare systems. http://www.epsos.eu/ (13 
April 2014). 
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another Member State,1114 the Commission must adopt guidelines supporting the 
Member States in developing the interoperability of e-prescriptions.1115 
 (4) Very similarly, the European Union also supports and facilitates 
cooperation and the exchange of information among Member States in relation to 
eHealth.1116 The Directive founded a voluntary network of national authorities 
responsible for eHealth development in the individual Member States.1117 Until 
today, both e-prescription and eHealth systems encounter serious problems such as 
interoperability and data protection. As the Directive declares, the eHealth network 
must work towards delivering sustainable economic and social benefits of European 
eHealth systems and services and interoperable applications, with a view to 
achieving a high level of trust and security, enhancing continuity of care and 
ensuring access to safe and high-quality healthcare.1118  
 
Whereas the first two issues involve a concrete obligation for the Member States, and 
thus establish concrete entitlements for the patients, the latter two can rather be 
considered instruments of a soft law nature lacking the possibility of enforcement. 
Therefore, their future effect on patients is highly questionable and more specific 
measures on these fields are demanded. 
V.1.4. Overall benefits of eHealth applications 
It is a widely agreed tenet that eHealth applications hold a great potential and 
– in certain ways – are capable of revolutionising healthcare. The main asset of the 
application of ICT in healthcare is that it can increase the efficiency of healthcare 
systems, improve quality of life and unlock innovation in health markets.1119 
                                                 
1114
 See footnote 928. 
1115
 Article 11 (2) (b) PMD. 
1116
 Article 14 (1) PMD. 
1117
 On the tasks assigned to the eHealth network, see Article 14 (2) PMD. 
1118
 Article 14 (2) (a) PMD. 
1119
 COM (2012) 736, p. 3. 
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Consequently, eHealth is a tool each party of healthcare delivery can profit from 
(these benefits are summarised in Annex III). 
Focusing on the patients’ side, it can be said that (1) first of all, eHealth can empower 
citizens to act as informed consumers by gathering health-related information online, 
using online knowledge bases, accessing their electronic health records; “e-health 
opens new avenues for patient-centered medicine, and enables evidence-based 
patient choice.”1120 (2) Secondly, enhanced communication between healthcare 
professionals and the involvement of the (better informed) patient can increase 
efficiency in healthcare and reduce both the money and time invested in treatments, 
for instance by avoiding duplicative or unnecessary diagnostic or therapeutic 
interventions.1121 (3) Thirdly, eHealth extends the scope of healthcare beyond its 
conventional boundaries both in a geographical and a conceptual sense.1122 While 
eHealth redefines the characteristics of the patient-provider relationship,1123 the 
provision of healthcare services at a distance can improve access to healthcare for the 
elderly,1124 people living with disabilities, or chronic or rare diseases and people 
living in remote areas. Moreover, they can help to shorten waiting lists, optimise the 
use of resources and enable productivity gains.1125 
Although these benefits do not only concern border-crossing patients, but anyone 
obtaining healthcare, they have the potential to facilitate cross-border patient 
movements in many ways. However, new opportunities bring new risks, so it should 
                                                 
1120
 EYSENBACH (2001). 
1121
 It is also remarkable that evidence describes “the use of modern IT strategies as a possible way of 
decreasing the occurrence of medical error.” Mariusz DUPLAGA and Krzysztof ZIELINSKI (2006): 
Evolution of IT-Enhanced Healthcare: From Telemedicine to e-Health. In Krzysztof ZIELINSKI, 
Mariusz DUPLAGA and David INGRAM (eds.): Information Technology Solutions for Healthcare. 
London: Springer-Verlag, p.17. 
1122
 EYSENBACH (2001). 
1123
 BALL and LILLIS (2001). 
1124
 See for instance http://www.southburnetttimes.com.au/news/telehealth-helps-elderly/1928158/ (13 
April 2014). 
1125
 COM (2008) 689, p. 2. 
The eHealth Action Plan also confirms the huge potential eHealth applications hold. “Fostering a 
spirit of innovation in eHealth in Europe is the way forward to ensure better health and better and 
safer care for EU citizens, more transparency and empowerment, a more skilled workforce, more 
efficient and sustainable health and care systems, better and more responsive public administrations, 
new business opportunities and a more competitive European economy that can benefit from 
international trade in eHealth.” COM (2012) 736, p. 14. 
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be asked what the barriers are to tackle in order to enable European patients to fully 
use what 21st century health technology can offer. These issues are addressed 
concisely in the next section. 
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V.2. THE HAZARDS ASSOCIATED WITH EHEALTH APPLICATIONS 
Traditional medicine has relied on direct, face-to-face contacts between 
health professionals and patients for centuries. Transforming this relationship 
gradually is thus not always welcome.1126 What is more, it evokes practical and legal 
obstacles. Without going into the details of a topic which goes far beyond the scope 
of this dissertation, a few remarks must be made from the border-crossing patients’ 
point of view in respect of those barriers which jeopardise the development of 
eHealth and its use in cross-border patient mobility situations.1127 In this section, the 
issues of (1) data security, (2) liability, (3) reimbursement, (4) regulation and (5) 
equal access are touched upon. 
 
(1) The most evident problem is that the possibility to exchange sensitive, 
medical data rapidly via information and communication technologies opens the 
Pandora’s Box of data protection as already mentioned.1128 eHealth applications 
cannot bloom unless patients’ privacy is absolutely safeguarded. Whether this is the 
case today and how this can be ensured in the future with the quick development of 
ICT, is a question for further research. 
(2) ICT tools manifest an external, new element integrated into a traditionally 
personal interaction, and can thus be considered as a new source of potential errors 
and mistakes. The question to be answered is where the liability for such defaults lie. 
                                                 
1126
 Switching from a paternalistic healthcare model to a more balanced, patient-centered model with 
ICT tools involved challenge each party of the healthcare provision, and dealing with this shift can be 
more problematic for some groups than others. See on this topic among others Farah AHMAD, Pamela 
L. HUDAK, Wendy LEVINSON, Kim BERCOVITZ and Elisa HOLLENBERG (2006): Are Physicians Ready 
for Patients With Internet-Based Health Information? Journal of Medical Internet Research, Vol 8 
Issue 3. 
1127
 The eHealth Action Plan highlights seven major barriers, namely (1) lack of awareness of, and 
confidence in eHealth solutions among patients, citizens and healthcare professionals; (2) lack of 
interoperability between eHealth solutions; (3) limited large-scale evidence of the cost-effectiveness 
of eHealth tools and services; (4) lack of legal clarity for health and wellbeing mobile applications 
and the lack of transparency regarding the utilisation of data collected by such applications; (5) 
inadequate or fragmented legal frameworks including the lack of reimbursement schemes for eHealth 
services; (6) high start-up costs involved in setting up eHealth systems; and (7) regional differences in 
accessing ICT services, limited access in deprived areas. COM (2012) 736, p. 5. 
1128
 See section V.1.3. 
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Since there is no Union legislation on medical liability,1129 it might be even more 
complicated to answer the above question in a cross-border context, in which more 
healthcare professionals and online service providers can be involved. 
 (3) Since eHealth applications often require considerable financial 
investment, it is crucial to clarify who has to cover the expenses, to what extent and 
in which form. It would be desirable if the new technologies were integrated into the 
public healthcare systems in Europe, so that they could join the group of healthcare 
services which are – at least partly – reimbursed.1130 
(4) From a legal point of view, it is problematic that many national healthcare 
regulations still consider direct patient-provider contact as the basis of healthcare 
delivery. This approach potentially limits the effect of eHealth applications, where 
the directness is transformed into a distant contact through ICT devices.1131 It is also 
worth mentioning that eHealth applications are subject to different European rules 
the interaction of which is not always clear and can result in a very complex legal 
situation.1132 
 (5) A last, but very important concern is that the costly, modern technologies 
can further deepen the already existing inequality in relation to access to healthcare 
                                                 
1129
 See also Article 4 (2) (d) PMD. 
1130
 CALLENS (2010: 582-584.). 
1131
 DUPLAGA and ZIELINSKI (2006: 17.). 
1132
 CALLENS collects those European legal instruments which are relevant in relation to eHealth, 
namely (1) the Data Protection Directive (see footnote 1110); (2) Medical Device Directives 
(Directive 2007/47/EC of the European Parliament and of the Council of 5 September 2007 amending 
Council Directive 90/385/EEC on the approximation of the laws of the Member States relating to 
active implantable medical devices, Council Directive 93/42/EEC concerning medical devices and 
Directive 98/8/EC concerning the placing of biocidal products on the market. OJ L 247 of 21 
September 2007); (3) the Directive on Distance Contracting (Directive 97/7/EC of the European 
Parliament and of the Council of 20 May 1997 on the protection of consumers in respect of distance 
contracts. OJ L 144 of 4 June 1997); (4) the Directive on the recognition of professional qualifications 
(see footnote 141); (5) the Directive on Electronic Signatures (Directive 1999/93/EC of the European 
Parliament and of the Council of 13 December 1999 on a Community framework for electronic 
signatures. OJ L 013 of 19 January 2000); (6) the E-commerce Directive (Directive 2000/31/EC of the 
European Parliament and of the Council of 8 June 2000 on certain legal aspects of information society 
services, in particular electronic commerce, in the Internal Market. OJ L 178 of 17 July 2000) and (7) 
European competition law. See Stefaan CALLENS (2009): Legal Basis of eHealth and Telemedicine. 
The European Files – eHealth in Europe, May-June 2009, No 17, 
http://www.epractice.eu/files/The%20European%20Files%20-%20eHealth%20in%20Europe%20-
%20EN.pdf (13 April 2014), p. 24 and CALLENS (2010: 563-572.). See also COM (2008) 689, pp. 9-
10. 
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services. As EYSENBACH notes very precisely, “(p)eople, who do not have the money, 
skills, and access to computers and networks, cannot use computers effectively. As a 
result, these patient populations (which would actually benefit the most from health 
information) are those who are the least likely to benefit from advances in 
information technology, unless political measures ensure equitable access for 
all.”1133 
These flashlights of potential barriers can illustrate – also for lack of further analysis 
– that there are still numerous tasks ahead both for the legislature and other 
stakeholders to make European healthcare systems ready to implement the new 
technologies for the benefits of both the patients and the systems themselves. 
  
                                                 
1133
 EYSENBACH (2001). 
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V.3. CONCLUSIONS 
In the age of laptops, tablets and smartphones, where cyberspace has 
captivated most everyday activities of our lives and the usage of internet-based 
applications, online communication and web-shopping have become ordinary, the 
sweep of eHealth cannot be stopped. 
The implementation of modern information and communication technologies into the 
healthcare schemes can bring considerable benefits to all parties involved. Most 
importantly, eHealth has the potential to improve patients’ lives by offering new 
tools to broaden their knowledge, communicate with healthcare professionals more 
quickly and easily, gain access to remote healthcare services and enjoy the assets of 
more efficiently functioning healthcare systems with better resource utilisation, 
shorter waiting times, and more speedy, transparent and patient-friendly medical 
administration. 
However, to reach these goals, much has to be done both on European and national 
levels. Current barriers leave many questions unanswered and situations unsolved. 
Although both patient mobility-related legal instruments incorporate ICT solutions to 
a certain extent and take steps towards the idea of barrier-free online applications for 
the benefit of European citizens, both the Coordination Regulations and the Patient 
Mobility Directive have had limited practical outcomes so far. Nevertheless, the 
works in relation to bringing EESSI to life, to supporting the creation of 
interoperable eHealth and e-prescription systems and the establishment of the 
patients’ right to their medical record is a promising start. 
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VI. CONCLUSIONS AND DE LEGE FERENDA SUGGESTIONS 
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“The free countries of Europe must not only 
demonstrate concern for the maintenance of peace, 
security and the good organization of their economy; 
there is another concern we have no right to ignore – 
human beings. If there is one area where we must act 
generously, it is in the area of health. If there is one 
area that seems to lend itself to unification, it is in the 
struggle against disease.”1134 
 
 
The main concept of the research has been to take a look beyond the words of 
the legislation, to make the patients the centre of interest and to bring a better 
understanding of those (potential) problems patients face when obtaining healthcare 
abroad. In searching for the answer whether free movement of patients exists in the 
European Union, the research led to the conclusion that the desired ‘borderless 
Europe’ is yet far away for European patients and despite its benefits, the long-
awaited Patient Mobility Directive did not bring much of a change in this sense. 
 
One might wonder why it is this difficult to tackle the problems of cross-border 
healthcare, whereas it involves a rather limited number of patients1135 and healthcare 
expenditure.1136 In my opinion, the main reason is that the field of healthcare is a 
multi-player arena where many different interests (of the patients, healthcare 
providers, healthcare funds, national governments, Union institutions etc), different 
competences (basically of the Member States and various EU institutions, but also 
within the Member States competences are often allocated among different levels, 
e.g. federal, regional, local) and different ideologies collide. This creates a tense 
                                                 
1134
 Citation from the speech of Robert SCHUMAN, one of the Founding Fathers of the European 
Communities, on 12 December 1952 in Paris. 
http://www.cvce.eu/obj/expose_de_robert_schuman_a_la_conference_preparatoire_a_la_communaute
_europeenne_de_la_sante_paris_12_decembre_1952-fr-1fba65da-1ae8-45a4-beb5-
e299ed4b4c6c.html (20 May 2014) 
1135
 See footnote 4. 
1136
 See footnote 5. 
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political atmosphere in which the patients’ well-being, which is supposed to be the 
starting point and the main aim of any health-related arguments, runs the risk of 
evaporating in the process. This might – at least partly – explain why, after more 
than fifty years of healthcare coordination and more than one and a half decades 
since the groundbreaking judgements of the ECJ,1137 European patients are still left 
with restricted cross-border mobility rights and impediments of free movement both 
from legal and non-legal points of view. 
In the former sections of my dissertation I focused on the individual problems 
accompanying cross-border patient movements within the European Union and 
suggested some possible solutions to tackle them. In this last chapter, however, I 
sketch a more comprehensive, global solution to enforce the patients’ mobility rights 
in Europe. Hereby I reflect upon the theses of this dissertation, which served as 
guiding lights throughout my research and offer de lege ferenda suggestions. I 
conclude this chapter with a table summarising the outcome of my research. (Table 
17) 
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 See footnotes 303 and 304. 
Gabriella BERKI: Cross-border patient mobility: The legal framework of obtaining 
healthcare abroad within the European Union – a patients’ perspective 
270 
 
VI.1. RIGHT AND ACCESS TO CROSS-BORDER TREATMENTS IN THE 
EUROPEAN UNION 
Thesis No11138 Research questions attached to Thesis No11139 
Although European patients have the right to 
cross-border healthcare, they encounter various 
difficulties – both of a non-legal and legal nature 
– that discourage or even deter them from using 
their rights. The current Union legislation on 
cross-border patient mobility has several defects 
due to which it cannot (fully) tackle the 
(potential) problems patients face when 
obtaining healthcare in a Member State other 
than their Member State of residence. 
(a) Do European patients have the right to obtain 
healthcare abroad? 
(b) Are European patients able to exercise their 
cross-border healthcare rights? 
(c) Which are the obstacles of cross-border 
patient movements? 
(d) Is the current legal framework capable of 
tackling these obstacles? 
 
It was confirmed that European border-crossing patients – although they have 
the right to access healthcare facilities in another Member State1140 – face serious 
difficulties when (intending to) obtain(ing) healthcare in a Member State other than 
their Member State of residence. The research led to the conclusion that the current 
Union legislation on cross-border patient mobility cannot fully cope with all the 
problems identified in the course of the research. 
VI.1.1. Tackling the obstacles of a non-legal nature – creating a solid 
institutional background 
On the one hand, concerning the practical obstacles, the research underlined 
that the issue of language gaps is not addressed on European level and the 
information rights of patients are not reassuringly settled.1141 
In my opinion, both problems could be efficiently tackled by creating a (more) 
empowered network of national contact points functioning as a knowledge and 
                                                 
1138
 See section I.2. 
1139
 These questions are investigated in Chapter III. 
1140
 See section III.1. 
1141
 See section III.2.1. 
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information centre for each party involved in cross-border healthcare provision, and 
having the means and infrastructure to provide remote interpretation and translation 
services for patients, and being coordinated by a central unit on supranational level. 
 
The findings of the research point to the need to create a solid institutional 
background in order to ensure the smooth functioning of European cross-border 
healthcare legislation in practice. As discussed supra,1142 the Patient Mobility 
Directive did take the first, important step towards the establishment of an 
institutional background for cross-border patient mobility by imposing the obligation 
on the Member States to designate one or more national contact points for cross-
border healthcare.1143 However, I find the provisions on the network of national 
contact points rather vague and I hold the firm opinion that for now, the Union is far 
from using the full potential of such a network. 
According to my ideas, a network of national contact points coordinated by a 
supranational central unit, a European Coordination Centre of Cross-Border 
Healthcare (hereinafter also referred to as ECC-CBHC), could be the right advocate 
for European (border-crossing) patients. This system could ensure that patients 
engaged in cross-border healthcare provision can exercise their rights simply by 
turning to a single institution on national level. 
In order to guarantee that these institutions work in the best interests of the patients 
and towards the enforcement of Union legislation without external influence, it is 
desirable that they function independently, separately from national healthcare 
funds.1144 There are a number of tasks in relation to cross-border patient mobility 
which could be delegated to these institutions. I enumerate the most essential ones 
below. 
(1) The national contact points serve as a knowledge base and information 
centre for cross-border healthcare. They should both provide information on request 
                                                 
1142
 See section III.2.1. 
1143
 Article 6 PMD. 
1144
 One might wonder though, how impartiality can be safeguarded at institutions as those in question 
when functioning on a national level. Nevertheless, the ECC-CBHC must monitor closely that the 
NCPs fulfill their tasks as required by European law. 
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and carry out information campaigns aimed at patients and providers. If the request 
for information concerns another Member State, they should contact the national 
contact point in that state at the shortest notice.1145 They could easily do so by means 
of a common online platform.1146 
(2) The national contact points should provide interpretation and translation 
services for patients in order to bridge potential language gaps. Modern information 
and communication technologies can significantly simplify this exercise.1147 
(3) The national contact points should establish a one-stop shop system1148 for 
patients by connecting each party involved in cross-border healthcare, and cooperate 
and frequently consult with patient organisations, healthcare providers and healthcare 
insurers.1149 
 
As to the central unit on EU level, its main mission is to enhance the cooperation 
between national contact points, monitor their functioning and deal with the tasks 
which go beyond borders, such as (1) training and researching on European cross-
border healthcare, (2) organising multilateral seminars and consultations where 
                                                 
1145
 Article 6 (2) PMD. See also section III.2.1.3. In this sense, I think they could function similarly to 
the SOLVIT network, but specialised in cross-border healthcare issues. Yet, differences are that (1) 
whereas SOLVIT is a service provided by the national administration of each Member State, NCPs 
must be independent institutions functioning on a national level, (2) whereas SOLVIT mostly deals 
with cases when public authorities breach Union law, NCPs must have a broader competence and deal 
with any issues related to cross-border healthcare and also, (3) whereas SOLVIT is mainly approached 
online, NCPs should offer various means by which they can be contacted by patients. 
However, the rules on the establishment and functioning of the SOLVIT network can provide some 
ideas. See European Commission: Communication from the Commission to the Council, the European 
Parliament, the Economic and Social Committee and the Committee of the Regions - Effective 
Problem Solving in the Internal Market ("SOLVIT"). COM (2001) 0702 final. 27. 11. 2001; European 
Commission: Commission Recommendation of 7 December 2001 on principles for using ‘SOLVIT’ – 
the Internal Market Problem Solving Network. C (2001) 3901. OJ L 331 of 15 December 2001 and 
European Commission: Commission Recommendation of 17 September 2013 on the principles 
governing SOLVIT. C (2013) 5869 final. 17. 9. 2013. 
1146
 See footnote 521. 
1147
 See section III.2.1.2. 
1148
 The point of a “one-stop shop for cross-border problems” is very well summarised by the 
Commission: Different mechanisms to assist citizens […] must also be better co-ordinated. The world 
looks different through the eyes of a citizen […] than through the eyes of the public sector. When 
citizens have a problem in the Internal Market, whether it relates to a bad experience when buying 
goods across borders or when trying to exercise their civil liberties, they do not wish to wander 
around looking for a helping hand. They want one door to knock on: A one-stop access to clear 
information about their rights, advice and a remedy. COM (2001) 0702. 
1149
 Article 6 (1) PMD. 
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experts can share their experience, (3) working on methods to develop cross-border 
mechanisms and (4) operating the European Healthcare Fund.1150 
 
One could argue that creating this system would add to the European bureaucracy 
and necessitate further investment. Without any doubt, investment would be 
needed.1151 However, taking into account that a network of national contact points is 
already operational, this reform would not start from zero but improve an existing 
structure in favour of the patients. I believe that a measure which could directly lead 
to increased awareness and comfort of the patients makes this investment reasonable 
and proportionate. 
  
                                                 
1150
 See section VI.2. infra. 
1151
 See section VI.4.3. infra. 
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VI.1.2. Tackling the obstacles of a legal nature – revamping European patient 
mobility legislation 
On the other hand, concerning the legal obstacles, the analysis showed that 
there are numerous weak points in the current European legislation on cross-border 
patient mobility. The legislative body is complex, the relation between the different 
legal tools is unclear, the administrative procedures are often lengthy and 
burdensome, the monitoring and enforcing mechanism is poor and the discretion of 
the national healthcare authorities restricts cross-border patient movements. In order 
to serve European patients better, both the legislation and the administration of 
patient mobility should be considerably simplified, the parallelisms should be ceased 
and the administration should be improved in a patient-friendly way.1152 
I found that these defects could be overcome by a consistent, integrated legal system 
which builds on the legacy of fifty years of healthcare coordination and which is 
complemented by the innovations of case law and the Patient Mobility Directive. The 
proposed integrated legal scheme is based on equal cross-border healthcare 
entitlements for each insured person without a distinction between planned and 
unplanned care, with as little administrative burden as possible and with access to 
any legally functioning healthcare provider who meets the universalised European 
standards. 
 
It is absolutely necessary to create a consistent legal framework which takes the 
interests of the (border-crossing) patients into due account. As I see it, the 
complexity of the issues related to cross-border patient mobility excludes the 
possibility to unite all the relevant rules in one single legal tool and requires a fine-
tuned, contradiction-free multi-level legislation instead. An integrated European 
patient mobility legislation has two basic tasks, namely (1) providing patients with 
clear provisions on their entitlements and (2) serving European patients better by, 
among others, ceasing the existing parallelisms. 
                                                 
1152
 See section III.2.2. 
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In my opinion, to design the integrated legislation of free movement of patients, the 
structure of the free movement legislation1153 could be used by analogy. In the field 
of free movement of workers, the basic entitlements are incorporated into a 
Regulation,1154 and a Directive has recently been adopted in order to facilitate the 
exercise of rights conferred on the workers.1155 
 
I believe that although the Coordination Regulations were initially not drafted for 
freely moving patients, they provide a solid basis to integrate the core of cross-border 
patient mobility rights into. The social security coordination legislation has been 
functioning for more than half of a century now and, although it has its limitations, it 
is undoubtedly one of the strongest shields of social security rights of people moving 
within the European Union. Therefore, I think that with some conceptual 
modifications it can be turned into an effective tool in the hands of border-crossing 
patients. 
Besides redesigning the sickness chapter of the Coordination Regulation, the Patient 
Mobility Directive should be kept as a complementary element of the legislation. It 
has great assets in relation to issues which do not fit in the Regulations, such as the 
network of national contact points1156 and cross-border cooperation.1157 These 
provisions do not overlap with the ones in the Regulations. The parallelisms are thus 
ceased in this respect. However, the Directive itself should also be improved. 
 
The research underlined the need for a drastic simplification both in terms of 
legislation and administration. This revision of the Coordination Regulations should 
definitely involve (1) the prior authorisation requirement, (2) the distinction between 
planned and unplanned care and (3) the circle of healthcare providers which patients 
                                                 
1153
 This field certainly has common points with patient mobility and – similar to the coordination of 
social security systems – has been long regulated by EU law. See footnote 181. 
1154
 Regulation (EU) No 492/2011 of the European Parliament and of the Council of 5 April 2011 on 
freedom of movement for workers within the Union. 
1155
 Directive 2014/54/EU of the European Parliament and of the Council of 16 April 2014 on 
measures facilitating the exercise of rights conferred on workers in the context of freedom of 
movement for workers. OJ L 128 of 30 April 2014. 
1156
 Article 6 PMD. 
1157
 Chapter IV PMD. 
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can turn to when using their cross-border healthcare rights. These issues are detailed 
in the next sections below. 
VI.1.2.1. Rethinking the prior authorisation requirement 
As to prior authorisation required for planned treatment abroad, the baseline 
of the patient mobility case law was that the Treaty precludes national rules which 
have the effect of making the provision of services (and the consumption of services) 
between Member States more difficult than the provision of services purely within 
one Member State.1158 Nevertheless, after refusing a series of possible grounds for 
justification of restrictions, the Court acknowledged that planning objectives can 
justify the maintenance of prior authorisation schemes.1159 Might the Member States’ 
heated objection1160 be – at least partly – responsible for the softening of the Court’s 
approach?1161 Whether or not this directly or indirectly influenced the jurisprudence, 
the fact is that opening up the possibility for the Member States to make 
reimbursement of medical costs occurred abroad subject to prior authorisation eroded 
the patients’ rights to cross-border treatments. Moreover, the Patient Mobility 
Directive took it a step further, and introduced grounds for justification – based on 
the protection of public health – which were not even verified by the Court.1162 As a 
consequence, the cross-border mobility of European patients is more restricted today 
than it was at the end of 1990s. 
It is clear that the great majority of European patients prefer to use healthcare 
facilities which are close to their home and which they are familiar with.1163 Hence, 
no indicators suggest that cross-border patient movements can be expected to grow 
                                                 
1158
 See footnote 308. 
1159
 See footnotes 735-736 and Annex II. 
1160
 See footnote 921. 
1161
 The question is especially valid in the light of the aftermath of the Court’s decisions in the Pierik 
cases. See footnote 314. 
1162
 See footnotes 756 and 757. 
1163
 See footnote 6. 
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into a mass phenomenon in Europe:1164 as it seems now, patient mobility will remain 
limited, although very important in certain areas and certain cases.1165 Nevertheless, 
the Member States’ vehemence with which they guard their national healthcare 
(authorisation) schemes against border-crossing patients hardly correlates with the 
figures on the current volume of cross-border patient movements. 
It might be the right time to raise the question: is the authorisation mechanism still 
necessary and proportionate? What would the implications be of the removal of the 
prior authorisation requirement? One might wonder what the impact of the full 
liberalisation of cross-border patient mobility might be. 
Since factual evidence does not support the Member States’ argument that the 
current volume of patient movements would constitute a major risk to their 
healthcare systems, the justification that prior authorisation should be maintained in 
meeting the desire to control costs and to prevent as far as possible, any wastage of 
financial, technical and human resources1166 is hardly valid in today’s 
circumstances. It can thus be argued that the prior authorisation requirement should 
be erased from the Regulations. Nevertheless, upon the occasion of abolition of prior 
authorisation schemes, a practical counterbalance could be introduced into the 
protection of national healthcare systems against any possible extreme change in 
patient mobility trends.1167 An ‘in case of emergency’ clause (hereinafter also 
referred to as ICE clause) could be inserted into the Regulations – similar to the one 
which has been applied to the free movement of workers in the newly accessed 
Member States – indicating that when a Member State undergoes or foresees 
disturbances in its national healthcare system which could seriously threaten the 
standard of healthcare provision or the national healthcare scheme in the given 
Member State, that Member State shall inform the Commission and other Member 
State thereof and shall supply them with all relevant particulars. On the basis of this 
information, the Member State may request the Commission to permit certain 
                                                 
1164
 The generally low willingness of insured persons to move across borders in order to obtain 
healthcare does not prognosticate a radical change in this respect. 
1165
 See footnote 7. 
1166
 See footnote 341. 
1167
 After all, it does not serve patients’ interest if national healthcare systems get hamstrung. 
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restrictions in order to restore to normal the situation in the healthcare system 
concerned.1168 
This way, the burden of proof would be shifted: instead of the patient being required 
to request an authorisation from the competent institution in advance and meet the 
conditions laid down in the legislation in order to receive an authorisation, the 
Member State has to provide evidence that patient movements put its system at a 
considerable risk. If such evidence cannot be given, patients are free to access 
healthcare in any other Member State. 
 
There are a number of arguments which the Member States would put forward 
against the idea of removing prior authorisation. I presume that beside (1) the 
argument that such a measure jeopardises their healthcare planning, Member States 
would play (2) the ‘combating fraud’ card and would argue that the maintenance of 
prior authorisation also serves (3) the purpose of safeguarding quality in the national 
healthcare schemes. I question whether any of these causes could justify this 
restriction of free movement of patients for the following reasons: 
 
(1) I have already dealt with the justification based on planning objectives in 
this section, where I stated that it is doubtful that the current features of patient 
movements would significantly influence national healthcare planning objectives. If 
so, and the individual Member State provides hard evidence on that, necessary and 
proportionate restrictions might indeed be permitted by the Commission on the 
ground of the aforementioned ICE clause. However, this restriction might not 
necessarily be the reinvention of prior authorisation. 
 
(2) It is undoubtable that another argument which should be included in any 
discussion about liberalising healthcare provision is how fraud and abuse can be 
                                                 
1168
 See by analogy for instance the Act concerning the conditions of accession of the Czech Republic, 
the Republic of Estonia, the Republic of Cyprus, the Republic of Latvia, the Republic of Lithuania, 
the Republic of Hungary, the Republic of Malta, the Republic of Poland, the Republic of Slovenia and 
the Slovak Republic and the adjustments to the Treaties on which the European Union is founded – 
Annexes to the Act of Accession – 1. Freedom of movement for persons, Article 7. 
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prevented and combated. Although this is a very complex topic,1169 it must 
nevertheless be underlined that more freedom on the one hand requires more control 
on the other. Without going into detail, I would like to point out that – in my view – 
controlling mechanisms should be developed at least on three levels, namely 
concerning fraudulent and abusive behaviours of (a) patients, (b) providers and (c) 
healthcare funds. 
(a) To prevent patients who lack entitlement from exercising cross-border healthcare 
rights, it should be made possible that healthcare providers anywhere in Europe are 
able to check patients’ entitlements. A European database available to each 
registered and accredited, legally functioning healthcare provider could tackle this 
problem.1170 However, considering the difficulties of the EESSI project,1171 it is 
highly questionable whether such a database could be put in place in the near future. 
An improved version of the European Health Insurance Card1172 should continue to 
serve as a universal European document incorporating entitlement to cross-border 
healthcare. Fraudulent usage of the EHIC (e.g. forged or fake cards or usage by 
someone else than the person the card was issued for) must be reported and 
investigated in each case. 
(b) On the one hand, providers must be closely monitored in terms of quality, but 
also their pricing practice and their administrative mechanisms should be checked by 
independent institutions. It must be made sure that providers respect the principle of 
equal treatment1173 and comply with the European rules of (cross-border) healthcare 
provision. 
                                                 
1169
 On the topic see among others Arash RASHIDIAN, Hossein JOUDAKI and Taryn VIAN (2012): No 
Evidence of the Effect of the Interventions to Combat Health Care Fraud and Abuse: A Systematic 
Review of Literature. PLoS One, Vol 7 Issue 8, 
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3427314/ (20 June 2014) and Marion DEL SOL (2014): 
Taking Measures Against European Healthcare Fraud. In HENNION and KAUFMANN (2014). 
1170
 Similar databases on nation level, where providers can check – or are even obliged to check – the 
entitlement of patients, exist in most Member States. The Hungarian system is outlined in footnote 
803. 
1171
 See section V.1.2. 
1172
 See section III.2.2.2.B. 
1173
 See footnote 550. 
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(c) Last but not least, healthcare funds should also be subject to monitoring, 
especially in relation to requests for reimbursement from the European Healthcare 
Fund.1174 It is of utmost importance that the sources of the fund are used rightfully 
and for the purpose they are intended for. 
Although there is no dispute that cross-border fraud must be prevented and tackled, 
the methods might be different. I cannot share the opinion that prior authorisation is 
an appropriate tool for that purpose.1175 I agree with DEL SOL on the idea that the key 
to effectively fight fraud and abuse in the field of healthcare is in an efficient inter-
institutional cooperation.1176 I think that a central coordinating institution – as 
suggested above – would hugely contribute to the common work of both European 
and national institutions in this respect. 
 
(3) Member States argue that prior authorisation systems do not only enable 
them to control costs and avoid wastage of resources1177 but also to safeguard the 
quality of healthcare services,1178 thus to protect both public health and the health of 
                                                 
1174
 See section VI.2 infra. 
1175
 The Court of Justice is reluctant to easily accept the argument of the fight against or the 
prevention of fraud and abuse of rights as proper justifications for impediments on free movement in 
relation to non-corporate entities. 
See among others the Court cases C-200/02 Kunqian Catherine Zhu and Man Lavette Chen v 
Secretary of State for the Home Department [ECR 2004 Page I-9925], where the Court refused the 
UK’s argument that the appellants in the main proceedings were not entitled to rely on the 
Community provisions in question, because Mrs Chen's move to Northern Ireland with the aim of 
having her child acquire the nationality of another Member State constitutes an attempt to improperly 
exploit the provisions of Community law (34.); and C-577/10 European Commission v Kingdom of 
Belgium [ECR 2012 Page 00000], where the Court expressly declared in relation to a prior declaration 
requirement for foreign posted employed and self-employed workers that a general presumption of 
fraud was not sufficient to justify a measure which compromises the objectives of the TFEU (53.). 
Furthermore, see on this topic Rita DE LA FERIA and Stefan VOGENAUER (2011): Prohibition of Abuse 
of Law. A New General Principle of EU Law? Oxford: Hart Publishing. 
1176
 DEL SOL (2014: 346-349.) 
1177
 See footnote 341. 
1178
 The issues related to the quality of healthcare services and patient safety are highly relevant in a 
cross-border context as well, but considering their complexity, they are beyond the scope of this 
dissertation. See footnote 27. See also Helena LEGIDO-QUIGLEY, Martin MCKEE, Ellen NOLTE and 
Irene A GLINOS (2008): Assuring the quality of health care in the European Union. Brussels: 
European Observatory on Health Systems and Policies, especially chapter III titled Patients, quality of 
care and cross-border care in the European Union. 
However, it is unavoidable to mention also this aspect among my suggestions. 
Gabriella BERKI: Cross-border patient mobility: The legal framework of obtaining 
healthcare abroad within the European Union – a patients’ perspective 
281 
 
individual patients.1179 As described supra, these arguments came up at an early 
phase in the healthcare case law,1180 and although the Court declined them, they 
survived and became legal grounds of justification of prior authorisation in the 
Patient Mobility Directive.1181 The questions which must be raised here are whether 
the authorisation system is the right measure to maintain quality, and how the 
removal of the prior authorisation requirement could be compensated in this respect. 
I share the opinion of the Court that the angst related to the quality of services on a 
more liberal healthcare market cannot justify the restriction of patients’ movements. 
Instead, any entities providing healthcare services on the territory of the Union 
should be closely monitored. European institutions1182 and responsible national 
authorities should effectively cooperate to ensure that in all Member States patients 
receive good quality healthcare services. To this end, quality standards should be 
harmonised1183 and a European registration and accreditation scheme for healthcare 
                                                 
1179
 To the argument of protecting public health via the supply of goods and the provision of services 
by persons authorised by law to pursue the profession, the ECJ answered that since the conditions for 
taking up and pursuing regulated professions have been harmonised on Community level, the 
provision of a treatment by a healthcare provider established in another Member State provides 
guarantees equivalent to those provided by a healthcare practitioner established in the national 
territory. C-215/87 Schumacher, 20; C-62/90 Commission v Germany, 18; C-120/95 Decker, 41-45; 
C-158/96 Kohll, 44-49; C-145/03 Keller, 50, 52; C-444/05 Stamatelaki, 37. See footnote 327. 
1180
 The argument first appeared before the Court at the end of the 1980s. See footnote 1179. 
1181
 See section III.2.2.1.C., especially footnotes 756 and 757. 
1182
 There is a number of Union institutions with a wide range of tasks related to healthcare among 
which they also have responsibilities in human health and safety protection. The most notable of these 
agencies are the European Medicines Agency, the European Monitoring Centre for Drugs and Drug 
Addiction, the European Centre for Disease Prevention and Control and the European Chemicals 
Agency. On this topic, see Govin PERMANAND and Ellen VOS (2010): EU regulatory agencies and 
health protection. In MOSSIALOS et al. (2010). 
1183
 Harmonising measures concerning special fields of healthcare already exist, such as (1) Council 
Directive 90/385/EEC of 20 June 1990 on the approximation of the laws of the Member States 
relating to active implantable medical devices, (2) Council Directive 93/42/EEC of 14 June 1993 
concerning medical devices, (3) Directive 98/79/EC of the European Parliament and of the Council of 
27 October 1998 on in vitro diagnostic medical devices, (4) Directive 2001/20/EC of the European 
Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and 
administrative provisions of the Member States relating to the implementation of good clinical 
practice in the conduct of clinical trials on medicinal products for human use, (5) Directive 
2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community 
code relating to medicinal products for human use, (6) Directive 2002/98/EC of the European 
Parliament and of the Council of 27 January 2003 setting standards of quality and safety for the 
collection, testing, processing, storage and distribution of human blood and blood components, (7) 
Directive 2004/23/EC of the European Parliament and of the Council of 31 March 2004 on setting 
standards of quality and safety for the donation, procurement, testing, processing, preservation, 
storage and distribution of human tissues and cells, (8) Regulation (EC) No 726/2004 of the European 
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providers should be developed. This way, it could be ensured that persons and 
institutions providing healthcare services in the Union meet the universal minimum 
standards set up on EU level. Furthermore, it must be frequently checked whether 
those standards are maintained throughout the daily functioning of the healthcare 
provider. I would find it laudable if a separate supranational institution, a European 
Monitoring Centre for Healthcare Provision, were established to carry out this task. 
 
Of course, less radical solutions than the abolishment of the prior authorisation 
schemes also exist which are a compromise between national interests and patients’ 
rights, such as a prior notification system described supra.1184 However, none of 
these solutions would be as beneficial for the patients as liberating them from the 
requirement of prior authorisation. 
Either way, the Member States would possibly heavily object to any measures that 
loosened their control over patient movements. Therefore, any alteration requires 
careful consideration of the interests of each party involved in order to reach a 
substantive solution. 
VI.1.2.2. Rethinking the distinction between planned and unplanned care 
The distinction between planned and unplanned care has occupied a place on 
the list of difficulties of healthcare coordination.1185 From a conceptual point of view, 
the difference lies in the (prior) intention of the person concerned, namely whether or 
not he/she willingly travelled abroad in search of medical treatment. However, a 
                                                                                                                                          
Parliament and of the Council of 31 March 2004 laying down Community procedures for the 
authorisation and supervision of medicinal products for human and veterinary use and establishing a 
European Medicines Agency, (9) Directive 2005/36/EC of the European Parliament and of the 
Council of 7 September 2005 on the recognition of professional qualifications and (10) Directive 
2010/53/EU of the European Parliament and of the Council of 7 July 2010 on standards of quality and 
safety of human organs intended for transplantation. 
1184
 See section III.2.2.2.C. 
1185
 See footnote 30. 
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genuine problem is how the intention of the person – when not obvious from the 
circumstances – can be unfolded.1186 
From an administrative point of view, the different nature of the health risks explains 
the different administrative procedures. Whereas necessary care, which may 
occasionally occur during a temporary stay abroad, can be obtained simply by 
presenting a valid European Health Insurance Card to the healthcare provider,1187 in 
case of planned care, where the aim of the travel is to receive healthcare in another 
Member State, a prior authorisation from the competent institution must be 
requested.1188 However, in a system in which no prior authorisation is required, as 
proposed above, the legal distinction between occasional and planned care becomes 
outdated. 
 
The removal of the distinction is in line with the Patient Mobility Directive, although 
in the Directive the lack of a distinction accompanied by the maintenance of the 
possibility to require prior authorisation resulted in an inconsistent situation.1189 
Nevertheless, with this change, instead of investigating the person’s intention, which 
is problematic, only the patient’s entitlement should be examined. 
However, this leads us to the next problem, namely how to define the benefit 
package patients are entitled to. Also on this point, basically two reverse approaches 
collide: either the entitlement to benefits provided for by the Member State of 
treatment or the entitlement to benefits provided for by the competent Member State 
is granted. Whereas in case of necessary treatment or when the person concerned 
lives outside of the competent state the full integration principle is applied based on 
equal treatment, so patients are treated as if they were insured in that country and as a 
consequence have access to the benefits included in that benefit basket;1190 when 
obtaining planned care, patients – as a principle – should rely on the benefits 
                                                 
1186
 See section III.2.2.1.B., especially C-255/13 I v HSE in footnote 537. 
1187
 On the issues related to the EHIC, see section III.2.2.2.B. 
1188
 On the issues related to prior authorisation, see section III.2.2.2.C. 
1189
 See section III.2.2.2.B. and Table 11. 
1190
 See footnotes 544 and 550. 
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determined by the competent Member State.1191 Hence, the question becomes: if the 
distinction between planned and unplanned care disappears, which benefit coverage 
concept should be put in place?  
The Directive opted for allowing the competent Member State to define which 
benefits the patients can obtain.1192 Although the Court has made efforts to limit the 
discretion of the Member States when determining the benefit coverage,1193 this 
choice still belongs to the core of the national autonomy in organising healthcare 
schemes.1194 The question arises, though, what must be done when there is no 
possibility – e.g. due to urgency – to check whether the proposed treatment, which is 
provided for in the Member State of treatment, is covered by the competent Member 
State. 
In my view, the most ideal solution to this dilemma is the progressive harmonisation 
of the national benefit packages,1195 with the aim to create standardised European 
benefit coverage.1196 It would guarantee the exact same entitlements to each insured 
person throughout Europe, who could then freely decide in which Member State 
he/she exercises his/her right to these benefits. However, this development would 
necessitate tremendous investments in many Member States. The likelihood that this 
achievement would be reached, which would raise European healthcare policy to a 
whole new level, is thus rather low under the current political and economic 
circumstances.1197 
                                                 
1191
 See section III.2.2.1.C. 
1192
 Article 7 (1) PMD. 
1193
 See section III.2.2.1.C. 
1194
 See footnote 648. 
1195
 See footnote 671. 
1196
 See footnote 672. 
1197
 See section VI.4. 
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VI.1.2.3. Rethinking the circle of available providers 
Another long-lasting teething trouble of European social security 
coordination is that only national statutory systems are coordinated.1198 The 
consequence of this characteristic in the field of healthcare is that under the scope of 
the Regulations, patients can – in principle –obtain treatments only from providers 
affiliated to the statutory healthcare system of the Member States.1199 This not only 
causes uncertainty and misunderstandings concerning the recognition of which 
providers do belong to the system and which do not,1200 but more importantly, it 
considerably limits the patients’ freedom to choose which provider they wish to turn 
to. 
It is a great merit of the Patient Mobility Directive that it covers both public and 
private providers, thus offering the patients significantly more options. This 
development should be built into the proposed integrated legislation of European 
patient mobility, which requires the Regulations to open up for private providers.1201 
Since the Member States did accept their inclusion for the Patient Mobility Directive, 
there is a chance that this could be transformed into the Regulations without major 
objections. Nevertheless, it must not be forgotten that private providers are now 
included because – by applying the principle of free movement of services – there 
was no justification to exclude them. However, in case of the Regulations – which 
are traditionally based on the free movement of persons – this is a considerable 
change which does not only affect the healthcare domain but the coordination of 
                                                 
1198
 The limitation of the Regulations might have been appropriate at the end of the 1950s, but in 
today’s social security systems the exclusion of the voluntary and supplementary elements of social 
security coverage is no longer acceptable. 
1199
 Of course, competent Member States are free to decide whether they cover costs occured at 
private providers, but they are not obliged to do so. See footnote 806. 
1200
 However, as discussed in section III.2.2.2.B., this problem can be easily fixed. See footnotes 808 
and 809. 
1201
 This issue certainly goes beyond the scope of healthcare coordination, and concerns also other 
social security branches, such as private pension schemes. However, this is not the subject of this 
dissertation. 
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social security schemes as a whole and Member States might be reluctant to go 
beyond the classic coordination measures and move towards harmonisation.1202 
I think what needs to be understood is that upgrading European patients’ legal status 
is hardly imaginable without deeper social integration, improved coordination and 
harmonisation. 
  
                                                 
1202
 See footnote 358 and section VI.4. infra. 
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VI.2. FINANCING CROSS-BORDER TREATMENTS IN THE EUROPEAN 
UNION 
Thesis No21203 Research questions attached to Thesis No21204 
Although Union law entitles European border-
crossing patients to claim the reimbursement of 
costs occurred in relation to cross-border 
healthcare, the interaction between the different 
financial regimes which are in place in the 
European Union is often unclear and results in 
confusion on the patients’ side. Furthermore, the 
financial mechanism of the Patient Mobility 
Directive has the potential to increase inequality 
and results in a one-sided European patient 
mobility pattern. 
(a) Which alternatives do European patients have 
to cover the costs of medical treatment abroad? 
(b) Which conditions must be met in order to 
guarantee that cross-border healthcare is covered 
by the patient’s health insurance? How can the 
patients get reimbursed under the current legal 
mechanisms in the European Union? 
(c) How might the financial regimes affect 
European patient movements? 
 
In relation to the financing of medical treatments abroad, the research 
highlighted that the currently existing reimbursement regimes greatly differ and that 
their interaction is not always clear. It is beyond dispute that the Regulation rules on 
financing are more favourable for the patients, since – in principle – they do not need 
to advance the medical costs and the full cost of medical intervention abroad is 
covered except for the co-payments. In relation to the latter, the introduction of the 
Vanbraekel-supplement results in a controversial situation, which – as demonstrated 
supra – leaves room for reverse discrimination.1205 The single asset of the Directive 
in this regard is that it offers reimbursement if the treatment was provided by non-
contracted healthcare providers, who are excluded from the scope of the 
Regulations.1206 
In the integrated scheme of patient mobility legislation, I suggest to apply the 
Regulations’ financial mechanism as a default reimbursement regime based on full 
cost coverage and inter-institutional settlement of financing. To compensate the 
Member States’ healthcare budgets for the expected extra costs resulting from the 
                                                 
1203
 See section I.2. 
1204
 These questions are investigated in Chapter IV. 
1205
 See footnote 1022. 
1206
 See section IV.2. 
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liberalisation of cross-border patient movements,1207 a European Healthcare Fund 
could be set up. 
 
Possibly the most complicated point of melding the Directive’s service-based 
concept with the Coordination Regulations is the highly different financing 
mechanisms of the two legal tools.1208 It is also the source of the Member States’ 
deepest concerns, worrying about the possible effects of cross-border patient 
movements on the financial equilibrium of their national healthcare schemes. 
The problem is that with the intention to avoid affecting the healthcare spending of 
the Member States, the Court – and by incorporating its case law, the Directive – 
created a parallel reimbursement mechanism, which is much less beneficial for the 
patients than the Coordination Regulations, and as a result of which many patients 
are practically deprived of the opportunity to exercise their cross-border healthcare 
rights.1209 The question is how to synchronise these regimes under the scope of an 
integrated system in favour of the patients, but without significantly intervening into 
national healthcare budgets. 
In my opinion, once again the starting point of the integrated system must be the 
financing mechanism of the Regulations, since it ensures higher protection for the 
patients. However, if the applicability of the tariff of the Member State of treatment 
is maintained while no prior authorisation is in place, unpredictable patient 
movements might produce high medical invoices and feed the Member States’ 
budgetary fears. This might affect especially those Member States in which tariffs 
                                                 
1207
 See section VI.1.2.1. 
1208
 See table 16 supra. As discussed supra (see Chapter IV.), the Regulations operate a protective 
financing mechanism, based – in principle – on the full reimbursement of costs and inter-institutional 
financial arrangements. In this system, patients are not required to advance the medical costs occurred 
abroad – unless the same requirement exists for the insured persons of that state (in the countries 
operating a reimbursement system, patients do advance the costs and get reimbursed afterwards) – and 
they only need to pay the co-payment. (On details of the financing regime of the Regulations, see 
section IV.2.1.) Contrarily, under the Directive’s regime, Member States are obliged to reimburse 
costs up to a maximum of the level of the domestic tariff in the Member State of affiliation, which 
leaves the price difference at the expense of the patient. Moreover, patients are expected to pay 
upfront and request (often only partial) reimbursement afterwards. (On details of the financing regime 
of the Directive, see section IV.2.2.) 
1209
 See section IV.2.3. 
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are considerably lower than in others. Thus, this scenario has the potential to deepen 
the division between western and northern Europe as patient exporters, where 
patients can easily access healthcare systems with lower tariffs, and eastern and 
southern Europe as patient importers, where patients have less chance to head 
towards countries with higher tariffs. A compensation mechanism is needed to tackle 
this defect. 
As an ambitious solution, I suggest to set up a European Healthcare Fund, which 
compensates the Member States for the difference between their domestic tariffs and 
the foreign tariffs invoiced for them. Hence, cross-border patient movements would 
leave national healthcare spending basically intact.1210 This European healthcare 
budget would ensure that patients of worse off Member States have the same 
opportunities in terms of cross-border healthcare as those with better financial 
conditions. It would thus be a manifestation of European supranational social 
solidarity.1211 
                                                 
1210
 For instance, in a given Member State A the required treatment costs 3000 euros, and in Member 
State B the same treatment costs 1000 euros. The patient wishes to obtain the treatment in MS A, 
whereas he/she is insured in MS B. There is a co-payment of 50 euros. Currently, the patient has 
multiple options which result in different financial outcomes on his/her side. 
(1) He/she uses his/her own means to finance the treatment, the financial burden left on the patient 
thus being 3000 euros.  
(2) He/she requests an authorisation under the Regulation. If the request is declined, he/she can still 
either use the Directive’s mechanism or finance the treatment him/herself. However, if the request is 
accepted and the authorisation is issued, the financial burden left on the patient is only 50 euros. 
(3) If the treatment is not subject to authorisation under the Directive, he/she can receive the treatment 
and pay 3000 euros upfront, but get back 1000 euros as a reimbursement, the financial burden left on 
the patient thus being 2000 euros. If the treatment is subject to authorisation and the authorisation is 
provided, the same rules apply, whereas if the request for authorisation is refused, he/she has to bear 
all the costs. 
Under the proposed integrated system, the patient has the right to receive the treatment abroad without 
prior authorisation. The healthcare provider in MS A has to send the invoice directly to the healthcare 
fund in MS B to which the patient is affiliated. The financing of the treatment comes from three 
sources: (1) the patient is invited to pay the co-payment of 50 euros; (2) MS B is obliged to finance up 
to its domestic tariff, in this case 1000 euros; (3) the remaining 1950 euros is financed from the 
proposed European healthcare fund. 
1211
 The idea of creating a common European fund for specific social purposes recently received a new 
stimulus. In Berlin on 13 June 2014, Commissioner László ANDOR outlined a scheme where the 
eurozone states would share the costs of a European short-term unemployment insurance. 
http://europa.eu/rapid/press-release_SPEECH-14-455_en.htm (18 June 2014). On a European 
unemployment insurance, see Sebastian DULLIEN (2012): A European unemployment insurance as a 
stabilization device – Selected issues. Paper prepared for DG EMPL. 
http://ec.europa.eu/social/BlobServlet?docId=10437&langId=en (5 December 2014). 
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However, an unavoidable question is where the revenues of this solidaristic fund 
should come from. In this respect also multiple options can be suggested; three of 
which are outlined below. 
(1) A possible alternative, which implies higher Union involvement, is that 
transfers are made from other European funds, such as the European Social Fund, for 
this special purpose. The advantage of this option is that it is based on a long-existing 
European fund. Transfers could thus be made rather promptly. Still, a huge 
disadvantage is that it takes away money from other (similarly important) social 
purposes. 
(2) Another solution – by analogy to what was proposed by Commissioner 
ANDOR in relation to the supranational unemployment scheme1212 – is that the Fund 
functions as a supranational healthcare insurance scheme; hence, all Member States 
pay a part of their revenues in the Fund. To this end, a universal contribution could 
be introduced to each insured person in Europe. 
I find this option fair and promising, because it embraces solidarity and unity, values 
which I think are supposed to be the leading stars of an enhanced social Union. 
However, it puts the financial burden directly on the citizens. Nevertheless, I think 
this burden – since shared by all insured persons in all the Member States – is far less 
per capita than the burden a patient might face in a cross-border situation without an 
appropriate financing mechanism. Therefore, I am convinced that this issue is worth 
further research. 
(3) Whereas countries with lower tariffs need to rely on the Fund to be able to 
pay medical invoices from other Member States, Member States with higher tariffs 
save money if their insured persons receive healthcare in a country with lower costs. 
Another element of cross-national solidarity would be, if a part of these savings 
would also be paid into the European healthcare fund. This is all the more 
reasonable, since otherwise Member States might be motivated to ‘outsource’ their 
patients to countries with good quality care but much cheaper treatments to save 
                                                 
1212
 See footnote 1211. 
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money.1213 The aim of the patient mobility legislation is certainly not to push patients 
– against their will – to receive healthcare services far from where they live, but to 
guarantee that in case they need or prefer to undergo a medical treatment in another 
Member State, they have both the right and the real possibility to do so on an equal 
basis without facing significant hurdles. Therefore, this option also seems to deserve 
more attention in the future. 
Nevertheless, with a well-functioning compensation mechanism in place the 
financing of cross-border patient movements would not significantly affect the 
financial balance of the national social security budgets. Hence, the Member States 
cannot use this argument to restrict the free movement of patients.1214 
 
Speaking of financial compensation mechanisms, I think the equality component is 
also essential in this respect. One of the most serious criticisms about the Patient 
Mobility Directive1215 and about the current patient mobility legislation in general1216 
is that it disproportionately benefits the highly mobile, educated, well-informed 
patients with higher incomes as opposed to the patients who have neither reliable 
information nor appropriate financial means to exercise their cross-border healthcare 
rights under the given framework.1217 Consequently, the Directive has the potential to 
reinforce the already existing healthcare inequalities. 
                                                 
1213
 It cannot be the aim of strengthening patients’ cross-border healthcare rights to encourage 
Member States to send their patients abroad instead of creating ideal circumstances for them to obtain 
healthcare at home if they prefer to do so. See in relation to long-term care CONNOLLY (2012). 
1214
 See footnotes 245 and 327. 
1215
 See footnote1056. 
1216
 See footnote 1055. 
1217
 The issue of the non-take-up of benefits deserves more attention both on political level and in the 
academic literature. Especially nowadays, when its counterpart, the misuse of benefits, is widely 
discussed (see also section VI.4.). On this topic, see Wim VAN OORSCHOT (1991): Non-take-up of 
Social Security Benefits in Europe. Journal of European Social Policy, Vol 1 Issue 1, 
https://perswww.kuleuven.be/~u0079125/wvo/ArtikelenOnline/non%20take-up.pdf (20 June 2014). 
The phenomenon is also known as the Matthew-effect, first described by Robert K. Merton in 1968. 
Robert K. MERTON (1968): Matthew-effect in Science. The reward and communication systems of 
science are considered. Science, Vol 159, 
http://www.unc.edu/~fbaum/teaching/PLSC541_Fall06/Merton_Science_1968.pdf (19 June 2014). In 
relation to healthcare, JOSEPH defined it as “the paradox that populations with a poor standard of 
health seem to achieve only meagre improvements over time, whereas those with a good standard of 
health seem to show continual, substantial improvement.” K. S. JOSEPH (1989): The Matthew effect in 
health development. British Medical Journal, Vol 298, p. 1497. 
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However, it can be argued that cross-border healthcare rights form an integral part of 
European social citizenship,1218 according to which citizens are granted the same 
entitlements and equal opportunities have to be ensured for them to enjoy these 
entitlements.1219 The suggestions made in this chapter serve this purpose. 
  
                                                                                                                                          
See also Flaminia TACCONI (2008): Freedom of Health and Medical Care Services within the 
European Union. Recent Jurisprudence of the European Court of Justice, with Particular Reference 
to Case C-372/04 Yvonne Watts, 16 May 2006. Zeitschrift für ausländisches öffentliches Recht und 
Völkerrecht, Vol 68, http://www.zaoerv.de/68_2008/68_2008_1_b_195_208.pdf (19 June 2014), pp. 
206-207. 
1218
 “If there is to be an EU social citizenship, it will have to erode rather than enshrine the 
differences in the capacity and willingness of Member States to provide social citizenship rights.” 
Scott L. GREER and Tomislav SOKOL (2014): Rules for Rights: European Law, Health Care and 
Social Citizenship. European Law Journal, Vol 20 No 1, p. 86. 
1219
 However, it is subject to discussion about to what extent an individual need can be prioritised as 
opposed to the needs of other patients. See GREER and SOKOL (2014: 79.) on absolute needs vs 
relative needs of patients. 
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VI.3. THE TIMELY PROVISION OF CROSS-BORDER TREATMENTS AND 
THE IMPACT OF ICT ON PATIENT MOVEMENTS IN THE EUROPEAN 
UNION 
Thesis No31220 Research question attached to Thesis No31221 
European healthcare systems should ensure the 
timely provision of healthcare. Waiting times are 
thus relevant to cross-border healthcare 
provision in many aspects. If waiting times in a 
Member State exceed a certain period, patients 
should have the right to seek treatment in 
another Member State on the account of their 
healthcare insurance. Therefore, it is in the 
common interest of both the Member States and 
the patients to apply efficient methods that have 
the potential of reducing waiting times, such as 
eHealth applications. 
(a) How can eHealth applications contribute to 
European cross-border patient mobility? 
 
 
European healthcare systems are challenged by increasing demand and 
increasing costs. As a result, efficiency optimising mechanisms are very much 
needed. The use of information and communication technologies in (cross-border) 
healthcare can bring benefits in various ways. Among other things, they can 
contribute to better resource utilisation, to shortening waiting lists and to 
empowering patients. 
Both the Coordination Regulations and the Patient Mobility Directive rely on modern 
technologies to a certain extent, but – as the research revealed – they are far from 
using the full potential of eHealth.1222 Since numerous risks of these technological 
solutions are not yet satisfyingly settled on European level, further actions are 
required in order to safely integrate these technologies into the European healthcare 
systems and thus into European cross-border patient mobility mechanisms.1223 
                                                 
1220
 See section I.2. 
1221
 This question is investigated in Chapter V. 
1222
 See section V.1. 
1223
 See section V.3. 
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The proposed integrated system of patient mobility legislation should be supported 
by ICT applications in various ways, such as (1) interoperable, digitalised databases 
where – among others – the insurance status of patients can be checked; (2) common 
online platforms where the administrative bodies involved can easily communicate 
with each other, and request and share information safely and (3) an ICT 
infrastructure which makes remote, simultaneous interpretation possible. 
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VI.4. THE LEGAL, POLITICAL AND ECONOMIC FEASIBILITY OF THE DE 
LEGE FERENDA SUGGESTIONS 
We live in a Europe which worships diversity, but where diversity ties our 
hands. As the Union has grown and pushed its own boundaries not only 
geographically but also in terms of the fields of life it influences, in the motto 
‘United in diversity’, emphasis shifted to the last word. Whereas in the beginning six 
– more or less – similar states united under the twelve stars of Europe,1224 today 
twenty-eight countries1225 try to gain footing there, diverse in their national identities, 
language, culture, political and social environment and economic capacity. In my 
opinion, the Union is reaching the point where a decision must be made: it either 
rises above the national differences and finds a way to create an enhanced European 
integration along the line of our common values; or the dream of the United States of 
Europe1226 falls apart for good. 
 
Within the area of healthcare the question rises whether European values, such as 
universality, access to good quality care, equity, solidarity1227 and the right to 
healthcare1228 overcome national diversity and lead to ‘Europe for patients’; or 
whether national fears and interests remain predominant over patients’ social rights 
in a divided healthcare market.1229 
                                                 
1224
 On the relation between European symbols and European identity, see Michael BRUTER (2003): 
Winning hearts and minds for Europe. The Impact of News and Symbols on Civic and Cultural 
European Identity. Comparative Political Studies, Vol 36 No 10. 
1225
 Thirty-two, if we count the EEA countries and Switzerland as well. See footnote 296. 
1226
 “It is to re-create the European Family, or as much of it as we can, and to provide it with a 
structure under which it can dwell in peace, in safety and in freedom. We must build a kind of United 
States of Europe. In this way only will hundreds of millions of toilers be able to regain the simple joys 
and hopes which make life worth living. The process is simple. All that is needed is the resolve of 
hundreds of millions of men and women to do right instead of wrong and to gain as their reward 
blessing instead of cursing.” Cititation from Winston CHURCHILL’s speech to the academic youth in 
Zürich on 19 September 1946. http://archive.today/hSYZV (13 June 2014). 
1227
 See footnote 229. 
1228
 See section III.1.2. 
1229
 Healthcare market integration goes further than only benefiting border-crossing patients. By 
providing patients with the possibility to ‘opt-out’ of their national healthcare system, the Union puts 
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The recent political and economic developments did not serve the idea of free 
movement in Europe. Although the financial crisis manhandled each national 
economy, it did not affect the different Member States to the same extent.1230 
Nevertheless, the increased level of unemployment, the recession and other negative 
impacts of economic stress fed anti-migration and Euro-sceptical voices1231 with new 
arguments, and made some Member States question the very fundamentum of the 
Union such as free movement. Welfare tourism1232 has become an even more 
fashionable anti-EU slogan ever since.1233 Without going into great detail,1234 it must 
                                                                                                                                          
pressure on the Member States to constantly develop their own systems in order to keep their own and 
possibly attract foreign patients. 
1230
 On the impact of the economic crisis on the Union, see Europe's Economic Crisis Timeline. 
http://www.stratfor.com/topics/economics-and-finance/europes-economic-crisis (13 June 2014). 
1231
 See for instance Frank MARKOVIC (2014): Restrictions to Freedom of Movement for Labour: the 
Culture of Something for Nothing. http://www.europeanpublicaffairs.eu/restrictions-to-freedom-of-
movement-for-labour-the-culture-of-something-for-nothing/ (14 June 2014). 
The results of the European elections in spring 2014 indeed seem to prove this point and highlight 
“Europe's perennial dilemma between national sovereignty and continental integration.” 
http://www.stratfor.com/sample/analysis/integration-debate-gains-momentum-europe (13 June 2014). 
1232
 Various terms are widely used. In the Union, the expressions welfare, social or benefit tourism are 
most often used with a negative connotation to describe the phenomenon of non-active migrants 
accessing welfare or social benefits. Several terms connecting healthcare and tourism were dealt with 
in section II.3.2. supra. 
1233
 The free movement debate reached its zenith in 2013 – ironically, in the year dedicated to 
European citizenship – and today continues to raise major concerns EU-wide. In April 2013, four 
ministers of influential Member States addressed a joint letter to the Irish Presidency and “launched a 
strong attack regarding the freedom of movement of EU citizens.” Yves PASCOUAU (2013): Strong 
attack against the freedom of movement of EU citizens: turning back the clock. 
http://www.epc.eu/pub_details.php?pub_id=3491 (13 June 2014). 
The ministers claimed that migrant EU citizens from other Member States (whom they referred to as 
“immigrants”, an expression which is associated to citizens of third countries) “avail themselves of the 
opportunities that freedom of movement provides, without, however, fulfilling the requirements for 
exercising this right.” http://docs.dpaq.de/3604-130415_letter_to_presidency_final_1_2.pdf (13 June 
2014). Soon after the ‘letter incident,’ British Prime Minister David CAMERON announced that the UK 
was willing to impose restrictions on the free movement of citizens of newly accessed Member States 
and called upon other Member States to do the same. Among others, he proposed “to require a new 
country to reach a certain income or economic output per head before full free movement was 
allowed. Individual member states could be freed to impose a cap if their inflow from the EU reached 
a certain number in a single year.” David CAMERON (2013): Free movement within Europe needs to 
be less free. Financial Times, 26 November 2013, http://www.ft.com/intl/cms/s/0/add36222-56be-
11e3-ab12-00144feabdc0.html#axzz34YclbICt (13 June 2014). 
As a response, the Foreign Ministers of the Visegrad countries (all of them among the ‘new’ Member 
States which joined the Union in 2004) issued a joint statement pointing to data which show how 
beneficial the immigration of workers from Central and Eastern European countries was to the UK’s 
economy. http://register.consilium.europa.eu/doc/srv?l=EN&f=ST%2017395%202013%20INIT (18 
June 2014). 
It is worth mentioning that in Switzerland [although not an EU Member State, as it is a member of the 
European Free Trade Association (hereinafter also referred to as EFTA), citizens of Switzerland enjoy 
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be made clear that benefiting from legal opportunities and exercising rights in good 
faith,1235 conferred on citizens by the Union legislation, is neither abuse, nor fraud. 
 
When placing the question whether the Union is ready to develop a barrier-free 
European area for patients into the aforementioned political context, it is obvious 
that the circumstances are far from ideal. The huge differences among the Member 
States do not leave the European legislation intact: reaching compromises in a tense 
political atmosphere is getting more and more difficult. Therefore, European 
legislation currently tends to transform from inflexible, directly applicable legal tools 
into legal solutions which ensure more flexibility for the Member States in order to 
apply the rules to their own individual situations. However, providing the Member 
States with more freedom might result in less certainty for the citizens and greater 
inequalities among them.1236 At the same time, more freedom for the citizens triggers 
                                                                                                                                          
the same rights as the EEA nationals] on 9 February 2014 a referendum resulted in favour of re-
introducing restrictions on the free movement of workers between the European Union and 
Switzerland. 
In the heated political debate, the European Commission was forced into the position to defend the 
basic freedoms. In response to the offense, not only did both Commissioner László ANDOR (DG 
EMPL) and Commissioner Viviane REDING (DG JUSTICE) repeatedly commit themselves to the free 
movement principle as a non-negotiable basic value of the single market, but the Commission also 
provided factual evidence that the main driver of intra-EU migration is employment and that migrants 
from other Member States are not more intensive users of welfare than nationals. ICF GHK and 
Milieu (2013): A fact finding analysis on the impact on the Member States' social security systems of 
the entitlements of non-active intra-EU migrants to special non-contributory cash benefits and 
healthcare granted on the basis of residence. Prepared for DG Employment, Social Affairs and 
Inclusion. http://ec.europa.eu/social/main.jsp?langId=en&catId=89&newsId=1980&furtherNews=yes 
(13 June 2014), p. 203. 
See also another recent analysis on the topic prepared by the European Parliamentary Research 
Service: Eva-Maria POPTCHEVA (2014): Freedom of movement and residence of EU citizens. 
http://www.europarl.europa.eu/RegData/bibliotheque/briefing/2014/140808/LDM_BRI(2014)140808
_REV1_EN.pdf (18 June 2014). 
1234
 The concept of welfare tourism itself is a suitable subject for a doctoral thesis. It is thus beyond 
the scope of this dissertation; nevertheless, it holds great potential for future research. 
1235
 SPAVENTA points out by referring to the Joined cases C-151/04 and C-152/04 Criminal 
proceedings against Claude Nadin, Nadin-Lux SA (C-151/04) and Jean-Pascal Durré (C-152/04) 
[ECR 2005 Page I-11203] that “the Court refers to the possibility for a Member State to 'prevent 
certain of its nationals from attempting, under cover of the rights created by the [EC] Treaty, 
improperly to circumvent their national legislation or to prevent individuals from improperly or 
fraudulently taking advantage of provisions of Community law'.” Eleanor SPAVETA (2011): Comments 
on Abuse of Law and the Free Movement of Workers. In DE LA FERIA and VOGENAUER (2011), p. 316. 
1236
 I agree with MARKOVIC who warns that “(m)ore flexibility would only lead to reinforcement of the 
existing category of second class member states and EU citizens.” MARKOVIC (2014). In another 
vitriolic and remarkable piece of writing he also draws attention to the inequality of citizens in reality 
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the Member States’ fears of losing (cost) control. It is a very valuable task to find a 
fine balance between these two. 
Having said this, it is reasonable to look into the (1) legal, (2) economic and (3) 
political feasibility of the suggestions made in this dissertation in more detail. These 
aspects are not seperable from each other. On the contrary, in the European Union 
the various angles of feasibility create a thick net of requirements, interests and 
compromises which only a small portion of suggestions can get through. 
Nevertheless, these aspects are able to articulate what the potential threats are to the 
– so far purely theoretic – ideas drafted above. 
VI.4.1. Legal feasibility 
The legal feasibility of a suggestion is more or less determined by two issues: 
(1) whether the legislative body has competence to legislate the question at stake and 
(2) whether it is possible to integrate the new legislation into the existing legal tools 
or whether a new tool has to be created. 
 (1) In accordance with the principle of subsidiarity, in areas which do not fall 
within its exclusive competence, the Union shall act only if and in so far as the 
objectives of the proposed action cannot be sufficiently achieved by the Member 
States, […] but can rather, by reason of the scale or effects of the proposed action, 
be better achieved at Union level.1237 It was shown by the European Commission that 
legislating cross-border healthcare issues on EU level is necessary1238 and – by 
adopting the Patient Mobility Directive – the Member States seemed to accept that. 
However, the Union is entitled to act only within the limits of the competence 
conferred on it in the Treaty.1239 
                                                                                                                                          
confronted to legal equality. Frank MARKOVIC (2013): In Europe, We’re All Equal (Unless We’re 
Not). http://www.europeanpublicaffairs.eu/in-europe-were-all-equal-unless-were-not/ (14 June 2014). 
1237
 Article 5 (3) TEU. See footnote 229. 
1238
 European Commission: Commission Staff Working Document. Accompanying document to the 
Proposal for a Directive of the European Parliament and of the Council on the application of 
patients’rights in cross-border healthcare. Impact Assessment. SEC (2008) 2163, 2. 7. 2008, p. 16. 
1239
 See footnote 224. 
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It was thoroughly discussed that patient mobility is a complex legal issue which 
relates to several European domains1240 such as (a) public health,1241 (b) free 
movement of workers1242 and (c) free movement of services.1243 Thus, legislative 
tools in this field are rooted in different legal bases. Whereas Article 48 TFEU gives 
power to the Union to introduce only coordinating measures in the field of social 
security as are necessary to provide freedom of movement for workers,1244 Article 
114 (1) permits to adopt harmonising measures,1245 since healthcare services are 
considered internal market services within the meaning of the Treaty.1246 However, 
as pointed out earlier, most Member States have been far from impressed by this 
expansion of Union competence in healthcare,1247 which is considered as a 
cornerstone of national social security systems, thus belonging to the competence 
that remains with the Member States.1248 No wonder that each new proposal related 
to European healthcare legislation faces Member States’ suspicion and must be 
carefully tested against going beyond current EU competence. 
 
A major setback of an integrated European patient mobility legislation as detailed 
supra1249 is that it intends to build on the legacy of social security coordination while 
aiming to harmonise healthcare schemes to a certain extent. This means that some of 
the suggestions drafted above are legally feasible and could be inserted into today’s 
legislation on cross-border patient movements, whereas others lack an appropriate 
legal base. Without repeating what was said about the issue of legal competence,1250 
it can be stated that measures such as a maximalised timeframe defining undue 
delay,1251 unified administrative deadlines1252 or a standardised healthcare 
                                                 
1240
 On the issues related to competence under EU law, see section III.1.3. See also section III.2.2.3. 
1241
 See section III.1.3.2. 
1242
 See section III.1.3.3. 
1243
 See section III.1.3.4. 
1244
 See footnote 907. 
1245
 See footnotes 918 and 919. 
1246
 See section III.1.3.4. and especially footnotes 316 and 317. 
1247
 See footnote 921. 
1248
 See section III.1.3.1. and especially footnote 227. 
1249
 See section VI.1.2. 
1250
 See especially section III.2.2.3. 
1251
 See section III.2.2.1.C., especially footnotes 720 and 721. 
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package,1253 which would largely affect how national healthcare sytems are 
organised, cannot be carried out under the current Treaty provisions on Union 
competence in healthcare. In order to enable the Union to adopt legal tools in relation 
to these questions, the division of healthcare competence between Member States 
and the Union institutions should be changed. From a legal point of view, this can be 
done with the agreement of all the EU countries. The question whether this could be 
done in practice leads to the issue of the political feasibility, which is dealt with in 
the next section. 
 (2) In my view, clear and consistent European patient mobility legislation 
does not necessitate the creation of new legal tools but a considerable revision of 
what we have today. The Treaty, the Coordination Regulations and the Patient 
Mobility Directive all form an integral part of the body of the legislation. As to the 
Treaty, modification is only possible if political willingness supports the idea of a 
shift of competence in healthcare. However, the Regulations and the Directive could 
be altered by the EU institutions and numerous suggestions could be realised under 
their scope.1254 The most important point to keep in mind is that the Regulations and 
the Directive should complement each other without overlapping or conflicting rules. 
VI.4.2. Political feasibility 
 The European Union is an entity which seeks to reconcile concurring political 
interests: concurring interests of the individual Member States and concurring 
interests of the Member States and the Union. This does not only affect strategic 
political decision-making but law-making as well. The Treaties are the framework 
which set the balance: they are the result of a compromise between the Member 
States and lay down the boundaries of the Union’s actions. 
The supranational nature of the Union implies that legislative powers are delegated 
to the institutions of the EU which “are able to take adventage of their discretion to 
                                                                                                                                          
1252
 See section III.2.2.2.C. 
1253
 See section III.2.2.1.C. 
1254
 See sections VI.1.2 and VI.5. 
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pursue their own policy preferences – for example, by seeking to advance the process 
of European integration beyond the lowest-common-denominator preferences of the 
EU member governments.”1255 Thus, although the playbook of this ‘power game’ 
was composed at a certain point in time, European integration can be considered as a 
work in progress, the rules of which are subject to potential changes. 
 
The field of cross-border patient mobility is a prominent example of this ‘race for 
competence’. Whereas healthcare was and still is a severely protected area of 
national sovereignty, the EU gained footing step by step and was awarded certain 
competences in certain domains related to patient mobility, which recently peaked 
when healthcare services became included in the internal market, thus enabling the 
EU to adopt harmonising measures concerning the cross-border provision (and 
consumption) of such services.1256 As detailed supra, this process was predominated 
by the Court with the intense support of the Commission and the Parliament,1257 
while the Member States were quite hostile and qualified this activism as unwanted 
and unwarranted.1258 
Most of the suggestions made in this dissertation have a federalising tendency which 
requires further integration and extended harmonisation. The question is whether this 
is politically plausible: are the Member States ready and willing to transform more of 
their sovereignity to the Union in this field? After the experience of the adoption of 
the new pair of Coordination Regulations and the Patient Mobility Directive,1259 this 
scenario seems rather unlikely. It does not mean though that this cannot change. 
Nevertheless, a solid reform of the legislation cannot be carried out without political 
willingness. 
Each national goverment has its own agenda and its own preferences. Since 
healthcare is a mayor priority for the citizens, it is certainly high on goverments’ 
                                                 
1255
 Mark A. POLLACK (2003): The Engines of European Integration. Delegation, Agency and Agenda 
Setting in the EU. New York: Oxford University Press, p. 7. 
1256
 See section III.1.3.4. 
1257
 See footnote 379. 
1258
 See section III.2.2.3 and especially footnote 922. 
1259
 See section III.1.3.4. and especially footnotes 357 and 358. 
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agendas. As WALUS points out aptly, “[t]he social and financial implications of 
healthcare result in the organisation of healthcare becoming a highly sensitive 
political issue.”1260 Before turning to the financial implications, there are some 
important matters with regard to social implications which must be addressed here 
since they are and will likely remain the focal point of political debates both on 
national and European level. These issues are related to (1) solidarity, (2) equality 
and (3) freedom of choice. 
 
 (1) Solidarity has been a foundational element of European welfare societies. 
In social security schemes, the unity of the interests manifests itself as a risk-sharing 
mechanism: carrying the risks of individual social crises together, so that in case 
such events occur, each participant is protected. Since solidarity is a common value 
shared by the Member States, the Union also puts great emphasis on it.1261 
Solidarity means that we all take on the burden (or part of it) so that we can all 
benefit from the social coverage when in need. As such, it is closely linked to the 
financial arrangement of our national health systems and the need to ensure 
accessibility to all.1262 One might say though that people who get treatment in 
another state break the circle of national solidarity by taking out money from the 
national healthcare budget brought together by all. As it was elaborated supra,1263 
this is the argument most often raised by the Member States, namely that cross-
border patient movements threaten the financial equilibrium of their healthcare 
systems.1264 This danger affects the system as a whole, thus also those patients who 
stayed in their home country. This concern is valid and deserves due attention. 
(a) Firstly, it must be noted that although in certain cases heathcare services abroad 
indeed mean extra costs for the Member States,1265 no hard evidence suggests that 
the current scale of European patient mobility would have the potential to endanger 
                                                 
1260
 WALUS (2015: 53.). 
1261
 For instance, see title IV of CFREU. See also EuC (2006). 
1262
 EuC (2006). 
1263
 See Chapter IV. and section VI.2. 
1264
 See footnote 978. 
1265
 This occurs when the patient receives treatment under the scope of the Regulation and it is more 
expensive in the MS of treatment than it is in the MS of affiliation. 
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national healthcare budgets and/or healthcare planning.1266 Of course, a reform 
liberalising patient mobility might change this, but it is argued that this matter should 
be tackled by reforming the financing of cross-border healthcare1267 instead of 
restricting the free movement of patients. 
(b) Secondly, sometimes treatments can actually be cheaper abroad, in which case 
mobile patients do not take money away, but on the contrary save money for their 
national healthcare system and contribute to the utilisation of healthcare services. 
(c) Thirdly, although from the national healthcare systems’ point of view cross-
border healthcare is usually looked at as a challenge, it is an opportunity at the same 
time. Patient mobility concerns not only outgoing but also incoming patients. The 
latter offers Member States the opportunity to develop their schemes as to make them 
more attractive for incoming patients, which provides income for the national 
healthcare budget. However, it is very important to ensure that such profiting from an 
integrated European healthcare market does not impair the accessibility of healthcare 
services for the domestic patients. Incoming patients should not be prioritised over 
domestic patients but treated equally. 
(d) Fourtly, many of the suggestions made in this dissertation involve the 
development of national healthcare systems, which benefits each person, both 
patients who are treated at home and those treated abroad. 
 
 (2) Concerning cross-border patient movements, there are two dimensions of 
equality, which are important to the same extent: (a) equal treatment between 
nationals of the Member State (domestic patients) and non-nationals of the Member 
State (incoming patients); and (b) equal treatment between mobile patients (outgoing 
patients) and “sedentary” patients (who are treated in their home country). 
Whereas the EU legislation on patient mobility ensures equality in the first 
situation,1268 the solution to the second case is mainly left to the Member States. The 
EU itself acknowledges that health inequalities and problems related to equal access 
                                                 
1266
 See footnote 5. 
1267
 See section VI.2. 
1268
 See footnote 550. 
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is a concern of the Member States,1269 but has no competence to influence the legal 
status of insured persons under national social legislation. Moreover, certain features 
of EU legislation add to these inequalities.1270 
I find it essential to close these gaps by empowering patients, educating them about 
their entitlements and the possible ways of enforcement of their rights, and tackling 
inequalities within the EU legislation. 
 
(3) Lastly, the issue of patients’ freedom of choice must be addressed 
briefly.1271 As it was mentioned, the possibility to obtain healthcare abroad also 
comes with the risk that Member States may decide not to maintain and/or develop 
(certain branches of) their healthcare schemes but to send their citizens to another 
country instead where the treatment needed is provided for a lower price and/or more 
quickly and/or in a better quality.1272 Whereas this outsourcing technique might be 
acceptable in some cases,1273 from the patients’ point of view, entitlements in 
association with treatment abroad conferred on them by the Union legislation should 
remain an opportunity, not an obligation. The Union legislation on patient mobility 
does not serve the purpose in any way to force patients to receive healthcare outside 
their catchment area, but offers the legal possibility to do so. 
VI.4.3. Economic feasibility 
When a new idea appears, in the end, it always comes down to the question: 
who is going to pay for this? Although much has been said about the financials of 
                                                 
1269
 Equity relates to equal access according to need, regardless of ethnicity, gender, age, social status 
or ability to pay. EU health systems also aim to reduce the gap in health inequalities, which is a 
concern of EU Member States. EuC (2006). 
1270
 See examples of reveserve discrimination in footnotes 836 and 1022, and concerns related to 
financial inequalities in footnotes 1055-1057.  
1271
 This issue was already dealt with in section VI.2. 
1272
 See section VI.2. 
1273
 See footnotes 125 and 126. 
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cross-border patient mobility,1274 it seems reasonable to observe the de lege ferenda 
suggestions also from this perspective. 
The suggestions – although different in nature – have in common that they 
necessitate financial investments, especially the ones suggesting to set up new 
institutions and to develop national healthcare schemes this way or another. I see 
basically three options where the money required for the changes could come from: 
(1) the patients themselves; (2) the Union or (3) the Member States. 
 
 (1) It can be argued that if patients wish to use their entitlements, they have to 
pay. However, the example of the Patient Mobility Directive’s financial regime 
showed that putting the financial burden associated with cross-border treatments 
directly on the patients results in magnifying healthcare inequalities and – despite of 
the equal legal status – practically restricts the free movement of patients who cannot 
deal with such additional costs.1275 This is the main reason why I think it should be 
avoided that the costs of the reforms are pushed on the patients. Although there is a 
possibility to share these costs among all insured persons on the ground of 
solidarity,1276 one can rightfully raise the question why the patients who do not make 
a use of cross-border healthcare and who are taking part in financing their national 
healthcare systems are obliged to contribute to the development of such a European 
feature. So charging the patients – though it might be feasible – is not desireable. 
 
 (2) The European Union should certainly take part in financing such changes 
since they aim to upgrade the citizens’ status and improve free movement within the 
internal market. Its role is especially important in building out the institutional 
background on EU level. Resources should be ensured for the establishment of a 
European Coordination Centre of Cross-Border Healthcare,1277 a European Medical 
                                                 
1274
 See section IV. and section VI.2. 
1275
 See section IV.2.2. and IV.2.3. 
1276
 See section VI.2. 
1277
 See section VI.1.1. 
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Interpretation Agency,1278 a European Monitoring Centre for Healthcare 
Provision1279 and a European Healthcare Fund.1280 Taking into account the extensive 
EU administration, I think that budgetary sources can be found for these specialised 
purposes if the legislative bodies decide so. 
 
 (3) In my view, the Achilles’ heel of the economic feasibility is the national 
side of the issue. In a post-crisis era, when numerous Member States needed to cut 
back social security budgets, it might not seem realistic to expect Member States to 
be keen on making investments in order to enable patients to receive healthcare 
abroad. Especially those suggestions which have a harmonising tendency such as 
reducing administrative deadlines and setting a deadline for undue delay might 
require a considerable amount of money to be realised. It is highly questionable 
whether the national governments are able and willing to transfer money to these 
areas nowadays. By establishing a European Healthcare Fund,1281 the Member States 
could be provided financial support for these purposes. However, without any 
external financial sources the economic feasibility of some of the suggestions is – 
unfortunately – rather low for now. 
 
Although – as I see it – it is doubtful that a radical positive change in European 
cross-border healthcare policy is just around the corner, there are alternatives – as I 
showed – to the current politically burdened, incomplete freedom for patients. My 
suggestions – although maybe overambitious among the current political and 
economic circumstances – aim at such a positive shift towards a (more) Social 
Europe.1282 
                                                 
1278
 See section III.2.1.2. 
1279
 See section VI.1.2.1. 
1280
 See section VI.2. 
1281
 See section VI.2. 
1282
 It is promising that the new Commissioner responsible for healthcare issues, Vytenis 
ANDRIUKAITIS, envisages “a single market for health services” and said that “moving around Europe 
is taken for granted, so systems should be in place that can take care of everyone wherever they are.” 
Peter O’DONNELL (2014): Andriukaitis calls for an EU health system to take care of everyone, 
wherever they are. http://www.europeanvoice.com/article/andriukaitis-calls-for-an-eu-health-system-
to-take-care-of-everyone-wherever-they-are/ (5 December 2014). 
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Since such changes cannot be expected to happen overnight, the next section 
provides for a detailed step-by-step approach which offers various policy options 
with various sets of suggestions.  
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VI.5. POLICY OPTIONS 
 European legislation and policy making need to seek compromises. It is a 
very delicate task to reach agreements when there are so many different interests and 
discrepancies, aspects and circumstances to take into account. Solutions which might 
seem ideal from certain perspectives, might not be feasible or even acceptable from 
others. 
Therefore, in the light of the feasibility test carried out above, I herewith draft a 
number of policy options which are different in their aims and expected effects. I 
start with the one which requires the least modifications to the current legislation, 
and thus holds the highest level of feasibility, but – as a result – cannot tackle many 
of the issues this research revealed. After going though a few intermediary options, I 
end the list with the most radical one, which – under the state of affairs given today – 
is the least feasible, but – to my mind – has the biggest potential to create a (greater) 
freedom of movement for patients in Europe. (Figure 4 infra) 
 
Figure 4: Policy options 
 
    Radicality 
     
Feasibility     
 
Legal base 
Policy option No 0 
(Art. 168 TFEU) 
Policy option No 1 
(Art. 168 and 114 
TFEU) 
Policy option No 2 
(Art. 48, 168 and 
114 TFEU) 
Policy option No 3 
(currently no 
appropriate legal 
base) 
 
          
 
Source: the author’s own summary 
VI.5.1. Policy option No 0: Soft measures 
 I consider the first alternative the baseline. In the framework of this policy 
option the body of the legislation remains mostly intact: no measures which would 
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probably induce heated political discussions are included. Within the limits of the 
current competences of the Union, soft law incentives could give further stimuli to 
strengthening inter-institutional cooperation in the field of cross-border healthcare 
and to the improved enforcement of patients’ rights. Article 168 TFEU is a proper 
legal base for this. It provides that the Union must encourage cooperation between 
Member States in the field of healthcare in the effort to ensure a high level of human 
health protection.1283 
The open method of coordination (hereinafter also referred to as the OMC) in the 
field of healthcare might be a useful tool. However, its nature and practical outcome 
is widely debated.1284 Nevertheless, it is argued that the OMC has gained a growing 
importance, because “it commits Member States to work together in reaching joint 
goals without seeking to homogenize their inherited policy regimes and institutional 
arrangements.”1285 Without going into detail, it must be noted that I have doubts 
whether the OMC is capable of efficiently contributing to the development of the 
right to free movement for patients via its mutual learning technique. Nevertheless, it 
must be acknowledged that in fields such as healthcare sitting in the very heart of 
national sovereignity, this might be the easiest tool to move things forward. 
The Union institutions (especially the Commission and the Court) have a huge 
responsibility in enhancing and effectively controlling the just and universal 
application of the existing legal tools. The Commission should continue and even 
widen its information-spreading activities1286 in order to make sure that all parties 
involved are aware of their rights and obligations (patients, providers as well as 
                                                 
1283
 Article 168 (1)-(2) TFEU. See also Recital 1 of the Preamble of the Patient Mobility Directive. 
1284
 The details of this fascinating discussion go beyond the scope of this dissertation, but more 
information can be found on the scholarly opinions in Egidijus BARCEVICIUS, Timo WEISHAUPT and 
Jonathan ZEITLIN (2014): Assessing the Open Method of Coordination. Institutional Design and 
National Influence of EU Social Policy Coordination. Basingstoke: Palgrave Macmillan. Especially 
Jonathan ZEITLIN, Egidijus BARCEVICIUS, and J. Timo WEISHAUPT (2014): Institutional Design and 
National Influence of EU Social Policy Coordination: Advancing a Contradictory Debate. In 
BARCEVICIUS et al. (2014: 1-15). See also Mark FLEAR (2009): The Open Method of Coordination on 
health care after the Lisbon Strategy II: Towards a neoliberal framing? In Sandra KRÖGER (ed.): 
What we have learnt: Advances, pitfalls and remaining questions in OMC research. European 
Integration online Papers, Special Issue 1, Vol. 13 No 12. 
1285
 ZEITLIN et al. (2014: 4.). 
1286
 See section III.2.1.3. and especially footnote 526. 
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healthcare institutions) in cross-border healthcare situations. The Administrative 
Commission remains to serve as a forum for Member State representatives to discuss 
and solve problems of application and interpretation that occur concerning the 
coordination of (among others) sickness benefits.1287 
As said, this policy option aims to basically keep the status quo. There are some 
politically neutral steps, which in the long run might somewhat improve patients’ 
rights, but – in my opinion – their short-term impacts are highly limited. 
VI.5.2. Policy option No 1: No radical changes of legislation 
 One step further already involves the change of hard law, but no radical 
modifications to the legislation take place yet. The alteration of secondary legislation 
is usually somewhat problematic – especially when it comes to healthcare – but this 
second policy option requires relatively minor changes such as clarifying measures 
and the establishment of coordinating institutions on EU level. 
Among the issues waiting for clarification, the debate on the material scope of the 
Patient Mobility Directive should be resolved right in the Directive itself, because for 
now the different interpretations result in legal uncertainty.1288 In this respect, I stand 
by the opinion that the Directive should be applied to both planned and unplanned 
care. 
As to establishing coordinating institutions, I refer to the European Coordination 
Centre of Cross-Border Healthcare, which I made a plea for supra,1289 and which 
could also include a European Medical Interpretation Agency – as an alternative to 
or coordinating the interpretation and translation services provided by the national 
contact points.1290 These additions to the existing network of national contact points 
have the potential to considerably strengthen patients’ information rights and to 
tackle the language gap. This exercise could be carried out by way of modifying the 
                                                 
1287
 See footnote 36. Article 72 BR. 
1288
 See footnotes 150 and 616. 
1289
 See section VI.1.1. 
1290
 The problem of the language gap was dealt with in section III.2.1.2 and VI.1.1. 
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Patient Mobility Directive and inserting separate articles on both institutions. In these 
provisions, it must be stated exactly what the responsibilities of these institutions are 
and how they function. In order to avoid overlapping competences and 
malfunctioning, there must be a clear distribution of tasks between the national 
contact points and the central unit.1291 
These changes can be carried out within the current limits of EU competence – with 
Article 168 and 114 TFEU as legal bases, as they served as legal bases for the 
Directive. Although both financial implications and fear for red tape might result in 
objections from the Member States, I think agreement could still be reached in these 
questions. 
In my view, these measures definitely go further than the ones in the previous 
section, but not far enough to offer solutions for each problem which border-crossing 
patients might encounter. 
VI.5.3. Policy option No 2: Essential changes of secondary law 
 In my opinion, with this policy option, we cross the line of today’s feasibility. 
When one starts to think out of the box, and redraw the characteristics of legislation 
which has been in force without much change for decades, one must expect at least 
resistance. I think most of the de lege ferenda suggestions made in this chapter fit 
into this category. Although they are legally feasible – based on Article 48, 114 and 
168 TFEU – their political and economic feasibility is rather uncertain.1292 
Creating an integrated legal system by erasing the parallelisms, removing the prior 
authorisation requirement,1293 abolishing the distinction between planned and 
unplanned care,1294 extending the coordination regime to private providers1295 and 
rethinking the financing of cross-border treatments1296 are all elements of a 
                                                 
1291
 See section VI.1.1. 
1292
 See section VI.4. supra. 
1293
 See section VI.1.2.1. 
1294
 See section VI.1.2.2. 
1295
 See section VI.1.2.3. 
1296
 See section VI.2. 
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comprehensive reform of patient mobility legislation. Although none of these 
suggestions necessitate further harmonisation, but rather build on a renewed 
framework of coordination, they would break time-worn traditions and require a high 
level of openness and flexibility from the Member States. 
It has been proved in the past that Member States do not easily reach a common 
standpoint in social security coordination issues.1297 Even though unanimity is no 
longer required in the Council,1298 a gradual change of the Regulations will not 
happen without long and thorny negotiations. Even more so since e.g. the extension 
of the scope of coordination to private providers does not only concern the healthcare 
branch, but also addresses the question whether a modern coordination system can 
fill its role without including the elements of private social security schemes. It goes 
much further than cross-border healthcare.1299 Moreover, both prior authorisation and 
financing touch upon the issue of (cost) control, which is an extremely critical 
question for all the Member States.1300 
Under this policy option essential changes would redesign both the Regulations and 
the Directive. The Regulations would exclusively legislate the way insured persons 
can obtain healthcare services outside of the Member State of affiliation on behalf of 
the competent institution; whereas the Directive would contain all those rules which 
are closely connected to cross-border healthcare provision but fall outside the scope 
of the Regulations, such as the rules on the information rights of patients, 
institutional background and interinstitutional cooperation. 
In my opinion, this relatively radical reform would improve European healthcare 
legislation in a patient-friendly manner and enable more patients to exercise their 
cross-border healthcare rights. 
                                                 
1297
 The adoption of the third generation of Coordiantion Regulations illustrated the difficulties aptly. 
See section III.1.3.4. 
1298
 See footnote 262. 
1299
 There are trends which aim to eliminate the flaws of the coordination system. In case of 
supplementary pension schemes – which do fall outside of the scope of the Regulations – directives 
were adopted to safeguard the social rights of migrant workers. 
http://ec.europa.eu/social/main.jsp?catId=468&langId=en (27 March 2015). 
1300
 See sections VI.4.2. and VI.4.3. 
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VI.5.4. Policy option No 3: Reforming the whole legal landscape 
 This last policy option is purely an alternative for the future, since for now, it 
lacks vital components of feasibility: any measures which involve harmonisation of 
the national healthcare systems invades the autonomy of the Member States and goes 
against the current wording of the Treaty.1301 In order to launch any Union action 
aiming to harmonise any element of national healthcare systems, competence has to 
be conferred on the Union institutions beforehand. This would erode national 
sovereignty further, which makes this unlikely to happen any soon.1302 Nevertheless, 
giving the Union the legislative power to harmonise national healthcare schemes 
would raise European healthcare policy to new heights and open the door to a more 
integrated European healthcare market with more equal opportunities for each 
European patient. 
As pointed out above, stardardising national benefit packages,1303 creating maximum 
waiting times in relation to undue delay1304 and introducing universal, European 
deadlines in healthcare administration1305 go beyond Union competence, since they 
affect how healthcare services are defined, organised, delivered and financed in the 
individual Member States.1306 
Since harmonising attempts have not been supported in the past,1307 these changes 
seem implausible. Whether social Europe can ever go as far as to harmonise social 
security systems, is a question to be answered in the coming decades.  
                                                 
1301
 Article 168 (7) TFEU. 
1302
 See section VI.4.1. 
1303
 See section III.2.2.1.C. 
1304
 See section III.2.2.1.C., especially footnotes 720 and 721. 
1305
 See section III.2.2.2.C. 
1306
 See section VI.4.1. 
1307
 See footnote 358. 
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VI.6. CLOSING THOUGHTS 
To sum up, the ideal system I find desirable to create in the long run in the 
European Union in order to serve European (border-crossing) patients best is based 
on equality and is legislated in an integrated, consistent system of legal tools. The 
core entitlements are codified in the Coordination Regulations, which provide access 
to healthcare in another Member State without prior administrative obstacles, without 
the limitation of available providers and with a solidaritarian financing mechanism, 
which ensures the possibility to obtain medical treatment abroad to each insured 
person who wishes or needs to do so. The additional rules on enhanced cooperation, 
patients’ information rights and institutional background are incorporated in the 
second pillar of the legislation, namely the Patient Mobility Directive. 
To my mind, the mission of science is to visualise future solutions in response to the 
present day problems. Thus, although I am fully aware that today the suggestions I 
have made exist only on paper, I considered it to fall under the scope of the mission 
of my dissertation to offer solutions for the problems I found. After placing these 
solutions in the context of real-life circumstances, it seems that they might never see 
the light of day. However, this cannot be a reason not to formulate them in the hope 
that Europe might actually get there once. 
 
It must be kept in mind that the most core human value is at stake here: human life 
and the quality thereof. Healthcare is one of the fundaments which mankind’s 
wellbeing lies upon. The right to access to healthcare is not only a fundamental 
human right but one of the most basic needs of each person. Thus, individual needs 
and differences cannot be disregarded. On the contrary, in my understanding, in an 
ideal healthcare system, it is the very need of the patients which gradually defines the 
healthcare provision. 
The controversial issues of cross-border healthcare are just a few of the many 
examples of the dilemma that are rooted in the Member States’ fear to give up (more 
pieces of) their national sovereignty as opposed to the Union’s steady intention to 
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develop the internal market and deepen integration. It seems clear that without 
further harmonisation, the questions surrounding cross-border healthcare 
entitlements will remain unsolved for a long time. I firmly believe that the European 
institutions and the Member States must join forces and work towards a more 
integrated, solidarity-based, socially sensitive European Union, providing equal 
rights and opportunities for all. 
 
  
Table 17: Outcome of the research 
Theses Research questions Questions 
examined in Findings of the research De lege ferenda suggestions 
Thesis No1: Although European 
patients have the right to cross-
border healthcare, they 
encounter various difficulties – 
both of a non-legal and legal 
nature – that discourage or even 
deter them from using their 
rights. The current Union 
legislation on cross-border 
patient mobility has several 
defects due to which it cannot 
(fully) tackle the (potential) 
problems patients face when 
obtaining healthcare in a 
Member State other than their 
Member State of residence. 
(a) Do European patients 
have the right to obtain 
healthcare abroad? 
III.1. European patients do have the right to medical 
treatment outside of their Member State of 
residence, if they meet certain conditions. 
 
(b) Are European patients 
able to exercise their 
cross-border healthcare 
rights? 
III.2. European patients often face serious 
difficulties when (intending to) obtain(ing) 
healthcare in a Member State other than their 
Member State of residence. 
(1) Tackling the obstacles of a non-legal 
nature – creating a solid institutional 
background: creating an empowered 
network of national contact points and a 
central unit on supranational level 
coordinating the work of the network 
(2) Tackling the obstacles of a legal nature 
– revamping European patient mobility 
legislation: creating a consistent, 
integrated legal system, a fine-tuned, 
contradiction-free multi-level legislation 
(a) abolishing prior authorisation schemes 
while introducing an ICE clause for the 
protection of national healthcare schemes; 
(b) ceasing the distinction between 
planned and unplanned care; 
(c) extending the scope of the system to 
private healthcare providers. 
(c) Which are the 
obstacles of cross-border 
patient movements? 
Obstacles of a non-legal nature (geographic 
distance, linguistic barriers and the lack of 
information) and of a legal nature (legal 
complexity, administrative burden and 
financial burden) were identified in the course 
of the research. 
The issue of language gaps is not addressed on 
European level and the information rights of 
patients are not reassuringly settled. 
(d) Is the current legal 
framework capable of 
tackling these obstacles? 
The current Union legislation on cross-border 
patient mobility cannot fully cope with all of 
these problems. 
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Thesis Research questions Questions 
examined in Findings of the research De lege ferenda suggestions 
Thesis No2: Although Union 
law entitles European border-
crossing patients to claim the 
reimbursement of costs 
occurred in relation to cross-
border healthcare, the 
interaction between the different 
financial regimes which are in 
place in the European Union is 
often unclear and results in 
confusion on the patients’ side. 
Furthermore, the financial 
mechanism of the Patient 
Mobility Directive has the 
potential to increase inequality 
and results in a one-sided 
European patient mobility 
pattern. 
(a) Which alternatives do 
European patients have to 
cover the costs of medical 
treatment abroad? 
IV.1. Three methods of financing medical 
treatments abroad were identified (out-of-
pocket payments, payments through 
specialised insurance for travelling purposes 
and payments through healthcare schemes), 
but the dissertation focuses on the last one. 
(1) The Regulations’ financial mechanism 
as a default reimbursement regime based 
on full cost coverage and inter-institutional 
settlement of financing, since it ensures the 
highest protection for the patients 
(2) In order to compensate for the expected 
extra costs: setting up a European 
Healthcare Fund, thus basically leaving 
the national healthcare budgets intact 
(3) Various options to feed the Fund: 
(a) other European funds; 
(b) a universal contribution for each 
insured person in the EU; 
(c) cross-border healthcare ‘profit’ of the 
MSs. 
(b) Which conditions 
must be met in order to 
guarantee that cross-
border healthcare is 
covered by the patient’s 
health insurance? How 
can the patients get 
reimbursed under the 
current legal mechanisms 
in the European Union? 
IV.2. The most relevant discrepancies between the 
two routes of patient mobility concern the 
level of reimbursement and the mechanism of 
reimbursement. Both a possible financial 
burden due to a cost difference and a 
requirement of advancing medical costs are 
features of the Patient Mobility Directive 
which are especially disadvantageous for the 
patients. 
(c) How might the 
financial regimes affect 
European patient 
movements? 
The lack of a compensation mechanism 
affects particularly adversely the patients with 
low incomes affiliated to a healthcare scheme 
with relatively low tariffs. 
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Thesis Research questions Questions 
examined in Findings of the research De lege ferenda suggestions 
Thesis No3: European 
healthcare systems should 
ensure the timely provision of 
healthcare. Waiting times are 
thus relevant to cross-border 
healthcare provision in many 
aspects. If waiting times in a 
Member State exceed a certain 
period, patients should have the 
right to seek treatment in 
another Member State on the 
account of their healthcare 
insurance. Therefore, it is in the 
common interest of both the 
Member States and the patients 
to apply efficient methods that 
have the potential of reducing 
waiting times, such as eHealth 
applications. 
(a) How can eHealth 
applications contribute to 
European cross-border 
patient mobility? 
V.1. Although both patient mobility-related legal 
instruments incorporate ICT solutions to a 
certain extent and take steps towards the idea 
of barrier-free online applications for the 
benefit of European citizens, both the 
Coordination Regulations and the Patient 
Mobility Directive have had limited practical 
outcomes so far. 
(1) Further actions are required in order to 
safely integrate ICT technologies into the 
European healthcare systems and thus into 
European cross-border patient mobility 
mechanisms 
(2) The proposed integrated system of 
patient mobility legislation should be 
supported by ICT applications in various 
ways 
Source: the author’s own summary 
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Annex I. The main healthcare cases in front of the ECJ 
CASE LAW 
Details Main findings 
C-120/95 Decker 
Keywords TEC Article 30, 36; free movement of goods; validity of relevant 
Regulation-provision; restriction of free movement; possible grounds 
for justification; reimbursement of medical expenses 
(1) Determination of national social security schemes: sole 
competence of the MSs [21-23]; 
(2) Medical products are subject to the Treaty rules on the free 
movement of goods [24]; 
(3) Prior authorisation is considered a barrier to free movement [36]; 
(4) The restriction of free movement is not justifiable [39-45]. 
MSs involved Luxembourg national (competent MS), treatment in Belgium (MS of 
stay) 
Treatment requested pair of spectacles with corrective lenses 
Reason of refusal of the 
request for 
reimbursement 
lack of prior authorisation 
C-158/96 Kohll 
Keywords TEC Article 59, 60; free movement of services; validity of relevant 
Regulation-provision; restriction of free movement; possible grounds 
for justification; reimbursement of medical expenses 
(1) Determination of national social security schemes: sole 
competence of the MSs [17-19]; 
(2) Medical treatments are subject to the Treaty rules on the free 
movement of services [21]; 
(3) Prior authorisation is considered a barrier to free movement [35]; 
(4) The restriction of free movement is not justifiable [53]. 
MSs involved Luxembourg national (competent MS), treatment in Germany (MS of 
stay) 
Treatment requested orthodontic treatment for his minor daughter 
Reason of refusal of the 
request for 
reimbursement 
request for prior authorisation was rejected: not urgent treatment, it 
could be provided in the competent MS 
C-368/98 Vanbraekel 
Keywords Reg 1408/71 Article 22 and 36; TEC Article 59; refusal of 
authorisation subsequently declared unfounded; reimbursement of 
hospital treatment costs incurred in another MS; additional 
reimbursement 
(1) Medical service is considered a service within the meaning of the 
Treaty [40-41]; 
(2) If the refusal of the request for prior authorisation is declared 
unfounded, the patient is entitled for reimbursement of medical costs 
as if authorisation had been properly granted in the first place [34]; 
(3) Although the Coordination Regulation does not consists such a 
MSs involved Belgian national (competent MS), treatment in France (MS of stay) 
Treatment requested orthopaedic surgery 
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Reason of refusal of the 
request for 
reimbursement 
request for prior authorisation was rejected: the request was not 
adequately supported 
provision, it follows from the Treaty rules on free movement that in 
case the reimbursement provided according to the tariffs of the 
competent MS is more beneficial for the patient than the 
reimbursement provided according to the tariffs of the MS of stay, 
additional reimbursement covering the difference shall be granted to 
the patient [53]. 
C-157/99 Geraets-Smits & Peerbooms 
Keywords TEC Article 59, 60; benefit in kind system; normal in the professional 
circles; necessary treatment; reimbursement of hospital treatment costs; 
(1) Determination of national social security schemes: sole 
competence of the MSs [44-46]; 
(2) Medical activities fall within the scope of the Treaty rules on the 
free movement of services [53-55]; 
(3) The essential characteristic of remuneration lies in the fact that it 
constitutes consideration for the service in question, therefore, the 
fact that hospital treatments are directly financed by the sickness 
insurance funds does not remove them from the sphere of services 
within the meaning of the Treaty [56-58]; 
(4) Prior authorisation is considered a barrier to free movement [69]; 
(5) In case of hospital treatment, a requirement that the assumption of 
costs provided in another MS must be subject to prior authorisation 
appears to be a measure which is both necessary and reasonable [76-
80]; 
(6) The system of prior authorisation must satisfy the requirement of 
proportionality [82] and be based on objective, non-discriminatory 
criteria which are known in advance [90]; 
(7) The requirement that the treatment must be regarded as normal is 
construed to the effect that authorisation cannot be refused on that 
ground where it appears that the treatment concerned is sufficiently 
tried and tested by international medical science [98]; 
(8) Authorisation can be refused on the ground of lack of medical 
necessity only if the same or equally effective treatment can be 
obtained without undue delay in the MS of affiliation [103-104]. 
MSs involved Geraets-Smits: Dutch national (competent MS), treatment in Germany 
(MS of stay); 
Peerbooms: Dutch national (competent MS), treatment in Austria (MS 
of stay) 
Treatment requested Geraets-Smits: multidisciplinary treatment of Parkinson’s disease; 
Peerbooms: special intensive therapy using neurostimulation. 
Reason of refusal of the 
request for 
reimbursement 
Geraets-Smits: reimbursement was denied: satisfactory and adequate 
treatment available in NL, no medical necessity justifying the 
treatment; besides, the specific clinical method was not regarded as 
normal treatment within the professional circles concerned; 
Peerbooms: request for reimbursement was refused: adequate treatment 
available in NL, experimental nature of the therapy; 
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C-385/99 Müller-Fauré &Van Riet 
Keywords TEC Art. 59 and 60; benefit in kind system; reimbursement of medical 
costs; requirement of prior authorisation; distinction between hospital 
and non-hospital treatment 
(1) Medical services fall within the scope of Treaty rules on free 
movement of services [38-40]; 
(2) The prior authorisation system constitute, both for insured 
persons and service providers, a barrier to freedom to provide 
services [44]; 
(3) A requirement that the assumption of costs, under a national 
social security system, of hospital treatment provided in a Member 
State other than that of affiliation must be subject to prior 
authorisation appears to be a measure which is both necessary and 
reasonable [81]; 
(4) The prior administrative authorisation scheme cannot legitimise 
discretionary decisions taken by the national authorities; must be 
based on objective and  non-discriminatory criteria which are known 
in advance; must likewise be based on a procedural system which is 
easily accessible and capable of ensuring that a request for 
authorisation will be dealt with objectively and impartially within a 
reasonable time and refusals to grant authorisation must also be 
capable of being challenged in judicial or quasi-judicial proceedings 
[84-85]; 
(5) A requirement that the assumption of costs, under a national 
social security system, of non-hospital treatment provided in a 
Member State other than that of affiliation must be subject to prior 
authorisation cannot be justified [108]. 
MSs involved Müller-Fauré: Dutch national (competent MS), treatment in Germany 
(MS of stay); 
Van Riet: Dutch national (competent MS), treatment in Belgium (MS 
of stay) 
Treatment requested Müller-Fauré: dental treatment involving the fitting of six crowns and 
a fixed prosthesis on the upper jaw; 
Van Riet: arthroscopy and ulnar reduction 
Reason of refusal of the 
request for 
reimbursement 
Müller-Fauré: reimbursement was denied: insured persons are entitled 
only to treatment itself and not to reimbursement of any related costs, 
except in exceptional circumstances; 
Van Riet: reimbursement was denied: there was no emergency nor any 
medical necessity, appropriate treatment was available in the NL 
within a reasonable period. 
C-326/00 Ioannidis 
Keywords Reg 1408/71 Article 31 and 36; Reg 574/72 Article 31 and 93; TEC 
Article 56, 59 and 60; hospital treatment of a pensioner abroad; 
distinction between immediate and planned treatment; chronic disease; 
(1) Pensioners fall within the provisions of Reg 1408/71 [32]; 
(2) The system established by Article 31 of Reg 1408/71 must be 
distinguished from that laid down by Article 22(1)(a) of that 
regulation [39]; 
(3) That provision cannot be interpreted as meaning that the 
enjoyment of the benefits in kind is limited solely to cases where the 
MSs involved Greek national (competent MS), treatment in Germany (MS of stay) 
Treatment requested catheterisation with a heart catheter 
Reason of refusal of the request for E 112 form was refused: the illness had not manifested 
Gabriella BERKI: Cross-border patient mobility: The legal framework of obtaining healthcare abroad within the European Union – a patients’ 
perspective 
379 
 
request for 
reimbursement 
itself sufficiently suddenly and it could have been properly treated in 
the MS of affiliation 
treatment provided has become necessary because of a sudden illness 
[40-41]; 
(4) Article 31 does not provide for a system of authorisation with 
respect to the provision of the benefits in kind which it guarantees to 
pensioners and members of their families staying in a Member State 
other than the State in which they reside [42-43]. 
C-56/01 Inizan 
Keywords Validity and interpretation of Article 22 of Reg 1408/71; TEC Article 
49 and 50; reimbursement of the costs of hospital treatment abroad; 
(1) Medical services fall within the scope of Treaty rules on free 
movement of services [16]; 
(2) Reg. 1408/71 helps to facilitate the free movement of insured 
persons and the cross-border provision of medical services between 
Member States by guaranteeing access to treatment in the other 
Member States on conditions of reimbursement as favourable as 
those enjoyed by insured persons [21]; 
(3) Insured persons are thus granted rights which they would not 
otherwise have since those rights cannot by definition be guaranteed 
to those persons under the legislation of the competent Member State 
alone [22]; 
(4) The second condition of Art. 22 (2) is not satisfied whenever it is 
apparent that treatment which is the same or equally effective for the 
patient can be obtained without undue delay in the Member State of 
residence [44-46]; 
(5) A requirement that the assumption of costs, under a national 
social security system, of hospital treatment abroad must be subject 
to prior authorisation appears to be a measure which is both 
necessary and reasonable and may be justified in the light of one of 
the derogations under the Treaty [56]. 
MSs involved French national (competent MS), treatment in Germany (MS of stay) 
Treatment requested multidisciplinary pain treatment 
Reason of refusal of the 
request for 
reimbursement 
request for reimbursement was refused: the requirements of the second 
subparagraph of Article 22 (2) of Reg 1408/71 had not been satisfied 
C-8/02 Leichtle 
Keywords TEC Article 49 and 50; reimbursement of ancillary expenses; (1) Medical services fall within the scope of Treaty rules on free 
movement of services [28]; 
(2) Treaty rules preclude the application of any national rule making 
MSs involved German national (competent MS), treatment in Italy (MS of stay) 
Treatment requested health cure 
Gabriella BERKI: Cross-border patient mobility: The legal framework of obtaining healthcare abroad within the European Union – a patients’ 
perspective 
380 
 
Reason of refusal of the 
request for 
reimbursement 
request for reimbursement was rejected: the condition that the 
treatment is absolutely necessary on account of the greatly increased 
prospects of success had not been met 
reimbursement of medical costs incurred abroad subject to a system 
of prior authorisation where it is apparent that such a system deters, 
or prevents, insured persons from approaching providers of medical 
services established abroad, save where the barrier to the freedom to 
provide services to which it gives rise is justifiable under one of the 
derogations allowed by the TEC [30]; 
(3) Ancillary expenses such as expenditure incurred on board, 
lodging, travel, visitors’ tax and the making of a final medical report 
in connection with a health cure taken in another Member State form 
an integral part of the treatment [33-36]. 
C-145/03 Keller 
Keywords Reg. 1408/71 Article 3, 19 and 22; reimbursement of costs of hospital 
treatment outside the Member State of affiliation; distinction between 
necessary care and planned care; scope of E111 and E112 
(1) The fact that the treatment was given outside Community territory 
is not enough to exclude the application of the coordination 
regulations, since the decisive criterion for their applicability is that 
the insured person concerned is affiliated to a social security scheme 
of a Member State [38]; 
(2) The achievement of the objective pursued by Reg 1408/71 Article 
22(1)(a)(i) and (c)(i) is based on a sharing of responsibilities between 
the competent institution and the institution of the MS of stay [47]; 
(3) Once it has agreed, by issuing a Form E 111 or Form E 112, that 
one of its insured persons may receive medical treatment outside the 
competent MS, the competent institution obliged to accept and 
recognise the findings and choices of treatment made by the doctors 
authorised by the institution of the MS of stay [50]; 
(4) The person concerned, covered by a Form E 111 or E 112, cannot 
be required to return to the competent MS to undergo a medical 
examination there, when doctors authorised by the institution of the 
MS of stay consider that his state of health requires urgent vitally 
necessary treatment [56]. 
MSs involved German national, resident in Spain (competent MS); treatment in 
Switzerland (MS of stay) 
Treatment requested treatment for a malignant tumour of the nose, the nasal cavity, the eye 
socket and the base of the skull, with ramification in the intercranial 
space 
Reason of refusal of the 
request for 
reimbursement 
application for reimbursement was refused: reimbursement of the costs 
of medical treatment provided in a non-member country required 
expressed prior authorisation 
C-372/04 Watts 
Keywords TEC Article 49 and 50; Reg. 1408/71 Article 22; freedom to provide (1) National health services financed by the State fall within the 
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services; reimbursement of medical expenses incurred in another MS; 
NHS; 
scope of Article 49 EC [36]; 
(2) In determining whether a treatment which is the same or equally 
effective for the patient is available without undue delay from an 
establishment on the territory of the MS of residence, the competent 
institution cannot base its decision exclusively on the existence of 
waiting lists on that territory without taking account of the specific 
circumstances of the patient’s medical condition [63]; 
(3) The second subparagraph of Reg 1408/71 Article 22(2) must be 
interpreted as meaning that, in order to be entitled to refuse to grant 
the authorisation on the ground that there is a waiting time for 
hospital treatment, the competent institution is required to establish 
that that time does not exceed the period which is acceptable on the 
basis of an objective medical assessment of the clinical needs of the 
person concerned in the light of all of the factors characterising his 
medical condition at the time when the request for authorisation is 
made or renewed, as the case may be [79]; 
(4) Where the delay arising from such waiting lists appears to exceed 
in the individual case concerned an acceptable period having regard 
to an objective medical assessment of all the circumstances of the 
situation and the clinical needs of the person concerned, the 
competent institution may not refuse the authorisation sought on the 
grounds of the existence of those waiting lists [120]. 
MSs involved UK national (competent MS), treatment in France (MS of stay) 
Treatment requested hip replacement operation 
Reason of refusal of the 
request for 
reimbursement 
request for a form E 112 was refused: the second condition set out in 
the second subparagraph of Reg. 1408/71 Article 22(2) was not 
satisfied; repeated request refused again: the waiting period for 
treatment locally had been reduced, so there was no undue delay 
C-466/04 Acereda Herrera 
Keywords Reg 1408/71 Article 22; Reimbursement of ancillary costs related to 
hospital treatment abroad; 
(1) Reg 1408/71 Article 22(1)(c) and (2) and Article 36 of must be 
interpreted as meaning that authorisation by the competent institution 
for an insured person to go to another Member State in order there to 
receive hospital treatment appropriate to his medical condition does 
not confer on such a person the right to be reimbursed by the 
competent institution for the costs of travel, accommodation and 
subsistence which that person and any person accompanying him 
incurred in the territory of that latter Member State, with the 
MSs involved Spanish national (competent MS), treatment in France (MS of stay) 
Treatment requested hospital treatment 
Reason of refusal of the 
request for 
reimbursement 
claim for reimbursement of the travel, accommodation and subsistence 
costs was refused 
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exception of the costs of accommodation and meals in hospital for 
the insured person himself [39]. 
C-444/05 Stamatelaki 
Keywords TEC Article 49; reimbursements of costs related to treatment in a 
private hospital abroad; 
(1) Medical services fall within the scope of Treaty rules on free 
movement of services [19]; 
(2) Article 49 EC precludes legislation of a Member State, such as 
that at issue in the main proceedings, which excludes all 
reimbursement by a national social security institution of the costs 
occasioned by treatment of persons insured with it in private 
hospitals in another Member State, except those relating to treatment 
provided to children under 14 years of age [38]. 
MSs involved Resident of Greece (competent MS); treatment in the United Kingdom 
(MS of stay) 
Treatment requested treatment in a private hospital 
Reason of refusal of the 
request for 
reimbursement 
application for reimbursement of the medical costs was dismissed: the 
cost of treatment in private hospitals abroad is not paid for, except 
where it relates to children under 14 years of age 
C-211/08 EU Comm. v Spain 
Keywords TEC Article 49; hospital care needed during a temporary stay in 
another MS; necessary care; complementary reimbursement in case of 
unscheduled treatment; 
(1) The applicability Reg. 1408/71 Article 22 does not mean that 
Article 49 EC cannot apply at the same time. The fact that national 
legislation may be in conformity with Regulation No 1408/71 does 
not have the effect of removing that legislation from the scope of the 
provisions of the EC Treaty [45]; 
(2) With regard to an insured person whose travel to another Member 
State is for reasons relating to tourism or education, for example, and 
not to any inadequacy in the health service to which he is affiliated, 
the rules of the Treaty on freedom of movement offer no guarantee 
that all hospital treatment services which may have to be provided to 
him unexpectedly in the MS of stay will be neutral in terms of cost. 
Given the disparities between one MS and another in matters of 
social security cover and the fact that the objective of Reg. 1408/71 is 
to coordinate the national laws but not to harmonise them, the 
conditions attached to a hospital stay in another MS may, according 
to the circumstances, be to the insured person’s advantage or 
disadvantage [61]. 
MSs involved Complainant: French national, resident in Spain (competent MS); 
hospital treatment in France (MS of stay) 
Treatment requested hospital treatment needed during a temporary stay in another MS 
Reason of refusal of the 
request for 
reimbursement 
- 
C-512/08 EU Comm. v France 
Keywords TEC Article 49; medical treatment proposed in another MS and (1) Medical services fall within the scope of Treaty rules on free 
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requiring the use of major medical equipment; requirement of prior 
authorisation concerning planned treatment provided in another MS; 
movement of services [30]; 
(2) Regardless of the setting, hospital or otherwise, in which it is 
intended to be installed and used, it must be possible for the major 
medical equipment to be the subject of planning policy, with 
particular regard to quantity and geographical distribution, in order to 
help ensure throughout national territory a rationalised, stable, 
balanced and accessible supply of up-to-date treatment, and also to 
avoid, so far as possible, any waste of financial, technical and human 
resources [37]; 
(3) While it is true that, in accordance with the settled case-law of the 
Court, mere administrative practices, by their nature alterable at will 
by the authorities, cannot be regarded as constituting proper 
fulfilment of Treaty obligations, the lack of any evidence of 
administrative practices contrary to European Union law does not 
give rise to a situation that deprives persons of the rights conferred by 
Article 49 EC [67]. 
MSs involved - 
Treatment requested - 
Reason of refusal of the 
request for 
reimbursement 
- 
C-173/09 Elchinov 
Keywords TEC Article 49; Reg 1408/71 Article 22 (2); reimbursement of costs of 
hospital treatment received abroad; 
(1) Medical services fall within the scope of Treaty rules on free 
movement of services [36]; 
(2) The applicability of Reg 1408/71 Article 22 to a certain situation 
does not mean that provisions on the freedom to provide services and 
TEC Article 49 , cannot apply at the same time [38]; 
(3) A national rule excluding, in all cases, payment for hospital 
treatment given in another MS without prior authorisation deprives 
the insured person of reimbursement from the competent institution 
in respect of such treatment, even though all other conditions for such 
reimbursement to be made are met, does not satisfy the requirement 
of proportionality, thus, it constitutes an unjustified restriction on the 
freedom to provide services [45-47]; 
(4) It is for each MS to decide which medical benefits are reimbursed 
by its own social security system. To that end, the MS concerned is 
MSs involved Bulgarian national (competent MS); treatment in Germany (MS of 
stay) 
Treatment requested the treatment for the eye consisting of the attachment of radioactive 
applicators or proton therapy 
Reason of refusal of the 
request for 
reimbursement 
Request for a form E 112 refused: the  treatment concerned was not 
one of the benefits provided for by the national legislation and 
reimbursed by national social security fund 
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entitled to list precisely treatments or treatment methods or to state 
more generally the categories or types of treatments or treatment 
methods [59]; 
(5) Reg 1408/71 Article 22(2) precludes the national bodies called 
upon to rule on an application for prior authorisation from presuming 
that the hospital treatment which cannot be given in the MS of 
residence is not included in the benefits for which reimbursement is 
provided for by the legislation of that State and, conversely, that the 
hospital treatment included in those benefits can be given in that MS 
[73]. 
C-490/09 EU Comm. v Luxembourg 
Keywords TEC Article 49; Non-reimbursement of costs relating to laboratory 
analyses and tests carried out in another MS; 
(1) Medical services are services within the meaning of TEC Article 
49 and that the latter precludes the application of any national rules 
which have the effect of making the provision of services between 
MSs more difficult than the provision of services within the same MS 
[16]; 
(2) The conditions on which social security benefits are granted by 
the MS of affiliation remain enforceable with respect to patients 
receiving care in another MS, but they must be neither discriminatory 
nor an obstacle to freedom of movement of persons [21, 52]. 
MSs involved Complainants: insured in Luxembourg (competent MS); treatment in a 
MS other than  the Grand Duchy of Luxembourg (in one of the cases in 
Germany – MS of stay) 
Treatment requested blood analyses and ultrasound examinations 
Reason of refusal of the 
request for 
reimbursement 
reimbursement of the costs refused: 
Case No 1: the relevant sickness insurance fund was not authorised to 
effect the reimbursement in the absence of a scale of charges for the 
benefit; 
Case No 2: the conditions laid down for reimbursement of those 
analyses could not be fulfilled. 
C‑255/09 EU Comm. v Portugal 
Keywords TEC Article 49; Reg 1408/71 Article 22; reimbursement of non-
hospital medical costs paid by the patient 
(1) Medical services supplied for consideration fall within the scope 
of the provisions on the freedom to provide services [46]; 
(2) The provision of medical services does not cease to be a provision 
of services for the purposes of Article 49 EC simply because, after 
paying the foreign provider for the care received, the insured person 
subsequently seeks reimbursement of the related costs through a 
MSs involved - 
Treatment requested - 
Reason of refusal of the 
request for 
- 
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reimbursement social security system [51]; 
(3) Although the rules at issue do not directly prevent the patients 
concerned from approaching providers of medical services 
established in another Member State, the prospect of financial loss in 
the event of refusal by the national health system to meet the medical 
costs as a result of an unfavourable administrative decision is per se 
clearly liable to deter them [62]. 
C-255/13 I v Health Service Executive 
Keywords Reg 987/2009 Article 11; definition of ‘residence’ and ‘stay’; person 
compelled to remain in the MS of treatment for 11 years as a result of 
his illness; 
(1) Coordination Regulations use the concept of residence as one of 
the connecting factors for the determination of the legislation 
applicable [42]; 
(2) In the course of determining where the habitual centre of one’s 
interests is to be found, account should be taken in particular of the 
family situation of the person concerned; the reasons which have led 
him to move; the length and continuity of his residence; the fact 
(where this is the case) that he is in stable employment; and his 
intention as it appears from all the circumstances [45]; 
(3) Since the determination of the place of residence of a person who 
is covered by insurance for social security purposes must be based on 
a whole range of factors, the simple fact that such a person has 
remained in a Member State, even continuously over a long period, 
does not necessarily mean that he resides in that State [48]. 
MSs involved Irish national (competent MS); treatment in Germany (MS of stay) 
Treatment requested specialist medical care for a rare, bilateral infarct to the brain stem, 
resulted in severe quadriplegia and loss of motor function, and for a 
genetic mutation affecting the composition of the blood 
Reason of refusal of the 
request for 
reimbursement 
The HSE refused to grant a further renewal of E 112 form on the 
ground that Mr I could not be considered to be habitually resident in 
Ireland. 
C-268/13 Petru 
Keywords Reg 1408/71 Article 22 (2); planned care; lack of medication and basic 
medical supplies and infrastructure; 
(1) The authorisation required cannot be refused if the same or 
equally effective treatment cannot be given in good time in the 
Member State of residence of the person concerned [31]; 
(2) In order to determine whether treatment which is equally effective 
for the patient can be obtained in due time in the Member State of 
residence, the competent institution is required to have regard to all 
the circumstances of each specific case and to take due account not 
only of the patient’s medical condition at the time when authorisation 
MSs involved Romanian national (competent MS; treatment in Germany (MS of stay) 
Treatment requested operation involving open heart surgery to replace the mitral valve and 
insert two stents 
Reason of refusal of the 
request for 
reimbursement 
The request was refused on the grounds that there was no indication in 
the general practitioner’s report that the healthcare service sought, 
which qualified as basic healthcare, could not be provided in a medical 
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establishment in Romania within a reasonable length of time in the 
light of Ms Petru’s current state of health and the course of the disease. 
is sought and, where appropriate, of the degree of pain or the nature 
of the patient’s disability which might, for example, make it 
impossible or extremely difficult for him to carry out a professional 
activity, but also of his medical history [32]; 
(3) One of the circumstances that the competent institution is 
required to take into account may, in a specific case, be the lack of 
medication and basic medical supplies and infrastructure. Such a 
lack, in the same way as the lack of specific equipment or particular 
expertise, make it impossible for the same or equally effective 
treatment to be provided in good time in the Member State of 
residence [33]; 
(4) Authorisation necessary under Article 22(1)(c)(i) of Reg 1408/71 
cannot be refused where it is because of a lack of medication and 
basic medical supplies and infrastructure that the hospital treatment 
concerned cannot be provided in good time in the insured person’s 
Member State of residence [36]. 
Source: author’s own based on the decisions of the ECJ 
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Annex II. Grounds of justification for maintaining a prior authorisation system in 
the case law of the ECJ 
Ground of 
justification Decision of the ECJ 
References to the relevant 
decisions 
Control of the 
healthcare 
expenditure 
NOT ACCEPTED – Aims of a purely 
economic nature cannot justify a 
barrier to the fundamental principle of 
the free movement. 
C-398/95 SETTG, 23; C-120/95 
Decker, 37-39; C-158/96 Kohll, 37, 41; 
C-385/99 Müller-Fauré and Van Riet, 
72 
Financial balance 
of the social 
security system 
NOT ACCEPTED – Reimbursement 
at a flat rate of the cost of medical 
goods purchased or treatment obtained 
in another Member States has no effect 
on the financing or balance of the 
social security system. 
C-120/95 Decker, 39-40; C-158/96 
Kohll, 38-42; C-368/98 Vanbraekel, 
47; C-157/99 Geraets-Smits and 
Peerbooms, 72; C-385/99 Müller-
Fauré and Van Riet, 73-74; C-145/03 
Keller, 68; C-372/04 Watts, 103; C-
444/05 Stamatelaki, 30; C-173/09 
Elchinov, 42; C-490/09 Commission v 
Luxemburg, 43 
Protection of 
public health 
NOT ACCEPTED – Since the 
conditions for taking up and pursuing 
regulated professions have been 
harmonised on Community level, the 
provision of a treatment by a healthcare 
provider established in another 
Member State provides guarantees 
equivalent to those provided by a 
healthcare practitioner established in 
the national territory. 
C-215/87 Schumacher, 20; C-62/90 
Commission v Germany, 18; C-120/95 
Decker, 41-45; C-158/96 Kohll, 44-49; 
C-145/03 Keller, 50, 52; C-444/05 
Stamatelaki, 37 
Maintaining a 
balanced medical 
and hospital 
service open to all 
NOT ACCEPTED – The rules on 
prior authorisation are not necessary to 
provide a balanced medical and 
hospital service accessible to all. 
C-158/96 Kohll, 50-52; C-368/98 
Vanbraekel, 48-49; C-157/99 Geraets-
Smits and Peerbooms, 73-74; C-385/99 
Müller-Fauré and Van Riet, 67; C-
372/04 Watts, 104-105; C-444/05 
Stamatelaki, 31-32; C-173/09 Elchinov, 
42; C-490/09 Commission v 
Luxemburg, 43 
Essential 
characteristics of 
benefit-in-kind 
systems 
NOT ACCEPTED – The evidence 
and arguments submitted to the Court 
do not show that removal of the 
requirement that sickness insurance 
funds grant prior authorisation to their 
insured to enable them to receive 
health care, in particular other than in a 
hospital, provided in a Member State 
C-385/99 Müller-Fauré and Van 
Riet,105-108; C-372/04 Watts, 74, 122; 
C-490/09 Commission v Luxemburg, 
18, 46 
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other than that of affiliation would 
undermine the essential characteristics 
of the sickness insurance scheme of 
any Member State with a benefit in 
kind system. 
Hospital planning ACCEPTED – A requirement that the 
assumption of costs, under a national 
social security system, of hospital 
treatment provided in another Member 
State must be subject to prior 
authorisation appears to be a measure 
which is both necessary and 
reasonable. 
C-157/99 Geraets-Smits and 
Peerbooms, 76, 78-80; C-385/99 
Müller-Fauré and Van Riet, 77-81; C-
56/01 Inizan, 56; C-145/03 Keller, 62; 
C-372/04 Watts, 108-110; C-173/09 
Elchinov, 43; C-512/08 Commission v 
France, 33-42 
Use of major 
medical 
equipment 
ACCEPTED – Regardless of the 
setting, hospital or otherwise, in which 
it is intended to be installed and used, it 
must be possible for the major medical 
equipment to be the subject of planning 
policy, with particular regard to 
quantity and geographical distribution, 
in order to help ensure throughout 
national territory a rationalised, stable, 
balanced and accessible supply of up-
to-date treatment, and also to avoid, so 
far as possible, any waste of financial, 
technical and human resources. 
C-512/08 Commission v France, 37 
Source: author’s own based on the decisions of the ECJ 
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Annex III. Benefits of eHealth 
eHealth empowers citizens: 
• to be better informed about disease prevention and alternative lifestyle strategies for self-help 
• to have confidence in an informed service delivering care according to a model more closely 
related 
• to their needs and perceptions 
• to exercise reasonable levels of choice, which will help them to take a more active role in 
managing their own health 
eHealth empowers the patients: 
• to gain access to information about diagnosis, treatment and best practice so they can be better 
informed about their responsibilities 
• to be more informed in their interactions with clinical professionals so they can be more aware 
of actions they can take in self-help 
• to interact with healthcare services that can provide the sort of consumer-oriented services 
available to them in other sectors 
eHealth empowers the clinicians and healthcare professionals: 
• to provide a more informed and patient-oriented service 
• to gain access to information on patients, treatment and diagnosis from other parts of the care 
process, and in particular, to improve the interfaces between primary and secondary care 
• to access information (about best practice, treatment profiles and drug interactions) to support 
their clinical activity 
• to ensure that other institutions are able to share information and gain access to it at the point of 
care 
• to gain access to disease management information which will improve their ability to deal with 
chronic care 
• to develop new clinical applications to improve their workflow and clinical business processes 
• to use valuable supporting information outside their own environment without increasing 
administrative workload 
Health enables managers and regulators 
• to secure access to accurate information generated at the point of care which is needed for 
operational and management functions 
• to generate cross-business information and share this information with those who are authorised 
to access and use it 
• to make better use of available resources through more efficient context-sensitive scheduling and 
ordering 
• to work more effectively with supporting businesses utilising cost-efficient supply chain support 
• to have greater confidence in information available for performance management where this 
information is generated at the point of care 
• to assess real activity and true performance characteristics in order to better understand the 
implications of new demands and priorities 
• to understand and articulate current societal changes in terms that are actually relevant to 
deliverers of care 
Source: HINE eHealth 2003 Report quoted by WILSON et al (2004: 29.) 
